10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2023

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-04321

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

(Exact name of registrant as specified in its charter)

Delaware	88-6187397
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
375 Park Avenue, 9th Floor, New York, NY	10152
(Address of principal executive offices)	(Zip Code)

(212) 478-9200

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
None	N/A	N/A

Securities registered pursuant to Section 12(g) of the Act:

Class S common shares of beneficial interest, par value $0.01 per share

Class D common shares of beneficial interest, par value $0.01 per share

Class I common shares of beneficial interest, par value $0.01 per share

(Title of class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.Yes o No x

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	x	Smaller reporting company	o
		Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.     o

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. o

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x

As of December 31, 2023, there was no established public market for any class of the registrant’s common shares of beneficial interest.

As of February 29, 2024, the registrant had outstanding 259,478, 241,439, and 14,938,167 Class S, Class D and Class I common shares of beneficial interest, respectively.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s proxy statement to be filed with the U.S. Securities and Exchange Commission pursuant to Regulation 14A in connection with the registrant’s 2024 Annual Meeting of Shareholders, which will be filed subsequent to the date hereof, are incorporated by reference into Part III of this Form 10-K. Such proxy statement will be filed with the U.S. Securities and Exchange Commission not later than 120 days following the end of the registrant’s fiscal year ended December 31, 2023.

Table of Contents

PART I
Item 1.	Business	2
Item 1A.	Risk Factors	21
Item 1B.	Unresolved Staff Comments	57
Item 1C	Cybersecurity	58
Item 2.	Properties	59
Item 3.	Legal Proceedings	59
Item 4.	Mine Safety Disclosures	59
PART II
Item 5.	Market for Registrant's Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities	60
Item 6.	Reserved	61
Item 7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	62
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	81
Item 8.	Consolidated Financial Statements and Supplementary Data:	83
	Report of Independent Registered Public Accounting Firm	84
	Consolidated Statements of Assets and Liabilities as of December 31, 2023 and 2022	85
	Consolidated Statements of Operations for the Year Ended December 31, 2023 and for the Period from February 8, 2022 (inception) through December 31, 2022	86
	Consolidated Statements of Changes in Net Assets for the Year Ended December 31, 2023 and for the Period from February 8, 2022 (inception) through December 31, 2022	87
	Consolidated Statements of Cash Flows for the Year Ended December 31, 2023 and for the Period from February 8, 2022 (inception) through December 31, 2022	88
	Consolidated Schedules of Investments as of December 31, 2023 and December 31, 2022	89
	Notes to Consolidated Financial Statements	97
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	124
Item 9A.	Controls and Procedures	125
Item 9B.	Other Information	126
Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	126
PART III
Item 10.	Directors, Executive Officers and Corporate Governance	126
Item 11.	Executive Compensation	126
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters	126
Item 13.	Certain Relationships and Related Transactions, and Director Independence	126
Item 14.	Principal Accountant Fees and Services	126
PART IV
Item 15.	Exhibit and Financial Statement Schedules	127
Item 16.	Form 10-K Summary	129
Signatures		130

PART I.

In this Annual Report, except where the context suggests otherwise:

•the terms “we,” “us,” “our,” and “Fund,” refer to Nuveen Churchill Private Capital Income Fund, together with any consolidated subsidiaries;

•the term “the Adviser” or “Churchill” refers to Churchill Asset Management LLC, a Delaware limited liability company, which serves as our investment adviser, pursuant to an investment advisory agreement, dated March 31, 2022 (as amended on August 3, 2022, January 10, 2023, and August 3, 2023, the “Advisory Agreement”);

•the term “the Sub-Adviser” or “Nuveen Asset Management” refers to Nuveen Asset Management, LLC, a Delaware limited liability company, which acting through its leveraged finance division, manages certain of our Liquid Investments (as described below) pursuant to a sub-advisory agreement, dated March 31, 2022 (as amended on August 3, 2022, the “Sub-Advisory Agreement”);

•the term “Nuveen” refers to Nuveen, LLC;

•the term “Administrator” refers to Churchill BDC Administration LLC (f/k/a Nuveen Churchill Administration LLC), a Delaware limited liability company, which serves as our administrator pursuant to an administration agreement, dated March 31, 2022 (the “Administration Agreement”).

•the term “committed capital” refers to capital committed to client accounts in the form of equity capital commitments from investors, as well as committed, actual or expected financing from leverage providers (including asset-based leveraged facilities, notes sold in the capital markets or any capital otherwise committed and available to fund investments that comprise assets under management). For purposes of this calculation, both drawn and undrawn equity and financing commitments are included. In determining committed capital in respect of funds and accounts that utilize internal asset-based leverage (e.g., levered funds and CLO warehouses), committed capital calculations utilize a leverage factor that assumes full utilization of such asset-based leverage in accordance with the account’s target leverage ratio as disclosed to investors. In determining committed capital in respect of Churchill’s management of an institutional separate account for its parent company, TIAA (as defined below), (i) committed capital in respect of private equity fund interests includes commitments made by TIAA to such strategy over the most recent 10 years, and the net asset value of all such investments aged more than 10 years, and (ii) committed capital in respect of equity co-investments, junior capital investments, structured capital investments, and senior loans includes the commitment made by TIAA for the most recent year, and the outstanding principal balance of investments made in all preceding years. In determining committed capital in respect of Churchill’s management of institutional separate accounts for third party institutional clients, committed capital includes the aggregate commitments made by such third party clients, so long as such commitments remain subject to recycling. Thereafter, outstanding principal balance is used in respect of any applicable commitment (or portion thereof) that has expired. Due to the foregoing, committed capital figures may be adjusted over the course of a financial period, based on accounts transitioning the calculation methodology from capital commitment to invested capital.

FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on our current expectations and estimates, our prospective portfolio investments, our industry, our beliefs and opinions, and our assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

•our future operating results;

•our business prospects and the prospects of our portfolio companies;

•the dependence of our future success on the general economy and its impact on the industries in which we invest;

•changes in the markets in which we invest and changes in financial and lending markets generally;

•the impact of a protracted decline in the liquidity of credit markets on our business;

•the impact of increased competition;

•an economic downturn and its impact on the ability of our portfolio companies to operate and the investment opportunities available to us;

•interest rate volatility, including the replacement of LIBOR with alternative rates and rising interest rates, could adversely affect our results, particularly if we elect to use leverage as part of our investment strategy;

•the impact of supply chain constraints and labor difficulties on our portfolio companies and the global economy;

•the elevated level of inflation, and its impact on our portfolio companies and on the industries in which we invest;

•the impact of geopolitical conditions, including the ongoing conflict between Ukraine and Russia and ongoing war in the Middle East, and its impact on financial market volatility, global economic markets, and various sectors, industries and markets for commodities globally, such as oil and natural gas;

•our contractual arrangements and relationships with third parties;

•the valuation of our investments in portfolio companies, particularly those having no liquid trading market;

•actual and potential conflicts of interest with Churchill and its affiliates;

•the ability of our portfolio companies to achieve their objectives;

•the use of borrowed money to finance a portion of our investments;

•the adequacy of our financing sources and working capital;

•the timing of cash flows, if any, from the operations of our portfolio companies;

•the ability of Churchill to locate suitable investments for us and to monitor and administer our investments and Nuveen Asset Management to manage certain of our Liquid Investments;

•the ability of Churchill to attract and retain highly talented professionals;

•our ability to qualify for and maintain our tax treatment as a regulated investment company (a “RIC”) and operate as a business development company (“BDC”);

•the impact of future legislation and regulation on our business and our portfolio companies;

1

•our ability to successfully invest capital raised in our offering;

Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of these assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. Important assumptions include our ability to originate new loans and investments, certain margins and levels of profitability and the availability of additional capital. In light of these and other uncertainties, the inclusion of a projection or a forward-looking statement in this report should not be regarded as a representation by us that our plans and objectives will be achieved. These forward-looking statements apply only as of the date of this report. Moreover, we assume no duty and do not undertake to update the forward-looking statements, except as otherwise provided by law.

ITEM 1. BUSINESS

We were formed on February 8, 2022 as a Delaware statutory trust. We are an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, we have elected to be treated for U.S. federal income tax purposes, and intend to qualify annually thereafter, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

On March 31, 2022, prior to our election to be regulated as a BDC under the 1940 Act, Teachers Insurance and Annuity Association of America (“TIAA”) contributed certain portfolio investments to the Fund and SPV I and, in connection therewith, the Fund entered into the Note (as described below) and issued Class I shares to TIAA.

We are offering on a continuous basis up to $2.5 billion of common shares of beneficial interest (“Common Shares”). On May 17, 2022, the Securities and Exchange Commission (the “SEC”) granted an exemptive order permitting the Fund to offer multiple classes of Common Shares and to impose varying sales loads, asset-based service and/or distribution fees and early withdrawal fees. The Fund intends to offer to sell any combination of three classes of Common Shares, Class S shares, Class D shares and Class I shares, with a dollar value up to the maximum offering amount. The share classes have different ongoing shareholder servicing and/or distribution fees. None of the share classes being offered will have early withdrawal fees. The purchase price per share for each class of Common Shares will equal our net asset value (“NAV”) per share as of the effective date of the monthly share purchase date. Nuveen Securities, LLC, as the intermediary manager for the offering (the “Intermediary Manager”), will use its best efforts to sell shares, but is not obligated to purchase or sell any specific amount of shares in the offering. As of June 1, 2023 (the “Escrow Break Date”), the Fund had satisfied the minimum offering requirement and the Fund’s Board of Trustees (the “Board”) authorized the release of proceeds from escrow.

We are externally managed by Churchill, which is responsible for sourcing potential investments, conducting due diligence on prospective investments, analyzing investment opportunities, structuring investments and monitoring our portfolio on an ongoing basis. The Adviser is registered as an investment adviser with the SEC under the Investment Advisers Act of 1940, as amended (the “Advisers Act”), The Adviser has engaged its affiliate, Nuveen Asset Management, acting through its leveraged finance division, to manage certain of its Liquid Investments (as defined below) pursuant to the Sub-Advisory Agreement. Under the Administration Agreement, we have agreed to reimburse the Administrator for the allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including, but not limited to, our allocable portion of the costs of compensation and related expenses of our Chief Financial Officer and his staff. The Adviser, Nuveen Asset Management, and the Administrator are all affiliates and subsidiaries of Nuveen, a wholly owned subsidiary of TIAA.

Our investment objective is to generate attractive risk-adjusted returns primarily through current income and, secondarily, long-term capital appreciation, by investing in a diversified portfolio of private debt and equity investments in U.S. middle market companies owned by leading private equity firms. We define “middle market companies” as those with $10 million to $250 million of earnings before interest, taxes, depreciation and amortization (“EBITDA”).

The Investment Adviser — Churchill Asset Management LLC 

Churchill serves as an investment adviser to the Fund pursuant to an investment advisory agreement (the “Investment Advisory Agreement”). In addition to serving as an investment adviser to the Fund, Churchill manages other middle-market investment strategies for affiliated entities such as TIAA, its ultimate parent company, as well as for third-party institutional investors, private funds and accounts, Nuveen Churchill Direct Lending Corp., a BDC, and NC SLF Inc., a closed-end fund registered under the 1940 Act.

2

Churchill managed (directly or as a sub-adviser) approximately $50 billion of committed capital across its integrated capital solutions platform as of January 1, 2024. Churchill managed a range of vehicles, including BDCs, a registered closed-end investment company, separate accounts, structured finance products, and private funds investing in private middle market leveraged loans, subordinated debt, equity related securities, private equity, limited partner commitments, and related strategies. Of its approximately $50 billion of committed capital across the platform, Churchill manages approximately $13 billion in limited partner capital commitments to approximately 300 private equity funds on behalf of TIAA’s general account and third-party investors. Churchill offers a full array of solutions across the capital structure, benefiting from the investment guidance of its principals who have a long history of disciplined investing in the middle market across various economic cycles. With over $30 billion of committed capital dedicated to middle market private credit as of January 1, 2024, Churchill provides us with the ability to invest in larger transactions while limiting concentration in our portfolio. While it is managed and operated independently of TIAA and Nuveen, Churchill benefits from the scale, capital and resources of its parent companies.

The Investment Committee

All investment decisions for the Fund require the unanimous approval of the members of an investment committee dedicated to management of the Fund’s portfolio (the “Investment Committee”) comprised of Churchill Founders, Kenneth Kencel and Randy Schwimmer, together with Mathew Linett and the head of its Private Equity and Junior Capital Solutions team, Jason Strife. The Investment Committee is responsible for reviewing and approving all investment opportunities for the Fund, which are sourced by Churchill’s separate and distinct investment committees dedicated to senior loan investments and junior capital opportunities, respectively.

Churchill provides investment advisory and management services to the Fund. Under the terms of the Investment Advisory Agreement, the Adviser: (i) identifies, evaluates and negotiates the structure of investments (including performing due diligence on prospective portfolio companies); (ii) closes and monitors investments; and (iii) determines the securities and other assets to be purchased, retained or sold.

The Investment Sub-Adviser — Nuveen Asset Management LLC 

Nuveen Asset Management conducts its high yield corporate and leveraged loan investment activities through its leveraged finance platform (“Nuveen Leveraged Finance”), offering investors access to high yield, leveraged loan and alternative credit strategies that draw upon Nuveen’s size and scale. Nuveen provides a comprehensive range of outcome-focused investment solutions designed to secure the long-term financial goals of institutional and individual investors. As the investment management business of TIAA, Nuveen has approximately $1.2 trillion in assets under management, with its affiliates offering deep expertise across a comprehensive range of traditional and alternative investments through a wide array of vehicles and customized strategies.

Investment Advisory Agreement

The Board, including all of the trustees who are not “interested persons” (as defined in Section 2(a)(19) of the 1940 Company Act) of the Fund (the “Independent Trustees”), has approved the Investment Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such trustees as required by, the 1940 Act. The Board, including all of the Independent Trustees, approved an amendment to the Investment Advisory Agreement on each of August 3, 2022, January 10, 2023 and August 3, 2023 to address comments issued by securities regulators from various states in connection with the Fund’s “blue sky” review of its offering.

Base Management Fee

Under the Investment Advisory Agreement, the Fund has agreed to pay the Adviser an annual management fee as well as an incentive fee based on its investment performance. The management fee will be payable monthly in arrears at an annual rate of 0.75% of the value of the Fund’s net assets as of the beginning of the first calendar day of the applicable month. For the first calendar month in which the Fund has operations, net assets will be measured as the beginning net assets as of the date on which the Fund breaks escrow. In addition, the Adviser has agreed to waive its management fee until the expiry of twelve months from the Escrow Break Date.

Incentive Fee

The incentive fee will consist of two components that are independent of each other, with the result that one component may be payable even if the other is not: (i) incentive fee on income and (ii) an incentive fee on capital gains. Each part of the incentive fee is outlined below.

3

Incentive Fee Based on Income

The portion based on income is based on Pre-Incentive Fee Net Investment Income Returns. “Pre-Incentive Fee Net Investment Income Returns” means, as the context requires, either the dollar value of, or percentage rate of return on the value of net assets at the end of the immediate preceding quarter from, interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Fund receives from portfolio companies) accrued during the calendar quarter, minus our operating expenses accrued for the quarter (including the management fee, expenses payable under the Administration Agreement, and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred shares, but excluding the incentive fee and any shareholder servicing and/or distribution fees).

Pre-Incentive Fee Net Investment Income Returns include, in the case of investments with a deferred interest feature (such as OID, debt instruments with PIK interest and zero coupon securities), accrued income that has not yet been received in cash. Pre-Incentive Fee Net Investment Income Returns do not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The impact of expense support payments and recoupments (as discussed further below) are also excluded from Pre-Incentive Fee Net Investment Income Returns.

Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of the Fund’s net assets at the end of the immediate preceding quarter, is compared to a “hurdle rate” of return of 1.50% per quarter (6% annualized).

The Fund will pay the Adviser an incentive fee quarterly in arrears with respect to Pre-Incentive Fee Net Investment Income Returns in each calendar quarter as follows:

•No incentive fee based on Pre-Incentive Fee Net Investment Income Returns in any calendar quarter in which our Pre-Incentive Fee Net Investment Income Returns do not exceed the hurdle rate of 1.50% per quarter (6% annualized);

•100% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns with respect to that portion of such Pre-Incentive Fee Net Investment Income Returns, if any, that exceeds the hurdle rate but is less than a rate of return of 1.76% (7.06% annualized). The Fund refers to this portion of Pre-Incentive Fee Net Investment Income Returns (which exceeds the hurdle rate but is less than 1.76%) as the “catch-up.” The “catch-up” is meant to provide the Adviser with approximately 15% of our Pre-Incentive Fee Net Investment Income Returns as if a hurdle rate did not apply if this net investment income exceeds 1.76% in any calendar quarter; and

•15% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns, if any, that exceed a rate of return of 1.76% (7.06% annualized). This reflects that once the hurdle rate is reached and the catch-up is achieved, 15% of all Pre-Incentive Fee Net Investment Income Returns thereafter are allocated to the Adviser.

These calculations will be pro-rated for any period of less than three months and adjusted for any share issuances or repurchases during the relevant quarter.

The Adviser has agreed to waive the incentive fee based on income until the expiry of twelve months from the Escrow Break Date.

Incentive Fee Based on Capital Gains

The second component of the incentive fee, the capital gains incentive fee, will be payable at the end of each calendar year in arrears. The amount payable will equal:

•15% of cumulative realized capital gains from inception through the end of such calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid incentive fee on capital gains as calculated in accordance with U.S. GAAP.

Each year, the fee paid for the capital gains incentive fee will be net of the aggregate amount of any previously paid capital gains incentive fee for all prior periods. The Fund will accrue, but will not pay, a capital gains incentive fee with respect to unrealized appreciation because a capital gains incentive fee would be owed to the Adviser if the Fund was to sell the relevant investment and realize a capital gain. In no event will the capital gains incentive fee payable pursuant to

4

the Investment Advisory Agreement be in excess of the amount permitted by the Advisers Act including Section 205 thereof.

The fees that are payable under the Investment Advisory Agreement for any partial period will be appropriately prorated.

Sub-Advisory Agreement

The Board, including all of the Independent Trustees, approved the Advisory Agreement and the amendments to the Advisory Agreement on August 3, 2022, January 10, 2023, and August 2, 2023 to address comments issued by securities regulators from various states in connection with the Fund’s “blue sky” review of its offering. The Sub-Adviser manages certain of the Liquid Investments pursuant to the Sub-Advisory Agreement. The Adviser has general oversight over the investment process on behalf of the Fund and manages the capital structure of the Fund, including, but not limited to, asset and liability management. The Adviser also has ultimate responsibility for the Fund’s performance under the terms of the Advisory Agreement. The Adviser will pay the Sub-Adviser monthly in arrears, 0.375% of the daily weighted average principal amount of the Liquid Investments managed by the Sub-Adviser pursuant to the Sub-Advisory Agreement.

Expense Support Agreement

The Fund entered into an expense support and conditional reimbursement agreement (the “Expense Support Agreement”) with the Adviser. Nuveen Alternative Holdings, an affiliate of the Adviser may pay (or cause one or more of its affiliates to pay) certain expenses of the Fund, provided that no portion of the payment will be used to pay any interest expenses of the Fund and/or shareholder servicing fees of the Fund (each, an “Expense Payment’). Such Expense Payment will be made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from the Adviser to pay such expense, and/or by an offset against amounts due from the Fund to the Adviser or its affiliates. For more information on the Expense Support Agreement see Note 5 to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K.

Employees

We do not have any employees. We depend on the investment expertise, skill and network of business contacts of the senior investment professionals of Churchill, who evaluate, negotiate, structure, execute, monitor and service our investments in accordance with the terms of the Investment Advisory Agreement.

Potential Competitive Strengths

We believe that our competitive advantages stem from long-standing market presence, significant lending capacity, scale to support attractive investments, strong relationships with private equity firms, differentiated sourcing capabilities, and ability to compete on factors other than pricing. Further, we believe that Churchill has built a reputation of professionalism and collaboration that positions us to be a preferred capital provider to support the needs of private equity sponsors. We believe Churchill has the scale, platform, and unique capabilities to effectively manage our U.S. private credit investment strategy, offering investors the following competitive advantages:

Scaled Platform with Extensive Private Credit Expertise

Since 2006, Churchill’s senior leadership team has worked together to establish a cycle-tested track record in direct lending and private capital investments, and today, we believe that Churchill is one of the largest managers of private capital investments. The Churchill team has deep middle market investment expertise, providing customized financing solutions to private equity-backed middle market companies across the capital structure, including senior loans, junior capital, equity co-investments and similar equity-related securities. Overseeing approximately $50 billion in committed capital as of January 1, 2024 and deploying nearly $10 billion in the year ended December 31, 2023 across its multiple investment strategies, Churchill is one of the most active direct lenders in the U.S. middle market. With over 150 dedicated professionals in New York, Charlotte, Chicago, Los Angeles and Dallas, Churchill operates a fully integrated investment platform with advanced infrastructure, risk management, investor relations, finance, operations, and legal support functions. The scale of Churchill’s platform provides us with the ability to invest in larger transactions with limited concentration in our portfolio. We believe that the breadth and depth of Churchill’s expertise, coupled with its long history of disciplined investment across industries and various economic cycles, provides differentiated strengths when sourcing and evaluating large and complex investment opportunities.

5

Unique Benefits from Alignment with Nuveen and TIAA

Churchill benefits substantially from the scale and resources of its parent company, Nuveen, and Nuveen’s ultimate parent company, TIAA. Nuveen, as the investment management division of TIAA, is one of the world’s largest asset managers with $1.2 trillion assets under management as of December 31, 2023, of which approximately $114 billion is invested in private capital. TIAA, a leading provider of secure retirement and outcome-focused investment solutions to millions of people and thousands of institutions, is the third largest private debt investor in the world. Together, TIAA and Nuveen have been investors in the private debt and equity markets for over 50 years.

Leveraging the scale, capital and resources of Nuveen’s platform, Churchill is able to focus on its middle market investment expertise. Specifically, Nuveen’s distribution capabilities from its approximately 180 person U.S. wealth coverage team enable Churchill to prioritize originating, underwriting and managing its high quality, diversified portfolios while relying on Nuveen’s retail and wealth distribution platform.

TIAA is an important part of Churchill’s committed capital base, as Churchill manages TIAA’s general account allocation to U.S. middle market private capital side-by-side with Churchill’s third-party investors. This provides for a unique alignment of interests that we believe causes Churchill to think and act like a long-term investor in the asset class.

Strong Private Equity Relationships and Fund Investments Drive Proprietary Origination Opportunities

Churchill believes it has established itself as a highly value-additive capital provider and partner of choice for leading private equity firms given its ability to provide a full array of scaled solutions across the capital structure. Churchill’s dedicated loan origination team has cultivated deep, long-standing relationships with over 400 middle market private equity firms across diversified strategies, industry focus and U.S. geographies. Of approximately $50 billion of committed capital as of January 1, 2024, approximately $13 billion is comprised of committed capital that supports a carefully constructed portfolio of primary limited partner capital commitments made by TIAA and certain other institutional investor clients of Churchill to approximately 300 private equity funds primarily focused on the U.S. middle market. This long-standing and growing portfolio of limited partner capital commitments positions Churchill as one of the largest and most active private equity fund investment managers focused on the core U.S. middle market. We believe Churchill’s role as a valuable limited partner and its fully integrated partnership approach helps drive differentiated origination opportunities often on an early look, first access basis. Additionally, we believe Churchill’s deep network of private equity relationships and representation on hundreds of private equity fund advisory boards further enhances Churchill’s proprietary deal sourcing advantages while remaining highly selective of investment opportunities without compromising on its stringent underwriting standards or transaction terms. In this capacity, Churchill is able to structure and negotiate transactions directly with the private equity sponsor, driving efficiencies and stronger relationships, often leading to the sponsor’s decision to select Churchill as a lead lending partner for subsequent transactions as well. Churchill’s sourcing strategy is not, however, entirely centered on leading every transaction as it also partners with other middle market lenders on attractive investment opportunities, helping to drive a more stable and reliable capital deployment pace in the middle market.

Many of Churchill’s senior management and investment team members have held senior positions at other middle market lending firms and continue to maintain strong relationships with numerous active participants in the segment. These long-established relationships help source incremental investment opportunities and contribute to the high levels of deal flow with approximately 1,000 first-lien senior secured debt and unitranche loan investment opportunities reviewed per year. In contrast, peer lenders who focus primarily on lead agency roles often can find themselves in direct competition with one another adversely impacting deal flow and selectivity. Churchill’s dual sourcing model emphasizes long-term partnerships, ensuring that Churchill can focus exclusively on investment credit quality. We believe we are well-positioned to take advantage of the demand for capital in the middle market, particularly from private equity sponsored middle market companies.

Ability to Deliver Scaled and Flexible Capital Solutions

We believe Churchill’s ability to provide a variety of capital solutions and to invest opportunistically across the capital structure is a key differentiator and highly valued by private equity sponsors. Churchill is able to provide a comprehensive set of customized capital solutions to meet the needs of the borrower. With respect to senior loans, the investment team can opportunistically pivot between traditional first-lien senior secured loans and unitranche loans, as well as offer delayed draw term loans, in order to deliver the most attractive risk-adjusted returns. Further, the investment team’s partnership approach offers a strong value proposition to private equity firms, as one of a handful of middle market lenders with the ability to commit up to $500 million per transaction. This flexibility and the ability to deliver a fully

6

underwritten solution ensures that Churchill has exposure to a wide range of transactions enabling it to be highly selective with respect to investment opportunities. Additionally, with respect to junior capital opportunities, the investment team has the ability to pivot between junior secured or unsecured debt instruments. Having the latitude to pivot across capital solutions differentiates Churchill compared to most other direct lenders in situations when capital requirements change during a transaction and thereby has positioned it as the preferred capital partner for private equity sponsors.

Disciplined and Rigorous Investment Approach with Comprehensive Portfolio Monitoring

Selectivity, broad industry diversification and rigorous underwriting standards are key to Churchill’s investment philosophy. Churchill provides us with a large and diverse pipeline of middle market investment opportunities, enhancing our ability to be highly selective and to maintain stringent underwriting standards and a diversified portfolio across sectors. Churchill employs a multi-step selection process when reviewing each potential investment opportunity that includes analyzing business prospects, thoroughly reviewing historical and pro forma financial information, meeting and discussing the business with the management team and private equity sponsor, understanding sponsor investment strategy and risk considerations, evaluating industry diligence to determine market position and competitive advantages, and assessing the track record of the private equity sponsor and its historical investments in other businesses.

Using a disciplined and cycle-tested investment approach, Churchill’s investment teams seek to limit credit losses through comprehensive due diligence of portfolio company fundamentals, terms and conditions and covenant packages. Following the closing of each investment, the investment professionals who initially underwrite the opportunity typically lead the hands-on portfolio monitoring effort to ensure continuity and the ability to respond efficiently to any portfolio company requests. Churchill implements a regimented credit monitoring system that involves a variety of discussions, analyses and reviews by its investment professionals on a daily, weekly, monthly, and quarterly basis, depending on the assessed monitoring need, which we believe enables Churchill to proactively detect and identify potential challenges at portfolio companies. See “ – Investment Process Overview” below.

Proven Leadership Team with Extensive Private Capital Experience Across Economic Cycles

Churchill is led by industry veterans who bring on average more than 25 years of experience in middle market investing, the majority of whom have worked together for over a decade and have demonstrated an ability to prudently invest across various economic cycles at Churchill and its predecessor entities. Churchill was founded by current senior management team members Kenneth Kencel, Randy Schwimmer and Christopher Cox (the “Churchill Founders”), who have together unanimously approved all of the over 800 senior loans made by Churchill and its predecessor entities since 2006. This core management team has been strengthened with the addition of several additional senior executives from Churchill’s predecessor entities and its ultimate parent company, TIAA. Among these additional senior management colleagues are Mathew Linett and Shai Vichness, who comprise the remaining members of the investment committee dedicated to senior loan opportunities alongside the Churchill Founders. Additionally, in connection with its affiliation with TIAA, Churchill assumed management of TIAA’s private equity and junior capital investment management platform, resulting in a unified middle market private capital asset management firm that capitalizes on opportunities throughout the U.S. sponsor-backed middle market.

Investment Strategy

We seek to meet our investment objective by primarily investing in directly originated debt and equity investments in U.S. middle market companies owned by leading private equity firms. We expect to primarily invest in first-lien senior secured debt and first-out positions in unitranche loans (collectively “Senior Loan Investments”), as well as junior debt investments, such as second-lien loans, unsecured debt, subordinated debt and last-out positions in unitranche loans (including fixed- and floating-rate instruments and instruments with payment-in-kind (“PIK”) income) (“Junior Capital Investments”). Senior Loans Investments and Junior Capital Investments may be originated alongside smaller related common equity positions to the same portfolio companies. Our portfolio will also include larger, stand-alone equity co-investments in private-equity backed companies that may or may not be originated alongside or separately from Senior Loan Investments and/or Junior Capital Investments to the applicable portfolio company (“Equity Co-Investments”). We will seek to partner with strong management teams executing long-term growth strategies. Target portfolio companies in Senior Loan Investments and Junior Capital Investments will typically exhibit some or all of the following characteristics:

•annual earnings before interest, taxes, depreciation and amortization (“EBITDA”) of $10 million -$250 million, with a focus on EBITDA of $10 million - $100 million;

•significant cash equity capitalization (typically 40% or more) supported by a private equity sponsor;

7

•sustainable leading positions in their respective markets;

•scalable revenues and operating cash flow;

•experienced management teams with successful track records and the ability to successfully operate in a leveraged environment and to adapt to challenging economic or business conditions;

•strong recurring revenue or “re-occurring” revenue, with good visibility of backlog and revenue;

•stable, predictable cash flows with low technology and market risks;

•diversified product offering and customer base;

•low capital expenditure requirements;

•a North American base of operations with a significant U.S. presence;

•strong customer relationships;

•products, services or distribution channels having distinctive competitive advantages; and

•defensible niche strategy or other barriers to entry.

While Churchill believes that the criteria listed above are important in identifying and investing in prospective portfolio companies, not all of these criteria necessarily will be met by each prospective portfolio company. We expect to target an investment portfolio consisting, directly or indirectly, of 75% to 90% Senior Loan Investments, 5% to 25% in Junior Capital Investments and up to 10% in Equity Co-Investments. To support our share repurchase program (as described below), liquid investments are expected to comprise 5% - 10% of our assets, subject to the pace and amount of investment activity in our middle-market investment program, and will be comprised of a portfolio of cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments (“Liquid Investments”). We typically refer to an investment as liquid if the investment is, or we expect it to be, actively traded (with a typical settlement period of one month with respect to broadly syndicated loans). While we will seek to achieve the targets described above, the composition of the Fund’s investment portfolio may vary from time to time due to various factors, such as market conditions and the availability of attractive investment opportunities.

In addition, subject to the Fund’s Fifth Amended and Restated Declaration of Trust (the “Declaration of Trust”) and the Fund’s Second Amended and Restated Bylaws (the “Bylaws”), the Fund may change its investment objective and/or investment criteria over time without notice to or consent from shareholders.

Portfolio Composition

As of December 31, 2023 and December 31, 2022, our investments consisted of the following (dollar amounts in thousands):

	December 31, 2023						December 31, 2022
	Amortized Cost		Fair Value		% of Fair Value		Amortized Cost		Fair Value		% of Fair Value
First-Lien Term Loans	$	402,858	$	399,882	78.10	%	$	253,940	$	251,371	71.92	%
Subordinated Debt (1)	103,888		101,930		19.90	%	95,481		93,809		26.84	%
Equity Investments	9,422		10,224		2.00	%	3,577		4,338		1.24	%
Total	$	516,168	$	512,036	100.00	%	$	352,998	$	349,518	100.00	%
Largest portfolio company investment	$	10,731	$	10,986	2.15	%	$	10,617	$	11,093	3.17	%
Average portfolio company investment	$	3,246	$	3,220	0.63	%	$	5,516	$	5,461	1.56	%

_______________

(1)Subordinated Debt is further comprised of Second Lien Term Loans and/or Second Lien Notes of $52,170 and Mezzanine Debt of $49,760 as of December 31, 2023, and $30,906 and $62,903 as of December 31, 2022, respectively.

8

The industry composition of our portfolio as a percentage of fair value as of December 31, 2023 and December 31, 2022 was as follows:

Industry	December 31, 2023		December 31, 2022
Aerospace & Defense	2.07	%	—	%
Automotive	1.10	%	1.11	%
Banking, Finance, Insurance, Real Estate	1.49	%	0.08	%
Beverage, Food & Tobacco	10.39	%	12.54	%
Capital Equipment	4.28	%	1.98	%
Chemicals, Plastics & Rubber	3.80	%	4.28	%
Construction & Building	4.78	%	4.52	%
Consumer Goods: Durable	3.76	%	4.48	%
Consumer Goods: Non-durable	5.97	%	7.56	%
Containers, Packaging & Glass	3.49	%	4.89	%
Energy: Electricity	0.43	%	—	%
Energy: Oil & Gas	3.08	%	6.09	%
Environmental Industries	3.04	%	2.19	%
Healthcare & Pharmaceuticals	10.08	%	7.31	%
High Tech Industries	4.81	%	2.74	%
Hotel, Gaming & Leisure	0.44	%	—	%
Media: Advertising, Printing & Publishing	1.33	%	1.98	%
Media: Broadcasting & Subscription	0.80	%	—	%
Metals and Mining	0.10	%	—	%
Services: Business	16.82	%	16.98	%
Services: Consumer	5.73	%	6.65	%
Sovereign & Public Finance	0.77	%	1.08	%
Telecommunications	2.33	%	1.92	%
Transportation: Cargo	2.32	%	3.12	%
Transportation: Consumer	0.78	%	—	%
Utilities: Electric	0.51	%	—	%
Wholesale	5.50	%	8.50	%
Total	100.00	%	100.00	%

See the consolidated schedule of investments as of December 31, 2023 and December 31, 2022 in our consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for more information on these investments, including a list of companies and type, cost and fair value of investments.

Investment Process Overview

Churchill views the investment process employed on behalf of the Fund as consisting of four distinct phases described below:

Origination. The Investment Team will source middle market investment opportunities through the investment team’s network of relationships with private equity firms and other middle market lenders. The Investment Team believes that the strength and breadth of its relationships with numerous middle market private equity funds and overall deal sourcing capabilities should enable them to maximize deal flow, support a highly selective investment process, and afford the Fund the opportunity to establish favorable portfolio diversification.

9

Investment Evaluation. The Investment Team intends to utilize a systematic, consistent approach to credit and portfolio company evaluation, with a particular focus on an acceptable level of debt repayment and deleveraging as well as accretive growth and exit assumptions under a “base case” set of projections (the “Base Case”); this Base Case generally reflects a more conservative estimate than the set of projections provided by a prospective portfolio company (the “Management Case”) and that of the private equity sponsor purchasing/financing the portfolio company, as applicable. The key criteria that the Investment Team evaluates includes (i) strong and resilient underlying business fundamentals, (ii) a substantial equity cushion in the form of capital ranking junior in right of payment to the Fund’s investment and (iii) a conclusion that the overall Base Case and in most cases the “Downside Case” allow for adequate debt repayment and deleveraging. In evaluating a particular investment opportunity, the Investment Team will put more emphasis on credit considerations (such as (i) debt repayment and deleveraging under a Base Case set of projections, (ii) the ability of the company to maintain a modest liquidity cushion under a Base Case set of projections, and (iii) the ability of the portfolio company to service its fixed charge obligations under a Base Case set of projections) than on profit potential and loan pricing (among other considerations both quantitative and qualitative). The Investment Team’s due diligence process for middle market investments will typically entail:

•a thorough review of historical and pro forma financial information (including both performance metrics and proposed capital structure and growth prospects);

•meetings and discussions with management and financial sponsors and their advisors;

•a review of loan documents and material contracts impactful to the operation and profitability of the business in question;

•third-party “quality of earnings” accounting due diligence;

•when appropriate, background checks on key management and/or sponsors;

•third-party research relating to the company’s business, industry, markets, products and services, customers, competitors and regulatory exposure/treatment;

•the commission of third-party analyses when appropriate;

•sensitivity of Management Case and “sponsor case” projections; and

•various comprehensive cash flow analyses and sensitivities.

The Investment Team’s deal screening, underwriting, approval and closing processes are substantially similar. The following chart summarizes the investment process of the Investment Team:

• Assess each potential financing opportunity based on defined screening criteria, or “credit box”, with a commitment to provide initial feedback in a timely manner • Evaluate worthwhile transactions through staged “Early Read” or “Matrix” process which employs proprietary screening and underwriting templates • Selected transactions clear the “Early Read” or “Matrix” process and enter due diligence	• Understand sponsor investment thesis and risk considerations • Assess qualitative factors, e.g., management meetings and site visit • Evaluate industry diligence to determine market position and competitive advantage • Review quarterly earnings, industry reports, and consultant reports • Produce financial models including management projections, proprietary base case projections, and break-even analysis	• Prepare Investment Approval Memorandum for review and approval by the applicable Investment Committee and by the Investment Committee of the Fund • Review and negotiate transaction documents • Closing Memo documents any changes from approval or provides results of any additional post-approval due diligence • Closing Memo required for funding

10

Execution. In executing transactions, the Investment Team will apply what it believes is a thorough, consistent approach to credit evaluation, and maintain discipline with respect to credit, pricing and structure to ensure the ultimate success of the financing. Upon completion of due diligence, the investment professionals working on a proposed portfolio investment will deliver a memorandum to the relevant Investment Committee(s). Once an investment has been approved by a unanimous vote of such Investment Committee, the memorandum will be delivered to the Investment Committee of the Fund. Once an investment has been approved by a unanimous vote of the Investment Committee, it will move through a series of steps, including an in-depth review of documentation by deal teams, negotiation of final documentation, including resolution of business points and the execution of original documents held in escrow. Upon completion of final documentation, a portfolio investment is funded after execution of a final closing memorandum.

Monitoring. The Investment Team views active portfolio monitoring as a vital part of the investment process and further consider regular dialogue with company management and sponsors as well as detailed, internally generated monitoring reports to be critical to monitoring performance. The Investment Team will implement a monitoring template designed to reasonably ensure compliance with these standards. This template will be used as a tool by the Investment Team to assess investment performance relative to plan.

As part of the monitoring process, the Senior Loan Investment Team has developed risk policies pursuant to which it will regularly assess the risk profile of each of the Fund’s Senior Loan investments, and in a similar manner the PEJC Investment Team will regularly assess the risk profile for each of the Fund’s Junior Capital Investments and Equity Co-Investments. The Investment Team will rate each investment based on our “Internal Risk Ratings”. For more information on the Internal Risk Ratings of our portfolio, see Part II, Item 7 of this Annual Report Form 10-K “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Portfolio and Investment Activity.”

The Investment Team monitors and, when appropriate, changes the investment ratings assigned to each investment in the Fund’s portfolio. The Investment Team reviews the investment ratings in connection with monthly and quarterly portfolio reviews. In addition, the Investment Team employs what they believe is a proactive monitoring approach as illustrated in the chart below:

Daily/ weekly	Monthly	Quarterly	Ongoing
• Weekly Joint Investment Team pipeline meeting • Investment Team meeting as required • Review news stories on borrowers/industries and market data via news wires and email alerts • Assess potential covenant defaults • Upgrades/downgrades of internal risk ratings evaluated by deal teams and senior management as information is learned	• Monthly meetings to discuss Management Notice and Watchlist Investments • Evaluate internal risk rating • Credit Surveillance Reports and/or Portfolio Review Templates updated monthly or quarterly following review of financials • Conduct analysis of company results, industry trends, key ratios, and liquidity	• Senior management review of portfolio level metrics and trends • Deals covered in portfolio review depend on internal risk rating with downgraded Senior Loan Investments and all Junior Capital Investments and Equity Co-Investments reviewed each quarter • Review quarterly financials and compliance certificates • Complete portfolio valuations • Compare financials to prior year, budget, and the Base Case • Evaluate cushion to breakeven cash flow and covenant default levels •    Review and confirmation of internal risk rating	• Amendments and waivers negotiated, approved, documented, and closed by deal team • Conduct calls with agent, sponsor, and borrower as needed • PEJC Investment Team attends advisory board meetings to the extent they have observation rights • Monitor ESG risks, concerns and opportunities

11

Use of Leverage

The amount of leverage we use in any period depends on a variety of factors, including cash available for investing, the cost of financing and general economic and market conditions. We may borrow money from time to time if immediately after such borrowing, the ratio of our total assets (less total liabilities other than indebtedness represented by senior securities) to our total indebtedness represented by senior securities plus preferred stock, if any, is at least 150%. This means that we generally can borrow up to $2 for every $1 of investor equity. See “Regulation as a Business Development Company — Senior Securities; Coverage Ratio” for more information regarding the foregoing and other regulatory considerations.

In any period, our interest expense will depend largely on the extent of our borrowing and we expect interest expense will increase as we increase our leverage over time subject to the limits of the 1940 Act. In addition, we may dedicate assets to financing facilities.

We currently have in place one special purpose vehicle asset credit facility (the “Bank of America Credit Facility”), and in the future may enter into additional credit facilities. For more information on the Bank of America Credit Facility, see Note 6 to the consolidated financial statements in Part II, Item 8 of this Form 10-K.

Environmental, Social and Governance Policies

Churchill has established an environmental, social and governance ("ESG") policy for its investment program. Churchill is focused on delivering attractive risk-adjusted returns to its clients, including the Fund, while upholding the highest ethical standards, including certain ESG factors, throughout its origination, underwriting and portfolio management processes. Churchill's ESG policy requires that it evaluate ESG-related risks that have the potential to damage a company’s operations and reputation, and perform an analysis of the issuer’s operating history to determine whether such risks are managed to minimize defaults that could give rise to investment losses. Pursuant to the ESG policy, Churchill’s investment teams apply a set of criteria against each investment opportunity through the use of an ESG rating template, the output of which is included in the materials presented to and reviewed by the applicable investment committee underwriting the investment opportunity. The ESG rating template used by Churchill requires an assessment of the materiality of ESG-related risks, review of ‘high-risk’ business activities that may violate applicable underwriting standards, and a management assessment. Using a proprietary ESG methodology, the template rates individual issuers based on its perceived management of ESG risk relative to peers. Post-investment, the ESG policy requires the relevant investment teams to conduct reviews with company management to discuss any ESG-related issues that have arisen. Any such issues are discussed and considered by the Churchill investment teams during periodic portfolio review meetings in order to perform an ongoing risk assessment.

Churchill’s ESG policy is updated as needed to reflect changing practices and industry standards. The consideration of ESG factors as part of Churchill’s underwriting and portfolio management process, however, does not mean that the Fund will pursue a specific ESG investment strategy or that a portfolio company will be selected solely on the basis of ESG factors. Churchill may make investment decisions for the Fund other than on the basis of ESG considerations.

12

Competition

Our primary competitors in providing credit investments to middle market companies include other BDCs, public and private funds, CLOs, commercial and investment banks, other middle market asset managers and, to the extent they provide an alternative form of financing, private equity and hedge funds. Many of our potential competitors are substantially larger and have considerably greater financial, technical and marketing resources than those available to the Fund. For example, some competitors may have a lower cost of capital and access to funding sources that are not available to the Fund. In addition, some of our competitors may have higher risk tolerances or different risk assessments than ours, which could allow them to consider a wider variety of investments and establish more relationships than those established by each of our investment teams. These characteristics could allow our competitors to consider a wider variety of investments, establish more relationships and offer better pricing and more flexible structuring than we are able to do. We may lose investment opportunities if we do not match our competitors’ pricing, terms or structure. If we are forced to match our competitors’ pricing, terms or structure, we may not be able to achieve acceptable returns on our investments or may bear substantial risk of capital loss. A significant part of our competitive advantage stems from the fact that the market for investments in middle market private U.S. companies is underserved by traditional commercial banks and other financial sources. A significant increase in the number and/or the size of our competitors in this target market could force us to accept less attractive investment terms. Furthermore, many of our competitors have greater experience operating under, or are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. There cannot be any assurance that the competitive pressures faced by us will not have a material adverse effect on its business, financial condition and results of operations. See “Risk Factors – We operate in a highly competitive market for investment opportunities, which could reduce returns and result in losses” for further information.

Human Resource Capital

We do not have any employees and do not expect to have any employees. We depend on the investment expertise, skill and network of business contacts of the senior investment professionals of Churchill, who source, evaluate, negotiate, structure, execute, monitor and service our investments in accordance with the terms of the Advisory Agreement.

Non-Exchange Traded, Perpetual-Life BDC

The Fund is non-exchange traded, meaning its Common Shares are not listed for trading on a stock exchange or other securities market, and a perpetual-life BDC, meaning it is an investment vehicle of indefinite duration, whose shares are intended to be sold by the BDC monthly on a continuous basis at a price generally equal to the BDC’s monthly NAV per share. In our perpetual-life structure, we may offer investors an opportunity to repurchase their Common Shares on a quarterly basis, but we are not obligated to offer to repurchase any Common Shares in any particular quarter in our discretion. We believe that our perpetual nature enables us to execute a patient and opportunistic strategy and be able to invest across different market environments. This may reduce the risk of the Fund being a forced seller of assets in market downturns compared to non-perpetual funds. While we may consider a liquidity event at any time in the future, we currently do not intend to undertake a liquidity event, and we are not obligated by our Declaration of Trust or otherwise to effect a liquidity event at any time.

Emerging Growth Company

We are an emerging growth company as defined in the JOBS Act and we are eligible to take advantage of certain specified reduced disclosure and other requirements that are otherwise generally applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”). We expect to remain an emerging growth company for up to five years measured from the date of the first sale of common equity securities pursuant to an effective registration statement, or until the earliest of (i) the last day of the first fiscal year in which our annual gross revenues equals or exceeds $1.235 billion, (ii) December 31 of the fiscal year that we become a “large accelerated filer” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the "Exchange Act") which would occur if the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the last business day of our most recently completed second fiscal quarter and we have been publicly reporting for at least 12 months or (iii) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the preceding three-year period. In addition, we will take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended (the "Securities Act") for complying with new or revised accounting standards.

13

Regulation as a Business Development Company

We have elected to be regulated as a BDC under the 1940 Act. The 1940 Act contains prohibitions and restrictions relating to transactions between BDCs and their affiliates (including any investment advisers or sub-advisers), principal underwriters and affiliates of those affiliates or underwriters and requires that a majority of the trustees be persons other than “interested persons,” as that term is defined in the 1940 Act.

In addition, the 1940 Act provides that we may not change the nature of our business so as to cease to be, or to withdraw our election as, a BDC unless approved by “a majority of our outstanding voting securities” as defined in the 1940 Act. A majority of the outstanding voting securities of a company is defined under the 1940 Act as the lesser of: (a) 67% or more of such company’s voting securities present at a meeting if more than 50% of the outstanding voting securities of such company are present or represented by proxy, or (b) more than 50% of the outstanding voting securities of such company. We do not anticipate any substantial change in the nature of our business.

We are not generally able to issue and sell our common stock at a price below NAV per share. We may, however, issue and sell our Common Shares, options or rights to acquire our Common Shares, at a price below the then-current NAV of our Common Shares if (1) our Board determines that such sale is in our best interests and the best interests of our shareholders, and (2) our shareholders approved our policy and practice of making such sales within the preceding 12 months.

We may also be prohibited under the 1940 Act from knowingly participating in certain transactions with our affiliates without the prior approval of our Independent Trustees and, in some cases, prior approval by the SEC.

We may invest up to 100% of our assets in securities acquired directly from issuers in privately negotiated transactions. We also do not intend to acquire securities issued by any investment company that exceed the limits imposed by the 1940 Act. Under these limits, except for registered money market funds, we generally cannot acquire more than 3% of the voting stock of any registered investment company, invest more than 5% of the value of our total assets in the securities of one investment company, or invest more than 10% of the value of our total assets in the securities of more than one investment company. With regard to that portion of our portfolio invested in securities issued by investment companies, if any, it should be noted that such investments might subject our shareholders to additional expenses as they will be indirectly responsible for the costs and expenses of such companies. None of our investment policies are fundamental, and thus may be changed without shareholder approval.

Qualifying Assets. Under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in Section 55(a) of the 1940 Act, which are referred to as “qualifying assets,” unless, at the time the acquisition is made, qualifying assets represent at least 70% of the BDC’s total assets. The principal categories of qualifying assets relevant to the Fund’s business are any of the following:

(1)Securities purchased in transactions not involving any public offering from the issuer of such securities, which issuer (subject to certain limited exceptions) is an eligible portfolio company, or from any person who is, or has been during the preceding 13 months, an affiliated person of an eligible portfolio company, or from any other person, subject to such rules as may be prescribed by the SEC. An eligible portfolio company is defined in the 1940 Act as any issuer which:

(a)is organized under the laws of, and has its principal place of business in, the United States;

(b)is not an investment company (other than a small business investment company wholly owned by the BDC) or a company that would be an investment company but for certain exclusions under the 1940 Act; and

(c)satisfies any of the following:

(i)does not have any class of securities that is traded on a national securities exchange;

(ii)has a class of securities listed on a national securities exchange, but has an aggregate market value of outstanding voting and non-voting common equity of less than $250 million;

(iii)is controlled by a BDC or a group of companies including a BDC and the BDC has an affiliated person who is a director of the eligible portfolio company; or

(iv)is a small and solvent company having total assets of not more than $4 million and capital and surplus of not less than $2 million; 

14

(2)Securities of any eligible portfolio company controlled by the Fund;

(3)Securities purchased in a private transaction from a U.S. issuer that is not an investment company or from an affiliated person of the issuer, or in transactions incident thereto, if the issuer is in bankruptcy and subject to reorganization or if the issuer, immediately prior to the purchase of its securities was unable to meet its obligations as they came due without material assistance other than conventional lending or financing arrangements;

(4)Securities of an eligible portfolio company purchased from any person in a private transaction if there is no ready market for such securities and the Fund already owns 60% of the outstanding equity of the eligible portfolio company;

(5)Securities received in exchange for or distributed on or with respect to securities described in (1) through (4) above, or pursuant to the exercise of warrants or rights relating to such securities; or

(6)Cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year or less from the time of investment.

In addition, a BDC must be operated for the purpose of making investments in the types of securities described in (1), (2) or (3) above.

Control, as defined in the 1940 Act, is presumed to exist where a BDC beneficially owns more than 25% of the outstanding voting securities of the portfolio company, but may exist in other circumstances based on the facts and circumstances.

Significant Managerial Assistance. A BDC must have been organized and have its principal place of business in the United States and must be operated for the purpose of making investments in the types of securities described above. A BDC must also offer to make available to the issuer of the qualifying assets significant managerial assistance; except that, where the BDC purchases such securities in conjunction with one or more other persons acting together, one of the other persons in the group may make available such managerial assistance. Making available significant managerial assistance means, among other things, any arrangement whereby the BDC, through its directors, officers or employees, offers to provide and, if accepted, does so provide, significant guidance and counsel concerning the management, operations or business objectives and policies of a portfolio company through monitoring of portfolio company operations, selective participation in board and management meetings, consulting with and advising a portfolio company’s officers or other organizational or financial guidance. The Administrator or its affiliate provides such services on our behalf to portfolio companies that accept our offer of managerial assistance.

Temporary Investments. Pending investment in other types of qualifying assets, as described above, the Fund’s investments can consist of cash, cash equivalents, U.S. government securities or high quality debt securities maturing in one year or less from the time of investment, which are referred to herein, collectively, as temporary investments, so that 70% of the Fund’s assets would be qualifying assets.

Issuance of Warrants, Options or Rights. Under the 1940 Act, a BDC is subject to restrictions on the issuance, terms and amount of warrants, options or rights to purchase shares of stock that it may have outstanding at any time. In particular, the amount of shares that would result from the conversion or exercise of all outstanding warrants, options or rights to purchase shares cannot exceed 25% of the BDC’s total outstanding shares.

Senior Securities; Asset Coverage Ratio. We are generally permitted, under specified conditions, to issue multiple classes of indebtedness and one class of stock senior to our Common Shares if immediately after such borrowing or issuance, the ratio of our total assets (less total liabilities other than indebtedness represented by senior securities) to our total indebtedness represented by senior securities plus preferred stock, if any, is at least 150%. In addition, while any senior securities remain outstanding, we will be required to make provisions to prohibit any distribution to our shareholders or the repurchase of such securities or shares unless we meet the asset coverage ratio requirement at the time of the distribution or repurchase. We also will be permitted to borrow amounts up to 5% of the value of our total assets for temporary or emergency purposes, which borrowings would not be considered senior securities. Our borrowings, whether for temporary purposes or otherwise, are subject to the asset coverage requirements of Section 61(a)(2) of the 1940 Act.

15

Code of Ethics. We and the Adviser have adopted a code of ethics pursuant to Rule 17j-1 under the 1940 Act and Rule 204A-1 under the Advisers Act, respectively, that establishes procedures for personal investments and restricts certain personal securities transactions. Personnel subject to the code are permitted to invest in securities for their personal investment accounts, including securities that may be purchased or held by us, so long as such investments are made in accordance with the code’s requirements. You may obtain copies of these codes of ethics by e-mailing our Adviser at Investor.relations@churchillam.com, or by writing to our Adviser at Investor Relations c/o Churchill Asset Management, 375 Park Avenue, 9th Floor, New York, NY 10152. The code of ethics is also available on the EDGAR database on the SEC’s Internet site at http://www.sec.gov. You may also obtain copies of the code of ethics, after paying a duplicating fee, by electronic request at the following email address: publicinfo@sec.gov.

Affiliated Transactions. We may be prohibited under the 1940 Act from conducting certain transactions with our affiliates without the prior approval of our Independent Trustees and, in some cases, the prior approval of the SEC. We have received an exemptive order from the SEC that permits us, among other things, to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions.

The Fund expects to co-invest on a concurrent basis with other affiliates of the Fund and the Adviser, unless doing so would be impermissible under existing regulatory guidance, applicable regulations, the terms of any exemptive relief granted to the Adviser and certain other funds and accounts sponsored or managed by the Adviser and/or its affiliates, and the allocation procedures of the Adviser. On June 7, 2019, the SEC issued an exemptive order (the “Order”) that permits the Fund to co-invest in portfolio companies with certain funds or entities managed by the Adviser or its affiliates in certain negotiated transactions where co-investing would otherwise be prohibited under the 1940 Act, subject to the conditions of the Order if the Board determines that it would be advantageous for the Fund to co-invest with other accounts sponsored or managed by the Adviser or its affiliates in a manner consistent with the Fund’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors. under the terms of the Order, a majority of the Independent Trustees are required to make certain determinations in connection with a co-investment transaction, including that (1) the terms of the proposed transaction are reasonable and fair to the Fund and the Fund’s shareholders and do not involve overreaching of the Fund or the Fund’s shareholders on the part of any person concerned and (2) the transaction is consistent with the interests of the Fund’s shareholders and is consistent with the Fund’s investment strategies and policies. The Board will regularly review the allocation policy of Churchill.

In addition, pursuant to an exemptive order issued by the SEC on April 8, 2020 and applicable to all BDCs through December 31, 2020 (the “Temporary Relief”), the Fund was permitted, subject to the satisfaction of certain conditions, to complete follow-on investments in our existing portfolio companies with certain affiliates that are private funds if such private funds did not hold an investment in such existing portfolio company. Without the Temporary Relief, such private funds would not be able to participate in such follow-on investments with us unless the private funds had previously acquired securities of the portfolio company in a co-investment transaction with the Fund. Although the Temporary Relief expired on December 31, 2020, the SEC’s Division of Investment Management had indicated that until March 31, 2022, it would not recommend enforcement action, to the extent that any BDC with an existing co-investment order continues to engage in certain transactions described in the Temporary Relief, pursuant to the same terms and conditions described therein. The conditional exemptive order is no longer effective; however, on October 14, 2022, the SEC granted the Fund’s request to amend the Order to make the Temporary Relief permanent for the Fund and permit the Fund to continue to complete follow-on investments in its existing portfolio companies with certain affiliates that are private funds if such private funds did not hold an investment in such existing portfolio company.

Other. The Fund will be periodically examined by the SEC for compliance with the 1940 Act, and be subject to the periodic reporting and related requirements of the Exchange Act.

The Fund is also required to provide and maintain a bond issued by a reputable fidelity insurance company to insure against larceny and embezzlement. Furthermore, as a BDC, the Fund is prohibited from protecting any director or officer against any liability to shareholders arising from willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such person’s office.

The Fund is also required to designate a chief compliance officer and to adopt and implement written policies and procedures reasonably designed to prevent violation of the federal securities laws and to review these policies and procedures annually for their adequacy and the effectiveness of their implementation.

16

The Fund is not permitted to change the nature of its business so as to cease to be, or to withdraw our election as, a BDC unless approved by a majority of its outstanding voting securities. A majority of the outstanding voting securities of a company is defined under the 1940 Act as the lesser of: (i) 67% or more of such company’s shares present at a meeting if more than 50% of the outstanding shares of such company are present or represented by proxy, or (ii) more than 50% of the outstanding shares of such company.

Proxy Voting Policies and Procedures

The Board has delegated the responsibility for voting proxies relating to portfolio securities held by the Fund to the Adviser, and has directed Churchill to vote proxies relating to portfolio securities held by the Fund consistent with the duties and procedures set forth in Churchill’s policies and procedures. Churchill may retain one or more vendors to review, monitor and recommend how to vote proxies in a manner consistent with the duties and procedures set forth in such policies and procedures, to ensure that such proxies are voted on a timely basis and to provide reporting and/or record retention services in connection with proxy voting for the Fund.

Churchill acts as a fiduciary of the Fund and must vote proxies in a manner consistent with the best interests of the Fund and its shareholders. In discharging this fiduciary duty, Churchill must maintain and adhere to its policies and procedures for addressing conflicts of interest and must vote proxies in a manner substantially consistent with its policies, procedures and guidelines, as presented to the Board.

Any actual or potential conflicts of interest between the Fund and Churchill arising from the proxy voting process will be addressed by the application of Churchill’s proxy voting procedures. In the event Churchill determines that a conflict of interest cannot be resolved under Churchill’s proxy voting procedures, Churchill is responsible for notifying the Board or the Audit Committee of such irreconcilable conflict of interest and assisting the Board or the Audit Committee with any actions it determines are necessary.

Proxy Policies

Churchill will vote all proxies relating to our portfolio securities in the best interest of our shareholders. Churchill reviews on a case-by-case basis each proposal submitted to a shareholder vote to determine its impact on the portfolio securities held by the Fund. Although Churchill will generally vote against proposals that may have a negative impact on our clients’ portfolio securities, Churchill may vote for such a proposal if there exist compelling long-term reasons to do so. Churchill will abstain from voting only in unusual circumstances and where there is a compelling reason to do so. Churchill may retain one or more vendors to review, monitor and recommend how to vote proxies in a manner consistent with the duties and procedures set forth in its policies and procedures, to ensure that such proxies are voted on a timely basis and to provide reporting and/or record retention services in connection with proxy voting for the Fund.

Churchill’s proxy voting decisions are made by members of the applicable Investment Team who are responsible for monitoring each of our investments. Any actual or potential conflicts of interest between the Fund and Churchill arising from the proxy voting process will be addressed by the application of the Churchill’s proxy voting procedures. In the event Churchill determines that a conflict of interest cannot be resolved under Churchill’s proxy voting procedures, Churchill will be responsible for notifying the Board or the audit committee of the Board of such irreconcilable conflict of interest and assisting the Board or the audit committee of the Board with any actions it determines are necessary.

Proxy Voting Records

You may obtain information about how Churchill voted proxies by making a written request for proxy voting information to: Nuveen Churchill Private Capital Income Fund, 375 Park Avenue, 9th Floor, New York, NY 10152, Attention: Chief Compliance Officer, John D. McCally.

Other

We expect to be periodically examined by the SEC for compliance with the 1940 Act and the Exchange Act, and are subject to the periodic reporting and related requirements of the Exchange Act.

We are also required to provide and maintain a bond issued by a reputable fidelity insurance company to protect against larceny and embezzlement. Furthermore, as a BDC, we are prohibited from protecting any trustee or officer against any liability to our shareholders arising from willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such person’s office.

17

We are also required to designate a chief compliance officer and to adopt and implement written policies and procedures reasonably designed to prevent violation of the federal securities laws and to review these policies and procedures annually for their adequacy and the effectiveness of their implementation.

We intend to operate as a non-diversified management investment company; however, we are currently and may, from time to time, in the future, be considered a diversified management investment company pursuant to the definitions set forth in the 1940 Act.

Privacy Policy

The following information is provided to help investors understand what personal information the Fund collects, how the Fund protects that information and why, in certain cases, the Fund may share information with select other parties.

In order to provide you with individualized service, the Fund collects certain nonpublic personal information about you from information you provide on your subscription agreement or other forms (such as your address and social security number), and information about your account transactions with the Fund (such as purchases of our Common Shares and account balances). The Fund may also collect such information through your account inquiries by mail, email, telephone, or web site.

The Fund does not disclose any nonpublic personal information about you to anyone, except as permitted by law. Specifically, so that the Fund, the Advisers and their affiliates may continue to offer services that best meet your investing needs, the Fund may disclose the information we collect, as described above, to companies that perform administrative or marketing services on behalf of the Fund, such as transfer agents, or printers and mailers that assist us in the distribution of investor materials. These companies will use this information only for the services for which they have been hired, and are not permitted to use or share this information for any other purpose.

We will continue to adhere to the privacy policies and practices described in this notice if you no longer hold our Common Shares.

The Fund and the Advisers maintain internal security procedures to restrict access to your personal and account information to those officers and employees who need to know that information to service your account. The Fund maintains physical, electronic and procedural safeguards to protect your nonpublic personal information.

Reporting Obligations

We furnish our shareholders with annual reports containing audited financial statements, quarterly reports, and such other periodic reports as we determine to be appropriate or as may be required by law. We are required to comply with all periodic reporting, proxy solicitation and other applicable requirements under the Exchange Act.

Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, as well as reports on Forms 3, 4 and 5 regarding directors, officers or 10% beneficial owners of us, filed or furnished pursuant to section 13(a), 15(d) or 16(a) of the Exchange Act, are available free of charge by contacting the Adviser at: 375 Park Avenue, 9th Floor, New York, NY, 10152. Shareholders and the public may also view any materials we file with the SEC on the SEC’s website (http://www.sec.gov).

Taxation as a Regulated Investment Company

We intend to elect and qualify annually thereafter, to be treated as a RIC for U.S. federal income tax purposes under Subchapter M of the Code. As a RIC, we generally will not be subject to U.S. federal income tax on any net ordinary income or capital gains that we timely distribute to our shareholders as dividends. Rather, dividends distributed by us generally will be taxable to our shareholders, and any net operating losses, foreign tax credits and other tax attributes of ours generally will not pass through to our shareholders, subject to certain exceptions and special rules for certain items such as net capital gains and qualified dividend income recognized by us.

To qualify as a RIC, we must, among other things, meet certain source-of-income and asset diversification requirements (as described below). In addition, to be eligible to be taxed as a RIC, we generally must timely distribute to our shareholders, for each taxable year, at least 90% of our “investment company taxable income,” which is generally our net ordinary income plus the excess of realized net short-term capital gains over realized net long-term capital losses (the “Annual Distribution Requirement”). The following discussion assumes that we qualify as a RIC and have satisfied the Annual Distribution Requirement.

18

If the Fund:

•qualifies as a RIC; and

•satisfies the Annual Distribution Requirement,

then we will not be subject to U.S. federal income tax on the portion of our income that is timely distributed (or is deemed to be timely distributed) to our shareholders as dividends. We will be subject to U.S. federal income tax at corporate rates on the portion of our income that is not timely distributed (or deemed distributed) to our shareholders.

We will be subject to a 4% nondeductible U.S. federal excise tax on certain undistributed income unless we distribute in a timely manner each calendar year an amount at least equal to the sum of (1) 98% of our net ordinary income for each calendar year, (2) 98.2% of our capital gain net income for the one-year period ending October 31 in that calendar year and (3) any ordinary income and net capital gain that we recognized in preceding years, but were not distributed during such years and on which we did not pay U.S. federal income tax (the “Excise Tax Avoidance Requirement”). While we intend to make distributions to our shareholders in each taxable year that will be sufficient to avoid any U.S. federal excise tax on our earnings, there can be no assurance that we will be successful in entirely avoiding this tax.

In order to qualify as a RIC for U.S. federal income tax purposes, we must, among other things:

•continue to qualify as a BDC under the 1940 Act at all times during each taxable year;

•derive in each taxable year at least 90% of gross income from dividends, interest, payments with respect to loans of certain securities, gains from the sale or other taxable disposition of stock or other securities or foreign currencies, net income from certain “qualified publicly traded partnerships,” or other income derived with respect to the business of investing in such stock or securities (the “90% Income Test”); and

•diversify our holdings so that at the end of each quarter of the taxable year:

◦at least 50% of the value of its assets consists of cash, cash equivalents, U.S. government securities, securities of other RICs, and other securities if such other securities of any one issuer do not represent more than 5% of the value of its assets or more than 10% of the outstanding voting securities of the issuer; and

◦no more than 25% of the value of its assets is invested in (i) the securities, other than U.S. government securities or securities of other RICs, of one issuer, (ii) securities, other than securities of other RICs, of two or more issuers that are controlled, as determined under applicable Code rules, by us and that are engaged in the same or similar or related trades or businesses or (iii) the securities of certain “qualified publicly traded partnerships” (the “Diversification Tests”).

For U.S. federal income tax purposes, the Fund may be required to include in our taxable income certain amounts that we have not yet received in cash. For example, if the Fund holds debt obligations that are treated under applicable tax rules as having original issue discount ("OID") (such as debt instruments with PIK interest or, in certain cases, increasing interest rates or issued with warrants), it must include in its taxable income in each year the portion of the OID that accrues over the life of the obligation, regardless of whether cash representing such income is received by the Fund in the same taxable year. The Fund may also have to include in its taxable income other amounts that it has not yet received in cash, such as accruals on a contingent payment debt instrument or deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. Because OID or other amounts accrued will be included in the Fund’s investment company taxable income for the year of accrual and before the Fund receives any corresponding cash payments, it may be required to make a distribution to shareholders in order to satisfy the Annual Distribution Requirement, even though it would not have received any corresponding cash payment.

Accordingly, to enable us to satisfy the Annual Distribution Requirement, we may need to sell some of our assets at times and/or at prices that we would not consider advantageous, we may need to raise additional equity or debt capital or we may need to forego new investment opportunities or otherwise take actions that are disadvantageous to our business (or be unable to take actions that are advantageous to our business). If we are unable to obtain cash from other sources to enable us to satisfy the Annual Distribution Requirement, we may fail to qualify for the U.S. federal income tax benefits allowable to RICs and, thus, become subject to U.S. federal income tax at corporate rates (and any applicable state and local taxes).

19

We may be prevented by financial covenants contained in our debt financing agreements, if any, from making distributions to our shareholders. In addition, under the 1940 Act, we are generally not permitted to make distributions to our shareholders while our debt obligations and other senior securities are outstanding unless certain "asset coverage" tests are met. Limits on distributions to our shareholders may prevent us from satisfying the Annual Distribution Requirement and, therefore, may jeopardize our qualification for taxation as a RIC or subject us to the 4% U.S. federal excise tax.

Although the Fund does not presently expect to do so, we may borrow funds and sell assets in order to make distributions to our shareholders that are sufficient for us to satisfy the Annual Distribution Requirement. However, the Fund’s ability to dispose of assets may be limited by (i) the illiquid nature of its portfolio and/or (ii) other requirements relating to its status as a RIC, including the Diversification Tests. If the Fund disposes of assets in order to meet the Annual Distribution Requirement or the Excise Tax Avoidance Requirement, it may make such dispositions at times that, from an investment standpoint, are not advantageous. If the Fund is unable to obtain cash from other sources to satisfy the Annual Distribution Requirement, it may fail to qualify for tax treatment as a RIC and become subject to tax as an ordinary corporation.

Certain of the Fund’s investment practices may be subject to special and complex U.S. federal income tax provisions that may, among other things: (i) disallow, suspend or otherwise limit the allowance of certain losses or deductions; (ii) convert lower taxed long-term capital gain into higher taxed short-term capital gain or ordinary income; (iii) convert an ordinary loss or a deduction into a capital loss (the deductibility of which is more limited); (iv) cause the Fund to recognize income or gain without a corresponding receipt of cash; (v) adversely affect the time as to when a purchase or sale of securities is deemed to occur; (vi) adversely alter the characterization of certain complex financial transactions; and (vii) produce income that will not be qualifying income for purposes of the 90% Income Test described above. The Fund will monitor its transactions and may make certain tax decisions in order to mitigate the potential adverse effect of these provisions.

A RIC is limited in its ability to deduct expenses in excess of its “investment company taxable income” (which is, generally, ordinary income plus the excess of net short-term capital gains over net long-term capital losses). If Fund expenses in a given year exceed investment company taxable income, the Fund would experience a net operating loss for that year. However, a RIC is not permitted to carry forward net operating losses to subsequent years. In addition, expenses can be used only to offset investment company taxable income, not net capital gain. Due to these limits on the deductibility of expenses, the Fund may, for tax purposes, have aggregate taxable income for several years that it is required to distribute and that is taxable to shareholders even if such income is greater than the aggregate net income it actually earned during those years. Such required distributions may be made from cash assets or by liquidation of investments, if necessary. The Fund may realize gains or losses from such liquidations. In the event the Fund realizes net capital gains from such transactions, a shareholder may receive a larger capital gain distribution than it would have received in the absence of such transactions.

Failure to Qualify as a RIC

If we fail to qualify for treatment as a RIC, we will be subject to U.S. federal income tax on all of our taxable income at regular corporate rates (and also will be subject to any applicable state and local taxes), regardless of whether we make any distributions to our shareholders. If we have qualified as RIC and then we subsequently fail to satisfy the 90% Income Test or the Diversification Tests for any taxable year or quarter of such taxable year, we may nevertheless continue to qualify as a RIC for such year if certain relief provisions of the Code apply (which may, among other things, require us to pay certain U.S. federal income taxes at corporate rates or to dispose of certain assets). If we fail to qualify for treatment as a RIC and such relief provisions do not apply to us, we will be subject to U.S. federal income tax on all of our taxable income at regular corporate rates (and also will be subject to any applicable state and local taxes), regardless of whether we make any distributions to our shareholders. In any taxable year that we do not qualify as a RIC, distributions would not be required and, if distributions were made, any such distributions would be taxable to our shareholders as ordinary dividend income to the extent of our current and accumulated earnings and profits. Subject to certain holding period requirements and other limitations under the Code, any such distributions to non-corporate shareholders may qualify as "qualified dividends" that are subject to U.S. federal income tax at a rate of 20%, and corporate distributees may be eligible for the dividends-received deduction. Distributions in excess of our current and accumulated earnings and profits would be treated first as a return of capital to the extent of the shareholder’s adjusted tax basis, and any remaining distributions would be treated as a capital gain. The term “return of capital” merely means distributions in excess of our earnings and as such may constitute a return on an investor's individual investments and does not mean a return on capital.

Subject to a limited exception applicable to RICs that qualified as such under Subchapter M of the Code for at least one year prior to disqualification and that requalify as a RIC no later than the second year following the non-

20

qualifying year, we could be subject to U.S. federal income tax on any unrealized net built-in gains in the assets held by us during the period in which we failed to qualify as a RIC that are recognized during the five-year period after our requalification as a RIC, unless we made a special election to pay U.S. federal income tax at corporate rates on such built-in gain at the time of our qualification or requalification as a RIC.

ITEM 1A. RISK FACTORS

You should carefully consider these risk factors, together with all of the other information included in this Annual Report on Form 10-K and the other reports and documents filed by us with the SEC. The risks set out below are not the only risks we face. Additional risks and uncertainties not presently known to us or not presently deemed material by us may also impair our operations and performance. If any of the following events occur, our business, financial condition, results of operations and cash flows could be materially and adversely affected. In such case, our net asset value and the trading price of our common stock could decline, and you may lose all or part of your investment. The risk factors described below are the principal risk factors associated with an investment in us as well as those factors generally associated with an investment company with investment objectives, investment policies, capital structure or trading markets similar to ours.

The following is a summary of the principal risk factors associated with an investment in the Fund. Further details regarding each risk included in the below summary list can be found further below.

We are subject to risks related to our business and structure.

•The Fund has a limited operating history.

•We depend upon the senior management of Churchill for our success, and upon its access to the investment professionals of Nuveen and its affiliates.

•There may be conflicts related to obligations that senior investment professionals of Churchill and members of its investment committee have to other clients. There may be conflicts related to the investment and related activities of TIAA, Nuveen and Churchill.

•The recommendations given to us by Churchill may differ from those rendered to its other clients.

•Our management and incentive fee structure may create incentives for Churchill and certain of its investment professionals that are not fully aligned with the interests of our shareholders.

•Our ability to enter into transactions with our affiliates is restricted, which may limit the scope of investments available to us.

•We will be subject to U.S. federal income tax at corporate rates if we are unable to qualify or maintain qualification as a RIC under Subchapter M of the Code.

•Regulations governing our operation as a BDC affect our ability to and the way in which we raise additional capital.

•We are exposed to risks associated with changes in interest rates.

•Many of our portfolio investments will be recorded at fair value as determined in good faith by the Adviser, as the valuation designee, subject to the oversight of the Board, and, as a result, there may be uncertainty as to the value of our portfolio investments.

•We may experience fluctuations in our quarterly operating results.

•Global economic, political and market conditions may adversely affect our business or cause us to alter our business strategy.

•We are currently operating in a period of significant market disruption and economic uncertainty, which may have a negative impact on our business, financial condition and operations.

•New or modified laws or regulations governing our operations could adversely affect our business.

21

•The failure of cybersecurity protection systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning, could impair our ability to conduct business effectively.

•Churchill may not be able to achieve the same or similar returns as those achieved by our senior management and investment personnel while they were employed at prior positions.

•Our access to confidential information may restrict our ability to take action with respect to some of our investments, which, in turn, may negatively affect our results of operations.

We are subject to risks related to our operations.

•Economic recessions or downturns could impair our portfolio companies and harm our operating results.

•We invest in middle-market, privately owned companies, which may present a greater risk of loss than loans to larger companies.

•We may be subject to risks associated with our investments in Senior Loan Investments, unitranche secured loans and securities, junior debt securities, “covenant-lite” loans and equity-related securities.

•The lack of liquidity in our investments may adversely affect our business.

•Defaults by our portfolio companies will harm our operating results.

We are subject to risks related to an investment in our Common Shares.

•There is currently no public market for our Common Shares, and the liquidity of your investment is limited.

•If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital.

•We may choose to pay a portion of our dividends in our own Common Shares, in which case you may be required to pay U.S. federal income taxes in excess of the cash you receive.

•Investing in our Common Shares may involve an above-average degree of risk.

•There are restrictions on the ability of holders of our Common Shares to transfer such Common Shares in excess of the restrictions typically associated with a private offering of securities under Regulation D and other exemptions from registration under the Securities Act, and these restrictions could limit the liquidity of an investment in our Common Shares and the price at which holders may be able to sell the Common Shares.

Risks Related to the Fund’s Business and Structure

The Fund has limited operating history.

The Fund began investment operations in March 2022, and, as a result, has limited operating history and limited financial information on which prospective investors can evaluate an investment in the Common Shares or prior performance. As a result, we are subject to the business risks and uncertainties associated with recently formed businesses, including the risk that we will not achieve our investment objective and the value of a shareholder’s investment could decline substantially or become worthless. Further, Churchill has not previously offered a non-traded BDC. While we believe that the past professional experiences of Churchill’s investment team, including investment and financial experience of Churchill’s senior management, will increase the likelihood that Churchill will be able to manage the Fund successfully, there can be no assurance that this will be the case.

Our Board may change our investment objective, operating policies and strategies without prior notice or shareholder approval, the effects of which may be adverse.

Our Board has the authority, except as otherwise prohibited by the 1940 Act, to modify or waive certain of our operating policies and strategies without prior notice and without shareholder approval. However, absent shareholder approval, we may not change the nature of our business so as to cease to be, or withdraw our election as, a BDC. We cannot predict the effect any changes to our current operating policies, investment criteria and strategies would have on our

22

business, NAV, operating results and the price value of our Common Shares. Nevertheless, any such changes could adversely affect our business and impair our ability to make distributions, and cause you to lose all or part of your investment. Moreover, we have significant flexibility in investing the net proceeds from our continuous offering and may use the net proceeds from our continuous offering in ways in which investors may not agree.

Our Board may amend our Declaration of Trust without prior shareholder approval.

Our Board may, without shareholder vote, subject to certain exceptions, amend or otherwise supplement the Declaration of Trust by making an amendment, a Declaration of Trust supplemental thereto or an amended and restated Declaration of Trust, including without limitation to classify the Board, to impose advance notice bylaw provisions for Trustee nominations or for shareholder proposals, to require super-majority approval of transactions with significant shareholders or other provisions that may be characterized as anti-takeover in nature.

Price declines and illiquidity in the corporate debt markets may adversely affect the fair value of our portfolio investments, reducing our NAV through increased net unrealized depreciation.

We are required to carry our investments at market value or, if no market quotation is readily available, at fair value as determined in good faith by the Adviser as the valuation designee. When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, we use the pricing indicated by the external event to corroborate our valuation. We record decreases in the market values or fair values of our investments as unrealized depreciation. Declines in prices and liquidity in the corporate debt markets may result in significant net unrealized depreciation in our portfolio. The effect of all of these factors on our portfolio may reduce our NAV by increasing net unrealized depreciation in our portfolio. Depending on market conditions, we could incur substantial realized losses and may suffer additional unrealized losses in future periods, which could have a material adverse effect on our business, financial condition and results of operations.

Our financial condition and results of operations depend on our ability to manage our business effectively.

Our ability to achieve our investment objective and grow depends on our ability to manage our business. This depends, in turn, on the ability of the Adviser to identify, invest in and monitor companies that meet our investment criteria. The achievement of our investment objective depends upon Adviser’s execution of our investment process, their ability to provide competent, attentive and efficient services to us and, to a lesser extent, our access to financing on acceptable terms. The Adviser has substantial responsibilities under the Investment Advisory Agreement. The senior origination professionals and other personnel of Adviser and its affiliates may be called upon to provide managerial assistance to our portfolio companies. These activities may distract them or slow our rate of investment. Any failure to manage our business and our future growth effectively could have a material adverse effect on our business, financial condition, and results of operations. Our results of operations depend on many factors, including the availability of opportunities for investment, readily accessible short and long-term funding alternatives in the financial markets and economic conditions. Furthermore, if we cannot successfully operate our business or implement our investment policies and strategies, it could negatively impact our ability to pay dividends or other distributions and you may lose all or part of your investment.

Churchill may not be able to achieve the same or similar returns as those achieved by our senior management and investment personnel while they were employed at prior positions.

The track record and achievements of the senior investment professionals of Churchill are not necessarily indicative of future results that will be achieved by Churchill. As a result, Churchill may not be able to achieve the same or similar returns as those previously achieved by the senior investment professionals of Churchill.

In addition, we depend upon the senior investment professionals of Churchill to maintain their relationships with financial institutions, sponsors and investment professionals, and we rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the senior investment professionals of Churchill fail to maintain such relationships, or to develop new relationships with other sources of investment opportunities, we will not be able to grow our investment portfolio. In addition, individuals with whom the senior investment professionals of Churchill have relationships are not obligated to provide us with investment opportunities, and, therefore, we can offer no assurance that these relationships will generate investment opportunities for us in the future.

23

We operate in a highly competitive market for investment opportunities, which could reduce returns and result in losses.

We compete with a number of specialty and commercial finance companies to make the types of investments that we make in middle-market companies, including BDCs, traditional commercial banks, private investment funds, regional banking institutions, small business investment companies, investment banks and insurance companies. Additionally, with increased competition for investment opportunities, alternative investment vehicles such as hedge funds may seek to invest in areas they have not traditionally invested in or from which they had withdrawn during the economic downturn, including investing in middle-market companies. As a result, competition for investments in middle-market companies has intensified, and we expect that trend to continue. Certain of our existing and potential competitors are large and may have greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments, which could allow them to consider a wider variety of investments and establish more relationships than us. These characteristics could allow our competitors to consider a wider variety of investments, establish more relationships and offer better pricing and more flexible structuring than we offer. We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. If we are forced to match our competitors’ pricing, terms and structure, however, we may not be able to achieve acceptable returns on our investments or may bear substantial risk of capital loss.

Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC or the source of income, asset diversification and distribution requirements we must satisfy to obtain and maintain our RIC tax treatment. The competitive pressures we face may have a material adverse effect on our business, financial condition and results of operations. As a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we may not be able to identify and make investments that are consistent with our investment objective.

Many of our portfolio investments will be recorded at fair value as determined in good faith by the Adviser, as the valuation designee, subject to the oversight of the Board, and, as a result, there may be uncertainty as to the value of our portfolio investments.

Our Board designated the Adviser as our valuation designee (the “Valuation Designee”) pursuant to Rule 2a-5 under the 1940 Act to determine the fair value of our investments that do not have readily available market quotations, effective beginning in the fiscal quarter ended March 31, 2023. Under the 1940 Act, we are required to carry our portfolio investments at market value or if there is no readily available market value, at fair value as determined by the Valuation Designee, subject to the oversight of the Board. Many of our portfolio investments may take the form of securities that are not publicly traded. The fair value of securities and other investments that are not publicly traded may not be readily determinable, and we value these securities at fair value as determined in good faith by the Valuation Designee, including to reflect significant events affecting the value of our securities. As part of the valuation process, we may take into account the following types of factors, if relevant, in determining the fair value of our investments:

•a comparison of the portfolio company’s securities to publicly traded securities;

•the enterprise value of a portfolio company;

•the nature and realizable value of any collateral;

•the portfolio company’s ability to make payments and its earnings and discounted cash flow;

•the markets in which the portfolio company does business; and

•changes in the interest rate environment and the credit markets generally that may affect the price at which similar investments may be made in the future and other relevant factors.

We expect that most of our investments (other than cash and cash equivalents) will be classified as Level 3 in the fair value hierarchy and require disclosures about the level of disaggregation along with the inputs and valuation techniques we use to measure fair value. This means that our portfolio valuations are based on unobservable inputs and our own assumptions about how market participants would price the asset or liability in question. Inputs into the determination of fair value of our portfolio investments require significant management judgment or estimation. Even if observable market data is available, such information may be the result of consensus pricing information or broker quotes, which include a

24

disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimers materially reduces the reliability of such information. We employ the services of one or more independent service providers to review the valuation of these securities. The types of factors that the Valuation Designee may take into account in determining the fair value of our investments generally include, as appropriate, comparison to publicly traded securities including such factors as yield, maturity and measures of credit quality, the enterprise value of a portfolio company, the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings and discounted cash flow, the markets in which the portfolio company does business and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Due to this uncertainty in the value of our portfolio investments, a fair value determination may cause NAV on a given date to materially understate or overstate the value that we may ultimately realize upon one or more of our investments. As a result, investors purchasing our Common Shares based on an overstated NAV would pay a higher price than the value of the investments might warrant. Conversely, investors selling Common Shares during a period in which the NAV understates the value of investments will receive a lower price for their Common Shares than the value the investment portfolio might warrant.

We will adjust quarterly the valuation of our portfolio to reflect the determination of the Valuation Designee of the fair value of each investment in our portfolio. Any changes in fair value are recorded in our statements of operations as net change in unrealized gain (loss) on investments.

We may not be able to pay distributions, our distributions may not grow over time and/or a portion of our distributions may be a return of capital.

We intend to pay distributions to our shareholders. We cannot assure you that we will achieve investment results that will allow us to sustain a specified level of cash distributions or make periodic increases in cash distributions. Our ability to pay distributions might be adversely affected by, among other things, the impact of one or more of the risk factors described herein. In addition, the inability to satisfy the asset coverage requirement applicable to us as a BDC could limit our ability to pay distributions. All distributions will be paid at the discretion of the Board and will depend on our earnings, our financial condition, maintenance of our RIC tax treatment, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time. We cannot assure you that we will continue to pay distributions to our shareholders.

When we make distributions, we will be required to determine the extent to which such distributions are paid out of current or accumulated earnings and profits. Distributions in excess of current and accumulated earnings and profits will be treated as a non-taxable return of capital to the extent of an investor’s adjusted tax basis in our Common Shares and, assuming that an investor holds our Common Shares as a capital asset, thereafter as a capital gain.

The amount of any distributions we may make is uncertain. Our distributions may exceed our earnings, particularly during the period before we have substantially invested the net proceeds from our public offering. Therefore, portions of the distributions that we make may represent a return of capital to you that will lower your adjusted tax basis in your Common Shares and reduce the amount of funds we have for investment in targeted assets.

We may fund our cash distributions to shareholders from any sources of funds available to us, including borrowings, net investment income from operations, capital gains proceeds from the sale of assets, non-capital gains proceeds from the sale of assets, dividends or other distributions paid to us on account of preferred and common equity investments in portfolio companies and fee and expense reimbursement waivers from the Adviser or the Administrator, if any. Our ability to pay distributions might be adversely affected by, among other things, the impact of one or more of the risk factors described in this Annual Report on Form 10-K. In addition, the inability to satisfy the asset coverage requirement applicable to us as a BDC may limit our ability to pay distributions. All distributions are and will be paid at the discretion of our Board and will depend on our earnings, our financial condition, maintenance of our RIC tax treatment, compliance with applicable BDC regulations and such other factors as our Board may deem relevant from time to time. We cannot assure you that we will continue to pay distributions to our shareholders in the future. In the event that we encounter delays in locating suitable investment opportunities, we may pay all or a substantial portion of our distributions from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which may constitute a return of your capital. A return of capital is a return of your investment, rather than a return of earnings or gains derived from our investment activities.

25

We have not established any limit on the amount of funds we may use from certain available sources, such as proceeds from this offering, to fund distributions (which may reduce the amount of capital we ultimately invest in assets).

Our use of borrowings, if any, to fund distributions is subject to the limitations set forth in Section VI.K of the NASAA Omnibus Guidelines (as defined below) and Section 5.4(f) of our Declaration of Trust. However, shareholders should understand that any distributions made from sources other than cash flow from operations or relying on fee or expense reimbursement waivers, if any, from the Adviser of the Administrator are not based on our investment performance, and can only be sustained if we achieve positive investment performance in future periods and/or the Adviser or the Administrator continues to makes such expense reimbursements, if any. The extent to which we pay distributions from sources other than cash flow from operations will depend on various factors, including the level of participation in our distribution reinvestment plan, how quickly we invest the proceeds from this and any future offering and the performance of our investments. Shareholders should also understand that our future repayments to the Adviser will reduce the distributions that they would otherwise receive. There can be no assurance that we will achieve such performance in order to sustain these distributions, or be able to pay distributions at all. The Adviser and the Administrator have no obligation to waive fees or receipt of expense reimbursements, if any.

Although we have implemented a share repurchase program, we have discretion to not repurchase your shares or to suspend the program.

Our Board may amend or suspend the share repurchase program at any time in its discretion. You may not be able to sell your shares on a timely basis in the event our Board amends or suspends the share repurchase program, absent a liquidity event, and we currently do not intend to undertake a liquidity event, and we are not obligated by our Declaration of Trust or otherwise to effect a liquidity event at any time. We will notify you of such developments in our quarterly reports or other filings. If less than the full amount of shares requested to be repurchased in any given repurchase offer are repurchased, funds will be allocated pro rata based on the total number of Common Shares being repurchased without regard to class. The share repurchase program will have many limitations and should not be considered a guaranteed method to sell shares promptly or at a desired price.

The timing of our repurchase offers pursuant to our share repurchase program may be at a time that is disadvantageous to our shareholders.

In the event a shareholder chooses to participate in our share repurchase program, the shareholder will be required to provide us with notice of intent to participate prior to knowing what the NAV per share of the class of Common Shares being repurchased will be on the repurchase date. Although a shareholder will have the ability to withdraw a repurchase request prior to the repurchase date, to the extent a shareholder seeks to sell Common Shares to us as part of our periodic share repurchase program, the shareholder will be required to do so without knowledge of what the repurchase price of our Common Shares will be on the repurchase date.

There are significant financial and other resources necessary to comply with the requirements of being an SEC reporting entity.

As a public entity, we are subject to the reporting requirements of the Exchange Act and requirements of the Sarbanes-Oxley Act. These requirements may place a strain on our systems and resources. The Exchange Act requires that we file annual, quarterly and current reports with respect to our business and financial condition. The Sarbanes-Oxley Act requires that we maintain effective disclosure controls and procedures and internal controls over financial reporting, which are discussed below. In order to maintain and improve the effectiveness of our disclosure controls and procedures and internal controls, significant resources and management oversight will be required. We have implemented procedures, processes, policies and practices for the purpose of addressing such standards and requirements applicable to public companies. These activities may divert management’s attention from other business concerns, which could have a material adverse effect on our business, financial condition, results of operations and cash flows. We expect to incur significant additional annual expenses related to these steps and, among other things, directors’ and officers’ liability insurance, trustee fees, reporting requirements of the SEC, transfer agent fees, additional administrative expenses payable to the Administrator to compensate them for hiring additional accounting, legal and administrative personnel, increased auditing and legal fees and similar expenses.

26

Efforts to comply with Section 404 of the Sarbanes-Oxley Act will involve significant expenditures, and noncompliance with Section 404 of the Sarbanes-Oxley Act may adversely affect us.

We are required to report on our internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. We are required to review on an annual basis our internal controls over financial reporting, and on a quarterly and annual basis to evaluate and disclose changes in our internal controls over financial reporting. As a result, we incur additional expenses that may negatively impact our financial performance. This process also may result in a diversion of management’s time and attention. We cannot be certain as to the timing of completion of our evaluation, testing and remediation actions or the impact of the same on our operations, and we may not be able to ensure that the process is effective or that our internal controls over financial reporting is or will be effective in a timely manner. In the event that we are unable to maintain or achieve compliance with Section 404 of the Sarbanes-Oxley Act and related rules, we may be adversely affected.

Our independent registered public accounting firm will not be required to formally attest to the effectiveness of our internal controls over financial reporting until the date on which we are a “large accelerated filer” or an “accelerated filer.” As a publicly reporting entity, we will be required to complete our initial assessment in a timely manner. If we are not able to implement the requirements of Section 404 in a timely manner or with adequate compliance, our operations, financial reporting or financial results could be adversely affected. Matters impacting our internal controls may cause us to be unable to report our financial information on a timely basis and thereby subject us to adverse regulatory consequences, including sanctions by the SEC, violations of the NYSE listing rules, and result in a breach of the covenants under the agreements governing any of our financing arrangements. There could also be a negative reaction in the financial markets due to a loss of investor confidence in us and the reliability of our financial statements. Confidence in the reliability of our financial statements could also suffer if we or our independent registered public accounting firm were to report a material weakness in our internal controls over financial reporting. This could materially adversely affect us and lead to a decline in the market price of our shares.

We may experience fluctuations in our quarterly operating results.

We could experience fluctuations in our quarterly operating results due to a number of factors, including our ability or inability to make investments in companies that meet our investment criteria, the interest rate payable on the debt securities we acquire, the default rate on such securities, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our markets and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods.

We are an “emerging growth company” under the JOBS Act, and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our Common Shares less attractive to investors.

We will be and we will remain an “emerging growth company” as defined in the JOBS Act up to five years measured from the date of the first sale of common equity securities pursuant to an effective registration statement, or until the earlier of (a) the last day of the first fiscal year (i) in which we have total annual gross revenue of at least $1.235 billion, or (ii) in which we are deemed to be a large accelerated filer, which means the market value of our Common Shares that is held by non-affiliates exceeds $700 million as of the date of our most recently completed second fiscal quarter, and (b) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. For so long as we remain an “emerging growth company,” we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act. We cannot predict if investors will find our Common Shares less attractive because we will rely on some or all of these exemptions. If some investors find our Common Shares less attractive as a result, there may be a less active trading market for our Common Shares and our share price may be more volatile.

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We will take advantage of the extended transition period for complying with new or revised accounting standards, which may make it more difficult for investors and securities analysts to evaluate us since our financial statements may not be comparable to companies that comply with public company effective dates and may result in less investor confidence.

27

Any unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available for distribution.

As a BDC, we will be required to carry our investments at market value or, if no market value is ascertainable, at the fair value as determined in good faith by our Board. Decreases in the market value or fair value of our investments relative to amortized cost will be recorded as unrealized depreciation. Any unrealized losses in our portfolio could be an indication of a portfolio company’s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods. In addition, decreases in the market value or fair value of our investments will reduce our NAV.

Terrorist attacks, acts of war, global health emergencies or natural disasters may affect any market for our Common Shares, impact the businesses in which we invest and harm our business, operating results and financial condition.

Terrorist acts, acts of war, global health emergencies or natural disasters may disrupt our operations, as well as the operations of the businesses in which we invest. Such acts have created, and continue to create, economic and political uncertainties and have contributed to global economic instability. Future terrorist activities, military or security operations, global health emergencies or natural disasters could further weaken the domestic/global economies and create additional uncertainties, which may negatively impact the businesses in which we invest directly or indirectly and, in turn, could have a material adverse impact on our business, operating results and financial condition. Losses from terrorist attacks, global health emergencies and natural disasters are generally uninsurable.

In late February 2022, Russia launched a large scale military attack on Ukraine. The invasion significantly amplified already existing geopolitical tensions among Russia, Ukraine, Europe, NATO and the West, including the United States. In response to the ongoing military action by Russia, various countries, including the United States, the United Kingdom, and European Union issued broad-ranging economic sanctions against Russia. Such sanctions included, among other things, a prohibition on doing business with certain Russian companies, large financial institutions, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications (“SWIFT”), the electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. Additional sanctions may be imposed in the future. Such sanctions (and any future sanctions) and other actions against Russia may adversely impact, among other things, the Russian economy and various sectors of the economy, including but not limited to, financials, energy, metals and mining, engineering and defense and defense-related materials sectors; result in a decline in the value and liquidity of Russian securities; result in boycotts, tariffs, and purchasing and financing restrictions on Russia’s government, companies and certain individuals; weaken the value of the ruble; downgrade the country’s credit rating; freeze Russian securities and/or funds invested in prohibited assets and impair the ability to trade in Russian securities and/or other assets; and have other adverse consequences on the Russian government, economy, companies and region. Further, several large corporations and U.S. states have announced plans to divest interests or otherwise curtail business dealings with certain Russian businesses.

In addition, the recent outbreak of hostilities in the Middle East and escalating tensions in the region may create volatility and disruption of global markets.

The ramifications of the hostilities and sanctions, however, may not be limited to Russia and the Middle East and Russian and Middle Eastern companies, respectively, but may spill over to and negatively impact other regional and global economic markets (including Europe and the United States), companies in other countries (particularly those that have done business with Russia) and on various sectors, industries and markets for securities and commodities globally, such as oil and natural gas. Accordingly, the actions discussed above and the potential for a wider conflict could increase financial market volatility, cause severe negative effects on regional and global economic markets, industries, and companies and have a negative effect on the Fund’s investments and performance, which may, in turn, impact the valuation of such portfolio companies. In addition, parties in such conflicts may take retaliatory actions and other countermeasures, including cyberattacks and espionage against other countries and companies around the world, which may negatively impact such countries and the companies in which the Fund invests. The extent and duration of the military action or future escalation of such hostilities, the extent and impact of existing and future sanctions, market disruptions and volatility, and the result of any diplomatic negotiations cannot be predicted. These and any related events could have a significant impact on the Fund’s performance and the value of an investment in the Fund.

28

We are currently operating in a period of significant market disruption and economic uncertainty, which may have a negative impact on our business, financial condition and operations. An extended disruption in the capital markets and the credit markets could negatively affect our business.

From time to time, capital markets may experience periods of disruption and instability. The U.S. capital markets have experienced extreme volatility and disruption following the global outbreak of COVID-19 that began in December 2019, the conflict between Russia and Ukraine that began in late February 2022, and the ongoing war in the Middle East. Even after the COVID-19 pandemic subsided, the U.S. economy, as well as most other major economies, have continued to experience unpredictable economic conditions, and we anticipate our businesses would be materially and adversely affected by any prolonged economic downturn or recession in the United States and other major markets. In addition, disruptions in the capital markets have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets.

The current economic conditions have resulted in an adverse impact on the ability of lenders to originate loans, the volume and type of loans originated, the ability of borrowers to make payments and the volume and type of amendments and waivers granted to borrowers and remedial actions taken in the event of a borrower default, each of which could negatively impact the amount and quality of loans available for investment by the Fund and returns to the Fund, among other things. The U.S. credit markets (in particular for middle-market loans) have experienced the following among, other things: (i) increased draws by borrowers on revolving lines of credit and other financing instruments; (ii) increased requests by borrowers for amendments and waivers of their credit agreements to avoid default, increased defaults by such borrowers and/or increased difficulty in obtaining refinancing at the maturity dates of their loans and increased uses of PIK features; and (iii) greater volatility in pricing and spreads and difficulty in valuing loans during periods of increased volatility, and liquidity issues.

These conditions and future market disruptions and/or illiquidity could have an adverse effect on our (and our portfolio companies’) business, financial condition, results of operations and cash flows. Ongoing unfavorable economic conditions may increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to our portfolio companies and/or us. These events have limited and could continue to limit our investment originations, limit our ability to grow and have a material negative impact on our operating results and the fair values of our debt and equity investments. We may have to access, if available, alternative markets for debt and equity capital, and a severe disruption in the global financial markets, deterioration in credit and financing conditions, continued increases in interest rates, or uncertainty regarding U.S. government spending and deficit levels or other global economic conditions could have a material adverse effect on our business, financial condition and results of operations.

While we intend to continue to source and invest in new loan transactions to U.S. middle market companies, we cannot be certain that we will be able to do so successfully or consistently. A lack of suitable investment opportunities may impair our ability to make new investments, and may negatively impact our earnings and result in decreased dividends to our shareholders.

If current economic conditions continue for an extended period of time, loan delinquencies, loan non-accruals, problem assets, and bankruptcies may increase. In addition, collateral for our loans may decline in value, which could cause loan losses to increase and the net worth and liquidity of loan guarantors could decline, impairing their ability to honor commitments to us. An increase in loan delinquencies and non-accruals or a decrease in loan collateral and guarantor net worth could result in increased costs and reduced income which would have a material adverse effect on our business, financial condition or results of operations. We continue to observe supply chain interruptions, labor difficulties, commodity inflation and elements of economic and financial market instability both globally and in the United States.

We will need to raise additional capital in the future in order to continue to make investments in accordance with our business and investing strategy and to pursue new business opportunities. Ongoing disruptive conditions in the financial industry and the impact of new legislation in response to those conditions could restrict our business operations and could adversely impact our results of operations and financial condition.

In addition, we are required to distribute at least 90% of our net ordinary income and net short-term capital gains in excess of net long-term capital losses, if any, to our shareholders to qualify for the tax benefits available to RICs. As a result, these earnings will not be available to fund new investments. An inability to access the capital markets successfully could limit our ability to grow our business and execute our business strategy fully and could decrease our earnings, if any, which may have a material adverse effect on our business, results of operations and financial performance.

29

We cannot be certain as to the duration or magnitude of the ongoing economic condition in the markets in which we and our portfolio companies operate and corresponding declines in economic activity that may negatively impact the U.S. economy and the markets for the various types of goods and services provided by U.S. middle market companies. Depending on the duration, magnitude and severity of these conditions and their related economic and market impacts, certain of our portfolio companies may suffer declines in earnings and could experience financial distress, which could cause them to default on their financial obligations to us and their other lenders. In consideration of these and related factors, we may make downgrades with respect to other portfolio companies in the future as conditions warrant and new information comes to light.

The failure of cybersecurity protection systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning, could impair our ability to conduct business effectively.

We,and others in our industry, are the targets of malicious cyber activity, which we work hard to prevent. A successful cyber-attack, whether perpetrated by criminal or state-sponsored actors, against us or our service providers, or an accidental disclosure of non-public information, could have an adverse effect on our ability to conduct business and on our results of operations and financial condition, particularly if those events affect our computer-based data processing, transmission, storage, and retrieval systems or destroy data. If a significant number of our managers were unavailable in the event of a disaster, our ability to effectively conduct our business could be severely compromised.

The Adviser and third-party service providers with which we do business depend heavily upon computer systems to perform necessary business functions. Despite the implementation of a variety of security measures, computer systems could be subject to unauthorized access, acquisition, use, alteration, or destruction, such as from the insertion of malware (including ransomware), physical and electronic break-ins or unauthorized tampering. The Adviser may experience threats to their data and systems, including malware and computer virus attacks, unauthorized access, system failures and disruptions. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, personal, and other information processed and stored in, and transmitted through, the Adviser’s computer systems and networks, or otherwise cause interruptions or malfunctions in operations, which could result in damage to our reputation, financial losses, litigation, increased costs, regulatory enforcement action and penalties and/or customer dissatisfaction or loss.

Third parties with which we do business are sources of cybersecurity or other technological risks. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as customer, counterparty, employee and borrower information. Cybersecurity failures or breaches by our Adviser and other service providers (including, but not limited to, accountants, custodians, transfer agents and administrators), and the issuers of securities in which we invest, also have the ability to cause disruptions and impact business operations, potentially resulting in financial losses, interference with our ability to calculate its NAV, impediments to trading, the inability of our shareholders to transact business, violations of applicable privacy and other laws, regulatory fines, penalties, reputation damages, reimbursement of other compensation costs, or additional compliance costs. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, acquisition, use, alteration or destruction of data, or other cybersecurity incidents, with increased costs and other consequences, including those described above. In addition, substantial costs may be incurred in order to prevent any cyber incidents in the future.

Privacy and information security laws and regulation changes, and compliance with those changes, may result in cost increases due to system changes and the development of new administrative processes. In addition, we may be required to expend significant additional resources to modify our protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks. Currently, we are covered under TIAA’s insurance policy relating to cybersecurity risks; however, we may be required to expend significant additional resources to modify our protective measures or to investigate and remediate vulnerabilities or other exposures, and we may be subject to litigation and financial losses that are not fully insured.

We and our service providers may be impacted by operating restrictions, which may include requiring employees to continue to work from remote locations. Policies of extended periods of remote working, whether by us or our service providers, could strain technology resources, introduce operational risks and otherwise heighten the risks described above. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts that seek to exploit weaknesses in a remote work environment. Accordingly, the risks described above are heightened under current conditions, which may continue for an unknown duration.

Our business is dependent on bank relationships and recent strain on the banking system may adversely impact us.

The financial markets recently have encountered volatility associated with concerns about the balance sheets of banks, especially small and regional banks that may have significant losses associated with investments that make it difficult to

30

fund demands to withdraw deposits and other liquidity needs. Although the federal government has announced measures to assist these banks and protect depositors, some banks have already been impacted and others may be materially and adversely impacted. Our business is dependent on bank relationships, including small and regional banks, and we are proactively monitoring the financial health of banks with which we (or our portfolio companies) do or may in the future do business. To the extent that our portfolio companies work with banks that are negatively impacted by the foregoing, such portfolio companies’ ability to access their own cash, cash equivalents and investments may be threatened. In addition, such affected portfolio companies may not be able to enter into new banking arrangements or credit facilities, or receive the benefits of their existing banking arrangements or credit facilities. Any such developments could harm our business, financial condition, and operating results, and prevent us from fully implementing our investment plan. Continued strain on the banking system may adversely impact our business, financial condition and results of operations.

We may not be able to obtain all required state licenses.

We may be required to obtain various state licenses in order to, among other things, originate commercial loans. Applying for and obtaining required licenses can be costly and take several months. There is no assurance that we will obtain all of the licenses that we need on a timely basis. Furthermore, we will be subject to various information and other requirements in order to obtain and maintain these licenses, and there is no assurance that we will satisfy those requirements. Our failure to obtain or maintain licenses might restrict investment options and have other adverse consequences.

Global economic, political and market conditions, including BREXIT, may adversely affect our business or cause us to alter our business strategy.

The current worldwide financial market situation, as well as various social and political tensions in the United States and around the world, may contribute to increased market volatility, may have long-term effects on the U.S. and worldwide financial markets, and may cause economic uncertainties or deterioration in the United States and worldwide. The U.S. and global capital markets experienced extreme volatility and disruption during the economic downturn that began in mid-2007, and the U.S. economy was in a recession for several consecutive calendar quarters during the same period. In 2010, a financial crisis emerged in Europe, triggered by high budget deficits and rising direct and contingent sovereign debt, which created concerns about the ability of certain nations to continue to service their sovereign debt obligations. Risks resulting from such debt crisis, including any austerity measures taken in exchange for bailout of certain nations, and any future debt crisis in Europe or any similar crisis elsewhere could have a detrimental impact on the global economic recovery, sovereign and non-sovereign debt in certain countries and the financial condition of financial institutions generally.

On January 31, 2020, the United Kingdom ended its membership in the European Union, referred to as Brexit. Following the termination of a transition period, the United Kingdom and the European Union entered into a trade and cooperation agreement to govern the future relationship between the parties, which was provisionally applied as of January 1, 2021 and entered into force on May 1, 2021 following ratification by the European Union. With respect to financial services, the agreement leaves decisions on equivalence and adequacy to be determined by each of the United Kingdom and the European Union unilaterally in due course. Such agreement is untested and could lead to ongoing political and economic uncertainty and periods of exacerbated volatility in both the United Kingdom and in wider European and global markets for some time. In addition, on December 24, 2020, the European Union and United Kingdom governments signed a trade deal that became provisionally effective on January 1, 2021 and that now governs the relationship between the United Kingdom and the European Union (the “Trade Agreement”). The Trade Agreement implements significant regulation around trade, transport of goods and travel restrictions between the United Kingdom and the European Union.

Notwithstanding the foregoing, the longer term economic, legal, political and social implications of Brexit are unclear at this stage and are likely to continue to lead to ongoing political and economic uncertainty and periods of increased volatility in both the United Kingdom and in wider European markets for some time. In particular, Brexit could lead to calls for similar referendums in other European Union jurisdictions, which could cause increased economic volatility in the European and global markets. This mid- to long-term uncertainty could have adverse effects on the economy generally and on our ability to earn attractive returns. In particular, currency volatility could mean that our returns are adversely affected by market movements and could make it more difficult or more expensive, for us to executed prudent currency hedging policies.

31

Compliance with the SEC’s Regulation Best Interest may negatively impact our ability to raise capital in our offering, which would harm our ability to achieve our investment objective.

Commencing June 30, 2020, broker-dealers must comply with Regulation Best Interest, which, among other requirements, enhances the existing standard of conduct for broker-dealers and natural persons who are associated persons of a broker-dealer when recommending to a retail customer any securities transaction or investment strategy involving securities to a retail customer. The impact of Regulation Best Interest on broker-dealers participating in our offering cannot be determined at this time, but it may negatively impact whether broker-dealers and their associated persons recommend our offering to retail customers. Regulation Best Interest imposes a duty of care for broker-dealers to evaluate reasonable alternatives in the best interests of their clients. Reasonable alternatives to the Fund exist and may have lower expenses and/or lower investment risk than the Fund. Under Regulation Best Interest, broker-dealers participating in the offering must consider such alternatives in the best interests of their clients. If Regulation Best Interest reduces our ability to raise capital in our offering, it would harm our ability to create a diversified portfolio of investments and achieve our investment objective and would result in our fixed operating costs representing a larger percentage of our gross income.

Risks Related to Our Investments

Our investments in leveraged portfolio companies may be risky, and you could lose all or part of your investment.

Investment in leveraged companies involves a number of significant risks. Leveraged companies in which we may invest may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold. Such developments may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of our realizing any guarantees that we may have obtained in connection with our investment. In addition, our junior secured loans are generally subordinated to Senior Loan Investments. As such, other creditors may rank senior to us in the event of an insolvency.

We typically invest in middle-market, privately owned companies, which may present a greater risk of loss than loans to larger companies.

We invest in loans to middle-market, privately owned companies. Compared to larger, publicly traded firms, these companies generally have more limited access to capital and higher funding costs, may be in a weaker financial position and may need more capital to expand, compete and operate their business. In addition, many of these companies may be unable to obtain financing from public capital markets or from traditional sources, such as commercial banks. Accordingly, loans made to these types of borrowers may entail higher risks than loans made to companies that have larger businesses, greater financial resources or are otherwise able to access traditional credit sources on more attractive terms.

Investing in middle-market, privately owned companies involves a number of significant risks, including, but not limited to, that middle-market companies:

•may have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns;

•are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us;

•typically have more limited access to the capital markets, which may hinder their ability to refinance borrowings;

•will be unable to refinance or repay at maturity the unamortized loan balance as we structure our loans such that a significant balance remains due at maturity;

•generally have less predictable operating results, may be particularly vulnerable to changes in customer preferences or market conditions, and may depend on one or a limited number of major customers;

•may be parties to litigation from time to time, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position; and

32

•generally have less publicly available information about their businesses, operations and financial condition, and, if we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and may lose all or part of our investment.

Any of these factors or changes thereto could impair a portfolio company’s financial condition, results of operation, cash flow or result in other adverse events, such as bankruptcy, any of which could limit a portfolio company’s ability to make scheduled payments on loans from us. This, in turn, may lead to their inability to make payments on outstanding borrowings, which could result in losses in our loan portfolio and a decrease in our net interest income and book value.

We are subject to risks associated with our Senior Loan Investments.

We invest in Senior Loan Investments. Senior Loan Investments are usually rated below investment grade or also may be unrated. As a result, the risks associated with senior loans may be considered by credit rating agencies to be similar to the risks of below investment grade fixed-income instruments. Senior Loan Investments rated below investment grade is considered speculative because of the credit risk of the company incurring the indebtedness. Such companies are more likely than investment grade issuers to default on their payments of interest and principal owed to us, and such defaults could have a material adverse effect on our performance. An economic downturn would generally lead to a higher non-payment rate, and a Senior Loan may lose significant market value before a default occurs. Moreover, any specific collateral used to secure a Senior Loan Investment may decline in value or become illiquid, which would adversely affect the Senior Loan’s value.

There may be less readily available and reliable information about most Senior Loan Investments than is the case for many other types of securities, including securities issued in transactions registered under the Securities Act or registered under the Exchange Act. As a result, Churchill will rely primarily on its own evaluation of a borrower’s credit quality rather than on any available independent sources. Therefore, we will be particularly dependent on the analytical abilities of Churchill.

In general, the secondary trading market for senior secured loans is not well developed. No active trading market may exist for certain Senior Loan Investments, which may make it difficult to value them. Illiquidity and adverse market conditions may mean that we may not be able to sell Senior Loan Investments quickly or at a fair price. To the extent that a secondary market does exist for certain Senior Loan Investments, the market for them may be subject to irregular trading activity, wide bid/ask spreads and extended trade settlement periods.

We are subject to risks associated with our Junior Capital Investments.

We invest in Junior Capital Investments, which will be comprised of second-lien loans, unsecured debt, subordinated debt and last-out positions in unitranche loans (including fixed- and floating-rate instruments and instruments with PIK income). Although certain Junior Capital Investments are typically senior to common stock or other equity securities, the equity and debt securities in which we will invest may be subordinated to substantial amounts of a portfolio company’s senior debt, all or a significant portion of which may be secured. Such junior or subordinated investments may be characterized by greater credit risks than those associated with the senior obligations of the same portfolio company. These subordinated securities may not be protected by financial covenants, such as limitations on the incurrence of additional indebtedness, that may apply to certain types of senior secured debt instruments. Holders of junior and subordinated debt generally are not entitled to receive full payments in bankruptcy or liquidation until senior creditors are paid in full. In addition, the remedies available to holders of junior debt are normally limited by restrictions benefiting senior creditors. In the event any portfolio company cannot generate adequate cash flow to meet senior debt service, we may suffer a partial or total loss of capital invested.

In addition, subordinated investments are generally more volatile than secured loans and are subject to greater risk of default than senior obligations as a result of adverse changes in the financial condition of the obligor or in general economic conditions. If we make a subordinated investment in a portfolio company, the portfolio company may be highly leveraged, and its relatively high loan-to-value (“LTV”) ratio may create increased risks that its operations might not generate sufficient cash flow to service all of its debt obligations. In the event a portfolio company that we invest in on a junior or subordinated basis cannot generate adequate cash flow to meet all of its debt obligations, we may suffer a partial or total loss of capital invested.

33

We are subject to risks associated with “covenant-lite” loans.

We invest in “covenant-lite” loans, which generally refers to loans that do not have a complete set of financial maintenance covenants. Generally, “covenant-lite” loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrower’s financial condition. Accordingly, to the extent we are exposed to “covenant-lite” loans, we may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants.

We are subject to risks associated with our investments in unitranche secured loans and securities.

We invest in unitranche secured loans, which are a combination of senior secured and junior secured debt in the same facility. Unitranche secured loans provide all of the debt needed to finance a leveraged buyout or other corporate transaction, both senior and junior, but generally in a first-lien position, while the borrower generally pays a blended, uniform interest rate rather than different rates for different tranches. Unitranche secured debt generally requires payments of both principal and interest throughout the life of the loan. Generally, we expect these securities to carry a blended yield that is between senior secured and junior debt interest rates. Unitranche secured loans provide a number of advantages for borrowers, including the following: simplified documentation, greater certainty of execution and reduced decision-making complexity throughout the life of the loan. In some cases, a portion of the total interest may accrue or be paid in kind. Because unitranche secured loans combine characteristics of senior and junior financing, unitranche secured loans have risks similar to the risks associated with senior secured and second-lien loans and junior debt in varying degrees according to the combination of loan characteristics of the unitranche secured loan.

We are subject to risks associated with our investments in equity-related securities.

We invest in equity-related securities, such as Equity Co-Investments or equity rights and/or warrants that may be converted into or exchanged for the issuer’s common stock or the cash value of the issuer’s common stock. The equity interests we hold may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we realize in the disposition of any equity interests may not be sufficient to offset any other losses we experience. We will generally have little, if any, control over the timing of any gains we may realize from our equity investments. We also may be unable to realize any value if a portfolio company does not have a liquidity event, such as a sale of the business, recapitalization or public offering, which would allow us to sell the underlying equity interests. We may be unable to exercise any put rights we acquire, which would grant us the right to sell our equity securities back to the portfolio company, for the consideration provided in its investment documents if the issuer is in financial distress. Additionally, we may make equity or equity-related investments alongside a Senior Loan investment, which may result in conflicts related to the rights of those investments.

The loans we make in portfolio companies may become nonperforming.

A loan or debt obligation may become non-performing for a variety of reasons. Such non-performing loans may require substantial workout negotiations or restructuring that may entail, among other things, a substantial reduction in the interest rate, a substantial write-down of the principal amount of the loan and/or the deferral of payments. In addition, such negotiations or restructuring may be quite extensive and protracted over time, and therefore may result in substantial uncertainty with respect to the ultimate recovery. We also may incur additional expenses to the extent that it is required to seek recovery upon a default on a loan or participate in the restructuring of such obligation. The liquidity for defaulted loans may be limited, and to the extent that defaulted loans are sold, it is highly unlikely that the proceeds from such sale will be equal to the amount of unpaid principal and interest thereon. In connection with any such defaults, workouts or restructuring, although we exercise voting rights with respect to an individual loan, we may not be able to exercise votes in respect of a sufficient percentage of voting rights with respect to such loan to determine the outcome of such vote.

The lack of liquidity in our investments may adversely affect our business.

Generally, all of our assets are invested in illiquid securities, and a substantial portion of our investments in leveraged companies will be subject to legal and other restrictions on resale or will otherwise be less liquid than more broadly traded public securities. The illiquidity of these investments may make it difficult for us to sell such investments when desired. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded these investments. As a result, we do not expect to achieve liquidity in our investments in the near-term. However, to maintain the election to be regulated as a BDC and qualify as a RIC, we may have to dispose of investments if we do not satisfy one or more of the applicable criteria under the respective regulatory frameworks.

34

Additionally, the ongoing disruption in economic activity has had, and may continue to have, a negative effect on the potential for liquidity events involving our investments. The illiquidity of our investments may make it difficult for us to sell such investments to access capital if required, and as a result, we could realize significantly less than the value at which we have recorded our investments if we were required to sell them for liquidity purposes. An inability to raise or access capital, and any required sale of all or a portion of our investments as a result, could have a material adverse effect on our business, financial condition or results of operations.

Our portfolio companies may prepay loans, which may reduce stated yields if capital returned cannot be invested in transactions with equal or greater expected yields.

Some of the loans and other investments that we make to our portfolio companies may be callable at any time, and many of them can be repaid with no premium to par. Whether a loan is called will depend both on the continued positive performance of the portfolio company and the existence of favorable financing market conditions that allow such company the ability to replace existing financing with less expensive capital. As market conditions change frequently, it is unknown when, and if, this may be possible for each portfolio company. In addition, prepayments may occur at any time, sometimes without premium or penalty, and that the exercise of prepayment rights during periods of declining spreads could cause us to reinvest prepayment proceeds in lower-yielding instruments. In the case of some of these loans, having the loan called early may reduce our achievable yield if the capital returned cannot be invested in transactions with equal or greater expected yields.

We may be subject to risks associated with our investments in the business services industry.

Portfolio companies in the business services sector are subject to many risks, including the negative impact of regulation, changing technology, a competitive marketplace and difficulty in obtaining financing. Portfolio companies in the business services industry must respond quickly to technological changes and understand the impact of these changes on customers’ preferences. Adverse economic, business, or regulatory developments affecting the business services sector could have a negative impact on the value of our investments in portfolio companies operating in this industry, and therefore could negatively impact our business and results of operations.

Our investments in the healthcare sector face considerable uncertainties.

Our investments in the healthcare sector are subject to substantial risks. The laws and rules governing the business of healthcare companies and interpretations of those laws and rules are subject to frequent change. Broad latitude is given to the agencies administering those regulations. Existing or future laws and rules could force our portfolio companies engaged in healthcare to change how they do business, restrict revenue, increase costs, change reserve levels and change business practices.

Healthcare companies often must obtain and maintain regulatory approvals to market many of their products, change prices for certain regulated products and consummate some of their acquisitions and divestitures. Delays in obtaining or failing to obtain or maintain these approvals could reduce revenue or increase costs. Policy changes on the local, state and federal level, such as the expansion of the government’s role in the healthcare arena and alternative assessments and tax increases specific to the healthcare industry or healthcare products as part of federal health care reform initiatives, could fundamentally change the dynamics of the healthcare industry.

We are exposed to risks associated with any OID income and PIK interest required to be included in taxable and accounting income prior to receipt of cash representing such income.

Our investments include OID components and PIK interest or PIK dividend components. We are exposed to risks associated with any OID income and PIK interest, including, but not limited to, the following:

•We must include in income each year a portion of the OID that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. Because any OID or other amounts accrued will be included in investment company taxable income for the year of the accrual, we may be required to make a distribution to our shareholders in order to satisfy our annual distribution requirements, even though we will not have received any corresponding cash amount. As a result, we may have to sell some of our

35

investments at times or at prices that would not be advantageous to us, raise additional debt or equity capital or forgo new investment opportunities.

•OID instruments may create heightened credit risks because the inducement to the borrower to accept higher interest rates in exchange for the deferral of cash payments typically represents, to some extent, speculation on the part of the lender.

•Even if the accounting conditions for income accrual are met, the borrower could still default when our actual collection is supposed to occur at the maturity of the obligation.

•OID instruments may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of the collateral.

•OID instruments generally represent a significantly higher credit risk than coupon loans.

•OID income received by us may create uncertainty about the source of our cash distributions to shareholders. For accounting purposes, any cash distributions to shareholders representing OID or market discount income are not treated as coming from paid-in capital, even though the cash to pay them comes from the offering proceeds. Thus, although a distribution of OID or market discount interest comes from the cash invested by the shareholders, Section 19(a) of the 1940 Act does not require that shareholders be given notice of this fact by reporting it as a return of capital.

•The deferral of PIK interest has a negative impact on liquidity, as it represents non-cash income that may require distribution of cash dividends to shareholders in order to maintain our RIC tax treatment. In addition, the deferral of PIK interest also increases the LTV ratio at a compounding rate, thus, increasing the risk that we will absorb a loss in the event of foreclosure.

•OID and market discount instruments create the risk of non-refundable incentive fee payments to the Adviser based on non-cash accruals that we may not ultimately realize.

We may hold the debt securities of leveraged companies that may, due to the significant volatility of such companies, enter into bankruptcy proceedings.

Leveraged companies may experience bankruptcy or similar financial distress. The bankruptcy process has a number of significant inherent risks. Many events in a bankruptcy proceeding are the product of contested matters and adversary proceedings and are beyond the control of the creditors. A bankruptcy filing by a portfolio company may adversely and permanently affect the portfolio company. If the proceeding is converted to a liquidation, the value of the issuer may not equal the liquidation value that was believed to exist at the time of the investment. The duration of a bankruptcy proceeding is also difficult to predict, and a creditor’s return on investment can be adversely affected by delays until the plan of reorganization or liquidation ultimately becomes effective. The administrative costs in connection with a bankruptcy proceeding are frequently high and would be paid out of the debtor’s estate prior to any return to creditors. Because the standards for classification of claims under bankruptcy law are vague, our influence with respect to the class of securities or other obligations we own may be lost by increases in the number and amount of claims in the same class or by different classification and treatment. In the early stages of the bankruptcy process, it is often difficult to estimate the extent of, or even to identify, any contingent claims that might be made. In addition, certain claims that have priority by law (for example, claims for taxes) may be substantial.

Our failure to make follow-on investments in our portfolio companies could impair the value of our portfolio.

Following an initial investment in a portfolio company, we may make additional investments in that portfolio company as “follow-on” investments, in seeking to:

•increase or maintain in whole or in part our position as a creditor or equity ownership percentage in a portfolio company;

•exercise warrants, options or convertible securities that were acquired in the original or subsequent financing; or

•preserve or enhance the value of our initial and overall investment.

We have discretion to make follow-on investments, subject to the availability of capital resources and the limitations of the     1940 Act. Failure on our part to make follow-on investments may, in some circumstances, jeopardize the

36

continued viability of a portfolio company and our initial investment, or may result in a missed opportunity for us to increase our participation in a successful operation of a portfolio company. Even if we have sufficient capital to make a desired follow-on investment, we may elect not to make a follow-on investment because we may not want to increase our level of risk, prefer other opportunities or are inhibited by compliance with 1940 Act requirements (including our Order) and RIC tax treatment.

We may not be able to exercise control over our portfolio companies or to prevent decisions by management of our portfolio companies, which could decrease the value of our investments.

We do not hold controlling equity positions in any of our portfolio companies and do not expect to hold controlling positions in the future. Our debt investments in portfolio companies may provide limited control features such as restrictions, for example, on the ability of a portfolio company to incur additional debt and limitations on a portfolio company’s discretion to use the proceeds of our investment for certain specified purposes. “Control” under the 1940 Act is presumed at more than 25% equity ownership, and also may be present at lower ownership levels where we provide managerial assistance. When we do not acquire a controlling equity position in a portfolio company, we may be subject to the risk that a portfolio company may make business decisions with which we disagree, and that the management and/or shareholders of a portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity of the debt and equity investments that we typically hold in our portfolio companies, we may not be able to dispose of our investments in the event we disagree with the actions of a portfolio company and may therefore suffer a decrease in the value of our investments.

Defaults by our portfolio companies will harm our operating results.

A portfolio company’s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, the termination of its loans and foreclosure on its assets. This could trigger cross-defaults under other agreements and jeopardize such portfolio company’s ability to meet its repayment and other obligations under the loans and other investments we hold. In addition, many of our investments will likely have a principal amount outstanding at maturity, which could result in a substantial loss to us if the borrower is unable to refinance or repay. We may incur expenses to seek recovery upon default or to negotiate new terms, which may include the waiver of certain financial covenants, with a defaulting portfolio company. This process will require time and resources that, if not resolved quickly and efficiently, could negatively impact our operating results.

Our portfolio companies may incur debt that ranks equally with, or senior to, the loans and other investments we make in such portfolio companies.

Although we expect that most of our investments in our portfolio companies will be secured, some investments may be unsecured and subordinated to substantive amounts of senior indebtedness incurred by our portfolio companies. The portfolio companies in which we invest usually have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt securities in which we invest and such debt instruments may provide that the holders are entitled to receive payment of interest or principal on or before the dates on which we are entitled to receive payments on our debt investments. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying senior creditors, the portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt securities in which we invest, we would have to share any distributions on an equal and ratable basis with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.

Additionally, certain loans that we make to portfolio companies may be secured on a second-priority basis by the same collateral securing senior secured debt of such companies. The first-priority liens on the collateral will secure the portfolio company’s obligations under any outstanding senior debt and may secure certain other future debt that may be permitted to be incurred by the portfolio company under the agreements governing the loans. The holders of obligations secured by first-priority liens on the collateral will generally control the liquidation of, and be entitled to receive proceeds from, any realization of the collateral to repay their obligations in full before us. In addition, the value of the collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from sales of all of the collateral would be sufficient to satisfy the loan obligations secured by the second-priority liens after payment in full of all obligations secured by the first-priority liens on the collateral. If such proceeds were not sufficient to repay amounts outstanding under the loan obligations secured by the

37

second-priority liens, then, to the extent not repaid from the proceeds of the sale of the collateral, we will only have an unsecured claim against the portfolio company’s remaining assets, if any.

The rights we may have with respect to the collateral securing the loans we make to our portfolio companies with senior debt outstanding also may be limited pursuant to the terms of one or more intercreditor agreements that we enter into with the holders of such senior debt, including in unitranche transactions. Under a typical intercreditor agreement, at any time that obligations that have the benefit of the first-priority liens are outstanding, any of the following actions that may be taken in respect of the collateral will be at the direction of the holders of the obligations secured by the first-priority liens:

•the ability to cause the commencement of enforcement proceedings against the collateral;

•the ability to control the conduct of such proceedings;

•the approval of amendments to collateral documents;

•releases of liens on the collateral; and

•waivers of past defaults under collateral documents.

We may not have the ability to control or direct such actions, even if our rights are adversely affected. In addition, a bankruptcy court may choose not to enforce an intercreditor agreement or other agreement with creditors.

We are subject to risks associated with syndicated loans.

From time to time, our investments may consist of syndicated loans. Under the documentation for such loans, a financial institution or other entity typically is designated as the administrative agent and/or collateral agent. This agent is granted a lien on any collateral on behalf of the other lenders and distributes payments on the indebtedness as they are received. The agent is the party responsible for administering and enforcing the loan and generally may take actions only in accordance with the instructions of a majority or two-thirds in commitments and/or principal amount of the associated indebtedness. In most cases, we do not expect to hold a sufficient amount of the indebtedness to be able to compel any actions by the agent. Accordingly, we may be precluded from directing such actions unless we act together with other holders of the indebtedness. If we are unable to direct such actions, we cannot assure you that the actions taken will be in our best interests.

There is a risk that a loan agent may become bankrupt or insolvent. Such an event would delay, and possibly impair, any enforcement actions undertaken by holders of the associated indebtedness, including attempts to realize upon the collateral securing the associated indebtedness and/or direct the agent to take actions against the related obligor or the collateral securing the associated indebtedness and actions to realize on proceeds of payments made by obligors that are in the possession or control of any other financial institution. In addition, we may be unable to remove the agent in circumstances in which removal would be in our best interests. Moreover, agented loans typically allow for the agent to resign with certain advance notice.

We are subject to risks associated with our investments in special situation companies.

We may make investments in companies involved in (or the target of) acquisition attempts or tender offers, or companies involved in spin-offs and similar transactions. In any investment opportunity involving any such type of business enterprise, the transaction in which such business enterprise is involved will either be unsuccessful, take considerable time or result in a distribution of cash or a new security, the value of which will likely be less than the purchase price to us of the security or other financial instrument in respect of which such distribution is received. Similarly, if an anticipated transaction does not occur, we may be required to sell our investment at a loss. In connection with such transactions, we may purchase securities on a when-issued basis, which means that delivery and payment take place sometime after the date of the commitment to purchase and are often conditioned upon the occurrence of a subsequent event, such as approval and consummation of a merger, reorganization or debt restructuring. The purchase price and/or interest rate receivable with respect to a when-issued security are typically fixed when we enter into the commitment, but such securities are subject to changes in market value prior to their delivery.

We may enter into repurchase agreements.

Subject to our investment objective and policies, we may invest in repurchase agreements as a buyer for investment purposes. Repurchase agreements typically involve the acquisition by the Fund of debt securities from a selling financial institution such as a bank, savings and loan association or broker-dealer. The agreement provides that the Fund

38

will sell the securities back to the institution at a fixed time in the future for the purchase price plus premium (which often reflects the interests). The Fund does not bear the risk of a decline in the value of the underlying security unless the seller defaults under its repurchase obligation. In the event of the bankruptcy or other default of a seller of a repurchase agreement, the Fund could experience both delays in liquidating the underlying securities and losses, including (1) possible decline in the value of the underlying security during the period in which the Fund seeks to enforce its rights thereto; (2) possible lack of access to income on the underlying security during this period; and (3) expenses of enforcing its rights. In addition, as described above, the value of the collateral underlying the repurchase agreement will be at least equal to the repurchase price, including any accrued interest earned on the repurchase agreement. In the event of a default or bankruptcy by a selling financial institution, the Fund generally will seek to liquidate such collateral. However, the exercise of the Fund’s right to liquidate such collateral could involve certain costs or delays and, to the extent that proceeds from any sale upon a default of the obligation to repurchase were less than the repurchase price, the Fund could suffer a loss.

The disposition of our investments in private companies may result in contingent liabilities.

We make a number of investments in securities of portfolio companies that are private companies. If we are required or desire to dispose of an investment in a private company, we may be required to make representations about the business and financial affairs of the portfolio company typical of those representations made by an owner in connection with the sale of its business. We also may be required to indemnify the purchasers of such investment to the extent that any such representations turn out to be inaccurate or with respect to potential liabilities. These arrangements may result in contingent liabilities that could result in the satisfaction of funding obligations through our return of distributions previously made to us.

We may not realize gains from our equity investments.

Senior Loan Investments and Junior Capital Investments may be originated alongside smaller-related common equity positions to the same Portfolio Companies. The Fund’s portfolio will also include larger, stand-alone Equity Co-Investments that may or may not be originated alongside or separately from Senior Loan Investments and/or Junior Capital Investments to the applicable Portfolio Company. Our goal is ultimately to realize gains upon our disposition of such equity interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. We also may be unable to realize any value if a portfolio company does not have a liquidity event, such as a sale of the business, recapitalization or public offering, which would allow us to sell the underlying equity interests. We often seek puts or similar rights to give us the right to sell our equity securities back to the portfolio company issuer. We may be unable to exercise these put rights for the consideration provided in our investment documents if the issuer is in financial distress.

Inflation may adversely affect the business, results of operations and financial condition of our portfolio companies, which may, in turn, impact the valuation of such portfolio companies.

Certain of our portfolio companies may be impacted by inflation, which may, in turn, impact the valuation of such portfolio companies. If such portfolio companies are unable to pass any increases in their costs along to their customers, it could adversely affect their results and their ability to pay interest and principal on our loans, particularly if interest rates rise in response to inflation. In addition, any projected future decreases in our portfolio companies’ operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in future unrealized losses and therefore reduce our net assets resulting from operations.

39

We are exposed to risks associated with changes in interest rates.

Because we have borrowed and intend to continue borrow money to make investments, our net investment income depends, in part, upon the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. Since March 2022, the Federal Reserve has been rapidly raising interest rates. Although the Federal Reserve left its benchmark rates steady in the fourth quarter of 2023, it has indicated that additional rate increases in the future may be necessary to mitigate inflationary pressures and there can be no assurance that the Federal Reserve will not make upwards adjustments to the federal funds rate in the future. However, there are reports that the Federal Reserve may begin to cut the benchmark rates in 2024. An increase in interest rates could decrease the value of any investments we hold which earn fixed interest rates and also could increase our interest expense, thereby decreasing our net income. Also, an increase in interest rates available to investors could make an investment in our common stock less attractive if we are not able to increase our distribution rate, which could reduce the value of our common stock. Further, rising interest rates could also adversely affect our performance if such increases cause our borrowing costs to rise at a rate in excess of the rate that our investments yield. It is possible that the Federal Reserve’s tightening cycle could also result in a recession in the United States, which could have a material adverse effect on our business, results of operations and financial condition.

In the current and future periods of rising interest rates, to the extent we borrow money subject to a floating interest rate (such as the Bank of America Credit Facility), our cost of funds would increase, which could reduce our net investment income if there is not a corresponding increase in interest income generated by our investment portfolio. Further, rising interest rates could also adversely affect our performance if we hold investments with floating interest rates, subject to specified minimum (or “floor”) interest rates, while at the same time engaging in borrowings subject to floating interest rates not subject to such minimums. In such a scenario, rising interest rates may temporarily increase our interest expense, even though our interest income from investments is not increasing in a corresponding manner if market rates remain lower than the existing floor rate.

If interest rates continue to rise, there is also a risk that the Portfolio Companies in which we hold floating rate securities will be unable to pay escalating interest amounts, which could result in a default under their loan documents with us. Rising interest rates could also cause Portfolio Companies to shift cash from other productive uses to the payment of interest, which may have a material adverse effect on their business and operations and could, over time, lead to increased defaults. In addition, rising interest rates may increase pressure on us to provide fixed rate loans to our Portfolio Companies, which could adversely affect our net investment income, as increases in our cost of borrowed funds would not be accompanied by increased interest income from such fixed-rate investments.

The alternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions.

LIBOR is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies.

The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom's Financial Conduct Authority (“FCA"), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBOR, including USD LIBOR, except in very limited circumstances.

In the United States, SOFR is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions.

As of the filing date of this Annual Report on Form 10-K, all of our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on the secured overnight financing rate (“CME Term SOFR”). CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed, one-month and three-month CME Group traded SOFR futures contracts and, in some

40

cases, over-the-counter SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Because CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be lower than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used.

There can be no guarantee that SOFR will not be discontinued or fundamentally altered in a manner that is materially adverse to the interests of investors in loans referencing SOFR. If the manner in which SOFR or CME Term SOFR is calculated is changed, that change may result in a reduction of the amount of interest payable on such loans and the trading prices of the SOFR Loans. In addition, there can be no guarantee that loans referencing SOFR or CME Term SOFR will continue to reference those rates until maturity or that, in the future, our loans will reference benchmark rates other than CME Term SOFR. Should any of these events occur, our loans, and the yield generated thereby, could be affected. Specifically, the anticipated yield on our loans may not be fully realized and our loans may be subject to increased pricing volatility and market risk.

Our ability to enter into transactions involving derivatives and unfunded commitment transactions may be limited.

In 2020, the SEC adopted Rule 18f-4 under the 1940 Act, which relates to the use of derivatives and other transactions that create future payment or delivery obligations by BDCs (and other funds that are registered investment companies). Under Rule 18f-4, for which compliance was required beginning in August 2022, BDCs that use derivatives are subject to a value-at-risk (“VaR”) leverage limit, certain derivatives risk management program and testing requirements and requirements related to board reporting. These requirements apply unless the BDC qualifies as a “limited derivatives user,” as defined in Rule 18f-4. A BDC that enters into reverse repurchase agreements or similar financing transactions could either (i) comply with the asset coverage requirements of Section 18, as modified by Section 61 of the 1940 Act, when engaging in reverse repurchase agreements or (ii) choose to treat such agreements as derivatives transactions under Rule 18f-4. In addition, under Rule 18f-4, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. If the BDC cannot meet this requirement, it is required to treat the unfunded commitment as a derivatives transaction subject to the aforementioned requirements of Rule 18f-4. Collectively, these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts.We qualify as a “limited derivatives user,” and as a result the requirements applicable to us under Rule 18f-4 may limit our ability to use derivatives and enter into certain other financial contracts. However, if we fail to qualify as a limited derivatives user and become subject to the additional requirements under Rule 18f-4, compliance with such requirements may increase cost of doing business, which could have a material adverse effect on our business, financial condition, results of operations, and cash flows.

We may incur lender liability as a result of our lending activities.

In recent years, a number of judicial decisions have upheld the right of borrowers and others to sue lending institutions on the basis of various evolving legal theories, collectively termed “lender liability.” Generally, lender liability is founded on the premise that a lender has either violated a duty, whether implied or contractual, of good faith and fair dealing owed to the borrower or has assumed a degree of control over the borrower resulting in the creation of a fiduciary duty owed to the borrower or its other creditors or shareholders. We may be subject to allegations of lender liability, which could be time-consuming and expensive to defend and result in significant liability.

We may incur liability as a result of providing managerial assistance to our portfolio companies.

In the course of providing significant managerial assistance to certain portfolio companies, certain of our management and trustees may serve as directors on the boards of such companies. To the extent that litigation arises out of investments in these companies, our management and trustees may be named as defendants in such litigation, which could result in an expenditure of our funds, through our indemnification of such officers and trustees, and the diversion of management time and resources.

41

Economic recessions or downturns could impair our portfolio companies and harm our operating results.

Many of our portfolio companies will be susceptible to economic slowdowns or recessions, including as a result of, among other things, the COVID-19 pandemic, elevated levels of inflation, and a rising interest rate environment, and may be unable to repay our loans during these periods. Therefore, any non-performing assets are likely to increase and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions may decrease the value of collateral securing some of our loans and the value of our equity investments and could lead to financial losses in our portfolio and a corresponding decrease in revenues, net income and assets.

Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events could prevent us from increasing our investments and harm our operating results.

A portfolio company’s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, acceleration of its loans and foreclosure on its assets, which could trigger cross-defaults under other agreements and jeopardize our portfolio company’s ability to meet its obligations under the debt securities that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company. It is possible that we could become subject to a lender liability claim, including as a result of actions taken if we or the Adviser renders significant managerial assistance to the borrower. Furthermore, if one of our portfolio companies were to file for bankruptcy protection, even though we may have structured our investment as senior secured debt, depending on the facts and circumstances, including the extent to which we or the Adviser provided managerial assistance to that portfolio company or otherwise exercise control over it, a bankruptcy court might re-characterize our debt as a form of equity and subordinate all or a portion of our claim to claims of other creditors.

Environmental, social and governance factors may adversely affect our business or cause us to alter our business strategy.

Our business faces increasing public scrutiny related to ESG activities. We risk damage to our brand and reputation if we fail to act responsibly in a number of areas, such as environmental stewardship, corporate governance and transparency and considering ESG factors in our investment processes. Additionally, we risk damage to our brand and reputation if Churchill fails to originate, underwrite and manage assets on our behalf consistent with its ESG policy. Adverse incidents with respect to ESG activities could impact the value of Churchill’s and the Fund’s brand, the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations. Additionally, new regulatory initiatives related to ESG could adversely affect our business.

The effect of global climate change may impact the operations and valuation of our portfolio companies.

Climate change creates physical and financial risk and some of our portfolio companies may be adversely affected by climate change. For example, the needs of customers of energy companies vary with weather conditions, primarily temperature and humidity. To the extent weather conditions are affected by climate change, energy use could increase or decrease depending on the duration and magnitude of any changes. Increases in the cost of energy could adversely affect the cost of operations of our portfolio companies if the use of energy products or services is material to their business. A decrease in energy use due to weather changes may affect some of our portfolio companies’ financial condition through, for example, decreased revenues, which may, in turn, impact the valuation of such portfolio companies. Extreme weather conditions in general require more system backup, adding to costs, and can contribute to increased system stresses, including service interruptions.

In December 2015, the United Nations adopted a climate accord (the “Paris Agreement”), which the United States rejoined in 2021, with the long-term goal of limiting global warming and the short-term goal of significantly reducing greenhouse gas emissions. Additionally, the Inflation Reduction Act of 2022 included several measures designed to combat climate change, including restrictions on methane emissions. As a result, some of our portfolio companies may become subject to new or strengthened regulations or legislation, which could increase their operating costs and/or decrease their revenues, which may, in turn, impact their ability to make payments on our investments.

42

Risks Related to Churchill and its Affiliates; Conflicts of Interests

We depend upon the senior management of Churchill for our success, and upon the strong referral relationships of the investment professionals of Churchill, Nuveen, Nuveen Leveraged Finance and its affiliates with financial institutions. Any inability to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.

We do not have any internal management capacity or employees. We depend on the investment expertise, skill and network of business contacts of the senior investment professionals of Churchill, who evaluate, negotiate, structure, execute, monitor and service our investments in accordance with the terms of the Investment Advisory Agreement, and the investment professionals of Nuveen Leveraged Finance with respect to our Liquid Investments in accordance with the terms of the Sub-Advisory Agreement. Our success depends to a significant extent on the continued service and coordination of the senior investment professionals of Churchill and Nuveen Leveraged Finance. These individuals may have other demands on their time now and in the future, and we cannot assure you that they will continue to be actively involved in our management. Each of these individuals is not subject to an employment contract with the Fund, and the departure of any of these individuals or competing demands on their time in the future could have a material adverse effect on our ability to achieve our investment objective.

The Adviser and Nuveen Asset Management evaluate, negotiate, structure, close and monitor our investments in accordance with the terms of the Investment Advisory Agreement and the Sub-Advisory Agreement, respectively. We can offer no assurance, however, that the current senior investment professionals of Churchill and Nuveen Leveraged Finance will continue to provide investment advice to us. If these individuals do not maintain their existing relationships with Nuveen and its affiliates and do not develop new relationships with other sources of investment opportunities, we may not be able to grow our investment portfolio or achieve our investment objective.

The Joint Investment Committee that oversees our investment activities is comprised of representatives of both Investment Teams. The Joint Investment Committee consists of Messrs. Kencel, Strife, Linett and Schwimmer. The loss of any member of the Joint Investment Committee or of other Churchill or Nuveen senior investment professionals could negatively impact the Fund’s ability to achieve its investment objective and operate as anticipated. This could have a material adverse effect on our financial condition and results of operations.

Our access to confidential information may restrict our ability to take action with respect to some of our investments, which, in turn, may negatively affect our results of operations.

We, directly or through Churchill, may obtain confidential information about the companies in which we may invest or be deemed to have such confidential information. Churchill may come into possession of material, non-public information through its members, officers, directors, employees, principals or affiliates. The possession of such information may, to our detriment, limit the ability of us and Churchill to buy or sell a security or otherwise to participate in an investment opportunity. In certain circumstances, employees of Churchill may serve as board members or in other capacities for portfolio or potential portfolio companies, which could restrict our ability to trade in the securities of such companies. For example, if personnel of our Adviser come into possession of material non-public information with respect to our investments, such personnel will be restricted by our Adviser’s information-sharing policies and procedures or by law or contract from sharing such information with our management team, even where the disclosure of such information would be in our best interests or would otherwise influence decisions taken by the members of the management team with respect to that investment. This conflict and these procedures and practices may limit the freedom of Churchill to enter into or exit from potentially profitable investments for us, which could have an adverse effect on our results of operations. Accordingly, there can be no assurance that we will be able to fully leverage the resources and industry expertise of our Adviser in the course of their duties. Additionally, there may be circumstances in which one or more individuals associated with our Adviser will be precluded from providing services to us because of certain confidential information available to those individuals or to other parts of our Adviser.

43

The Adviser and its affiliates, including our officers and some of our Trustees, face conflicts of interest caused by compensation arrangements with us and our affiliates, which could result in actions that are not in the best interests of our shareholders.

The Adviser and its affiliates receive substantial fees from us in return for their services, and these fees could influence the advice provided to us. We pay to the Adviser an incentive fee that is based on the performance of our portfolio and a base management fee that is based on the value of our net assets as of the beginning of the first calendar day of the applicable month. Because the incentive fee is based on the performance of our portfolio, the Adviser may be incentivized to make investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The way in which the incentive fee is determined may also encourage the Adviser to use leverage to increase the return on our investments. Our compensation arrangements could therefore result in our making riskier or more speculative investments than would otherwise be the case. This could result in higher investment losses, particularly during cyclical economic downturns. See “Certain Relationships and Related Party Transactions.”

We may be obligated to pay the Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio.

Our Investment Advisory Agreement entitles the Adviser to receive Pre-Incentive Fee Net Investment Income Returns regardless of any capital losses. In such case, we may be required to pay the Adviser incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or if we incur a net loss for that quarter.

In addition, any Pre-Incentive Fee Net Investment Income Returns may be computed and paid on income that may include interest that has been accrued but not yet received. If a portfolio company defaults on a loan that is structured to provide accrued interest, it is possible that accrued interest previously included in the calculation of the incentive fee will become uncollectible. The Adviser is not under any obligation to reimburse us for any part of the incentive fee it received that was based on accrued income that we never received as a result of a default by an entity on the obligation that resulted in the accrual of such income, and such circumstances would result in our paying an incentive fee on income we never received.

There may be conflicts related to obligations that senior investment professionals of Churchill and members of its investment committee have to other clients. There also may be conflicts related to the investment and related activities of TIAA, Nuveen and Churchill, and these conflicts could prevent us from making or disposing of certain investments on the terms desired.

The senior investment professionals and members of the investment committee of the Investment Team serve or may serve as officers, directors, members, or principals of entities that operate in the same or a related line of business as we do, or of investment funds, accounts or other investment vehicles sponsored or managed by Churchill or its affiliates. Similarly, Churchill may have other clients or other accounts with similar, different or competing investment objectives as us. In serving in these multiple capacities, they may have obligations to other clients or investors in those entities, the fulfillment of which may not be in our best interests or in the best interest of our shareholders. For example, Messrs. Kencel, Strife, Linett and Schwimmer have and will continue to have management responsibilities for other investment funds, including Nuveen Churchill Direct Lending Corp., a BDC, and NC SLF Inc., a closed-end investment company registered under the 1940 Act, and other accounts or other investment vehicles sponsored or managed by affiliates of Churchill. Churchill seeks to allocate investment opportunities among eligible accounts in a manner that is fair and equitable over time and consistent with their respective allocation policies. In addition, Churchill or its affiliates also earn additional fees related to the securities in which the Fund invests, which may result in conflicts of interests for the senior investment professionals and members of the investment committee making investment decisions. For example, Churchill and its affiliates may act as an arranger, syndication agent or in a similar capacity with respect to securities in which the Fund invests, where Churchill’s investment staff sources and arranges financing transactions that may be eligible for investment by its client accounts (including the Fund), and in connection therewith commits to source, arrange and issue such financing instruments as may be required by the related issuer(s). In connection with such sourcing and arranging activity, such issuer(s) agree to pay to in which case Churchill and its affiliates compensation in the form of closing or arrangement fees, which compensation is paid to them at or immediately prior to the funding of such financing, separately from management fees paid by the Fund. Additionally, affiliates of Churchill may act as the administrative agent on credit facilities under which such securities are issued, which may contemplate additional compensation to such affiliates for the service of acting as administrative agent thereunder.

44

Each of Churchill and Nuveen Asset Management has separate account, fund-of-one or other managed account arrangements in place with TIAA or subsidiaries thereof. Consistent with their respective investment allocation policies and the Order, Churchill and Nuveen Asset Management also may be managing certain securities for the Fund and allocating the same investments to TIAA (or subsidiaries thereof) pursuant to such arrangements, which may lead to conflicts of interest.

In certain instances, it is possible that other entities managed by Churchill or Nuveen Asset Management or a proprietary account of TIAA may be invested in the same or similar loans or securities as held by the Fund, and which may be acquired at different times at lower or higher prices. Those investments also may be in securities or other instruments in different parts of the company’s capital structure that differ significantly from the investments held by the Fund, including with respect to material terms and conditions, including without limitation seniority, interest rates, dividends, voting rights and participation in liquidation proceeds. Consequently, in certain instances these investments may be in positions or interests that are potentially adverse to those taken or held by the Fund. In such circumstances, measures will be taken to address such actual or potential conflicts, which may include, as appropriate, establishing an information barrier between or among the applicable personnel of the relevant affiliated entities (including as between officers of Churchill), requiring recusal of certain personnel from participating in decisions that give rise to such conflicts, or other protective measures as shall be established from time to time to address such conflicts.

Further, an affiliate of TIAA may serve as the administrative or other named agent on behalf of the lenders with respect to investments by the Fund and/or one or more of its affiliates. In some cases, investments that are originated or otherwise sourced by Churchill may be funded by a loan syndicate organized by Churchill or its affiliates. The participants in such loan syndicate (the “Loan Syndicate Participants”), in addition to the Fund and its affiliates may include other lenders and various institutional and sophisticated investors (through private investment vehicles in which they invest). The entity acting as agent may serve as an agent with respect to loans made at varying levels of a borrower’s capital structure. Loan Syndicate Participants may hold investments in the same or distinct tranches in the loan facilities of which the Portfolio investment is a part or in different positions in the capital structure under such portfolio investment. As is typical in such agency arrangements, the agent is the party responsible for administering and enforcing the terms of the loan facility, may take certain actions and make certain decisions in its discretion and generally may take material actions only in accordance with the instructions of a designated percentage of the lenders. In the case of loan facilities that include both senior and subordinate tranches, the agent may take actions in accordance with the instructions of the holders of one or more of the senior tranches without any right to vote or consent (except in certain limited circumstances) by the subordinated tranches of such indebtedness. Churchill expects that the portfolio investments held by the Fund and its affiliates may represent less than the amount of debt sufficient to direct, initiate or prevent actions with respect to such loan facility or a tranche thereof of which the Fund’s investment is a part (other than preventing those that require the consent of each lender). As a result of an affiliate of TIAA acting as agent for an agented loan where a Loan Syndicate Participant may own more of the related indebtedness of the obligor or hold indebtedness in a position in the capital structure of an obligor different from that of the Fund and its affiliates, such Loan Syndicate Participants will be in a position to exercise more control with respect to the related loan facility than that which Churchill could exercise on behalf of the Fund, and may exercise such control in a manner adverse to the interests of the Fund.

In addition, TIAA and other client accounts of Churchill, in connection with an advisory relationship with Churchill, may be a limited partner investor in many of the private equity funds that own the portfolio companies in which the Fund will invest or TIAA may otherwise have a relationship with the private equity funds or portfolio companies, which may give rise to certain conflicts or limit the Fund’s ability to invest in such portfolio companies. TIAA (and other private clients managed by Churchill and its affiliates) also may hold passive equity co-investments in such private equity funds or portfolio companies owned by such fund, or in holding companies elsewhere in the capital structure of the private equity fund or portfolio company, which may give rise to certain conflicts for the investment professionals of affiliates of the Adviser when making investment decisions.

45

Nuveen Asset Management manages our Liquid Investments pursuant to the Sub-Advisory Agreement. Nuveen Asset Management may serve as managing member, adviser or sub-adviser to one or more affiliated private funds or other pooled investment vehicles. Investment professionals associated with Nuveen Asset Management are actively involved in other investment activities not concerning the Fund and will not devote all of their professional time to the affairs of the Fund. For example, Nuveen Asset Management may compete with other affiliates and other accounts for investments for the Fund, subjecting Nuveen Asset Management to certain conflicts of interest in evaluating the suitability of investment opportunities and making or recommending acquisitions on the Fund’s behalf. In the event that a conflict of interest arises, Nuveen Asset Management will endeavor, so far as it is able, to ensure that such conflict is resolved in a manner consistent with applicable law and its internal policies. There can be no assurance that Nuveen Asset Management will resolve all conflicts of interest in a manner that is favorable to the Fund and any such conflicts of interest could have a material adverse effect on the Fund.

The time and resources that individuals employed by the Adviser devote to us may be diverted and we may face additional competition because individuals employed by the Adviser are not prohibited from raising money for or managing other entities that make the same types of investments that we target.

The Adviser and individuals employed by the Adviser are generally not prohibited from raising capital for and managing other investment entities that make the same types of investments as those we target. As a result, the time and resources that these individuals may devote to us may be diverted. In addition, we may compete with any such investment entity for the same investors and investment opportunities. We may participate in certain transactions originated by the Adviser or its affiliates under our exemptive relief from the SEC that allows us to engage in co-investment transactions with the Adviser and its affiliates, subject to certain terms and conditions. However, while the terms of the exemptive relief require that the Adviser will be given the opportunity to cause us to participate in certain transactions originated by affiliates of the Adviser, the Adviser may determine that we not participate in those transactions and for certain other transactions (as set forth in guidelines approved by the Board) the Adviser may not have the opportunity to cause us to participate. Affiliates of the Adviser, whose primary business includes the origination of investments or investing in non-originated assets, engage in investment advisory business with accounts that compete with us. However, the Adviser will devote such time and attention to our affairs as it determines in its discretion is necessary to carry out our operations effectively.

Our ability to enter into transactions with our affiliates is restricted, which may limit the scope of investments available to us.

We are prohibited under the 1940 Act from participating in certain transactions with our affiliates, including Nuveen Churchill Direct Lending Corp., NC SLF Inc., and other funds and accounts that the Adviser manages, without the prior approval of our Independent Trustees and, in some cases, of the SEC. Any person that owns, directly or indirectly, five percent or more of our outstanding voting securities is our affiliate for purposes of the 1940 Act, and we are generally prohibited from buying any security from such affiliate, absent the prior approval of our Independent Trustees. The 1940 Act also prohibits us from participating in certain “joint” transactions with certain of our affiliates, including Nuveen Churchill Direct Lending Corp., NC SLF Inc., and other funds and accounts that the Adviser manages, which could include investments in the same portfolio company without prior approval of our Independent Trustees and, in some cases, of the SEC. For example, we are prohibited from buying or selling any security from or to any person (or certain affiliates of a person) who owns more than 25% of our voting securities, or entering into prohibited joint transactions with such persons, absent the prior approval of the SEC. As a result of these restrictions, we may be prohibited from buying or selling any security (other than any security of which we are the issuer) from or to any portfolio company at the same time as another fund managed by the Adviser or their affiliates without the prior approval of the SEC, which may limit the scope of investment opportunities that would otherwise be available to us.

We may, however, co-invest with the Adviser and its affiliates’ other clients in certain circumstances where doing so is consistent with applicable law and SEC staff interpretations. For example, we may co-invest with such accounts consistent with guidance promulgated by the SEC staff permitting us and such other accounts to purchase interests in a single class of privately placed securities so long as certain conditions are met, including that the applicable Adviser, acting on our behalf and on behalf of other clients, negotiates no term other than price. We may also co-invest with the Adviser’s or its affiliates’ other clients as otherwise permissible under regulatory guidance, applicable regulations, and the Adviser’s allocation policy, which the Adviser maintains in writing. Under this allocation policy, a portion of each opportunity, which may vary based on asset class and from time to time, is offered to us and similar eligible accounts, as periodically determined by the Adviser. However, we can offer no assurance that investment opportunities will be allocated to us fairly or equitably in the short-term or over time.

46

Additionally, the Adviser and certain other funds and accounts sponsored or managed by the Adviser and their affiliates have been granted the Order by the SEC, which permits the Fund greater flexibility to negotiate the terms of co-investments if the Board determines that it would be advantageous for the Fund to co-invest with other accounts sponsored or managed by the Adviser or its affiliates in a manner consistent with the Fund’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors.

In situations where co-investment with other funds managed by one of the Adviser or its affiliates is not permitted or appropriate, such as when there is an opportunity to invest in different securities of the same issuer on a differential basis between clients or where the different investments could be expected to result in a conflict between our interests and those of other clients of the Adviser that cannot be mitigated or otherwise addressed pursuant to the policies and procedures of the applicable Adviser, the applicable Adviser must decide which client will proceed with the investment. The Adviser makes these determinations based on its policies and procedures, which generally require that such opportunities be offered to eligible accounts on a basis that will be fair and equitable over time (and which takes into consideration the ability of the relevant account(s) to acquire securities in an amount and on terms suitable for the relevant transaction). Moreover, there will be a conflict of interest if we invest in any issuer in which a fund managed by the Adviser or its affiliates, including Nuveen Churchill Direct Lending Corp., NC SLF Inc., and other funds and accounts that the Adviser manages, has previously invested, and in some cases, we will be restricted from making such investment. Similar restrictions limit our ability to transact business with our officers or trustees or their affiliates.

The Adviser and Nuveen Asset Management can resign on 120 days’ notice, and we may not be able to find a suitable replacement within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations.

Each of the Adviser and Nuveen Asset Management has the right to resign under the Advisory Agreement and the Sub-Advisory Agreement, respectively, without penalty at any time upon 120 days’ written notice to us, whether we have found a replacement or not. If the Adviser resigns, we may not be able to find a new investment adviser or hire internal management with similar expertise and ability to provide the same or equivalent services on acceptable terms within 120 days, or at all. If Nuveen Asset Management resigns, we may not be able to find a new sub-adviser or hire internal management with similar expertise to manage our Liquid Investments and ability to provide the same or equivalent services on acceptable terms within 120 days, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations as well as our ability to pay distributions are likely to be adversely affected and the market price of our Common Shares may decline. In addition, the coordination of our internal management and investment activities is likely to suffer if we are unable to identify and reach an agreement with a single institution or group of executives having the expertise possessed by the Adviser and Nuveen Asset Management and their affiliates. Even if we were able to retain comparable management, whether internal or external, the integration of such management and their lack of familiarity with our investment objective may result in additional costs and time delays that may adversely affect our financial condition, business and results of operations.

The Administrator can resign on 60 days’ notice from its role as our administrator under the Administration Agreement, and we may not be able to find a suitable replacement within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations.

The Administrator has the right to resign under the Administration Agreement without penalty upon 60 days’ written notice to us, whether we have found a replacement or not. If the Administrator resigns, we may not be able to find a new administrator or hire internal management with similar expertise and ability to provide the same or equivalent services on acceptable terms, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations as well as our ability to pay distributions are likely to be adversely affected and the market price of our Common Shares may decline. In addition, the coordination of our internal management and administrative activities is likely to suffer if we are unable to identify and reach an agreement with a service provider or individuals with the expertise possessed by the Administrator. Even if we were able to retain a comparable service provider or individuals to perform such services, whether internal or external, their integration into our business and lack of familiarity with our investment objective may result in additional costs and time delays that may adversely affect our financial condition, business and results of operations.

47

Our Common Shares may be purchased by the Adviser or its affiliates.

The Adviser and its affiliates expect to purchase our Common Shares. The Adviser and its affiliates will not acquire any Common Shares with the intention to resell or re-distribute such Common Shares. The purchase of Common Shares by the Adviser and its affiliates could create certain risks, including, but not limited to, the following:

•the Adviser and its affiliates may have an interest in disposing of our assets at an earlier date so as to recover their investment in our Common Shares; and

•substantial purchases of Common Shares by the Adviser and its affiliates may limit the Adviser’s ability to fulfill any financial obligations that it may have to us or incurred on our behalf.

The recommendations that the Adviser gives to the Fund may differ from those rendered to its other clients.

The Adviser and its affiliates may give advice and recommend securities to other clients which may differ from advice given to, or securities recommended or bought for, the Fund even though such other clients’ investment objectives may be similar to the Fund’s, which could have an adverse effect on our business, financial condition and results of operations.

The Investment Team or the Investment Committee may, from time to time, possess material nonpublic information, limiting our investment discretion.

The managing members and the senior origination professionals of Churchill, Nuveen Asset Management, the Investment Team and the senior professionals and members of the Investment Committee may serve as directors of, or in a similar capacity with, companies in which we invest, the securities of which are purchased or sold on our behalf. In the event that material nonpublic information is obtained with respect to such companies, or we become subject to trading restrictions under the internal trading policies of those companies or as a result of applicable law or regulations, we could be prohibited for a period of time from purchasing or selling the securities of such companies, and this prohibition may have a material adverse effect on us.

Soft dollars and research received and conducted on our behalf will be shared by others.

We may bear more or less of the costs of soft dollar or other research than other clients of Churchill, Nuveen Asset Management and each of their respective affiliates who benefit from such products or services. These research products or services may and will also benefit and be used to assist other clients of Churchill and its affiliates. Research generated for Churchill’s credit strategy on our behalf will be used to benefit other investment strategies of Churchill and its affiliates, including Nuveen Churchill Direct Lending Corp. and NC SLF Inc. and other funds and accounts that Churchill manages. Furthermore, Churchill’s implementation of a credit strategy on our behalf will rely on its affiliates, research efforts to manage the client/fund portfolios of such affiliates.

The compensation we pay to the Adviser and, indirectly, to Nuveen Asset Management will be determined without independent assessment on our behalf, and these terms may be less advantageous to us than if such terms had been the subject of arm’s-length negotiations.

The Investment Advisory Agreement and the Sub-Advisory Agreement will not be entered into on an arm’s-length basis with an unaffiliated third party. As a result, the form and amount of compensation we pay the Adviser, and indirectly to Nuveen Asset Management to manage our portfolio investments and certain of our Liquid Investments, respectively, may be less favorable to us than they might have been had an investment advisory agreement been entered into through arm’s-length transactions with an unaffiliated third party.

The Intermediary Manager’s influence on this offering gives it the ability to increase the fees payable to the Adviser.

The Adviser is paid a base management fee calculated as a percentage of our net assets and unrelated to net income or any other performance base or measure. The Intermediary Manager, an affiliate of the Adviser will be incentivized to raise more proceeds in this offering to increase our net assets, even if it would be difficult for us to efficiently deploy additional capital, which in turn would increase the base management fee payable to the Adviser.

48

Because the Intermediary Manager is an affiliate of the Adviser, you will not have the benefit of an independent review of our offering customarily performed in underwritten offerings.

The Intermediary Manager is an affiliate of the Adviser and will not make an independent review of us or the offering. Accordingly, you will have to rely on your own broker-dealer to make an independent review of the terms of our offering. If your broker-dealer does not conduct such a review, you will not have the benefit of an independent review of the terms of our offering. Further, the due diligence investigation of us by the Intermediary Manager cannot be considered to be an independent review and, therefore, may not be as meaningful as a review conducted by an unaffiliated broker-dealer or investment banker. You will not have the benefit of an independent review and investigation of our offering of the type normally performed by an unaffiliated, independent underwriter in an underwritten public securities offering. In addition, we do not, and do not expect to, have research analysts reviewing our performance or our securities on an ongoing basis. Therefore, you will not have an independent review of our performance and the value of our Common Shares relative to publicly traded companies.

Risks Related to Business Development Companies

If we do not invest a sufficient portion of our assets in qualifying assets, we could fail to qualify as a BDC, which would have a material adverse effect on our business, financial condition and results of operations.

As a BDC, we may not acquire any assets other than “qualifying assets” unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets. See Item 1. “Regulation as a Business Development Company — Qualifying Assets.” We believe that most of the investments that we may acquire in the future will constitute qualifying assets. However, we may be precluded from investing in what we believe are attractive investments if such investments are not qualifying assets for purposes of the 1940 Act. If we do not invest a sufficient portion of our assets in qualifying assets, we could violate the 1940 Act provisions applicable to BDCs. As a result of such violation, specific rules under the 1940 Act could prevent us, for example, from making follow-on investments in existing portfolio companies, which could result in the dilution of our position or could require us to dispose of investments at inappropriate times in order to come into compliance with the 1940 Act. If we need to dispose of investments quickly, it could be difficult to dispose of such investments on favorable terms. We may not be able to find a buyer for such investments and, even if we do find a buyer, we may have to sell the investments at a substantial loss. Any such outcomes would have a material adverse effect on our business, financial condition, results of operations, and cash flows.

Failure to maintain our status as a BDC would reduce our operating flexibility.

If we do not remain a BDC, we might be regulated as a registered closed-end investment company under the 1940 Act, which would subject us to substantially more regulatory restrictions under the 1940 Act and correspondingly decrease our operating flexibility. For example, we intend to employ leverage as market conditions permit and at the discretion of the Adviser. Such leverage may arise in the form of borrowings, including loans from certain financial institutions, the issuance of debt securities, repurchase agreement transactions, the issuance of CLOs, and other forms of financial indebtedness. As a BDC, the 1940 Act allows us to borrow up to $2 for every $1 of equity, or an asset coverage ratio of 150%. However, if we are regulated as a registered closed-end investment company under the 1940 Act, we would be subject to asset coverage ratio requirements of 300% for the issuance of debt securities, meaning that for every $1 of debt issued, we would need to have $3 of total assets immediately after such issuance. Such regulations would restrict our ability to execute our investment strategy and thereby reduce our operating flexibility.

Further, as a BDC, we are able to pay our Adviser both a base management fee and incentive fee on income and capital gains as compensation for its efforts. If we were to become regulated as a registered closed-end investment company, we could not pay our Adviser an incentive fee on capital gains unless we restricted sales of our Common Shares to “qualified clients” under the Advisers Act. Such a compensation structure could have the effect of de-incentivizing our Adviser in its efforts to seek and retain the best investment opportunities for us in fulfillment of our strategy.

Finally, as a BDC, we retain greater flexibility to engage in transactions with our affiliates in alignment with the provisions set forth in Section 57 of the 1940 Act. If we were to become regulated as a registered closed-end investment company, we would be subject to the provisions governing transactions with affiliates set forth in Section 17 of the 1940 Act, including prohibitions on transactions with affiliates of our Adviser absent an exemptive order from the SEC. These restrictions would limit our ability to effectuate our investment strategy and potentially hinder our operations and, in turn, our results.

49

Regulations governing our operation as a BDC affect our ability to and the way in which we raise additional capital.

We may issue debt securities or preferred shares and/or borrow money from banks or other financial institutions, which we refer to collectively as “senior securities,” up to the maximum amount permitted by the 1940 Act. Under the provisions of the 1940 Act, we are permitted as a BDC to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 150% of total assets less all liabilities and indebtedness not represented by senior securities, immediately after each issuance of senior securities. If the value of our assets declines, we may be unable to satisfy this requirement. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. This could have a material adverse effect on our operations and we may not be able to make distributions in an amount sufficient to be subject to taxation as a RIC, or at all. In addition, issuance of securities could dilute the percentage ownership of our current shareholders in us.

No person or entity from which we borrow money will have a veto power or a vote in approving or changing any of our fundamental policies. If we issue preferred shares, the preferred shares would rank “senior” to Common Shares in our capital structure, preferred shareholders would have separate voting rights on certain matters and might have other rights, preferences or privileges more favorable than those of our shareholders, and the issuance of preferred shares could have the effect of delaying, deferring or preventing a transaction or a change of control that might involve a premium price for holders of our Common Shares or otherwise be in your best interest. Holders of our Common Shares will directly or indirectly bear all of the costs associated with offering and servicing any preferred shares that we issue. In addition, any interests of preferred shareholders may not necessarily align with the interests of holders of our Common Shares and the rights of holders of preferred shares to receive dividends would be senior to those of holders of our Common Shares.

As a BDC, we generally are not able to issue our Common Shares at a price below NAV per share without first obtaining the approval of our shareholders and our Independent Trustees. If we raise additional funds by issuing more Common Shares or senior securities convertible into, or exchangeable for, our Common Shares, then percentage ownership of our shareholders at that time would decrease, and you might experience dilution. We may seek shareholder approval to sell Common Shares below NAV in the future.

We are uncertain of our sources for funding our future capital needs; if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected.

The net proceeds from the sale of Common Shares will be used for our investment opportunities, operating expenses and for payment of various fees and expenses such as base management fees, incentive fees and other expenses. Any working capital reserves we maintain may not be sufficient for investment purposes, and we may require debt or equity financing to operate. Accordingly, in the event that we develop a need for additional capital in the future for investments or for any other reason, these sources of funding may not be available to us. Consequently, if we cannot obtain debt or equity financing on acceptable terms, our ability to acquire investments and to expand our operations will be adversely affected. As a result, we would be less able to create and maintain a broad portfolio of investments and achieve our investment objective, which may negatively impact our results of operations and reduce our ability to make distributions to our shareholders.

We are a non-diversified investment company within the meaning of the 1940 Act, and therefore we are not limited by the 1940 Act with respect to the proportion of our assets that may be invested in securities of a single issuer.

We are classified as a non-diversified investment company within the meaning of the 1940 Act, which means that we are not limited by the 1940 Act with respect to the proportion of our assets that we may invest in securities of a single issuer. Our portfolio may be concentrated in a limited number of portfolio companies and industries. Beyond the asset diversification requirements associated with our qualification as a RIC under the Code, we will not have fixed guidelines for diversification. If we obtain large positions in the securities of a small number of issuers, our NAV is likely to fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market’s assessment of such issuer. We also may be more susceptible to any single economic or regulatory occurrence than a diversified investment company. As a result, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, while we are not targeting any specific industries, our investments may be concentrated in relatively few industries. As a result, a downturn in any particular industry in which we are invested could also significantly impact the aggregate returns we realize.

50

Risks Related to Debt Financing

When we use leverage, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us. Leverage also may adversely affect the return on our assets, reduce cash available for distribution to our shareholders, and result in losses.

The use of borrowings, also known as leverage, increases the volatility of investments by magnifying the potential for loss on invested equity capital. When we use leverage to partially finance our investments, through borrowing from banks and other lenders, shareholders will experience increased risks of investing in our Common Shares. If the value of our assets decreases, leveraging would cause NAV to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Such a decline could negatively affect our ability to make distributions to our shareholders. In addition, our shareholders will bear the burden of any increase in our expenses as a result of our use of leverage, including interest expenses and any increase in the management fees or incentive fees payable to the Adviser.

We use and intend to continue to use leverage to finance our investments. The amount of leverage that we employ will depend on the Adviser’s and our Board’s assessment of market and other factors at the time of any proposed borrowing. There can be no assurance that leveraged financing will be available to us on favorable terms or at all. However, to the extent that we use leverage to finance our assets, our financing costs will reduce cash available for distributions to shareholders. Moreover, we may not be able to meet our financing obligations and, to the extent that we cannot, we risk the loss of some or all of our assets to liquidation or sale to satisfy the obligations. In such an event, we may be forced to sell assets at significantly depressed prices due to market conditions or otherwise, which may result in losses.

We generally are required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred shares that we may issue in the future, of at least 150%. If this ratio were to fall below 150%, we could not incur additional debt and could be required to sell a portion of our investments to repay some debt when it is disadvantageous to do so. This could have a material adverse effect on our operations and investment activities. Moreover, our ability to make distributions to shareholders may be significantly restricted or we may not be able to make any such distributions whatsoever. The amount of leverage that we will employ will be subject to oversight by our Board, a majority of whom are Independent Trustees with no material interests in such transactions.

Although leverage has the potential to enhance overall returns that exceed the Fund’s cost of funds, they will further diminish returns (or increase losses on capital) to the extent overall returns are less than the Fund’s cost of funds. In addition, borrowings by the Fund may be secured by the shareholders’ investments as well as by the Fund’s assets and the documentation relating to such transactions may provide that during the continuance of a default under such arrangement, the interests of the holders of shares may be subordinated to the interests of our lenders or debtholders.

Our credit facility and other borrowing arrangements impose financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our qualification as a RIC under the Code. A failure to renew our facility or to add new or replacement debt facilities or issue additional debt securities or other evidences of indebtedness could have a material adverse effect on our business, financial condition, results of operations and liquidity.

Provisions in our credit facility may limit discretion.

Our existing and any future credit facilities may be backed by all or a portion of our loans and securities on which the lenders will have a security interest.

We may pledge up to 100% of our assets and may grant a security interest in all of our assets under the terms of any debt instrument we enter into with lenders. We expect that any security interests we grant will be set forth in a pledge and security agreement and evidenced by the filing of financing statements by the agent for the lenders. In addition, we expect that the custodian for our securities serving as collateral agent for such loan would include in its electronic systems notices indicating the existence of such security interests and, following notice of occurrence of an event of default, if any, and during its continuance, will only accept transfer instructions with respect to any such securities from the lender or its designee. If we were to default under the terms of any debt instrument, the agent for the applicable lenders would be able to assume control of the timing of disposition of any or all of our assets securing such debt, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In connection with our credit facility entered into by the Fund, distributions to shareholders may be subordinated to payments required in connection with any indebtedness contemplated thereby.

51

In addition, any security interests and/or negative covenants required by a credit facility may limit our ability to create liens on assets to secure additional debt and may make it difficult for us to restructure or refinance indebtedness at or prior to maturity or obtain additional debt or equity financing. In addition, if our borrowing base under a credit facility were to decrease, we may be required to secure additional assets in an amount sufficient to cure any borrowing base deficiency. In the event that all of our assets are secured at the time of such a borrowing base deficiency, we could be required to repay advances under a credit facility or make deposits to a collection account, either of which could have a material adverse impact on our ability to fund future investments and to make distributions.

In addition, we may be subject to limitations as to how borrowed funds may be used, which may include restrictions on geographic and industry concentrations, loan size, payment frequency and status, average life, collateral interests and investment ratings, as well as regulatory restrictions on leverage which may affect the amount of funding that may be obtained. There also may be certain requirements relating to portfolio performance, including required minimum portfolio yield and limitations on delinquencies and charge-offs, a violation of which could limit further advances and, in some cases, result in an event of default. An event of default under a credit facility could result in an accelerated maturity date for all amounts outstanding thereunder, which could have a material adverse effect on our business and financial condition. This could reduce our liquidity and cash flow and impair our ability to grow our business.

Any defaults under a credit facility could adversely affect our business.

In the event we default under a credit facility or other borrowings, our business could be adversely affected as we may be forced to sell a portion of our investments quickly and prematurely at what may be disadvantageous prices to us in order to meet our outstanding payment obligations and/or support working capital requirements under such borrowing facility, any of which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, following any such default, the agent for the lenders under such borrowing facility could assume control of the disposition of any or all of our assets, including the selection of such assets to be disposed and the timing of such disposition, which would have a material adverse effect on our business, financial condition, results of operations and cash flows.

We may form one or more CLOs, which may subject us to certain structured financing risks.

To finance investments, we may securitize certain of our secured loans or other investments, including through the formation of one or more CLOs, while retaining all or most of the exposure to the performance of these investments. This would involve contributing a pool of assets to a special purpose entity, and selling debt interests in such entity on a non-recourse or limited-recourse basis to purchasers. It is possible that an interest in any such CLO held by us may be considered a “non-qualifying” portfolio investment for purposes of the 1940 Act.

If we create a CLO, we will depend in part on distributions from the CLO’s assets out of its earnings and cash flows to enable us to make distributions to shareholders. The ability of a CLO to make distributions will be subject to various limitations, including the terms and covenants of the debt it issues. Also, a CLO may take actions that delay distributions in order to preserve ratings and to keep the cost of present and future financings lower or the CLO may be obligated to retain cash or other assets to satisfy over-collateralization requirements commonly provided for holders of the CLO’s debt, which could impact our ability to receive distributions from the CLO. If we do not receive cash flow from any such CLO that is necessary to satisfy the annual distribution requirement for maintaining RIC tax treatment, and we are unable to obtain cash from other sources necessary to satisfy this requirement, we may not maintain our qualification as a RIC, which would have a material adverse effect on an investment in the Common Shares.

In addition, a decline in the credit quality of loans in a CLO due to poor operating results of the relevant borrower, declines in the value of loan collateral or increases in defaults, among other things, may force a CLO to sell certain assets at a loss, reducing their earnings and, in turn, cash potentially available for distribution to us for distribution to shareholders. To the extent that any losses are incurred by the CLO in respect of any collateral, such losses will be borne first by us as owner of equity interests in the CLO.

The manager for a CLO that we create may be the Fund, the Adviser or an affiliate, and such manager may be entitled to receive compensation for structuring and/or management services. To the extent the Adviser or an affiliate other than the Fund serves as manager and the Fund is obligated to compensate the Adviser or the affiliate for such services, we, the Adviser or the affiliate will implement offsetting arrangements to assure that we, and indirectly, our shareholders, pay no additional management fees to the Adviser or the affiliate in connection therewith. To the extent we serve as manager, we will waive any right to receive fees for such services from the Fund (and indirectly its shareholders) or any affiliate.

52

U.S. Federal Income Tax Risks

We will be subject to U.S. federal income tax at corporate rates on our earnings if we are unable to qualify or maintain qualification as a RIC under Subchapter M of the Code.

We have elected, and intend to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code; however, no assurance can be given that we will be able to qualify for and maintain RIC tax treatment. To receive RIC tax treatment under the Code, we must meet certain requirements, including source-of-income, asset diversification and distribution requirements. The annual distribution requirement applicable to RICs generally is satisfied if we timely distribute at least 90% of our net ordinary income and net short-term capital gains in excess of net long-term capital losses, if any, to our shareholders on an annual basis. We will be subject to U.S. federal income tax at corporate rates on any income that we do not timely distribute. In addition, we will be subject to a 4% nondeductible U.S. federal excise tax to the extent that we do not satisfy certain additional minimum distribution requirements on a calendar year basis. To the extent we use debt financing, we will be subject to certain asset coverage ratio requirements under the 1940 Act and may be subject to financial covenants under loan and credit agreements, each of which could, under certain circumstances, restrict us from making annual distributions necessary to receive RIC tax treatment. If we are unable to obtain cash needed to pay such annual distributions from other sources, we may fail to be taxed as a RIC and, thus, may be subject to U.S. federal income tax at corporate rates on our entire taxable income without regard to any distributions made by us. In order to be taxed as a RIC, we must also meet certain asset diversification requirements at the end of each quarter of our taxable year. Failure to meet these tests may result in our having to dispose of certain investments quickly in order to prevent the loss of RIC tax treatment. Because most of our investments are in private or thinly traded public companies, any such dispositions could be made at disadvantageous prices and may result in substantial losses. If we fail to be taxed as a RIC for any reason and become subject to U.S. federal income tax at corporate rates, the resulting tax could substantially reduce our net assets, the amount of income available for distributions to shareholders and the amount of our distributions and the amount of funds available for new investments. Such a failure would have a material adverse effect on us and our shareholders.

We may have difficulty paying our required distributions if we recognize income before, or without, receiving cash representing such income.

For U.S. federal income tax purposes, we will include in income certain amounts that we have not yet received in cash, such as OID, or through contracted PIK interest, which represents contractual interest added to the loan balance and due at the end of the loan term. OID, which could be significant relative to our overall investment activities, or increases in loan balances as a result of contracted PIK arrangements, will be included in income before we receive any corresponding cash payments. We also may be required to include in income certain other amounts that we will not receive in cash.

That part of the incentive fee payable by us that relates to our net investment income is computed and paid on income that may include interest that has been accrued but not yet received in cash, such as OID and PIK interest. If we pay a net investment income incentive fee on interest that has been accrued, but not yet received in cash, it will increase the basis of our investment in that loan, which will reduce the capital gains incentive fee that we would otherwise pay in the future. Nevertheless, if we pay a net investment income incentive fee on interest that has been accrued but not yet received, and if that portfolio company defaults on such a loan, it is possible that accrued interest previously included in the calculation of the incentive fee will become uncollectible.

Because we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirements applicable to RICs. In such a case, we may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital or reduce new investment originations and sourcings to meet these distribution requirements. If we are not able to obtain such cash from other sources, we may fail to qualify for the tax benefits available to RICs and thus be subject to U.S. federal income tax on our earnings at corporate rates.

Some of our investments may be subject to U.S. federal income tax at corporate rates.

We may invest in certain debt and equity investments through taxable subsidiaries and the taxable income of these taxable subsidiaries will be subject to U.S. federal and state income taxes at corporate rates. We may invest in certain foreign debt and equity investments that could be subject to foreign taxes (such as income tax, withholding and value added taxes).

53

Our portfolio investments may present special tax issues.

The Fund expects to invest in debt securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Investments in these types of instruments may present special tax issues for the Fund. U.S. federal income tax rules are not entirely clear about issues such as when the Fund may cease to accrue interest, OID or market discount, when and to what extent deductions may be taken for bad debts or worthless instruments, how payments received on obligations in default should be allocated between principal and income and whether exchanges of debt obligations in a bankruptcy or workout context are taxable. These and other issues will be addressed by the Fund, to the extent necessary, to preserve its tax treatment as a RIC and to distribute sufficient income to not become subject to U.S. federal income tax at corporate rates.

We cannot predict how new tax legislation will affect us, our Advisers, our investments, or our shareholders, and any such legislation could adversely affect our business.

Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. The Biden Administration has proposed significant changes to the existing U.S. tax rules, and there are a number of proposals in Congress that would similarly modify the existing U.S. tax rules. The likelihood of any such legislation being enacted is uncertain, but new legislation and any U.S. Treasury regulations, administrative interpretations or court decisions interpreting such legislation could have adverse consequences, including significantly and negatively affect our ability to qualify for tax treatment as a RIC or otherwise impact the U.S. federal income tax consequences applicable to us and our investors. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our shares.

Risks Related to an Investment in the Common Shares

We may have difficulty sourcing investment opportunities.

We cannot assure investors that we will be able to locate a sufficient number of suitable investment opportunities to allow us to deploy all investments successfully. In addition, privately-negotiated investments in loans and illiquid securities of private middle market companies require substantial due diligence and structuring, and we cannot assure investors that we will achieve our anticipated investment pace. As a result, investors will be unable to evaluate any future portfolio company investments prior to purchasing our Common Shares. Additionally, our Adviser will select our investments subsequent to our offering, and our shareholders will have no input with respect to such investment decisions. These factors increase the uncertainty, and thus the risk, of investing in our Common Shares. To the extent we are unable to deploy all investments, our investment income and, in turn, our results of operations, will likely be materially adversely affected.

We face risks associated with the deployment of our capital.

In light of the nature of our continuous offering as well as ongoing and periodic private offerings in relation to our investment strategy and the need to be able to deploy potentially large amounts of capital quickly to capitalize on potential investment opportunities, if we have difficulty identifying investments on attractive terms, there could be a delay between the time we receive net proceeds from the sale of our Common Shares in our offering or any private offering and the time we invest the net proceeds. Our proportion of privately-negotiated investments may be lower than expected. We may also from time to time hold cash pending deployment into investments or have less than our targeted leverage, which cash or shortfall in target leverage may at times be significant, particularly at times when we are receiving high amounts of offering proceeds and/or times when there are few attractive investment opportunities. Such cash may be held in an account for the benefit of our shareholders that may be invested in money market accounts or other similar temporary investments, each of which are subject to the management fees.

54

In the event we are unable to find suitable investments, such cash may be maintained for longer periods, which would be dilutive to overall investment returns. This could cause a substantial delay in the time it takes for your investment to realize its full potential return and could adversely affect our ability to pay regular distributions of cash flow from operations to you. It is not anticipated that the temporary investment of such cash into money market accounts or other similar temporary investments pending deployment into investments will generate significant interest, and investors should understand that such low interest payments on the temporarily invested cash may adversely affect overall returns. In the event we fail to timely invest the net proceeds of sales of our Common Shares or do not deploy sufficient capital to meet our targeted leverage, our results of operations and financial condition may be adversely affected.

We may have difficulty paying distributions and the tax character of any distributions is uncertain.

We generally intend to distribute substantially all of our available earnings annually by paying distributions on a monthly basis, as determined by the Board in its discretion. We cannot assure investors that we will achieve investment results that will allow us to make a specified level of cash distributions (particularly during the early stages of our operations) or year-to-year increases in cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this Annual Report on Form 10-K. Due to the asset coverage test applicable to us under the 1940 Act as a BDC, we may be limited in our ability to make distributions. In addition, for so long as our credit facility is outstanding, or pursuant to any other credit facility or borrowing facility we enter into in the future, we may be required by its terms to use all payments of interest and principal that we receive from our current investments as well as any proceeds received from the sale of our current investments to repay amounts outstanding thereunder, which could adversely affect our ability to make distributions.

Furthermore, the tax treatment and characterization of our distributions may vary significantly from time to time due to the nature of our investments. The ultimate tax characterization of our distributions made during a taxable year may not finally be determined until after the end of that taxable year. We may make distributions during a taxable year that exceed our investment company taxable income and net capital gains for that taxable year. In such a situation, the amount by which our total distributions exceed our current and accumulated earnings and profits generally would be treated as a return of capital up to the amount of a shareholder’s adjusted tax basis in the shares, with any amounts exceeding such adjusted tax basis treated as a gain from the sale or exchange of such shares. A return of capital generally is a return of a shareholder’s investment rather than a return of earnings or gains derived from our investment activities. Moreover, we may pay all or a substantial portion of our distributions from borrowings or sources other than cash flow from operations in anticipation of future cash flow, which could constitute a return of shareholders’ capital and will lower such shareholders’ adjusted tax basis in our Common Shares, which may result in increased tax liability to shareholders when they sell such Common Shares.

An investment in our Common Shares will have limited liquidity.

Our Common Shares will constitute illiquid investments for which there is not, and will likely not be, a secondary market at any time prior to a public offering and listing of our Common Shares on a national securities exchange. There can be no guarantee that we will conduct a public offering and list our Common Shares on a national securities exchange. Investment in the Fund is suitable only for sophisticated investors and requires the financial ability and willingness to accept the high risks and lack of liquidity inherent in an investment in the Fund. Except in limited circumstances for legal or regulatory purposes, shareholders are not entitled to redeem their Common Shares. Shareholders must be prepared to bear the economic risk of an investment in our Common Shares for an extended period of time.

Certain investors will be subject to Exchange Act filing requirements.

Because our Common Shares will be registered under the Exchange Act, ownership information for any person who beneficially owns 5% or more of our Common Shares will have to be disclosed in a Schedule 13G or other filings with the SEC. Beneficial ownership for these purposes is determined in accordance with the rules of the SEC, and includes having voting or investment power over the securities. In some circumstances, our shareholders who choose to reinvest their dividends may see their percentage stake in the Fund increased to more than 5%, thus triggering this filing requirement.Although we provide in our quarterly financial statements the amount of our outstanding shares and the amount of the investor’s shares, the responsibility for determining the filing obligations and preparing the filing remains with the investor. In addition, owners of 10% or more of our Common Shares are subject to reporting obligations under Section 16(a) of the Exchange Act.

55

Certain investors may be subject to the short-swing profits rules under the Exchange Act..

Our shareholders who hold more than 10% of a class of our Common Shares may be subject to Section 16(b) of the Exchange Act, which recaptures for the benefit of the Fund profits from the purchase and sale of registered stock (and securities convertible or exchangeable into such registered stock) within a six-month period.

Certain ERISA considerations.

We intend to conduct our affairs so that our assets should not be deemed to constitute “plan assets” under ERISA and the Plan Asset Regulations. In this regard, until such time as all classes of our Common Shares are considered “publicly-offered securities” within the meaning of the Plan Asset Regulations, we intend either to (i) limit investment in each class of our Common Shares by “benefit plan investors” to less than 25% of the total value of each class of our Common Shares (within the meaning of the Plan Asset Regulations) and/or (ii) prohibit “benefit plan investors” from acquiring Common Shares that are not a part of a class of Common Shares which are considered “publicly-offered securities”.

If, notwithstanding our intent, the assets of the Fund were deemed to be “plan assets” of any shareholder that is a “benefit plan investor” under the Plan Asset Regulations, this would result, among other things, in (i) the application of the prudence and other fiduciary responsibility standards of ERISA to investments made by the Fund, and (ii) the possibility that certain transactions in which the Fund might seek to engage could constitute “prohibited transactions” under ERISA and the Code. If a prohibited transaction occurs for which no exemption is available, the Adviser and/or any other fiduciary that has engaged in the prohibited transaction could be required to (i) restore to the “benefit plan investor” any profit realized on the transaction and/or (ii) reimburse the Covered Plan for any losses suffered by the “benefit plan investor” as a result of the investment. In addition, each disqualified person (within the meaning of Section 4975 of the Code) involved could be subject to an excise tax equal to 15% of the amount involved in the prohibited transaction for each year the transaction continues and, unless the transaction is corrected within statutorily required periods, to an additional tax of 100%. The Fiduciary of a “benefit plan investor” who decides to invest in the Fund could, under certain circumstances, be liable for prohibited transactions or other violations as a result of their investment in the Fund or as co-fiduciaries for actions taken by or on behalf of the Fund or the Adviser. With respect to a “benefit plan investor” that is an individual retirement account (an “IRA”) that invests in the Fund, the occurrence of a prohibited transaction involving the individual who established the IRA, or his or her beneficiaries, would cause the IRA to lose its tax-exempt status.

Until such time as all the classes of our Common Shares constitute “publicly traded securities” within the meaning of the Plan Asset Regulations, we have the power to (a) exclude any shareholder or potential shareholder from purchasing our Common Shares; (b) prohibit any redemption of our Common Shares; and (c) redeem some or all Common Shares held by any holder if, and to the extent that, our Board determines that there is a substantial likelihood that such holder’s purchase, ownership or redemption of Common Shares would result in our assets to be characterized as “plan assets,” for purposes of the fiduciary responsibility or prohibited transaction provisions of ERISA or Section 4975 of the Code, and all Common Shares of the Fund shall be subject to such terms and conditions.

Prospective investors should carefully review the matters discussed under “Restrictions on Share Ownership” and should consult with their own advisors as to the consequences of making an investment in the Fund.

Our Board may consider certain mergers.

The Independent Trustees of our Board may undertake to approve mergers between us and certain other funds or vehicles. These mergers may involve funds managed by affiliates of the Adviser. The Independent Trustees also may seek to convert the form and/or jurisdiction of organization, including to take advantage of laws that are more favorable to maintaining board control in the face of dissident shareholders.

Shareholders may experience dilution.

All distributions declared in cash payable to shareholders that are participants in our distribution reinvestment plan will generally be automatically reinvested in our Common Shares. As a result, shareholders that do not participate in our distribution reinvestment plan may experience dilution over time.

56

Holders of our Common Shares will not have preemptive rights to any Common Shares we issue in the future. Our Declaration of Trust allows us to issue an unlimited number of Common Shares. After you purchase Common Shares in our offering, our Board of Trustees may elect, without shareholder approval, to: (1) sell additional Common Shares in this or future public offerings; (2) issue Common Shares or interests in any of our subsidiaries in private offerings; (3) issue Common Shares upon the exercise of the options we may grant to our Independent Trustees or future employees; or (4) subject to applicable law, issue Common Shares in payment of an outstanding obligation to pay fees for services rendered to us. To the extent we issue additional Common Shares after your purchase in our offering, your percentage ownership interest in us will be diluted. Because of these and other reasons, our shareholders may experience substantial dilution in their percentage ownership of our Common Shares or their interests in the underlying assets held by our subsidiaries.

Investing in our Common Shares involves a high degree of risk.

The investments we make in accordance with our investment objective may result in a higher amount of risk than alternative investment options and a higher risk of volatility or loss of principal. Our investments in portfolio companies may be highly speculative and aggressive and, therefore, an investment in our Common Shares may not be suitable for someone with lower risk tolerance.

The NAV of our Common Shares may fluctuate significantly.

The NAV and liquidity, if any, of the market for our Common Shares may be significantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include:

•changes in the value of our portfolio of investments as a result of changes in market factors, such as interest rate shifts, and also portfolio specific performance, such as portfolio company defaults, among other reasons;

•changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;

•failure to maintain our qualification for RIC tax treatment;

•distributions that exceed our net investment income and net income as reported according to U.S. GAAP;

•changes in earnings or variations in operating results;

•changes in accounting guidelines governing valuation of our investments;

•any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts;

•departure of the Adviser or certain of its key personnel;

•general economic trends and other external factors; and

•loss of a major funding source.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

57

ITEM 1C. CYBERSECURITY

Cybersecurity

The Fund depends on and engages various third parties and service providers, including suppliers, custodians, transfer agents, administrative agents, fund administrators and other third parties to source, make and manage its investments. Accordingly, the Fund’s business is dependent on the communications and information technology (“IT”) systems that it shares with the Advisers and their ultimate parent company, TIAA, which further relies upon the systems of third-party IT service providers to TIAA. TIAA has established a cybersecurity program across its enterprise, which applies to certain of its affiliates, including the Advisers and the Fund. When identifying and overseeing risks from cybersecurity threats associated with its use of third-party service providers, the Fund further relies upon the expertise of risk management, legal, information technology, and compliance personnel of TIAA. TIAA conducts onboarding and ongoing due diligence of certain of the Fund’s key third-party service providers to identify and oversee risks from cybersecurity threats associated with the Fund’s use of such entities.

Cybersecurity Program Overview

TIAA has instituted an enterprise cybersecurity program designed to identify, assess, and mitigate cyber risks applicable to TIAA and its affiliates, which applies to the Fund and the Advisers. This cyber risk management program is integrated into TIAA’s overall risk management program and involves risk assessments, implementation of security measures, and ongoing monitoring of systems and networks, including networks on which the Fund relies. TIAA relies on its internal subject matter experts and external experts, as needed, including, but not limited to, cybersecurity assessors, consultants, and auditors, to evaluate cybersecurity measures and risk management processes applicable to the Advisers, the Fund and other affiliates of TIAA.

TIAA actively monitors the current cyber threat landscape in an effort to identify material risks arising from new and evolving cybersecurity threats, including material risks faced by the Fund and the Advisers in connection with their day-to-day operations. TIAA’s cybersecurity leadership team are responsible for maintaining and overseeing the overall state of TIAA’s cybersecurity program, information on the current threat landscape, and risks from cybersecurity threats and cybersecurity incidents impacting TIAA and its affiliates, including the Fund, the Advisers and their respective third-party service providers.

TIAA’s cybersecurity team, including its Chief Information Security Officer, is responsible for assessing and managing material risks from cybersecurity threats to the TIAA organization, including the Fund and the Advisers. TIAA’s Chief Information Security Officer and cybersecurity leaders have significant expertise in in this area, including in IT and cybersecurity engineering, and have cybersecurity leadership experience in other major financial institutions.

Management of the Fund is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents impacting the Fund, including through the receipt of notifications from third party service providers and reliance on communications with cybersecurity, risk management, legal, IT, and/or compliance personnel of TIAA.

Oversight of Cybersecurity Risk

The potential impact of risks from cybersecurity threats on the Fund is assessed on an ongoing basis, as well as how such risks could materially affect the Fund’s business strategy, operational results, and financial condition. Cybersecurity risk remains heightened to the financial industry, including the Fund, and a failure in or breach of our systems or infrastructure, or those of a material third party or service provider, could cause disruption and adversely impact the Fund’s operations. TIAA and the Advisers continue to invest in the cybersecurity program to protect against emerging threats, including threats against third parties and service providers. The Fund has not experienced any material cybersecurity incident, and the Fund is not aware of any cybersecurity risks that are reasonably likely to materially affect its business.

TIAA’s cybersecurity team periodically reports to the Fund’s management on cybersecurity matters, primarily through presentations. Such reporting will include updates on TIAA’s cybersecurity program as it relates to the Fund, the external cybersecurity threat environment, and TIAA’s programs to address and mitigate the risks associated with the evolving cybersecurity threat environment. These reports also include updates on TIAA’s preparedness, prevention, detection, responsiveness and recovery with respect to cybersecurity incidents.

The Board has the primary responsibility for overseeing and reviewing the guidelines and policies with respect to risk assessment and risk management, including cybersecurity. The Board receives periodic updates from the Fund’s management regarding TIAA’s cybersecurity program, information on current threat landscape and risks from cybersecurity threats and cybersecurity incidents impacting the Fund.

58

ITEM 2. PROPERTIES

We do not own any real estate or other physical properties materially important to our operation. Our corporate headquarters are located at 375 Park Avenue, 9th Floor, New York, NY 10152, and are provided by the Administrator in accordance with the terms of our Administration Agreement. We believe that our office facilities are suitable and adequate for our business as it is contemplated to be conducted.

ITEM 3. LEGAL PROCEEDINGS

We, and our consolidated subsidiaries, the Adviser and the Sub-Adviser are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us or them. From time to time, we, our consolidated subsidiaries and/or the Adviser and Sub-Adviser may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Our business also is subject to extensive regulation, which may result in regulatory proceedings against us.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

59

PART II.

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Share Issuances

The offering consists of three classes of shares, Class S shares, Class D shares and Class I shares. The share classes have different ongoing stockholder servicing fees. Other than the differences in ongoing stockholder servicing fees, each class of common stock has the same economics and voting rights. Shares of our common stock are not listed for trading on a stock exchange or other securities market and there is no established public trading market for our common stock.

We expect to determine our NAV for each class of shares each month as of the last day of each calendar month. The NAV per share for each class of shares is determined by dividing the value of total assets attributable to the class minus liabilities attributable to the class by the total number of Common Shares outstanding of the class at the date as of which the determination is made.

Market Information

Our Common Shares are not listed for trading on a stock exchange or other securities market and there is no established public trading market for our Common Shares.

Holders

As of February 29, 2024, there was 671 holder of record of our Class I shares of beneficial interest, 94 holders of record of our Class S shares of beneficial interest and 87 holders of record of our Class D shares of beneficial interest.

Sales of Unregistered Securities

We did not sell any securities during the period covered by this Annual Report on Form 10-K that were not registered under the Securities Act of 1933, as amended.

Share Repurchase Program

Beginning with the fiscal quarter ended September 30, 2023, the Fund commenced a share repurchase program in which it intends to repurchase in each quarter, at the discretion of the Board, up to 5% of its Common Shares outstanding (either by number of shares or aggregate NAV) as of the close of the previous calendar quarter. The Board, in its sole discretion, may amend, suspend or terminate the share repurchase program if it deems such action to be in the best interest of the Fund’s shareholders. As a result, share repurchases may not be available each quarter, such as when a repurchase offer would place an undue burden on our liquidity, adversely affect the Fund’s operations or risk having an adverse impact on the Fund that would outweigh the benefit of the repurchase offer. Following any such suspension, the Board will consider on at least a quarterly basis whether the continued suspension of the Share Repurchase Program is in the best interest of the Fund and shareholders, and will reinstate the Share Repurchase Program when and if appropriate and subject to its fiduciary duty to the Fund and shareholders. However, our Board is not required to authorize the recommencement of our Share Repurchase Program within any specified period of time. The Fund intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Securities Exchange Act of 1934, as amended, and the 1940 Act. All Common Shares purchased by the Fund pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued Common Shares.

Under the share repurchase program, to the extent the Fund offers to repurchase Common Shares in any particular quarter, the Fund expects to repurchase Common Shares pursuant to tender offers using a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter, except that Common Shares that have not been outstanding for at least one year will be repurchased at 98% of such NAV (an “Early Repurchase Deduction”). The one-year holding period is measured as of the subscription closing date immediately following the prospective repurchase date. The Early Repurchase Deduction may be waived in the case of repurchase requests arising from the death, divorce or qualified disability of the holder. The Early Repurchase Deduction will be retained by the Fund for the benefit of remaining shareholders.Common Shares. The repurchase of the Adviser’s shares, if any, will be on the same terms and subject to the same limitations as other shareholders under the Share Repurchase Program.

60

Payment for repurchased shares may require us to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. Our Adviser intends to take measures, subject to policies as may be established by our Board, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of shares. Class I shares owned by TIAA will be subject to the following restrictions. TIAA may submit its Class I shares for repurchase beginning on March 31, 2027. Beginning March 31, 2027, the total amount of TIAA shares eligible for repurchase will be limited to no more than 1.67% of our aggregate NAV per calendar quarter; provided that, if in any quarter the total amount of aggregate repurchase requests of all classes of Common Shares does not exceed the Share Repurchase Plan limit of 5% of the aggregate NAV per calendar quarter, these redemption limits on the TIAA shares will not apply for that quarter, and TIAA will be entitled to submit its shares for repurchase up to the overall Share Repurchase Plan limits.

For the year ended December 31, 2023, no Common Shares were repurchased.

ITEM 6. RESERVED

61

ITEM 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

The information in this management's discussion and analysis of financial condition and results of operations relates to Nuveen Churchill Private Capital Income Fund., including its wholly owned subsidiaries (collectively, "we", "us", "our" or the "Fund"). The information contained in this section should be read in conjunction with our consolidated financial statements and related notes appearing elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements, which relate to future events or the future performance or financial condition and involves numerous risks and uncertainties, including, but not limited to, those set forth in “Risk Factors” in Part I, Item 1A of and elsewhere in this Annual Report on Form 10-K. This discussion should be read in conjunction with the “Forward-Looking Statements” in this Annual Report on Form 10-K. Actual results could differ materially from those implied or expressed in any forward-looking statements.

Overview

We were formed as a Delaware statutory trust on February 8, 2022. We are an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). We are externally managed by Churchill Asset Management LLC (“Churchill” or the “Adviser”), which is responsible for sourcing potential investments, conducting due diligence on prospective investments, analyzing investment opportunities, structuring investments and monitoring our portfolio on an ongoing basis. The Adviser is registered as an investment adviser with the Securities and Exchange Commission (the “SEC”) under the Investment Advisers Act of 1940, as amended (the “Advisers Act”). We have elected to be treated, and intend to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Our investment objective is to generate attractive risk-adjusted returns primarily through current income and, secondarily, long-term capital appreciation, by investing in a diversified portfolio of private debt and equity investments in U.S. middle market companies owned by leading private equity firms, which we define as companies with $10 million to $250 million of earnings before interest, taxes, depreciation and amortization (“EBITDA”). We primarily focus on investing in U.S. middle market companies with $10 million to $100 million of EBITDA, which we consider the core middle market.

We primarily invest in first-lien senior secured debt and first-out positions in unitranche loans (collectively “Senior Loan Investments”), as well as junior debt investments, such as second-lien loans, unsecured debt, subordinated debt and last-out positions in unitranche loans (including fixed- and floating-rate instruments and instruments with payment-in-kind income) (“Junior Capital Investments”). Senior Loan Investments and Junior Capital Investments may be originated alongside smaller related common equity positions to the same portfolio companies. Our portfolio also will include larger, stand-alone direct equity co-investments in private-equity backed companies that may or may not be originated alongside or separately from Senior Loan Investments and/or Junior Capital Investments to the applicable portfolio company (“Equity Co-Investments”). We target an investment portfolio consisting, directly or indirectly, of 75% to 90% in Senior Loan Investments, 5% to 25% in Junior Capital Investments and up to 10% in Equity Co-Investments. To support our share repurchase program, we will also invest 5% to 10% of our assets in cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments (“Liquid Investments”). While we seek to achieve the targets described above, the composition of the Fund’s investment portfolio may vary from time to time due to various factors, such as market conditions and the availability of attractive investment opportunities. For example, it is possible that the Fund will from time to time maintain a portfolio exclusively comprised of Senior Loan Investments, Junior Capital Investments or other fixed-income instruments, such as during its initial ramp-up phase.

NCPIF SPV I LLC (“SPV I”) and NCPIF Equity Holdings LLC (“Equity Holdings”) are wholly owned subsidiaries of the Fund and are consolidated in these consolidated financial statements.

On March 31, 2022, prior to our election to be regulated as a BDC under the 1940 Act, Teachers Insurance and Annuity Association of America (“TIAA”) contributed certain portfolio investments to the Fund and SPV I and, in connection therewith, the Fund entered into the Note (as described below) and issued Class I shares to TIAA.

Under our Investment Advisory Agreement with the Adviser (the “Advisory Agreement”), we have agreed to pay the Adviser an annual management fee as well as an incentive fee based on our investment performance. The Adviser has engaged its affiliate, Nuveen Asset Management, LLC (“Nuveen Asset Management” or “Sub-Adviser”), acting through its leveraged finance division, to manage certain of its Liquid Investments (as defined below) pursuant to a sub-advisory agreement between the Adviser and Nuveen Asset Management (the “Sub-Advisory Agreement”). Under the administration agreement (the “Administration Agreement”) with Churchill BDC Administration LLC (f/k/a Nuveen Churchill Administration LLC), as our administrator (the “Administrator”), we have agreed to reimburse the Administrator for the allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including, but not limited to, our allocable portion of the costs of compensation and related expenses of our Chief Financial Officer and Chief Compliance Officer and their respective staffs. The Adviser, Nuveen Asset Management, and the Administrator are all affiliates and subsidiaries of Nuveen, LLC (“Nuveen”), the investment management division of TIAA.

62

Key Components of Our Results of Operations

Investments

Our level of investment activity varies substantially from period to period depending on many factors, including the amount we have available to invest as well as the amount of debt and equity capital available to middle-market companies, the level of merger and acquisition activity in the middle market, the general economic environment and the competitive environment for the types of investments we make, and other market conditions.

To qualify as a RIC, we must, among other things, meet certain source-of-income and asset diversification requirements. To the extent we qualify as a RIC, we generally will not be subject to U.S federal income tax on any income we timely distribute to our shareholders.

As a BDC, we are required to comply with certain regulatory requirements. For instance, we are generally required to invest at least 70% of our total assets in “qualifying assets,” including securities of private or thinly traded public U.S. companies, cash, cash equivalents, U.S. government securities and high-quality debt investments that mature in one year or less.

As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” Under the 1940 Act, the term “eligible portfolio company” includes all private companies, companies whose securities are not listed on a national securities exchange, and certain public companies that have listed their securities on a national securities exchange and have a market capitalization of less than $250.0 million. We also must be organized in the United States to qualify as a BDC.

Revenues

We generate revenue primarily in the form of interest income on our Senior Loan Investments, our Junior Capital Investments and our Liquid Investments, and capital gains and dividend income from our Equity Co-Investments in our portfolio companies. Our Senior Loan Investments typically bear interest at a floating rate usually determined on the basis of a benchmark, such as the Secured Overnight Financing Rate (“SOFR”). Our Junior Capital Investments generally include cash paying subordinated debt (including fixed-rate subordinated loans, which may have a portion of PIK income, and floating-rate second-lien term loans), subordinated PIK notes (with no current cash payments) and/or equity securities (with no current cash payments). Our Liquid Investments includes a portfolio of cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments. The principal amount of the debt securities and any accrued but unpaid PIK interest generally will become due at the maturity date. Original Issue discounts and market discounts or premiums will be capitalized, and we will accrete or amortize such amounts as interest income. We will record prepayment premiums on loans and debt securities as interest income.

Dividend income, if any, will be recognized on an accrual basis to the extent that we expect to collect such amounts. In addition, we generate revenue in the form of commitment, loan origination, structuring or diligence fees, fees for providing managerial assistance to our portfolio companies, and possibly consulting fees.

Expenses

Churchill, Nuveen Asset Management and their affiliates are responsible for the compensation and routine overhead expenses allocable to personnel providing investment advisory and management services to the Fund. The Fund will bear all other out-of-pocket costs and expenses of its operations and transactions, including those costs and expenses incidental to the provision of investment advisory and management services to the Fund (such as items (iii) and (iv) listed below).

For the avoidance of doubt, unless the Adviser or Nuveen Asset Management elects to bear or waive any of the following costs, the Fund will bear the following costs:

(i)organization of the Fund;

(ii)calculating NAV (including the cost and expenses of any independent third-party valuation firm);

(iii)expenses, including travel, entertainment, lodging and meal expenses, incurred by the Adviser, Nuveen Asset Management, or members of its investment teams, or payable to third parties, in evaluating, developing, negotiating, structuring and performing due diligence on prospective portfolio companies, including such expenses related to potential investments that were not consummated, and, if necessary, enforcing the Fund’s rights;

(iv)fees and expenses incurred by the Adviser (and its affiliates), Nuveen Asset Management (and its affiliates), or the Administrator (or its affiliates) payable to third parties, including agents, consultants or other advisors, in monitoring

63

financial and legal affairs for the Fund and in conducting research and due diligence on prospective investments and equity sponsors, analyzing investment opportunities, structuring the Fund’s investments and monitoring investments and portfolio companies on an ongoing basis;

(v)any and all fees, costs and expenses incurred in connection with the incurrence of leverage and indebtedness of the Fund, including borrowings, dollar rolls, reverse purchase agreements, credit facilities, securitizations, margin financing and derivatives and swaps, and including any principal or interest on the Fund’s borrowings and indebtedness (including, without limitation, any fees, costs, and expenses incurred in obtaining lines of credit, loan commitments, and letters of credit for the account of the Fund and in making, carrying, funding and/or otherwise resolving investment guarantees);

(vi)offerings, sales, and repurchases of the Common Shares and other securities;

(vii)fees and expenses payable under the Intermediary Manager Agreement and selected dealer agreements, if any;

(viii)investment advisory fees payable under Section 7 of the Advisory Agreement;

(ix)administration fees and expenses, if any, payable under the Administration Agreement (including payments under the Administration Agreement between us and the Administrator, based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including the allocable portion of the cost of the Fund’s chief financial officer and chief compliance officer and their respective staffs);

(x)costs incurred in connection with investor relations and Board relations;

(xi)any applicable administrative agent fees or loan arranging fees incurred with respect to portfolio investments by the Adviser, Nuveen Asset Management (and its affiliates), the Administrator or an affiliate thereof;

(xii)any and all fees, costs and expenses incurred in implementing or maintaining third-party or proprietary software tools, programs or other technology for the benefit of the Fund (including, without limitation, any and all fees, costs and expenses of any investment, books and records, portfolio compliance and reporting systems, general ledger or portfolio accounting systems and similar systems and services, including, without limitation, consultant, software licensing, data management and recovery services fees and expenses);

(xiii)transfer agent, dividend agent and custodial fees and expenses;

(xiv)federal and state registration fees;

(xv)all costs of registration and listing the Common Shares on any securities exchange;

(xvi)federal, state and local taxes;

(xvii)independent trustees’ fees and expenses, including reasonable travel, entertainment, lodging and meal expenses, and any legal counsel or other advisors retained by, or at the discretion or for the benefit of, the independent trustees;

(xviii)costs of preparing and filing reports or other documents required by the SEC, FINRA, U.S. Commodity Futures Trading Commission, or other regulators, and all fees, costs and expenses related to compliance-related matters (such as developing and implementing specific policies and procedures in order to comply with certain regulatory requirements) and regulatory filings related to the Fund’s activities and/or other regulatory filings, notices or disclosures of the Adviser, Nuveen Asset Management, and their respective affiliates relating to the Fund and its activities;

(xix)costs of any reports, proxy statements or other notices to shareholders, including printing costs;

(xx)fidelity bond, trustees’ and officers’/errors and omissions liability insurance, and any other insurance premiums;

(xxi)direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors, tax preparers and outside legal costs;

(xxii)proxy voting expenses;

(xxiii)all expenses relating to payments of dividends or interest or distributions in cash or any other form made or caused to be made by the Board to or on account of holders of the securities of the Fund, including in connection with the distribution reinvestment plan or the share repurchase program;

64

(xxiv)costs incurred in connection with the formation or maintenance of entities or vehicles to hold the Fund’s assets for tax or other purposes;

(xxv)the allocated costs incurred by the Adviser, Nuveen Asset Management, and/or the Administrator in providing managerial assistance to those portfolio companies that request it;

(xxvi)allocable fees and expenses associated with marketing efforts on behalf of the Fund;

(xxvii)all fees, costs and expenses of any litigation involving the Fund or its portfolio companies and the amount of any judgments or settlements paid in connection therewith, Trustee and officers, liability or other insurance (including costs of title insurance) and indemnification (including advancement of any fees, costs or expenses to persons entitled to indemnification) or extraordinary expense or liability relating to Fund’s affairs;

(xxviii)fees, costs and expenses of winding up and liquidating the Fund’s assets; and

(xxix)all other expenses incurred by the Fund, the Adviser, Nuveen Asset Management, or the Administrator in connection with administering the Fund’s business.

With respect to (i) above, Nuveen Alternative Holdings LLC, an affiliate of the Adviser (“Nuveen Alternative Holdings”) agreed to advance (or cause one or more of its affiliates to advance) all of our organization and offering expenses on our behalf through the Escrow Break Date. Unless Nuveen Alternative Holdings elects to cover such expenses pursuant to the expense support and conditional reimbursement agreement with the Adviser (the “Expense Support Agreement”), we may be obligated to reimburse Nuveen Alternative Holdings under the terms of the Expense Support Agreement for such advanced expenses. Any reimbursements will not exceed actual expenses incurred by Nuveen Alternative Holdings.

From time to time, the Adviser, the Administrator or their affiliates may pay third-party providers of goods or services. We will reimburse the Adviser, the Administrator or such affiliates thereof for any such amounts paid on our behalf. From time to time, the Adviser or the Administrator may defer or waive fees and/or rights to be reimbursed for expenses. All of the foregoing expenses will ultimately be borne by our shareholders, subject to the cap on organization and offering expenses described above.

Portfolio and Investment Activity

Portfolio Composition

Our portfolio and investment activity for the year ended December 31, 2023 and for the period February 8, 2022 (inception) through December 31, 2022, is presented below (information presented herein is at amortized cost unless otherwise indicated) (dollar amounts in thousands):

	For the Years Ended December 31,
	2023		2022 (1)
Investments:
Total investments, beginning of period	$	352,998	$	—
Purchase of investments	206,879		389,785
Proceeds from principal repayments and sales of investments	(47,485)		(38,221)
Payment-in-kind interest	2,188		1,275
Amortization of premium/accretion of discount, net	820		506
Net realized gain (loss) on investments	768		(347)
Total investments, end of period	$	516,168	$	352,998
Portfolio companies at beginning of period	64		—
Number of new portfolio companies funded	104		67
Number of portfolio companies sold or repaid	(9)		(3)
Portfolio companies at end of period	159		64
Count of investments	252		102
Count of industries	27		20

_______________

(1)For the period February 8, 2022 (inception) through December 31, 2022

65

As of December 31, 2023, our portfolio companies had a weighted average reported EBITDA (including all private debt investments and excluding quoted assets) of $62.3 million. Including the quoted assets, our portfolio companies had a weighted average reported EBITDA of $191.7 million. EBITDA amounts are derived from the most recently available portfolio company financial statements and are weighted based on the fair market value of each respective investment as of its most recent valuation.

As of December 31, 2023 and December 31, 2022, our investments consisted of the following (dollar amounts in thousands):

	December 31, 2023						December 31, 2022
	Amortized Cost		Fair Value		% of Fair Value		Amortized Cost		Fair Value		% of Fair Value
First-Lien Term Loans	$	402,858	$	399,882	78.10	%	$	253,940	$	251,371	71.92	%
Subordinated Debt (1)	103,888		101,930		19.90	%	95,481		93,809		26.84	%
Equity Investments	9,422		10,224		2.00	%	3,577		4,338		1.24	%
Total	$	516,168	$	512,036	100.00	%	$	352,998	$	349,518	100.00	%
Largest portfolio company investment	$	10,731	$	10,986	2.15	%	$	10,617	$	11,093	3.17	%
Average portfolio company investment	$	3,246	$	3,220	0.63	%	$	5,516	$	5,461	1.56	%

_______________

(1)As of December 31, 2023, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $52,170 and mezzanine debt of $49,760 at fair value, and second lien term loans and/or second lien notes of $53,365 and mezzanine debt of $50,523 at amortized cost. As of December 31, 2022, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903 at fair value, and second lien term loans and/or second lien notes of $32,189 and mezzanine debt of $63,292 at amortized cost.

The industry composition of our portfolio as a percentage of fair value as of December 31, 2023 and December 31, 2022 was as follows:

Industry	December 31, 2023		December 31, 2022
Aerospace & Defense	2.07	%	—	%
Automotive	1.10	%	1.11	%
Banking, Finance, Insurance, Real Estate	1.49	%	0.08	%
Beverage, Food & Tobacco	10.39	%	12.54	%
Capital Equipment	4.28	%	1.98	%
Chemicals, Plastics & Rubber	3.80	%	4.28	%
Construction & Building	4.78	%	4.52	%
Consumer Goods: Durable	3.76	%	4.48	%
Consumer Goods: Non-durable	5.97	%	7.56	%
Containers, Packaging & Glass	3.49	%	4.89	%
Energy: Electricity	0.43	%	—	%
Energy: Oil & Gas	3.08	%	6.09	%
Environmental Industries	3.04	%	2.19	%
Healthcare & Pharmaceuticals	10.08	%	7.31	%
High Tech Industries	4.81	%	2.74	%
Hotel, Gaming & Leisure	0.44	%	—	%
Media: Advertising, Printing & Publishing	1.33	%	1.98	%
Media: Broadcasting & Subscription	0.80	%	—	%
Metals and Mining	0.10	%	—	%
Services: Business	16.82	%	16.98	%
Services: Consumer	5.73	%	6.65	%
Sovereign & Public Finance	0.77	%	1.08	%
Telecommunications	2.33	%	1.92	%
Transportation: Cargo	2.32	%	3.12	%
Transportation: Consumer	0.78	%	—	%
Utilities: Electric	0.51	%	—	%
Wholesale	5.50	%	8.50	%
Total	100.00	%	100.00	%

66

The weighted average yields of our investments as of December 31, 2023 and December 31, 2022 was as follows:

	December 31, 2023		December 31, 2022
Weighted average yield on debt and income producing investments, at cost (1)	11.33	%	10.84	%
Weighted average yield on debt and income producing investments, at fair value (1)	11.44	%	10.97	%
Percentage of debt investments bearing a floating rate	84.74	%	76.79	%
Percentage of debt investments bearing a fixed rate	15.26	%	23.21	%

_______________

(1)There were no investments on non-accrual status as of December 31, 2023 and December 31, 2022..

As of December 31, 2023, 73.75% and 73.86% of our debt and income producing investments at cost and at fair value, respectively, had interest rate floors that limit the minimum applicable interest rates on such loans. As of December 31, 2022, 74.64% and 74.79% of our debt and income producing investments at cost and at fair value, respectively, had interest rate floors that limit the minimum applicable interest rates on such loans.

The weighted average yield of our debt and income producing securities is not the same as a return on investment for our shareholders, but rather relates to our investment portfolio and is calculated before the payment of all of our and our subsidiary’s fees and expenses. The weighted average yield was computed using the effective interest rates as of each respective date, including accretion of original issue discount, but excluding investments on non-accrual status, if any. There can be no assurance that the weighted average yield will remain at its current level. Total weighted average yields of our debt and income producing investments, at cost, increased from 10.84% to 11.33% from December 31, 2022 to December 31, 2023. The increase in weighted average yields was primarily due to rising benchmark interest rates.

While the macro-economic environment continues to present challenges for borrowers, with interest rates remaining at elevated levels, we believe the current environment for private credit investing remains attractive. Spreads tightened modestly into year-end as the broadly syndicated loan market recovered amidst healthy collateralized loan obligations ("CLO") issuance levels, but remain attractive relative to historical levels.

As markets stabilize and there is more clarity around the direction of interest rates, we are seeing private equity mergers and acquisitions ("M&A") volumes increase, leading to higher levels of demand for middle-market financings. Prepayment activity is also increasing as a result, driven primarily by M&A activity, as opposed to repricing and refinancing. While prepayments serve as an offset to new transaction activity, we believe that lenders who are well positioned with available liquidity as well as incumbent positions in portfolio companies will benefit from increased levels of activity in the market.

Keeping the macro-economic environment in mind, we are closely monitoring the impacts to our portfolio companies, and we will continue to seek to invest in defensive businesses with low levels of cyclicality and strong levels of free cash flow generation. While we are not seeing signs of a broad-based deterioration in our performance or that of our portfolio companies at this time, there can be no assurance that the performance of certain of our portfolio companies will not be negatively impacted by economic conditions, which could have a negative impact on our future results.

Asset Quality

In addition to various risk management and monitoring tools, we use the Adviser’s investment rating system to characterize and monitor the credit profile and expected level of returns on each investment in our portfolio, with the exception of the Liquid Investments managed by the leveraged finance division of our Sub-Adviser. Each Investment Team intends to utilize a systematic, consistent approach to credit evaluation, with a particular focus on an acceptable level of debt repayment and deleveraging under a “base case” set of projections (the “Base Case”), which reflects a more conservative estimate than the set of projections provided by a prospective portfolio company (the “Management Case”). The following is a description of the conditions associated with each investment rating:

1.Performing - Superior: Borrower is performing significantly above Management Case.

2.Performing - High: Borrower is performing at or near the Management Case (i.e., in a range slightly below to slightly above).

3.Performing - Low Risk: Borrower is operating well ahead of the Base Case to slightly below the Management Case.

4.Performing - Stable Risk: Borrower is operating at or near the Base Case (i.e., in a range slightly below to slightly above). This is the initial rating assigned to all new borrowers.

67

5.Performing - Management Notice: Borrower is operating below the Base Case. Adverse trends in business conditions and/or industry outlook are viewed as temporary. There is no immediate risk of payment default and only a low to moderate risk of covenant default.

6.Watch List - Low Maintenance: Borrower is operating below the Base Case, with declining margin of protection. Adverse trends in business conditions and/or industry outlook are viewed as probably lasting for more than a year. Payment default is still considered unlikely, but there is a moderate to high risk of covenant default.

7.Watch List - Medium Maintenance: Borrower is operating well below the Base Case, but has adequate liquidity. Adverse trends are more pronounced than in Internal Risk Rating 6 above. There is a high risk of covenant default, or it may have already occurred. Payments are current, although subject to greater uncertainty, and there is a moderate to high risk of payment default.

8.Watch List - High Maintenance: Borrower is operating well below the Base Case. Liquidity may be strained. Covenant default is imminent or may have occurred. Payments are current, but there is a high risk of payment default. Negotiations to restructure or refinance debt on normal terms may have begun. Further significant deterioration appears unlikely and no loss of principal is currently anticipated.

9.Watch List - Possible Loss: At the current level of operations and financial condition, the borrower does not have the ability to service and ultimately repay or refinance all outstanding debt on current terms. Liquidity is strained. Payment default may have occurred or is very likely in the short term unless creditors grant some relief. Loss of principal is possible.

10.Watch List - Probable Loss: At the current level of operations and financial condition, the borrower does not have the ability to service and ultimately repay or refinance all outstanding debt on current terms. Payment default is very likely or may have already occurred. Liquidity is extremely limited. The prospects for improvement in the borrower’s situation are sufficiently negative that loss of some or all principal is probable.

The Adviser regularly monitors and, when appropriate, changes the investment rating assigned to each investment in our portfolio, excluding Liquid Investments managed by the leveraged finance division of our Sub-Adviser. Each investment team will review the investment ratings in connection with monthly or quarterly portfolio reviews. Based on a generally uncertain economic outlook in the United States (which includes a possible recession), we have increased oversight and analysis of credits in any vulnerable industries to mitigate any decline in loan performance and reduce credit risk.

The following table shows the investment ratings of the investments in our portfolio (dollar amounts in thousands):

	December 31, 2023					December 31, 2022
	Fair Value(1)		% of Portfolio		Number of Portfolio Companies(1)	Fair Value(1)		% of Portfolio		Number of Portfolio Companies(1)
1	$	—	—	%	—	$	—	—	%	—
2	—		—		—	—		—		—
3	42,066		8.22		7	13,698		3.92		2
4	347,567		67.88		89	318,565		91.15		60
5	61,745		12.06		10	9,797		2.80		1
6	16,554		3.23		3	7,458		2.13		1
7	—		—		—	—		—		—
8	—		—		—	—		—		—
9	—		—		—	—		—		—
10	—		—		—	—		—		—
Total	$	467,932	91.39	%	109	$	349,518	100.00	%	64

(1)Liquid Investments managed by the leveraged finance division of our Sub-Adviser are excluded from the investment ratings table. As of December 31, 2023, there were 50 portfolio companies in the Liquid Investments portfolio, which had a total fair value of $44,104 or 8.61% of the portfolio. There were no Liquid Investments managed by the leveraged finance division of our Sub-Advisor held as of December 31, 2022.

As of December 31, 2023 and December 31, 2022, the weighted average Internal Risk Rating of our investment portfolio was 4.1 and 4.0, respectively.

68

Results of Operations

Operating results for the year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022 were as follows (dollar amounts in thousands):

	For the Years Ended December 31,
	2023		2022(1)
Investment income:
Non-controlled/non-affiliated company investments:
Interest income	$	45,200	$	20,741
Payment-in-kind interest income	2,333		1,275
Dividend income	123		—
Other income	178		504
Total investment income	47,834		22,520
Expenses:
Organizational expenses	—		1,081
Interest and debt financing expenses	10,752		4,083
Interest expense on Note (See Note 5)	—		226
Professional fees	762		708
Management fees (See Note 5)	1,292		—
Income based incentive fees (See Note 5)	3,108		—
Board of Trustees’ fees	508		385
Administration fees	517		299
Other general and administrative expenses	682		260
Distribution and shareholder servicing fees
Class S	5		—
Class D	1		—
Offering costs	659		228
Total expenses	18,286		7,270
Expense support (See Note 5)	(750)		(1,558)
Management fees waived (See Note 5)	(1,292)		—
Incentive fees waived (See Note 5)	(3,108)		—
Net expenses	13,136		5,712
Net investment income before excise taxes	34,698		16,808
Excise taxes	31		2
Net investment income (loss)	$	34,667	$	16,806
Realized and unrealized gain (loss) on investments:
Net realized gains (losses)	$	768	$	(347)
Net change in unrealized gains (losses)	(652)		(3,480)
Income tax (provision) benefit	(61)		—
Total net change in unrealized gain (loss)	(713)		(3,480)
Total net realized and change in unrealized gains (losses)	55		(3,827)
Net increase (decrease) in net assets resulting from operations	$	34,722	$	12,979

_______________

(1)For the period February 8, 2022 (inception) through December 31, 2022

A net increase (decrease) in net assets resulting from operations will vary from period to period as a result of various factors, including the level of new investment commitments, expenses, the recognition of realized gains and losses, and changes in unrealized appreciation and depreciation on the investment portfolio.

69

Investment Income

On March 31, 2022, prior to the Fund’s election to be regulated as a BDC under the 1940 Act, TIAA contributed certain portfolio investments to the Fund and SPV I. The Fund accrued investment income on this portfolio beginning April 1, 2022.

Investment income increased to $47.8 million for the year ended December 31, 2023, from $22.5 million for the comparable period in the prior year, primarily due to increased investment activity and an increase in interest income from higher weighted average interest rates. As of December 31, 2023, the size of our portfolio increased to $516.2 million from $353.0 million, as of December 31, 2022, at cost. As of December 31, 2023, the weighted average yield of our debt and income producing investments increased to 11.33% from 10.84% as of December 31, 2022, at cost, primarily due to increases in base interest rates. We expect our portfolio will continue to grow as we raise and deploy capital through our offering and our investment income to grow commensurately. The shifting environment in base interest rates, such as SOFR and alternate rates, may affect our investment income over the long term.

Expenses

Total expenses before expense support increased to $18.3 million for the year ended December 31, 2023, from $7.3 million for the period February 8, 2022 (inception) through December 31, 2022. Our Adviser has agreed to waive the management fee and the incentive fees until June 1, 2024, the expiry of twelve months from the Escrow Break Date.

Interest and debt financing expenses increased for the year ended December 31, 2023 compared to the year ended December 31, 2022 primarily due to higher average daily borrowings and higher average interest rates. The average daily borrowings for the year ended December 31, 2023 was $136.9 million, compared to $116.2 million for the year ended for the period from February 8, 2022 (inception) through December 31, 2022. The average interest rate for the year ended December 31, 2023 was 7.73% compared to 4.90% for the period February 8, 2022 (inception) through December 31, 2022. We anticipate certain operational expenses to decrease in relation to our income as we continue to ramp up our portfolio.

The expense support amount represents the amount of expenses paid by the Adviser on our behalf in accordance with the Expense Support Agreement. These expenses are subject to reimbursement by us in accordance with the terms of the Expense Support Agreement.

Net realized gain (loss) and Net change in unrealized gains (losses) on investments

We had a net realized gain on investments of $768 thousand for the year ended December 31, 2023 primarily related to realizations and repayments of multiple portfolio companies compared to a net realized loss of $(347) thousand for the period February 8, 2022 (inception) through December 31, 2022.

We recorded a net change in unrealized gains of $(0.7) million for the year ended December 31, 2023, compared to a net unrealized loss of $(3.5) million for the period February 8, 2022 (inception) through December 31, 2022, which reflects the net change in the fair value of our investment portfolio relative to its cost basis over the period. The increase in unrealized gains for the year ended ended December 31, 2023 compared to the comparable period in 2022 resulted primarily due to the tightening of market spreads.

The unrealized loss for the period February 8, 2022 (inception) through December 31, 2022 was primarily related to the economic uncertainty relating to both macroeconomic and geopolitical factors in the financial markets that, in turn, negatively impacted the valuation of our portfolio investments primarily through a combination of the overall market widening of credit spreads and the modest softening of our portfolio companies' credit metrics.

Financial Condition, Liquidity and Capital Resources

We expect to generate cash primarily from (i) the net proceeds of our offering of Common Shares, (ii) cash flows from income earned from our investments and principal repayments, (iii) proceeds from net borrowings on our Bank of America Credit Facility and (iv) any future offerings of our equity or debt securities.

Our primary uses of cash will be for (i) investments in portfolio companies in accordance with investment objective and investment strategies and to comply with certain portfolio diversification requirements, (ii) the cost of operations (including paying the Adviser and the Administrator), (iii) cost of any borrowings under our Bank of America Credit Facility or other financing arrangements, and (iv) cash distributions to the holders of our Common Shares. Due to an uncertain economic outlook and current market volatility, we regularly evaluate our overall liquidity position and take proactive steps to maintain that position based on such circumstances.

70

Cash and cash equivalents as of December 31, 2023, taken together with our available debt, is expected to be sufficient for our investment activities and to conduct our operations in the near term. As of December 31, 2023, we had $51.9 million available borrowings under our Bank of America Credit Facility.

For the for the year ended December 31, 2023, our cash and cash equivalents balance decreased by $57.1 million. During that period, $127.9 million was used in operating activities, primarily due to investment purchases of $206.9 million, offset by $47.5 million in repayments and sales of investments in portfolio companies. During the same period, $70.8 million was used in financing activities, consisting primarily of proceeds from secured borrowings of $135.3 million, and repayments of secured borrowings of $124.5 million.

For the for the period ended December 31, 2022, our cash and cash equivalents balance was $65.8 million. During that period, $43.2 million was used in operating activities, primarily due to investment purchases of $93.6 million, offset by $38.2 million in repayments and sales of investments in portfolio companies. During the same period, $108.9 million was used in financing activities, consisting primarily of proceeds from secured borrowings of $162.5 millions, and repayments of secured borrowings of $7.5 millions.

Net Worth of Sponsors

The North American Securities Administrators Association (“NASAA’), in its Omnibus Guidelines Statement of Policy adopted on March 29, 1992 and as amended on May 7, 2007 and from time to time (the “Omnibus Guidelines”), requires that our affiliates and Adviser, or our Sponsor, as defined under the Omnibus Guidelines, have an aggregate financial net worth, exclusive of home, automobiles and home furnishings, of the greater of either $100,000, or 5.0% of the first $20 million of both the gross amount of securities currently being offered in our offering and the gross amount of any originally issued direct participation program securities sold by our affiliates and sponsors within the past 12 months, plus 1.0% of all amounts in excess of the first $20 million. Based on these requirements, our Adviser and its affiliates, while not liable directly or indirectly for any indebtedness we may incur, have an aggregate financial net worth in excess of those amounts required by the Omnibus Guidelines Statement of Policy.

Equity

The Fund is authorized to issue an unlimited number of Common Shares. On March 30, 2022, we issued an initial 40 Class I shares to TIAA in connection with our formation. On March 31, 2022, TIAA contributed certain portfolio investments in the amount of $296.2 million (fair value as of March 31, 2022) and we entered into a promissory note with TIAA (the “Note”) as the lender. In connection therewith, we issued to TIAA 10,540,000 shares of our Class I shares of beneficial interest at $25.00 per share. We fully repaid the balance of the Note to TIAA on June 3, 2022.

As of June 1, 2023 (the “Escrow Break Date”), the Fund had satisifed the minimum offering requirement and the Board authorized the release of proceeds from escrow.

71

The following table presents transactions in Common Shares during the year ended December 31, 2023 (dollars in thousands except share amounts):

	December 31, 2023
	Shares	Amount
CLASS S
Subscriptions	149,441	$	3,671
Share transfers between classes	—	—
Distributions reinvested	397	10
Shares repurchases	—	—
Net increase (decrease)	149,838	$	3,681
CLASS D
Subscriptions	106,881	$	2,629
Share transfers between classes	—	—
Distributions reinvested	385	9
Shares repurchases	—	—
Net increase (decrease)	107,266	$	2,638
CLASS I
Subscriptions	3,517,694	$	86,550
Share transfers between classes	—	—
Distributions reinvested	33,652	828
Shares repurchases	—	—
Net increase (decrease)	3,551,346	$	87,378

The Fund determines NAV for each class of Common Shares as of the last day of each calendar month. Share issuances related to monthly subscriptions are effective the first calendar day of each month. Shares are issued at an offering price equivalent to the most recent NAV per share available for each share class, which will be the prior calendar day NAV per share (i.e. the prior month-end NAV). The following table presents each month-end NAV per share for Class S, Class D, and Class I common shares for the year ended December 31, 2023:

	NAV Per Share
For the Month Ended	Class S (1)	Class D (1)	Class I
January 31, 2023	$—	$—	$24.70
February 28, 2023	$—	$—	$24.70
March 31, 2023	$—	$—	$24.65
April 30, 2023	$—	$—	$24.68
May 31, 2023	$—	$—	$24.66
June 30. 2023	$—	$—	$24.63
July 31, 2023	$—	$—	$24.60
August 31, 2023	$—	$—	$24.56
September 30, 2023	$—	$—	$24.61
October 31, 2023	$24.58	$24.59	$24.60
November 30, 2023	$24.59	$24.60	$24.60
December 31, 2023	$24.69	$24.73	$24.73

Distributions

The following table summarizes the Fund’s distributions declared from inception through December 31, 2023 (dollars in thousands, except per share amounts):

72

			Class S
Declaration Date	Record Date	Payment Date	Distribution per Share	Distribution Amount
October 27, 2023	October 31, 2023	November 28, 2023	$0.233	$9
November 27, 2023	November 30, 2023	December 28, 2023	$0.233	$17
December 28, 2023	December 31, 2023	January 29, 2024	$0.233	$35

			Class D
Declaration Date	Record Date	Payment Date	Distribution per Share	Distribution Amount
October 27, 2023	October 31, 2023	November 28, 2023	$0.245	$2
November 27, 2023	November 30, 2023	December 28, 2023	$0.245	$11
December 28, 2023	December 31, 2023	January 29, 2024	$0.245	$26

			Class I
Declaration Date	Record Date	Payment Date	Distribution per Share		Distribution Amount
September 30, 2022	September 30, 2022	October 28, 2022	$0.870	(1)	$9,170
October 31, 2022	October 31, 2022	November 28, 2022	$0.180		$1,897
November 30, 2022	November 30, 2022	December 28, 2022	$0.190		$2,003
December 31, 2022	December 31, 2022	January 28, 2023	$0.295	(2)	$3,109
January 31, 2023	January 31, 2023	February 28, 2023	$0.200		$2,108
February 28, 2023	February 28, 2023	March 28, 2023	$0.200		$2,108
March 31, 2023	March 31, 2023	April 28, 2023	$0.230		$2,424
April 28, 2023	April 30, 2023	May 26, 2023	$0.240		$2,530
May 25, 2023	May 31, 2023	June 28, 2023	$0.240		$2,530
June 28, 2023	June 30, 2023	July 28, 2023	$0.240		$2,605
July 28, 2023	July 31, 2023	August 28, 2023	$0.270	(3)	$3,081
August 23, 2023	August 31, 2023	September 28, 2023	$0.270	(3)	$3,133
September 29, 2023	September 30, 2023	October 27, 2023	$0.250		$3,070
October 27, 2023	October 31, 2023	November 28, 2023	$0.250		$3,244
November 27, 2023	November 30, 2023	December 28, 2023	$0.250		$3,435
December 28, 2023	December 31, 2023	January 29, 2024	$0.250		$3,523

_______________

(1)Represents monthly dividend of $0.14 per share for each of April 2022, May 2022 and June 2022, and monthly dividend of $0.15 per share for each of July 2022, August 2022 and September 2022.

(2)Comprised of $0.19 regular dividend and $0.105 supplemental dividend attributable to accrued net investment income.

(3)Comprised of $0.25 regular dividend and $0.020 special dividend attributable to accrued net investment income.

Distribution Reinvestment Plan

The Fund has adopted a distribution reinvestment plan, pursuant to which it will reinvest all cash dividends declared by the Board on behalf of its shareholders who do not elect to receive their dividends in cash, except for shareholders in certain states. As a result, if the Board authorizes, and we declare, a cash dividend or other distribution, then our shareholders who have not opted out of our distribution reinvestment plan will have their cash distributions automatically reinvested in additional Common Shares, rather than receiving the cash dividend or other distribution. Alabama, Arkansas, Idaho, Kansas, Kentucky, Maine, Maryland, Massachusetts, Nebraska, New Jersey, North Carolina, Ohio, Oregon, Vermont and Washington investors and clients of certain participating brokers that do not permit automatic enrollment in our distribution reinvestment plan will automatically receive their distributions in cash unless they elect to have their cash distributions reinvested in additional Common Shares. Distributions on fractional shares will be credited to each participating shareholder’s account to three decimal places.

73

Share Repurchase Program

Beginning with the fiscal quarter ended September 30, 2023, the Fund commenced a share repurchase program in which it intends to repurchase in each quarter, at the discretion of the Board, up to 5% of its Common Shares outstanding (either by number of shares or aggregate NAV) as of the close of the previous calendar quarter. The Board, in its sole discretion, may amend, suspend or terminate the share repurchase program if it deems such action to be in the best interest of the Fund’s shareholders. As a result, share repurchases may not be available each quarter, such as when a repurchase offer would place an undue burden on our liquidity, adversely affect the Fund’s operations or risk having an adverse impact on the Fund that would outweigh the benefit of the repurchase offer. Following any such suspension, the Board will consider on at least a quarterly basis whether the continued suspension of the Share Repurchase Program is in the best interest of the Fund and shareholders, and will reinstate the Share Repurchase Program when and if appropriate and subject to its fiduciary duty to the Fund and shareholders. However, our Board is not required to authorize the recommencement of our Share Repurchase Program within any specified period of time. The Fund intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Securities Exchange Act and the 1940 Act. All Common Shares purchased by the Fund pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued.

Under the share repurchase program, to the extent the Fund offers to repurchase Common Shares in any particular quarter, the Fund expects to repurchase Common Shares pursuant to tender offers using a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter, except that Common Shares that have not been outstanding for at least one year will be repurchased at 98% of such NAV (an “Early Repurchase Deduction”). The one-year holding period is measured as of the subscription closing date immediately following the prospective repurchase date. The Early Repurchase Deduction may be waived in the case of repurchase requests arising from the death, divorce or qualified disability of the holder. The Early Repurchase Deduction will be retained by the Fund for the benefit of remaining shareholders. Common Shares. The repurchase of the Adviser’s shares, if any, will be on the same terms and subject to the same limitations as other shareholders under the Share Repurchase Program.

Payment for repurchased shares may require us to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. Our Adviser intends to take measures, subject to policies as may be established by our Board, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of shares. Class I shares owned by TIAA will be subject to the following restrictions. TIAA may submit its Class I shares for repurchase beginning on March 31, 2027. Beginning March 31, 2027, the total amount of TIAA shares eligible for repurchase will be limited to no more than 1.67% of our aggregate NAV per calendar quarter; provided that, if in any quarter the total amount of aggregate repurchase requests of all classes of Common Shares does not exceed the Share Repurchase Plan limit of 5% of the aggregate NAV per calendar quarter, these redemption limits on the TIAA shares will not apply for that quarter, and TIAA will be entitled to submit its shares for repurchase up to the overall Share Repurchase Plan limits.

For the for the year ended December 31, 2023, no Common Shares were repurchased.

Income Taxes

The Fund has elected to be regulated as a BDC under the 1940 Act. The Fund also intends to qualify annually to be treated as a RIC under the Code. So long as the Fund maintains its RIC tax treatment, it generally will not be subject to U.S federal income tax on any ordinary income or capital gains that it timely distributes to its shareholders as dividends. Rather, any tax liability related to income earned and distributed by the Fund would represent obligations of the Fund’s investors and would not be reflected in the financial statements of the Fund.

The Fund evaluates tax positions taken or expected to be taken in the course of preparing its financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof.

To qualify for and maintain qualification as a RIC, the Fund must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Fund must distribute to its shareholders, for each taxable year, at least the sum of (i) 90% of its “investment company taxable income” for that year (without regard to the deduction for dividends paid), which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses and (ii) 90% of its net tax-exempt income.

74

In addition, based on the excise tax distribution requirements, the Fund is subject to a 4% nondeductible U.S. federal excise tax on undistributed income unless the Fund distributes in a timely manner in each taxable year an amount at least equal to the sum of (1) 98% of its ordinary income for the calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income realized, but not distributed, in prior years. For this purpose, however, any ordinary income or capital gain net income retained by the Fund that is subject to corporate income tax is considered to have been distributed.

Bank of America Credit Facility

In accordance with the 1940 Act, the Fund is only permitted to borrow amounts such that its asset coverage, as defined in the 1940 Act, is maintained at a level of at least 150% after such borrowing. The Fund’s asset coverage was 314.08% and 267.94% as of December 31, 2023 and December 31, 2022, respectively.

On April 19, 2022, SPV I entered into a credit agreement (the “Credit Agreement” and the revolving credit facility thereunder, the “Bank of America Credit Facility”) with the lenders from time to time parties thereto, Bank of America, N.A., as administrative agent, the Fund, as servicer, U.S. Bank Trust Company, National Association, as collateral administrator, and U.S. Bank National Association, as collateral custodian.

On October 4, 2022, SPV I entered into Amendment No. 1 to the Credit Agreement (the “Amendment”). The Amendment, among other things: (i) increased the maximum amount available under the Bank of America Credit Facility from $200 million to $250 million; and (ii) increased the rate to be paid from Daily SOFR (as defined below) plus 2.00% to Daily SOFR plus 2.15% with a “step up” on the one year anniversary of the Closing Date (as defined in the Amendment) increasing from Daily SOFR plus 2.15% to Daily SOFR plus 2.40%, as reflected in the Amendment.

Borrowings under the Credit Agreement are secured by all of the assets held by SPV I and bear interest based on either (x) an annual rate equal to SOFR determined for any day (“Daily SOFR”) for the relevant interest period, plus an applicable spread, or (y) the highest of (i) the Federal Funds Rate plus an applicable spread, (ii) the Prime Rate in effect for any day and (iii) Daily SOFR plus an applicable spread. Interest is payable monthly in arrears. Advances under the Credit Agreement are secured by a pool of broadly-syndicated and middle-market loans subject to eligibility criteria and advance rates specified in the Credit Agreement. Advances under the Credit Agreement may be prepaid and reborrowed at any time during the Availability Period (as defined therein), and SPV I may terminate or reduce the facility amount subject to certain conditions. As of December 31, 2023, the Bank of America Credit Facility bears interest at a rate of Daily SOFR, reset daily plus 2.40% per annum. Interest is payable monthly in arrears. Any amounts borrowed under the Credit Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) April 19, 2027, the fifth anniversary of the effective date of April 19, 2022, or (ii) upon certain other events in connection with a refinancing under the Credit Agreement. Borrowing under the Credit Agreement is subject to certain restrictions contained in the 1940 Act.

Prior to the closing of the Bank of America Credit Facility, the Fund contributed and/or sold certain assets to SPV I pursuant to a contribution and sale agreement and TIAA contributed and/or sold certain assets to SPV I pursuant to a master participation and assignment agreement, and the Fund expects to contribute and/or sell additional assets to SPV I pursuant to a contribution and sale agreement in the future. The Fund may, but will not be required to, repurchase and/or substitute certain assets previously transferred to SPV I subject to the conditions specified in the contribution and sale agreement and the Credit Agreement.

The fair value of the Bank of America Credit Facility, which would be categorized as Level 3 within the fair value hierarchy as of December 31, 2023 and as of December 31, 2022, approximates their carrying values. The following table presents outstanding borrowing as of December 31, 2023 and December 31, 2022:

	December 31, 2023
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	165,750		165,750
Unused Portion (2)	84,250		84,250
Amount Available (3)	51,883		51,883

_______________

(1)Borrowings outstanding on the consolidated statements of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

75

	December 31, 2022
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	155,000		155,000
Unused Portion (2)	95,000		95,000
Amount Available (3)	81,855		81,855

_______________

(1)Borrowings outstanding on the consolidated statements of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

For the year ended December 31, 2023 and for the period February 8, 2022 (inception) through December 31, 2022, the components of interest expense and debt financing expenses were as follows:

	For the Years Ended December 31,
	2023			2022(1)
Borrowing interest expense	$	10,144		$	3,697
Unused fees	434			312
Amortization of deferred financing costs (2)	174			74
Total interest and debt financing expenses	$	10,752		$	4,083
Average interest rate (3)	7.73		%	4.90		%
Average daily borrowings	$	136,894		$	116,212

_______________

(1) Period from February 8, 2022 (inception) through December 31, 2022

(2) For the year ended December 31, 2023 and the period from February 8, 2022 (inception) through December 31, 2022, $2 and $462, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement.

(3) Average interest rate includes borrowing interest expense and unused fees.

We have entered into a number of business relationships with affiliated or related parties, including the following:

•the Advisory Agreement;

•the Sub-Advisory Agreement;

•the Administration Agreement; and

•the Expense Support Agreement.

In addition to the aforementioned agreements, the SEC has granted an exemptive order (the “Order”) that permits us to participate in negotiated co-investment transactions with certain other funds and accounts sponsored or managed by either of the Adviser and/or their affiliates. Co-investment under the Order is subject to certain conditions therein, including the condition that, in the case of each co-investment transaction, the Board determines that it would be in the Fund’s best interest to participate in the transaction. Neither we nor the affiliated funds are obligated to invest or co-invest when investment opportunities are referred to us or them.

76

In addition, pursuant to an exemptive order issued by the SEC on April 8, 2020 and applicable to all BDCs through December 31, 2020 (the “Temporary Relief”), BDCs were permitted, subject to the satisfaction of certain conditions, to complete follow-on investments in existing portfolio companies with certain affiliates that are private funds if such private funds did not hold an investment in such existing portfolio company. Without the Temporary Relief, such private funds would not be able to participate in such follow-on investments unless the private funds had previously acquired securities of the portfolio company in a co-investment transaction with the BDC. Although the Temporary Relief expired on December 31, 2020, the SEC’s Division of Investment Management had indicated that until March 31, 2022, it would not recommend enforcement action, to the extent that any BDC with an existing co-investment order continues to engage in certain transactions described in the Temporary Relief, pursuant to the same terms and conditions described therein. The conditional exemptive order is no longer effective; however, on October 14, 2022, the SEC granted the Fund’s request to amend the Order to make the Temporary Relief permanent for the Fund and permit the Fund to complete follow-on investments in its existing portfolio companies with certain affiliates that are private funds if such private funds do not hold an investment in such existing portfolio company.

Expense Support Agreement

We have entered into the Expense Support Agreement with the Adviser. The Expense Support Agreement provides that, at such times as it determines, Nuveen Alternative Holdings may pay (or cause one or more of its affiliates to pay) certain expenses of the Fund, including organization and offering expenses, provided that no portion of the payment will be used to pay any interest expense and/or shareholder servicing fees of the Fund (each, an “Expense Payment”). Such Expense Payment will be made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from Nuveen Alternative Holdings to pay such expense, and/or by an offset against amounts due from us to Nuveen Alternative Holdings.

Following any calendar month in which Available Operating Funds (as defined below) exceed the cumulative distributions accrued to our shareholders based on distributions declared with respect to record dates occurring in such calendar month (such amount referred to as the “Excess Operating Funds”), we will pay such Excess Operating Funds, or a portion thereof (each, a “Reimbursement Payment”), to Nuveen Alternative Holdings that previously paid such expenses, until such time as all Expense Payments made by such entity within three years prior to the last business day of such calendar quarter have been reimbursed. “Available Operating Funds” means the sum of (i) net investment income (including net realized short-term capital gains reduced by net realized long-term capital losses), (ii) net capital gains (including the excess of net realized long-term capital gains over net realized short-term capital losses) and (iii) dividends and other distributions paid to us on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above). The amount of the Reimbursement Payment for any calendar month will equal the lesser of (i) the Excess Operating Funds in such quarter and (ii) the aggregate amount of all Expense Payments made by Nuveen Alternative Holdings to us within three years prior to the last business day of such calendar quarter that have not been previously reimbursed by us to Nuveen Alternative Holdings.

The Expense Support Agreement provides additional restrictions on the amount of each Reimbursement Payment for any calendar quarter and no Reimbursement Payment will be made for any month if: (1) the annualized rate (based on a 365-day year) of regular cash distributions per share of beneficial interest declared by our Board exclusive of returns of capital, distribution rate reductions due to any fees (including to a transfer agent) payable in connection with distributions, and any declared special dividends or distributions (the “Effective Rate of Distributions Per Share”) declared by us at the time of such Reimbursement Payment is less than the Effective Rate of Distributions Per Share at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) our Operating Expense Ratio (as defined below) at the time of such Reimbursement Payment is greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Reimbursement Payment relates. The “Operating Expense Ratio” is calculated by dividing Operating Expenses (as defined below), less organizational and offering expenses, base management and incentive fees owed to the Adviser, and interest expense, by our net assets. “Operating Expenses” means all of our operating costs and expenses incurred, as determined in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Adviser may waive its right to receive all or a portion of any Reimbursement Payment in any particular calendar quarter, so that such Reimbursement Payment may be reimbursable in a future calendar quarter within three years of the date of the applicable Expense Payment.

The Fund’s obligation to make a Reimbursement Payment will automatically become a liability of the Fund on the last business day of the applicable calendar month, except to the extent the Adviser has waived the right to receive such payment for the applicable month.

77

The following table presents a cumulative summary of the expense payments and reimbursement payments since the Fund’s commencement of operations (dollar amounts in thousands):

For the Quarter Ended	Expense Payments by Adviser		Reimbursement Payments to Adviser		Unreimbursed Expense Payments		Effective Rate of Distribution per Share (1)		Reimbursement Eligibility Expiration	Operating Expense Ratio (2)
March 31, 2022	$	983	$	—	$	983	—	%	March 31, 2025	0.08	%
June 30, 2022	677		—		677		6.62	%	June 30, 2025	0.19	%
September 30, 2022	379		—		379		7.23	%	September 30, 2025	0.21	%
December 31, 2022	176		—		176		9.07	%	December 31, 2025	0.14	%
March 31, 2023	198		—		198		10.22	%	March 31, 2026	0.22	%
June 30, 2023	113		—		113		11.69	%	June 30, 2026	0.22	%
September 30, 2023	327		—		327		12.19	%	September 30, 2026	0.27	%
December 31, 2023	115		—		115		12.13	%	December 21, 2026	0.13	%
Total	$	2,968	$	—	$	2,968

__________

(1)The effective rate of distribution per share is expressed as a percentage equal to the projected annualized distribution amount as of the end of the applicable period (which is calculated by annualizing the regular monthly cash distributions per share as of such date without compounding), divided by the Fund’s gross offering price per share as of each quarter ended.

(2)The operating expense ratio is calculated by dividing the quarterly operating expenses, less organizational and offering expenses, base management fee and incentive fees owed to the Adviser, and interest expense, by the Fund’s net assets as of each quarter end.

Off-Balance Sheet Arrangements

In the ordinary course of its business, the Fund enters into contracts or agreements that contain indemnifications or warranties. Future events could occur which may give rise to liabilities arising from these provisions against us. We believe that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in the consolidated financial statements as of December 31, 2023 and December 31, 2022. We may in the future become obligated to fund commitments such as delayed draw commitments.

For more information on our off-balance sheet arrangements, commitments and contingencies see Note 7 to the consolidated financial statements in Part II, Item 8 of this Form 10-K..

Critical Accounting Policies and Estimates

The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Changes in the economic environment, financial markets, and any other parameters used in determining such estimates could cause actual results to differ. Our critical accounting policies and estimates, including those relating to the valuation of our portfolio investments, are described below. We consider the most significant accounting policies to be those related to our Valuation of Portfolio Investments, Revenue Recognition, and U.S. Federal Income Taxes, which are described below. The valuation of investments is our most significant critical accounting estimate. The critical accounting policies and estimates should be read in connection with our risk factors as disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023.

Valuation of Portfolio investments

Consistent with U.S. GAAP and the 1940 Act, we conduct a valuation of our assets, pursuant to which our net asset value is determined.

Our assets are valued on a quarterly basis, or more frequently if required under the 1940 Act. Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Fund's valuation designee (the “Valuation Designee”) to determine the fair value of the Fund's investments that do not have readily available market quotations, which became effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Fund's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Fund's assets for which market quotations are not readily available, subject to the oversight of the Board.

Investments for which market quotations are readily available are typically valued at those market quotations. Market quotations are obtained from independent pricing services, where available. Generally investments marked in this manner will be

78

marked at the mean of the bid and ask of the quotes obtained. To validate market quotations, we utilize a number of factors to determine if the quotations are representative of fair value, including the source and number of the quotations.

With respect to investments for which market quotations are not readily available, we or an independent third-party valuation firm engaged by the Valuation Designee, will take into account relevant factors in determining the fair value of our investments, including and in combination of: comparison to publicly traded securities, including factors such as yield, maturity and measures of credit quality; the enterprise value of a portfolio company; the nature and realizable value of any collateral; the portfolio company's ability to make payments and its earnings and discounted cash flows; and the markets in which the portfolio company does business. Investment performance data utilized are the most recently available financial statements and compliance certificates received from the portfolio companies as of the measurement date which in many cases may reflect a lag in information. The independent third-party valuation firm provides a fair valuation report, a description of the methodology used to determine the fair value and their analysis and calculations to support their conclusion.

When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, we use the pricing indicated by the external event to corroborate our valuation.

U.S. GAAP establishes a hierarchical disclosure framework which ranks the level of observability of market price inputs used in measuring investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment and the characteristics specific to the investment and state of the marketplace, including the existence and transparency of transactions between market participants. Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets generally have a higher degree of market price observability and a lesser degree of judgment applied in determining fair value. We review pricing and methodologies in order to determine if observable market information is being used, versus unobservable inputs.

Our accounting policy on the fair value of our investments is critical because the determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of these valuations, and any change in these valuations, on the consolidated financial statements.

For more information on the fair value hierarchy, our framework for determining fair value and the composition of our portfolio see Note 4 to the consolidated financial statements in Part II, Item 8 of this Form 10-K.

Revenue Recognition

Our revenue recognition policies are as follows:

Net realized gains (losses) on investments: Investment transactions are recorded on the trade date. Realized gains or losses are measured by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment using the specific identification method

Investment Income: Interest income, including amortization of premium and accretion of discount on loans are recorded on the accrual basis. We accrue interest income based on the effective yield if we expect that, ultimately, we will be able to collect such income. We may have loans in our portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with our investment activities as well as any fees for managerial assistance services rendered by us to our portfolio companies. Such fees are recognized as income when earned or the services are rendered.

Non-accrual: Generally, if a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments, the Sub-Adviser will place the loan on non-accrual status and we will cease recognizing interest income on that loan until all principal and interest is current through payment or until a restructuring occurs, such that the interest income is deemed to be collectible even though we remain contractually entitled to this interest. We may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated.

79

U.S. Federal Income Taxes

We have elected to be regulated as a BDC under the 1940 Act. We have elected, and intend to qualify annually, to be treated as a RIC under the Code. So long as we maintain our qualification as a RIC, we generally will not be subject to U.S. federal income tax on any ordinary income or capital gains that we timely distribute at least annually to our shareholders as dividends. As a result, any tax liability related to income earned and distributed by us represents obligations of our shareholders and will not be reflected in our consolidated financial statements.

We evaluate tax positions taken or expected to be taken in the course of preparing our financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reversed and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof.

Our accounting policy on income taxes is critical because if we are unable to maintain our status as a RIC, we would be required to record a provision for U.S. federal income taxes which may be significant to our financial results.

Contractual Obligations

We have entered into the Advisory Agreement with the Adviser to provide us with investment advisory services and the Administration Agreement with the Administrator to provide us with administrative services. Payments for investment advisory services under the Advisory Agreement and reimbursements under the Administration Agreement.

We entered into the Bank of America Credit Facility and intend to establish additional credit facilities or enter into other financing arrangements in the future to facilitate investments and the timely payment of our expenses. It is anticipated that any such credit facilities will bear interest at floating rates at to-be-determined spreads, such as SOFR. We cannot assure shareholders that we will be able to enter into a credit facility on favorable terms or at all. In connection with a credit facility or other borrowings, lenders may require us to pledge assets, commitments and/or drawdowns (and the ability to enforce the payment thereof) and may ask to comply with positive or negative covenants that could have an effect on our operations.

Promissory Note

On March 31, 2022, we entered into a promissory note (the “Note”) with TIAA as the lender. The Note is issued under the Purchase and Sales Agreement dated as of March 31, 2022, by and among the Fund, SPV I and TIAA in connection with the contribution of portfolio investments by TIAA to the Fund and SPV I. The principal amount of the Note equals (i) the fair value of portfolio investments contributed as of March 31, 2022, minus (ii) $263.5 million. The Note was due to mature on March 30, 2023, with an interest rate of 4% per annum on the unpaid principal amount, compounded quarterly.

On June 3, 2022, the Fund fully repaid the balance on the Note to TIAA which was comprised of $32.7 million and $0.2 million of principal and interest, respectively.

Recent Developments

Distributions

On January 26, 2024, we declared regular distributions for each class of our common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on February 28, 2024 to shareholders of record as of January 31, 2024.

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

On February 28, 2024, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on March 28, 2024 to shareholders of record as of February 29, 2024.

80

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

Through the date of issuance of the consolidated financial statements, we accepted approximately $384.2 million net proceeds relating to the issuance of Class I shares, Class S shares, and Class D shares.

Chief Compliance Officer Appointment

On February 20, 2024, John D. McCally submitted his resignation as our Chief Compliance Officer to our Board, effective as of March 1, 2024. Mr. McCally will continue to serve as our Vice President and Secretary. In connection with the foregoing, on February 20, 2024, our Board appointed Charmagne Kukulka as our Chief Compliance Officer, effective as of March 1, 2024.

Charmagne Kukulka, 34, has been a Principal and Deputy Chief Compliance Officer at Churchill since May 2023. Ms. Kukulka is responsible to managing Churchill’s compliance program and provides compliance support in connection with regulatory matters affecting the business. Prior to joining Churchill, Ms. Kukulka was the Chief Compliance Officer at 13D Management LLC, specializing in investment adviser and investment company act rules and regulations from January 2022 to May 2023. She began her compliance career at Blackstone Inc., where she held various roles within the legal and compliance teams administering the compliance program for Blackstone’s registered funds platform from August 2013 to January 2022. Ms. Kukulka received her B.A. in Business and Corporate Communications from Arizona State University’s W.P. Carey School of Business.

There are no family relationships between Ms. Kukulka and any of our directors or executive officers, and she is not a party to any transaction that is required to be reported pursuant to Item 404(a) of Regulation S-K.

ITEM 7A. Quantitative and Qualitative Disclosures about Market Risk

Uncertainty with respect to, among other things, the rising interest rates, inflationary pressures, the ongoing conflict between Russia and Ukraine, the ongoing war in the Middle East, and the failure of major financial institutions introduced significant volatility in the financial markets, and the effects of this volatility has materially impacted and could continue to materially impact our market risks, including those listed below

Valuation Risk

We have invested, and plan to continue to invest, primarily in illiquid debt and equity securities of private companies. Most of our investments do not have a readily available market price, and we value these investments at fair value as determined in good faith by the Adviser, as the valuation designee, in accordance with our valuation policy subject to the oversight of the Board and, based on, among other things, the input of the independent third-party valuation firms engaged at the direction of the valuation designee. There is no single standard for determining fair value. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. If we were required to liquidate a portfolio investment in a forced or liquidation sale, we may realize amounts that are different from the amounts presented and such differences could be material.

Interest Rate Risk

We are subject to interest rate risk. Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, variability of spread relationships, the difference in re-pricing internals between our assets and liabilities and the effect that interest rates may have on our cash flows. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. Our net investment income is also affected by fluctuations in various interest rates, including the replacement of LIBOR with alternate rates and prime rates, to the extent our debt investments include floating interest rates. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.

Since March 2022, the Federal Reserve has been rapidly raising interest rates bringing it to the 5.25% to 5.50% range. Although the Federal Reserve left its benchmark rates steady in the fourth quarter of 2023, it has indicated that additional rate increases in the future may be necessary to mitigate inflationary pressures and there can be no assurance that the Federal Reserve will not make upwards adjustments to the federal funds rate in the future. However, there are reports that the Federal Reserve may begin to cut the benchmark rates in 2024. In a high interest rate environment, our cost of funds would increase, which could reduce our net

81

investment income if there is not a corresponding increase in interest income generated by our investment portfolio. It is possible that the Federal Reserve's tightening cycle could result the United States into a recession, which would likely decrease interest rates. Conversely, a prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in base rates, such as SOFR or other alternate rates, are not offset by corresponding increases in the spread over such base rate that we earn on any portfolio investments, a decrease in our operating expenses, or a decrease in the interest rate associated with our borrowings.

As of December 31, 2023, on a fair value basis, approximately 15.26% of our debt investments bear interest at a fixed rate and approximately 84.74% of our debt investments bear interest at a floating rate. As of December 31, 2023, 87.16% of our floating rate debt investments are subject to interest rate floors. Additionally, the Bank of America Credit Facility is subject to floating interest rates and are currently paid based on floating SOFR rates.

The following table estimates the potential changes in net cash flow generated from interest income and expenses, should interest rates increase by 100, 200 or 300 basis points, or decrease by 100, 200 or 300 basis points. Interest income is calculated as revenue from interest generated from our portfolio of investments held on December 31, 2023. Interest expense is calculated based on the terms of the Bank of America Credit Facility, using the outstanding balance as of December 31, 2023. Interest expense on the Bank of America Credit Facility is calculated using the interest rate as of December 31, 2023, adjusted for the impact of hypothetical changes in rates, as shown below. The base interest rate case assumes the rates on our portfolio investments remain unchanged from the actual effective interest rates as of December 31, 2023.

Actual results could differ significantly from those estimated in the table (dollars amounts in thousands).

Changes in Interest Rates	Interest Income		Interest Expense		Net Income
- 300 Basis Points	$	(12,965)	$	(4,973)	$	(7,992)
- 200 Basis Points	(8,644)		(3,315)		(5,329)
- 100 Basis Points	(4,322)		(1,658)		(2,664)
+100 Basis Points	4,322		1,658		2,664
+200 Basis Points	8,644		3,315		5,329
+300 Basis Points	12,965		4,973		7,992

82

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Set forth below is an index to our financial statements attached to this Annual Report.

	Page
Report of Independent Registered Public Accounting Firm (PCAOB ID 238)	84
Consolidated Statements of Assets and Liabilities as of December 31, 2023 and 2022	85
Consolidated Statements of Operations for the Year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022	86
Consolidated Statements of Changes in Net Assets for the Year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022	87
Consolidated Statements of Cash Flows for the Year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022	88
Consolidated Schedules of Investments as of December 31, 2023 and 2022	89
Notes to Consolidated Financial Statements	97

83

Report of Independent Registered Public Accounting Firm

To the Board of Trustees and Shareholders of Nuveen Churchill Private Capital Income Fund

Opinion on the Financial Statements

We have audited the accompanying consolidated statements of assets and liabilities, including the consolidated schedules of investments, of Nuveen Churchill Private Capital Income Fund and its subsidiaries (the “Company”) as of December 31, 2023 and 2022, and the related consolidated statements of operations, changes in net assets and cash flows for the year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022, including the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations, changes in its net assets and its cash flows for the year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our procedures included confirmation of securities owned as of December 31, 2023 and 2022 by correspondence with the custodian. We believe that our audits provide a reasonable basis for our opinion.

/s/ PricewaterhouseCoopers LLP

New York, New York

February 29, 2024

We have served as the Company’s auditor since 2022.

84

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES

(dollars in thousands, except share and per share data)

	December 31, 2023		December 31, 2022
Assets
Investments
Non-controlled/non-affiliate company investments, at fair value (amortized cost of $516,168 and $352,998, respectively)	$	512,036	$	349,518
Cash and cash equivalents	8,679		65,785
Due from affiliate expense support (See Note 5)	2,968		2,215
Interest receivable	5,758		4,282
Receivable for investments sold	161		196
Prepaid expenses	41		29
Total assets	$	529,643	$	422,025
Liabilities (See Note 6)
Secured borrowings (net of $749 and $647 deferred financing costs)	$	165,001	$	154,353
Distributions payable	3,584		3,109
Payable for investments purchased	338		—
Interest payable	630		533
Due to affiliate expense support (See Note 5)	2,968		2,215
Board of Trustees' fees payable	128		128
Accounts payable and accrued expenses	2,163		1,386
Total liabilities	174,812		$	161,724
Commitments and contingencies (See Note 7)
Net Assets: (See Note 8)
Class S Common shares of beneficial interest, $0.01 par value, unlimited shares authorized, 149,838 and 0 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	$	1	$	—
Class D Common shares of beneficial interest, $0.01 par value, unlimited shares authorized, 107,266 and 0 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	1		—
Class I Common shares of beneficial interest, $0.01 par value, unlimited shares authorized, 14,091,386 and 10,540,040 shares issued and outstanding as of December 31,2023 and December 31, 2022, respectively	141		105
Paid-in-capital in excess of par value	357,241		263,396
Total distributable earnings (loss)	(2,553)		(3,200)
Total net assets	$	354,831	$	260,301
Total liabilities and net assets	$	529,643	$	422,025
Net asset value per Class S share	$	24.69	$	—
Net asset value per Class D share	$	24.73	$	—
Net asset value per Class I share	$	24.73	$	24.70

The accompanying notes are an integral part of these consolidated financial statements.

85

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED STATEMENTS OF OPERATIONS

(dollars in thousands, except share and per share data)

	For the Years Ended December 31,
	2023		2022 (1)
Investment income:
Non-controlled/non-affiliated company investments:
Interest income	$	45,200	20,741
Payment-in-kind interest income	2,333		1,275
Dividend income	123		—
Other income	178		504
Total investment income	47,834		22,520
Expenses:
Organizational expenses	—		1,081
Interest and debt financing expenses	10,752		4,083
Interest expense on Note (See Note 5)	—		226
Professional fees	762		708
Management fees (See Note 5)	1,292		—
Income based incentive fees (See Note 5)	3,108		—
Board of Trustees’ fees	508		385
Administration fees	517		299
Other general and administrative expenses	682		260
Distribution and shareholder servicing fees
Class S	5		—
Class D	1		—
Offering costs	659		228
Total expenses	18,286		7,270
Expense support (See Note 5)	(750)		(1,558)
Management fees waived (See Note 5)	(1,292)		—
Incentive fees waived (See Note 5)	(3,108)		—
Net expenses	13,136		5,712
Net investment income before excise taxes	34,698		16,808
Excise taxes	31		2
Net investment income (loss)	34,667		16,806
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments	768		(347)
Net change in unrealized appreciation (depreciation):
Non-controlled/non-affiliated company investments	(652)		(3,480)
Income tax (provision) benefit	(61)		—
Total net change in unrealized gain (loss)	(713)		(3,480)
Total net realized and unrealized gain (loss) on investments	55		(3,827)
Net increase (decrease) in net assets resulting from operations	$	34,722	$	12,979
Per share data:
Net investment income (loss) per share - Class S common share	$	0.73	$	—
Net investment income (loss) per share - Class D common share	$	0.76	$	—
Net investment income (loss) per share - Class I common share	$	2.97	$	1.60
Net increase (decrease) in net assets resulting from operations per share - Class S Common Share	$	0.90	$	—
Net increase (decrease) in net assets resulting from operations per share - Class D Common Share	$	0.98	$	—
Net increase (decrease) in net assets resulting from operations per share - Class I Common Share	$	2.98	$	1.24
Weighted average common shares outstanding - Class S common share	88,660		—
Weighted average common shares outstanding - Class D common share	53,295		—
Weighted average common shares outstanding - Class I common share	11,644,451		10,501,989

_______________

(1) Period from February 8, 2022 (inception) through December 31, 2022

The accompanying notes are an integral part of these consolidated financial statements.

86

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS

(dollars in thousands, except share and per share data)

	For the Years Ended December 31,
	2023		2022(1)
Increase (decrease) in net assets resulting from operations:
Net investment income (loss)	$	34,667	$	16,806
Net realized gain (loss) on investments	768		(347)
Total net change in unrealized gain (loss)	(713)		(3,480)
Net increase (decrease) in net assets resulting from operations	34,722		12,979
Shareholder Distributions:
Class S	(61)		—
Class D	(39)		—
Class I	(33,789)		(16,179)
Net increase (decrease) in net assets resulting from shareholder distributions	(33,889)		(16,179)
Capital share transactions:
Class S:
Issuance of common shares, net	3,671		—
Reinvestment of shareholder distributions	10		—
Net increase (decrease) in net assets resulting from capital share transactions - Class S	3,681		—
Class D:
Issuance of common shares, net	2,629		—
Reinvestment of shareholder distributions	9		—
Net increase (decrease) in net assets resulting from capital share transactions - Class D	2,638		—
Class I:
Issuance of common shares, net	86,550		263,501
Reinvestment of shareholder distributions	828		—
Net increase (decrease) in net assets resulting from capital share transactions - Class I	87,378		263,501
Total increase (decrease) in net assets	94,530		260,301
Net assets, at beginning of period	260,301		—
Net assets, at end of period	$	354,831	$	260,301

____________________

(1)Period from February 8, 2022 (inception) through December 31, 2022

The accompanying notes are an integral part of these consolidated financial statements.

87

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in thousands, except share and per share data)

	For the Years Ended December 31,
	2023		2022(1)
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations	$	34,722	$	12,979
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities
Purchase of investments	(206,879)		(93,554)
Proceeds from principal repayments and sales of investments	47,485		38,221
Payment-in-kind interest	(2,333)		(1,275)
Amortization of premium/accretion of discount, net	(820)		(506)
Net realized (gain) loss on investments	(768)		347
Net change in unrealized (appreciation) depreciation on investments	652		3,480
Amortization of deferred financing costs	174		14
Changes in operating assets and liabilities:
Due from affiliate expense support	(753)		(2,215)
Receivable for investments sold	35		(196)
Interest receivable	(1,330)		(4,282)
Prepaid expenses	(12)		(29)
Payable for investments purchased	338		—
Interest payable	97		533
Due to affiliate expense support	753		2,215
Board of Trustees' fees payable	—		128
Accounts payable and accrued expenses	777		985
Net cash provided by (used in) operating activities	(127,862)		(43,155)
Cash flows from financing activities:
Proceeds from issuance of common shares	92,850		1
Proceeds from secured borrowings	135,250		162,500
Repayments of secured borrowings	(124,500)		(7,500)
Repayments of Note	—		(32,731)
Distributions paid	(32,568)		(13,070)
Payments of deferred financing costs	(276)		(260)
Net cash provided by (used in) financing activities	70,756		108,940
Net increase (decrease) in cash and cash equivalents	(57,106)		65,785
Cash and cash equivalents, beginning of period	65,785		—
Cash and cash equivalents, end of period	$	8,679	$	65,785
Supplemental information and non-cash activities:
Purchases of investments	$	—	$	(296,231)
Cash paid during the period for interest	$	10,482	$	3,702
Financing costs paid through expense support	$	2	$	462
Amortization of deferred financing costs paid through expense support	$	—	$	60
Cash paid during the period for excise taxes	$	2	$	—
Issuance of Class I common shares, net	$	—	$	263,500
Reinvestment of Shareholder Distributions	$	847	$	—

____________________

(1)Period from February 8, 2022 (inception) through December 31, 2022

The accompanying notes are an integral part of these consolidated financial statements.

88

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit		Cost		Fair Value			% of Net Assets (5)
Investments
Debt Investments
Aerospace & Defense
Precision Aviation Group	(4) (6)	First Lien Term Loan	S + 5.75%	11.12	%	12/21/2029	$	7,520	$	7,370	$	7,370		2.08	%
Precision Aviation Group (Delayed Draw)	(4) (11)	First Lien Term Loan	S + 5.75%	11.12	%	12/21/2029	2,480		(25)		(49)			(0.01)	%
Turbine Engine Specialist, Inc	(4)	Subordinated Debt	S + 9.50%	14.96	%	3/1/2029	1,973		1,925		1,937			0.54	%
Total Aerospace & Defense									9,270		9,258			2.61	%
Automotive
Adient US LLC	(6) (12)(13)	First Lien Term Loan	S + 3.25%	8.72	%	4/13/2028	875		878		879			0.25	%
Belron Finance US LLC	(6) (12)(13)	First Lien Term Loan	S + 2.43%	8.07	%	4/13/2028	871		874		874			0.24	%
Randys Holdings, Inc	(4) (6) (7)	First Lien Term Loan	S + 6.50%	11.88	%	11/1/2028	3,957		3,888		3,907			1.10	%
Randys Holdings, Inc (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 6.50%	11.88	%	11/1/2028	1,332		—		(17)			—	%
Total Automotive									5,640		5,643			1.59	%
Banking, Finance, Insurance, Real Estate
Patriot Growth Insurance Service (Delayed Draw) (Incremental)	(4) (6) (7)	First Lien Term Loan	S + 5.75%	11.25	%	10/14/2028	5,972		5,924		5,836			1.65	%
Ryan Specialty Group LLC	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.46	%	9/1/2027	1,245		1,248		1,247			0.35	%
SS&C Technology Holdings Inc	(6) (12)(13)	First Lien Term Loan	S + 2.25%	7.71	%	3/22/2029	297		298		298			0.08	%
SS&C Technology Holdings Inc	(6) (12)(13)	First Lien Term Loan	S + 2.25%	7.71	%	3/22/2029	177		177		177			0.05	%
Total Banking, Finance, Insurance, Real Estate									7,647		7,558			2.13	%
Beverage, Food & Tobacco
Bakeovations Intermediate, LLC (d/b/a Commercial Bakeries)	(4) (6) (10)(13)	First Lien Term Loan	S + 6.25%	11.60	%	9/25/2029	4,236		4,156		4,152			1.17	%
Cold Spring Brewing Company	(4) (6)	First Lien Term Loan	S + 4.75%	10.11	%	12/19/2025	6,188		6,188		6,188			1.75	%
Fortune International, LLC	(4) (6)	First Lien Term Loan	S + 4.75%	10.20	%	1/17/2026	6,878		6,839		6,812			1.92	%
Fresh Edge	(4) (6)	Subordinated Debt	S+ 4.50% (Cash) 5.13% (PIK)	15.20	%	4/3/2029	2,954		2,888		2,886			0.81	%
Harvest Hill Beverage Company	(4)	Subordinated Debt	S + 9.00%	14.46	%	2/28/2029	2,800		2,723		2,749			0.77	%
Nonni's Foods, LLC	(4) (6)	First Lien Term Loan	S + 5.50%	11.10	%	3/1/2025	6,890		6,887		6,849			1.93	%
Palmetto Acquisitionco, Inc.	(4) (6)	First Lien Term Loan	S + 5.75%	11.10	%	9/18/2029	3,348		3,292		3,291			0.93	%
Palmetto Acquisitionco, Inc. (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.75%	11.10	%	9/18/2029	1,217		294		277			0.08	%
Sugar Foods	(4) (6) (7)	First Lien Term Loan	S + 6.00%	11.34	%	10/2/2030	4,221		4,128		4,130			1.16	%
Sugar Foods (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 6.00%	11.34	%	10/2/2030	1,173		(13)		(25)			(0.01)	%
Summit Hill Foods	(4) (6)	First Lien Term Loan	S + 6.00%	11.39	%	11/29/2029	2,893		2,850		2,850			0.80	%
Sunny Sky Products	(4) (6)	First Lien Term Loan	S + 5.25%	10.60	%	12/23/2028	1,857		1,839		1,839			0.52	%
Sunny Sky Products (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.25%	10.60	%	12/23/2028	464		—		(4)			—	%
SW Ingredients Holdings, LLC	(4)	Subordinated Debt	N/A	10.50% (Cash) 1.00% (PIK)		7/3/2026	10,179		10,179		9,898			2.79	%
Total Beverage, Food & Tobacco									52,250		51,892			14.62	%
Capital Equipment
Clarios Global LP (f/k/a Johnson Controls Inc)	(6) (10)(12)(13)	First Lien Term Loan	S + 3.75%	9.11	%	5/6/2030	998		998		1,001			0.28	%
EFC Holdings, LLC	(4)	Subordinated Debt	N/A	11.00% (Cash) 2.50% (PIK)		5/1/2028	2,436		2,372		2,413			0.68	%
GenServe LLC	(4) (6) (7)	First Lien Term Loan	S + 5.75%	11.21	%	6/30/2024	6,878		6,865		6,843			1.93	%
Hayward Industries, Inc.	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.22	%	5/30/2028	747		741		748			0.21	%
Motion & Control Enterprises	(4) (6)	First Lien Term Loan	S + 5.50%	11.03	%	6/1/2028	1,600		1,581		1,581			0.45	%
Motion & Control Enterprises (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.50%	11.03	%	6/1/2028	4,400		2,691		2,643			0.74	%
Ovation Holdings, Inc.	(4) (6)	First Lien Term Loan	S + 6.25%	11.78	%	2/3/2029	2,973		2,914		2,941			0.83	%
Ovation Holdings, Inc. (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.25%	11.78	%	2/3/2029	703		568		568			0.16	%
RTH Buyer LLC (dba Rhino Tool House)	(4) (6)	First Lien Term Loan	S + 6.25%	11.97	%	4/4/2029	2,673		2,623		2,651			0.75	%
RTH Buyer LLC (dba Rhino Tool House) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.25%	11.97	%	4/4/2029	626		317		315			0.09	%
Total Capital Equipment									21,670		21,704			6.12	%
Chemicals, Plastics, & Rubber
Chroma Color Corporation (dba Chroma Color)	(4) (6)	First Lien Term Loan	S + 6.00%	11.41	%	4/21/2029	1,744		1,712		1,712			0.49	%
Chroma Color Corporation (dba Chroma Color) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.41	%	4/21/2029	381		(3)		(7)			—	%
INEOS US Finance LLC	(6) (12)(13)	First Lien Term Loan	S + 3.75%	9.21	%	11/8/2027	497		497		500			0.14	%
INEOS US Petrochem LLC	(6) (12)(13)	First Lien Term Loan	S + 4.25%	9.71	%	4/3/2029	874		874		869			0.24	%
Kraton Polymers LLC	(6) (12)(13)	First Lien Term Loan	S + 3.25%	8.90	%	3/15/2029	497		491		488			0.14	%
Nouryon Finance B.V.	(6) (12)(13)	First Lien Term Loan	S + 4.00%	9.35	%	4/3/2028	747		744		751			0.21	%
Spartech	(4) (6) (7)	First Lien Term Loan	S + 4.75%	10.16	%	5/6/2028	3,930		3,930		3,166			0.89	%
SupplyOne, Inc.	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.50% (PIK)		2/1/2025	10,227		10,227		10,227			2.88	%
Tronox Finance LLC	(6) (12)(13)	First Lien Term Loan	S + 3.50%	8.85	%	8/16/2028	1,000		996		1,001			0.28	%
Total Chemicals, Plastics, & Rubber									19,468		18,707			5.27	%
Construction & Building
Gannett Fleming	(4) (6)	First Lien Term Loan	S + 6.60%	11.95	%	12/20/2028	1,980		1,946		1,982			0.55	%
Hyphen Solutions, LLC	(4) (6) (7)	First Lien Term Loan	S + 5.50%	10.98	%	10/27/2026	6,877		6,839		6,752			1.90	%
MEI Rigging & Crating	(4) (6)	First Lien Term Loan	S + 6.50%	11.86	%	6/30/2029	3,158		3,097		3,130			0.88	%
MEI Rigging & Crating (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.50%	11.86	%	6/30/2029	501		(2)		(4)			—	%
Quikrete Holdings, Inc.	(6) (12)	First Lien Term Loan	S + 2.75%	8.22	%	3/19/2029	996		998		1,000			0.28	%
SPI LLC	(4) (6) (7)	First Lien Term Loan	S + 5.00%	10.46	%	12/21/2027	6,878		6,800		6,878			1.94	%
Summit Materials, LLC	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.57	%	12/14/2027	996		1,002		999			0.28	%
Vertex Service Partners	(4) (6)	First Lien Term Loan	S + 5.50%	10.90	%	11/8/2030	1,230		1,212		1,212			0.34	%
Vertex Service Partners (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.50%	10.90	%	11/8/2030	2,369		586		558			0.16	%
WSB Engineering Holdings Inc.	(4) (6)	First Lien Term Loan	S + 6.00%	11.39	%	8/31/2029	1,639		1,616		1,616			0.46	%
WSB Engineering Holdings Inc. (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.39	%	8/31/2029	1,096		(8)		(16)			—	%
Total Construction & Building									24,086		24,107			6.79	%
Consumer Goods: Durable
Copeland (Emerson Climate Technologies)	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.36	%	5/31/2030	1,247		1,250		1,253			0.35	%
Freedom U.S. Acquisition Corporation	(4) (6)	First Lien Term Loan	S + 5.75%	11.25	%	9/30/2024	6,980		6,980		6,935			1.96	%
NMC Skincare Intermediate Holdings II, LLC	(4) (6) (7)	First Lien Term Loan	S + 6.00%	10.44% (Cash) 1.00% (PIK)		10/31/2026	6,630		6,586		6,294			1.77	%
SRAM LLC	(6) (12)	First Lien Term Loan	S + 2.75%	6.00	%	5/18/2028	750		751		750			0.21	%
Topgolf Callaway Brands Corp	(6) (12)(13)	First Lien Term Loan	S + 3.50%	8.96	%	3/15/2030	497		499		498			0.14	%
Xpressmyself.com LLC (a/k/a SmartSign)	(4) (6)	First Lien Term Loan	S + 5.75%	11.22	%	9/7/2028	1,531		1,503		1,518			0.43	%
Xpressmyself.com LLC (a/k/a SmartSign)	(4) (6)	First Lien Term Loan	S + 5.50%	10.98	%	9/7/2028	2,024		2,008		1,989			0.56	%
Total Consumer Goods: Durable									19,577		19,237			5.42	%
Consumer Goods: Non-Durable
Accupac, Inc.	(4) (6) (7)	First Lien Term Loan	S + 6.00%	11.52	%	1/17/2026	6,875		6,859		6,625			1.87	%
Elevation Labs	(4) (6)	First Lien Term Loan	S + 5.75%	11.23	%	6/30/2028	1,302		1,292		1,215			0.34	%
Elevation Labs (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.75%	11.23	%	6/30/2028	599		(2)		(40)			(0.01)	%
Image International Intermediate Holdco II, LLC (Incremental)	(4) (6) (7)	First Lien Term Loan	S + 5.50%	11.03	%	7/10/2024	6,992		6,967		6,882			1.94	%
Perrigo Company plc	(6) (12)(13)	First Lien Term Loan	S + 2.25%	7.71	%	4/20/2029	999		998		999			0.28	%
Protective Industrial Products (“PIP”)	(4) (6) (7)	First Lien Term Loan	S + 5.00%	10.47	%	12/29/2027	1,343		1,294		1,356			0.38	%
Revision Buyer LLC	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		12/1/2028	10,176		10,013		10,176			2.87	%
Ultima Health Holdings, LLC	(4)	Subordinated Debt	N/A	11.00% (Cash) 1.50% (PIK)		3/12/2029	1,326		1,304		1,303			0.37	%
US Foods, Inc	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.97	%	11/22/2028	1,250		1,254		1,257			0.35	%
Total Consumer Goods: Non-Durable									29,979		29,773			8.39	%
Containers, Packaging & Glass
New ILC Dover, Inc.	(4) (6) (7)	First Lien Term Loan	S + 5.25%	10.70	%	1/31/2026	6,875		6,868		6,875			1.95	%
Oliver Packaging	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		1/6/2029	1,326		1,305		1,255			0.35	%
Online Labels Group	(4) (6)	First Lien Term Loan	S + 5.25%	10.61	%	12/19/2029	979		969		969			0.27	%
Online Labels Group (Delayed Draw)	(4) (11)	First Lien Term Loan	S + 5.25%	10.61	%	12/19/2029	119		—		(1)			—	%
Online Labels Group (Delayed Draw)	(4) (11)	First Lien Term Loan	S + 5.25%	10.61	%	12/19/2029	119		—		(1)			—	%
PG Buyer, LLC	(4) (6)	Subordinated Debt	N/A	10.00% (Cash) 1.50% (PIK)		9/2/2026	8,215		8,215		8,215			2.32	%
Total Containers, Packaging & Glass									17,357		17,312			4.89	%
Energy: Electricity
Covanta Holding Corp	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.86	%	11/30/2028	53		53		53			0.01	%
Covanta Holding Corp	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.86	%	11/30/2028	694		692		695			0.20	%
National Power	(4) (6)	First Lien Term Loan	S + 6.00%	11.36	%	10/20/2029	1,485		1,463		1,464			0.41	%
National Power (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.36	%	10/20/2029	799		(2)		(11)			—	%
Total Energy: Electricity									2,206		2,201			0.62	%
Energy: Oil & Gas
Dresser Utility Solutions, LLC	(4) (6)	First Lien Term Loan	S + 5.25%	10.71	%	9/30/2025	3,438		3,438		3,438			0.97	%
Dresser Utility Solutions, LLC (Incremental)	(4) (6)	First Lien Term Loan	S + 4.00%	9.46	%	10/1/2025	3,437		3,408		3,402			0.96	%
Marco APE Opco Holdings, LLC	(4)	Subordinated Debt	N/A	15.00% (PIK)		9/2/2026	9,888		9,467		8,927			2.51	%
Total Energy: Oil & Gas									16,313		15,767			4.44	%
Environmental Industries
GFL Environmental	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.91	%	5/31/2027	1,247		1,251		1,253			0.35	%
Impact Environmental Group	(4) (6)	First Lien Term Loan	S + 6.00%	11.28	%	3/23/2029	2,076		2,037		2,059			0.58	%
Impact Environmental Group (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.28	%	3/23/2029	970		849		845			0.24	%
Impact Environmental Group (Incremental)	(4) (6)	First Lien Term Loan	S + 6.00%	11.28	%	3/23/2029	425		418		422			0.12	%
Impact Environmental Group (Delayed Draw) (Incremental)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.28	%	3/23/2029	1,716		(8)		(14)			—	%
North Haven Stack Buyer, LLC	(4) (6) (7)	First Lien Term Loan	S + 5.50%	11.03	%	7/16/2027	6,877		6,853		6,871			1.93	%
Nutrition 101 Buyer LLC (a/k/a 101, Inc.)	(4) (6)	First Lien Term Loan	S + 5.25%	10.73	%	8/31/2028	816		810		800			0.23	%
Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance)	(4) (6)	First Lien Term Loan	S + 6.25%	11.65	%	7/1/2029	3,420		3,370		3,371			0.95	%
Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.25%	11.65	%	7/1/2029	2,571		(6)		(37)			(0.01)	%
Total Environmental Industries									15,574		15,570			4.39	%
Healthcare & Pharmaceuticals
Grifols Worldwide Operations LTD	(6) (10)(12)(13)	First Lien Term Loan	S + 2.00%	7.54	%	11/15/2027	499		495		499			0.14	%
Health Management Associates	(4) (6)	First Lien Term Loan	S + 6.50%	11.73	%	3/31/2029	3,364		3,302		3,334			0.94	%
Health Management Associates (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.50%	11.73	%	3/31/2029	607		180		186			0.05	%
Heartland Veterinary Partners LLC (Incremental)	(4)	Subordinated Debt	S + 7.50%	12.96	%	12/10/2027	1,000		985		987			0.28	%
Heartland Veterinary Partners LLC (Incremental) (Delayed Draw)	(4)	Subordinated Debt	S + 7.50%	12.96	%	12/10/2027	5,000		5,000		4,936			1.39	%
Jazz Pharmaceuticals plc	(6) (10)(12)(13)	First Lien Term Loan	S + 3.50%	8.97	%	5/5/2028	1,244		1,246		1,251			0.35	%
New You Bariatric Group, LLC	(4) (6)	First Lien Term Loan	S + 5.25%	10.75	%	8/26/2024	6,874		6,874		6,491			1.83	%
Organon & Co	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.47	%	6/2/2028	1,250		1,255		1,255			0.35	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners)	(4) (6)	First Lien Term Loan	S + 5.75%	11.21	%	10/7/2029	2,242		2,199		2,215			0.62	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.75%	11.21	%	10/7/2029	733		467		459			0.13	%
Select Medical Corporation	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.36	%	3/6/2027	1,245		1,248		1,248			0.35	%
Thorne HealthTech	(4) (6)	First Lien Term Loan	S + 5.75%	11.10	%	10/16/2030	2,788		2,761		2,763			0.78	%
TIDI Products	(4) (6) (7)	First Lien Term Loan	S + 5.50%	10.86	%	12/19/2029	4,566		4,521		4,520			1.27	%
TIDI Products (Delayed Draw)	(4) (7) (11)	First Lien Term Loan	S + 5.50%	10.86	%	12/19/2029	1,201		—		(12)			—	%
US Radiology Specialists, Inc.	(4) (6) (7)	First Lien Term Loan	S + 5.25%	10.75	%	12/15/2027	1,863		1,793		1,851			0.52	%
W2O Holdings, Inc.(Delayed Draw)	(4) (6)	First Lien Term Loan	S + 5.25%	10.82	%	6/12/2026	6,877		6,877		6,877			1.94	%
Wellspring Pharmaceutical	(4) (6)	First Lien Term Loan	S + 5.75%	11.03	%	8/22/2028	4,054		3,988		3,958			1.12	%
Wellspring Pharmaceutical (Delayed Draw)	(4)	First Lien Term Loan	S + 5.75%	11.03	%	8/22/2028	1,885		1,873		1,841			0.52	%
Young Innovations	(4) (6) (7)	First Lien Term Loan	S + 5.75%	11.09	%	12/1/2029	6,867		6,799		6,801			1.92	%
Young Innovations (Delayed Draw)	(4) (7) (11)	First Lien Term Loan	S + 5.75%	11.09	%	12/1/2029	1,431		—		(14)			—	%
Total Healthcare & Pharmaceuticals									51,863		51,446		0	14.50	%
High Tech Industries
Acclaim MidCo, LLC (dba ClaimLogiQ)	(4) (6)	First Lien Term Loan	S + 6.00%	11.35	%	6/13/2029	2,216		2,174		2,196			0.62	%
Acclaim MidCo, LLC (dba ClaimLogiQ) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.35	%	6/13/2029	891		(4)		(8)			—	%
Evergreen Services Group II	(4) (6) (7)	First Lien Term Loan	S + 6.00%	11.35	%	10/4/2030	3,323		3,274		3,276			0.92	%
Evergreen Services Group II (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 6.00%	11.35	%	10/4/2030	2,677		1,747		1,716			0.48	%
GTCR W Merger Sub LLC (Worldpay)	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.33	%	1/31/2031	340		338		342			0.10	%
II-VI Inc.	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.22	%	7/2/2029	726		728		730			0.21	%
Infinite Electronics (Incremental)	(4) (6) (7)	First Lien Term Loan	S + 6.25%	11.88	%	3/2/2028	1,967		1,917		1,901			0.54	%
Infobase Acquisition, Inc.	(4) (6)	First Lien Term Loan	S + 5.50%	10.93	%	6/14/2028	731		725		725			0.20	%
Infobase Acquisition, Inc. (Delayed Draw)	(4) (11)	First Lien Term Loan	S + 5.50%	10.93	%	6/14/2028	122		—		(1)			—	%
Informatica LLC	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.22	%	10/27/2028	1,245		1,250		1,249			0.35	%
Instructure Holdings Inc	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.68	%	10/30/2028	996		999		1,002			0.28	%
ITSavvy LLC	(4) (6)	First Lien Term Loan	S + 5.25%	10.89	%	8/8/2028	1,775		1,761		1,775			0.50	%
ITSavvy LLC (Delayed Draw)	(4) (11)	First Lien Term Loan	S + 5.25%	10.89	%	8/8/2028	239		201		203			0.06	%
MKS Instruments Inc.	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.84	%	8/17/2029	996		998		1,000			0.28	%
Red Ventures LLC	(6) (12)	First Lien Term Loan	S + 3.00%	8.36	%	3/3/2030	872		870		871			0.25	%
Specialist Resources Global Inc. (Delayed Draw)	(4) (6)	First Lien Term Loan	S + 4.50%	10.46	%	9/23/2027	6,876		6,876		6,876			1.94	%
UPC Finance Partnership	(6) (10)(12)(13)	First Lien Term Loan	S + 3.00%	8.48	%	1/31/2029	500		489		499			0.14	%
Total High Tech Industries									24,343		24,352			6.87	%
Hotel, Gaming & Leisure
Cinemark USA Inc.	(6) (12)(13)	First Lien Term Loan	S + 3.75%	9.14	%	5/24/2030	996		997		998			0.28	%
Delta 2	(6) (10)(12)(13)	First Lien Term Loan	S + 2.25%	7.60	%	1/15/2030	1,250		1,255		1,255			0.35	%
Total Hotel, Gaming & Leisure									2,252		2,253			0.63	%
Media: Advertising, Printing & Publishing
Getty Images Inc	(6) (12)	First Lien Term Loan	S + 4.50%	9.95	%	2/19/2026	496		498		499			0.14	%
Viking Target, LLC	(4) (6)	First Lien Term Loan	S + 5.00%	10.47	%	8/9/2024	6,360		6,346		6,334			1.79	%
Total Media: Advertising, Printing & Publishing									6,844		6,833			1.93	%
Media: Broadcasting & Subscription
DIRECTV (AKA DIRECTV Financing LLC)	(6) (12)(13)	First Lien Term Loan	S + 5.00%	10.65	%	8/2/2027	379		375		379			0.11	%
Gray Television, Inc.	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.96	%	1/2/2026	500		498		500			0.14	%
Nexstar Media Inc	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.97	%	9/18/2026	1,000		1,001		1,002			0.28	%
Virgin Media Bristol LLC	(6) (10)(12)(13)	First Lien Term Loan	S + 3.25%	8.73	%	1/31/2029	1,250		1,230		1,250			0.35	%
WideOpenWest Finance LLC	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.35	%	12/20/2028	497		493		462			0.13	%
Ziggo Financing Partnership	(6) (10)(12)(13)	First Lien Term Loan	S + 2.50%	7.98	%	4/30/2028	500		490		499			0.14	%
Total Media: Media: Broadcasting & Subscription									4,087		4,092			1.15	%
Metals and Mining
Arsenal AIC Parent LLC	(6) (12)	First Lien Term Loan	S + 4.50%	9.86	%	8/18/2030	499		501		502			0.14	%
Total Metals and Mining									501		502			0.14	%
Services: Business
ALKU Intermediate Holdings, LLC	(4) (6)	First Lien Term Loan	S + 6.25%	11.61	%	5/23/2029	2,711		2,660		2,688			0.75	%
Aramsco	(4) (6) (7)	First Lien Term Loan	S + 4.75%	10.10	%	10/10/2030	2,980		2,921		2,923			0.82	%
Aramsco (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 4.75%	10.10	%	10/10/2030	520		—		(10)			—	%
ARMstrong	(4) (6)	First Lien Term Loan	S + 6.25%	11.70	%	10/6/2029	2,996		2,953		2,954			0.83	%
ARMstrong (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.25%	11.70	%	10/6/2029	1,007		(7)		(14)			—	%
BroadcastMed Holdco, LLC	(4)	Subordinated Debt	N/A	10.00% (Cash) 3.75% (PIK)		11/12/2027	2,673		2,627		2,587			0.73	%
Class Valuation	(4)	Subordinated Debt	N/A	11.00	%	9/30/2026	444		438		412			0.12	%
Colibri (McKissock LLC)	(4) (6) (7)	First Lien Term Loan	S + 5.00%	10.38	%	3/12/2029	6,000		5,853		6,007			1.69	%
CrossCountry Consulting	(4) (6) (7)	First Lien Term Loan	S + 5.75%	11.21	%	6/1/2029	1,379		1,356		1,387			0.39	%
CrossCountry Consulting (Delayed Draw)	(4) (7) (11)	First Lien Term Loan	S + 5.75%	11.21	%	6/1/2029	560		(5)		3			—	%
CV Intermediate Holdco Corp.	(4)	Subordinated Debt	N/A	11.00	%	9/30/2026	10,000		9,882		9,278			2.61	%
Evergreen Services Group	(4) (6) (7)	First Lien Term Loan	S + 6.25%	11.70	%	6/15/2029	4,027		3,959		3,948			1.11	%
Evergreen Services Group (Delayed Draw)	(4) (6) (7)	First Lien Term Loan	S + 6.25%	11.70	%	6/15/2029	963		955		945			0.27	%
ICON Publishing Ltd	(6) (10)(12)(13)	First Lien Term Loan	S + 2.25%	7.86	%	7/3/2028	342		343		344			0.10	%
ICON Publishing Ltd	(6) (12)	First Lien Term Loan	S + 2.25%	7.86	%	7/3/2028	85		86		86			0.02	%
Ingram Micro T/L (09/23) TARGET FACILITY	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.61	%	6/30/2028	875		876		879			0.25	%
Keng Acquisition, Inc. (Engage Group Holdings, LLC)	(4) (6) (7)	First Lien Term Loan	S + 6.25%	11.60	%	8/1/2029	2,431		2,395		2,396			0.68	%
Keng Acquisition, Inc. (Engage Group Holdings, LLC) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 6.25%	11.60	%	8/1/2029	2,342		296		268			0.08	%
Kofile, Inc.	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.75% (PIK)		7/29/2026	10,308		10,308		9,720			2.74	%
KRIV Acquisition, Inc	(4) (6)	First Lien Term Loan	S + 6.50%	11.85	%	7/6/2029	5,221		5,081		5,070			1.43	%
KRIV Acquisition, Inc (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.50%	11.85	%	7/6/2029	779		(9)		(23)			(0.01)	%
Micronics	(4)	Subordinated Debt	S + 5.25%	10.00	%	2/17/2027	1,880		1,842		1,843			0.52	%
OMNIA Partners, LLC (Delayed Draw)	(6) (7) (11)(12)	First Lien Term Loan	S + 4.25%	9.63	%	7/25/2030	129		(1)		1			—	%
OMNIA Partners, LLC	(6) (7) (12)	First Lien Term Loan	S + 4.25%	9.63	%	7/25/2030	1,371		1,358		1,381			0.39	%
Open Text Corp	(6) (10)(12)(13)	First Lien Term Loan	S + 2.75%	8.21	%	1/31/2030	1,219		1,220		1,223			0.34	%
Phaidon International	(4) (6) (10)(13)	First Lien Term Loan	S + 5.50%	10.96	%	8/22/2029	6,538		6,483		6,538			1.84	%
Red Dawn SEI Buyer, Inc.	(4)	Subordinated Debt	S + 8.25%	13.60	%	11/26/2026	6,650		6,650		6,650			1.87	%
Red Dawn SEI Buyer, Inc. (Incremental)	(4)	Subordinated Debt	S + 8.50%	13.95	%	11/26/2026	3,350		3,350		3,350			0.94	%
Tempo Acquisition LLC	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.11	%	8/31/2028	1,223		1,225		1,230			0.35	%
Transit Buyer LLC (dba“Propark”)	(4) (6)	First Lien Term Loan	S + 6.25%	11.69	%	1/31/2029	2,526		2,482		2,518			0.71	%
Transit Buyer LLC (dba“Propark”) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.25%	11.69	%	1/31/2029	1,157		472		488			0.14	%
Trilon Group, LLC	(4) (6)	First Lien Term Loan	S + 6.25%	11.78	%	5/27/2029	596		592		588			0.17	%
Trilon Group, LLC	(4) (6)	First Lien Term Loan	S + 6.25%	11.75	%	5/27/2029	2,963		2,938		2,925			0.82	%
Trilon Group, LLC (Delayed Draw)	(4) (6)	First Lien Term Loan	S + 6.25%	11.78	%	5/27/2029	2,970		2,970		2,932			0.83	%
Trilon Group, LLC (Delayed Draw)	(4) (6)	First Lien Term Loan	S + 6.25%	11.78	%	5/27/2029	397		397		392			0.11	%
Total Services: Business									84,946		83,907			23.64	%
Services: Consumer
ADPD Holdings, LLC (a/k/a NearU)	(4) (6) (7)	First Lien Term Loan	S + 6.00%	11.68	%	8/16/2028	4,941		4,904		4,618			1.30	%
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 6.00%	11.68	%	8/16/2028	920		—		(60)			(0.02)	%
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 6.00%	11.68	%	8/16/2028	1,000		—		(65)			(0.02)	%
A Place for Mom, Inc.	(4) (6)	First Lien Term Loan	S + 4.50%	9.97	%	2/10/2026	6,851		6,851		6,764			1.90	%
COP Exterminators Acquisition, Inc.	(4)	Subordinated Debt	N/A	9.00% (Cash) 4.00% (PIK)		1/28/2030	647		630		630			0.18	%
COP Exterminators Acquisition, Inc. (Delayed Draw)	(4) (11)	Subordinated Debt	N/A	9.00% (Cash) 4.00% (PIK)		1/28/2030	503		(6)		(13)			—	%
Excel Fitness	(4) (6)	First Lien Term Loan	S + 5.25%	10.75	%	4/29/2029	5,925		5,867		5,769			1.63	%
Norton Lifelock Inc.	(6) (12)(13)	First Lien Term Loan	S + 2.00%	7.46	%	9/12/2029	467		467		468			0.13	%
Legacy Service Partners, LLC (“LSP”)	(4) (6)	First Lien Term Loan	S + 6.50%	12.00	%	1/9/2029	4,065		3,993		4,122			1.16	%
Legacy Service Partners, LLC (“LSP”) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.50%	12.00	%	1/9/2029	1,894		1,579		1,615			0.46	%
Perennial Services, Group, LLC	(4) (6)	First Lien Term Loan	S + 6.00%	11.49	%	9/8/2029	1,693		1,669		1,668			0.47	%
Perennial Services, Group, LLC (Delayed Draw)	(4) (6)	First Lien Term Loan	S + 6.00%	11.49	%	9/8/2029	1,515		1,512		1,493			0.42	%
Prime Security Services	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.84	%	10/14/2030	735		728		738			0.21	%
Total Services: Consumer									28,194		27,747			7.82	%
Sovereign & Public Finance
LMI Consulting, LLC (LMI)	(4) (6)	First Lien Term Loan	S + 6.50%	11.90	%	7/18/2028	734		722		737			0.21	%
LMI Consulting, LLC (LMI) (Incremental)	(4) (6)	First Lien Term Loan	S + 6.50%	11.89	%	7/18/2028	2,955		2,874		2,968			0.83	%
Total Sovereign & Public Finance									3,596		3,705			1.04	%
Telecommunications
Arise Holdings Inc.	(4) (6)	First Lien Term Loan	S + 4.25%	9.73	%	12/9/2025	6,875		6,840		6,452			1.83	%
Iridium Satellite LLC	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.86	%	9/20/2030	1,000		1,002		1,004			0.28	%
Mobile Communications America Inc	(4) (6)	First Lien Term Loan	S + 6.00%	11.35	%	10/16/2029	4,537		4,470		4,472			1.26	%
Mobile Communications America Inc (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.35	%	10/16/2029	1,463		(11)		(21)			(0.01)	%
Total Telecommunications									12,301		11,907			3.36	%
Transportation: Cargo
FSK Pallet Holding Corp. (DBA Kamps Pallets)	(4) (6)	First Lien Term Loan	S + 6.00%	11.53	%	12/23/2026	5,925		5,835		5,770			1.62	%
Kenco Group, Inc.	(4) (6)	First Lien Term Loan	S + 5.00%	10.39	%	11/15/2029	5,099		5,010		5,099			1.44	%
Kenco Group, Inc. (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.00%	10.39	%	11/15/2029	850		(14)		—			—	%
Uber Technologies Inc	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.13	%	3/3/2030	995		997		998			0.28	%
Total Transportation: Cargo									11,828		11,867			3.34	%
Transportation: Consumer
Air Canada	(6) (12)(13)	First Lien Term Loan	S + 3.50%	9.14	%	8/11/2028	996		999		1,001			0.28	%
American Student Transportaton Partners, Inc	(4)	Subordinated Debt	N/A	10.00% (Cash) 3.50% (PIK)		9/11/2029	1,606		1,564		1,564			0.44	%
United Airlines Inc	(6) (12)(13)	First Lien Term Loan	S + 3.75%	9.22	%	4/21/2028	1,245		1,250		1,251			0.36	%
Total Transportation: Consumer									3,813		3,816			1.08	%
Utilities: Electric
Pinnacle Supply Partners, LLC	(4) (6)	First Lien Term Loan	S + 6.00%	11.47	%	4/3/2030	2,533		2,486		2,515			0.71	%
Pinnacle Supply Partners, LLC (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.47	%	4/3/2030	1,455		(12)		(10)			—	%
Total Utilities: Electric									2,474		2,505			0.71	%
Wholesale
CDI AcquisitionCo, Inc.	(4) (6)	First Lien Term Loan	S + 4.25%	9.55	%	12/24/2024	6,684		6,672		6,679			1.88	%
Industrial Service Group (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.75%	11.11	%	12/7/2028	2,259		238		213			0.06	%
INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS)	(4) (6)	First Lien Term Loan	S + 6.50%	12.03	%	1/20/2029	4,583		4,504		4,590			1.29	%
INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.50%	12.03	%	1/20/2029	1,139		(19)		2			—	%
ISG Merger Sub, LLC (dba Industrial Service Group)	(4) (6)	First Lien Term Loan	S + 6.25%	11.60	%	12/7/2028	2,454		2,411		2,470			0.70	%
ISG Merger Sub, LLC (dba Industrial Service Group) (Delayed Draw)	(4) (6)	First Lien Term Loan	S + 6.25%	11.60	%	12/7/2028	1,277		1,272		1,286			0.36	%
New Era Technology, Inc	(4) (6) (7)	First Lien Term Loan	S + 6.25%	11.78	%	10/31/2026	6,723		6,703		6,512			1.84	%
Solaray, LLC	(4) (6) (7)	First Lien Term Loan	S + 6.50%	11.97	%	12/15/2025	6,889		6,886		6,399			1.80	%
Total Wholesale									28,667		28,151			7.93	%
Total Debt Investments									506,746		501,812			141.42	%

Portfolio Company (1) (2)	Footnotes	Investment	Acquisition Date	Share / Unit	Cost	Fair Value	% of Net Assets (5)
Equity Investments
Aerospace & Defense
BPC Kodiak LLC (Turbine Engine Specialist, Inc)	(4) (8) (9) (14)	Class A-1 Units	9/1/2023	1,180,000	1,180	1,245	0.35	%
Clarity Innovations, Inc.	(4) (8) (9)	Partnership Interests	12/7/2023	77,000	76	77	0.02	%
Total Aerospace & Defense					1,256	1,322	0.37	%
Banking, Finance, Insurance, Real Estate
Inszone	(4) (8) (9)(13)	Partnership Interests	11/30/2023	80,208	77	80	0.02	%
Total Banking, Finance, Insurance, Real Estate					77	80	0.02	%
Beverage, Food & Tobacco
Fresh Edge - Common	(4) (8) (9)	Class B Common Units	10/3/2022	454	—	67	0.02	%
Fresh Edge - Preferred	(4) (8) (9)	Class A Preferred Units	10/3/2022	454	454	507	0.14	%
Marlin Coinvest LP	(4) (8) (9)(13)	Limited Partnership Interests	5/9/2023	200,000	200	236	0.07	%
Sugar PPC Holdings LLC	(4) (8) (9)(13)	Parent Units	9/29/2023	2,000	200	200	0.06	%
Spice World	(4) (8) (9)	LLC Common Units	3/31/2022	1,000	126	115	0.03	%
Tech24	(4) (8) (9)	Company Unit	10/5/2023	200	200	200	0.06	%
Total Beverage, Food & Tobacco					1,180	1,325	0.38	%
Capital Equipment
EFC Holdings, LLC	(4) (8) (9)(13)	Series A Preferred Units	3/1/2023	114	114	121	0.03	%
EFC Holdings, LLC	(4) (8) (9)(13)	Class A Common Units	3/1/2023	114	46	87	0.02	%
Total Capital Equipment					160	208	0.05	%
Chemicals, Plastics & Rubber
SupplyOne, Inc.	(4) (8) (9)	LLC Common Units	3/31/2022	1,000	504	759	0.21	%
Total Chemicals, Plastics & Rubber					504	759	0.21	%
Construction & Building
Gannett Fleming	(4) (8) (9) (14)	Limited Partnership Interests	12/20/2022	84,949	85	124	0.03	%
Gannett Fleming	(4) (8) (9)	Series F Units	5/27/2023	113,901	118	166	0.05	%
Trench Plate Rental Co.	(4) (8) (9)	Common Equity	3/31/2022	1,000	127	97	0.03	%
Total Construction & Building					330	387	0.11	%
Consumer Goods: Non-Durable
RVGD Aggregator LP (Revision Skincare)	(4) (8) (9)	Limited Partnership Interests	3/31/2022	100	98	108	0.03	%
Ultima Health Holdings, LLC	(4) (8) (9)	Preferred Units	9/12/2022	11	130	121	0.03	%
WCI Holdings LLC	(4) (8) (9)(13)	Class A1 Units	2/6/2023	534,934	535	581	0.16	%
Total Consumer Goods: Non-Durable					763	810	0.22	%
Containers, Packaging & Glass
Oliver Packaging	(4) (8) (9)	Class A Common Units	7/12/2022	6,710	671	420	0.12	%
PG Aggregator, LLC	(4) (8) (9)(13)	LLC Units	3/31/2022	100	109	135	0.04	%
Total Containers, Packaging & Glass					780	555	0.16	%
Healthcare & Pharmaceuticals
Health Management Associates	(4) (8) (9)	Class A Common Units	3/31/2023	161,953	162	173	0.05	%
Total Healthcare & Pharmaceuticals					162	173	0.05	%
High Tech Industries
ITSavvy LLC	(4) (8) (9)	Class A Common Units	8/8/2022	119	119	285	0.08	%
Total High Tech Industries					119	285	0.08	%
Services: Business
BroadcastMed Holdco, LLC	(4) (8)	Series A-3 Preferred Units	10/4/2022	43,679	655	682	0.19	%
Class Valuation	(4) (8) (9)	Class A Common Units	12/8/2023	1,038	105	34	0.01	%
FCP-Cranium Holdings P/S A	(4) (8) (9)(10)(13)	Class A Common Shares	9/11/2023	375	—	—	—	%
FCP-Cranium Holdings, LLC (Brain labs)	(4) (8) (9)(10)(13)	Series A Preferred Shares	9/11/2023	1,026	389	407	0.11	%
FCP-Cranium Holdings, LLC (Brain labs)	(4) (8) (9)(10)(13)	Series B Preferred Shares	9/11/2023	375	600	600	0.17	%
Kofile, Inc.	(4) (8) (9)	Class A-2 Common Units	3/31/2022	100	108	57	0.02	%
KRIV Acquisition, Inc	(4) (8) (9)	Class A Units	7/17/2023	200	200	236	0.07	%
Smith System	(4) (8) (9)	Common Units	12/13/2023	84,000	84	84	0.03	%
Worldwide Clinical Trials	(4) (8) (9)	Class A Interests	12/12/2023	7	74	74	0.02	%
Worldwide Clinical Trials	(4) (8) (9)	Series A Preferred	12/12/2023	49	47	49	0.01	%
Total Services: Business					2,262	2,223	0.63	%
Services: Consumer
ADPD Holdings, LLC (a/k/a NearU)	(4) (7) (8) (9)	Limited Partnership Interests	8/11/2022	1,419	142	91	0.03	%
AirX Climate Solutions Company	(4) (8) (9)	Partnership Interests	11/7/2023	96	77	96	0.03	%
COP Exterminators Investment, LLC	(4) (8) (9)	Class A Units	7/31/2023	770,000	862	898	0.25	%
Legacy Service Partners, LLC (“LSP”)	(4) (8) (9)	Class B Units	1/9/2023	1,963	196	217	0.06	%
Perennial Services Investors LLC	(4) (8) (9)(13)	Class A Units	9/8/2023	1,957	196	271	0.08	%
Total Services: Consumer					1,473	1,573	0.45	%
Sovereign & Public Finance
LMI Renaissance	(4) (8) (9)	Limited Partnership Interests	6/30/2022	109,456	107	237	0.07	%
Total Sovereign & Public Finance					107	237	0.07	%
Transportation: Consumer
ASTP Holdings Co-Investment LP	(4) (8) (9)	Limited Partnership Interest	6/30/2022	160,609	137	175	0.05	%
Total Transportation: Consumer					137	175	0.05	%
Utilities: Electric
Pinnacle Supply Partners, LLC	(4) (8) (9)	Subject Partnership Units	4/3/2023	111,875	112	112	0.03	%
Total Utilities: Electric					112	112	0.03	%
Total Equity Investments					9,422	10,224	2.88	%

Portfolio Company (1) (2)	Interest Rate	Par Amount/Unit	Cost		Fair Value		% of Net Assets (5)
Cash Equivalents
First American Government Obligations Fund	5.26%	15	15		15		—	%
U.S. Bank National Association Money Market Deposit Account	4.72%	1,989	1,989		1,989		0.56	%
U.S. Bank National Association Money Market Deposit Account	2.05%	5,586	5,586		5,586		1.57	%
Total Cash Equivalents			7,590		7,590		2.13	%
Total Investments			$	523,758	$	519,626	146.43	%

____________________

(1)All investments are non-controlled/non-affiliated investments as defined by the Investment Company Act of 1940, as amended (the "1940 Act"). The 1940 Act classifies investments based on the level of control that the Fund maintains in a particular portfolio company. As defined in the 1940 Act, a portfolio company is generally presumed to be “non-controlled” when the Fund owns 25% or less of the portfolio company’s voting securities and “controlled” when the Fund owns more than 25% of the portfolio company’s voting securities. The 1940 Act also classifies investments further based on the level of ownership that the Fund maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally deemed as “non-affiliated” when the Fund owns less than 5% of a portfolio company’s voting securities and “affiliated” when the Fund owns 5% or more of a portfolio company’s voting securities.

(2)Unless otherwise indicated, issuers of debt and equity held by the Fund are domiciled in the United States.

(3)The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Fund has provided the spread over SOFR and the current contractual interest rate in effect at December 31, 2023. As of December 31, 2023, effective rates for 1M S, 3M S, 6M S and 12M S are 5.35%, 5.33%, 5.16% and 4.77%, respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

(4)Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies - Valuation of Portfolio Investments” for more information.

(5)Percentage is based on net assets of $354,831 as of December 31, 2023.

(6)Denotes that all or a portion of the assets are owned by SPV I (as defined in Note 1 “Organization”). SPV I entered into a senior secured revolving credit facility (the “Bank of America Credit Facility”) on April 19, 2022. The lenders of the Bank of America Credit Facility have a first lien security interest in substantially all of the assets of SPV I. Accordingly, such assets are not available to creditors of the Fund. See Note 6 “Secured Borrowings” for more information.

(7)Investment is a unitranche position.

(8)Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of December 31, 2023, the Fund held forty restricted securities with an aggregate fair value of $10,224, or 2.88% of the Fund’s net assets.

(9)Equity investments are non-income producing securities unless otherwise noted.

(10)This portfolio company is not domiciled in the United States. A portfolio company that is not domiciled in the United States is considered a non-qualifying asset under Section 55(a) of the 1940 Act. See Note 3 "Investments" for more information.

(11)Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 7 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

(12)Investments valued using observable inputs (Level 2), if applicable. See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

(13)The investment is considered as a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Fund's total assets. As of December 31, 2023, total non-qualifying assets at fair value represented 10.16% of the Fund's total assets calculated in accordance with the 1940 Act.

(14)Represents an investment held through an aggregator vehicle organized as a pooled investment vehicle.

89

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit		Cost		Fair Value		% of Net Assets (5)
Investments
Debt Investments
Automotive
Randys Holdings, Inc	(4) (6) (7)	First Lien Term Loan	S+ 6.50%	11.09	%	11/1/2028	$	3,996	$	3,918	$	3,919	1.51	%
Randys Holdings, Inc (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S+ 6.50%	11.09	%	11/1/2028	1,332		—		(26)		(0.01)	%
Total Automotive									3,918		3,893		1.50	%
Banking, Finance, Insurance, Real Estate
Patriot Growth Insurance Service (Delayed Draw) (Incremental)	(4) (6) (7) (11)	First Lien Term Loan	L+ 5.75%	10.52	%	10/14/2028	5,999		375		266		0.10	%
Total Banking, Finance, Insurance, Real Estate									375		266		0.10	%
Beverage, Food & Tobacco
Cold Spring Brewing Company	(4) (6)	First Lien Term Loan	S+ 4.75%	9.11	%	12/19/2025	6,805		6,805		6,804		2.61	%
Fortune International, LLC	(4) (6)	First Lien Term Loan	L+ 4.75%	9.52	%	1/17/2026	6,948		6,891		6,802		2.61	%
Fresh Edge	(4)	Subordinated Debt	S+ 9.00%	13.36	%	4/2/2029	2,890		2,820		2,820		1.08	%
Mr. Greens	(4)	Subordinated Debt	N/A	10.00% (Cash) 2.00% (PIK)		1/26/2026	10,153		9,807		10,153		3.90	%
Nonni's Foods, LLC	(4) (6)	First Lien Term Loan	L+ 5.00%	9.39	%	12/1/2023	6,963		6,958		6,915		2.66	%
SW Ingredients Holdings, LLC	(4)	Subordinated Debt	N/A	10.50% (Cash) 1.00% (PIK)		7/3/2026	10,076		10,076		9,521		3.67	%
Total Beverage, Food & Tobacco									43,357		43,015		16.53	%
Capital Equipment
GenServe LLC	(4) (6) (7)	First Lien Term Loan	S+ 5.25%	9.84	%	4/12/2024	6,947		6,891		6,937		2.66	%
Total Capital Equipment									6,891		6,937		2.66	%
Chemicals, Plastics, & Rubber
Spartech	(4) (6) (7)	First Lien Term Loan	L+ 4.75%	9.52	%	5/8/2028	3,970		3,970		3,863		1.48	%
SupplyOne, Inc.	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.50% (PIK)		2/1/2025	10,113		10,113		10,113		3.89	%
Total Chemicals, Plastics, & Rubber									14,083		13,976		5.37	%
Construction & Building
Gannett Fleming	(4) (6)	First Lien Term Loan	S+ 6.50%	11.09	%	12/20/2028	2,000		1,960		1,960		0.76	%
Hyphen Solutions, LLC	(4) (6) (7)	First Lien Term Loan	L+ 5.50%	9.89	%	10/27/2026	6,947		6,898		6,804		2.61	%
SPI LLC	(4) (6) (7)	First Lien Term Loan	S+ 5.00%	9.59	%	12/21/2027	6,948		6,855		6,804		2.61	%
Total Construction & Building									15,713		15,568		5.98	%

90

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit	Cost	Fair Value	% of Net Assets (5)
Consumer Goods: Durable
Freedom U.S. Acquisition Corporation	(4) (6)	First Lien Term Loan	L+ 4.50%	9.27	%	11/10/2023	7,000	7,000	6,955	2.67	%
NMC Skincare Intermediate Holdings II, LLC (Incremental)	(4) (6) (7)	First Lien Term Loan	L+ 5.00%	9.77	%	10/31/2024	6,946	6,849	6,672	2.56	%
Xpressmyself.com LLC (a/k/a SmartSign)	(4) (6)	First Lien Term Loan	S+ 5.00%	9.59	%	9/7/2028	2,045	2,026	2,026	0.78	%
Total Consumer Goods: Durable								15,875	15,653	6.01	%
Consumer Goods: Non-Durable
Accupac, Inc.	(4) (6) (7)	First Lien Term Loan	S+ 5.50%	10.09	%	1/14/2026	6,946	6,923	6,815	2.62	%
Elevation Labs	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	6/30/2028	1,315	1,303	1,301	0.50	%
Elevation Labs (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S+ 5.25%	9.84	%	6/30/2028	599	(3)	(6)	—	%
Image International Intermediate Holdco II, LLC (Incremental)	(4) (6) (7)	First Lien Term Loan	L+ 5.50%	10.27	%	7/10/2024	6,992	6,950	6,873	2.64	%
Revision Buyer LLC	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		12/1/2028	10,075	9,889	9,896	3.80	%
Ultima Health Holdings, LLC	(4)	Subordinated Debt	N/A	11.00% (Cash) 1.50% (PIK)		3/12/2029	1,306	1,282	1,278	0.49	%
Total Consumer Goods: Non-Durable								26,344	26,157	10.05	%
Containers, Packaging & Glass
New ILC Dover, Inc.	(4) (6) (7)	First Lien Term Loan	L+ 5.00%	9.77	%	1/31/2026	6,947	6,935	6,946	2.67	%
Oliver Packaging	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		1/6/2029	1,332	1,308	1,265	0.48	%
PG Buyer, LLC	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.50% (PIK)		9/2/2026	8,092	8,092	8,092	3.11	%
Total Containers, Packaging & Glass								16,335	16,303	6.26	%
Energy: Oil & Gas
AmSpec Group, Inc.	(4) (6) (7)	First Lien Term Loan	L+ 5.75%	10.52	%	7/2/2024	6,946	6,946	6,945	2.67	%
Dresser Utility Solutions, LLC	(4) (6)	First Lien Term Loan	L+ 4.25%	8.64	%	10/1/2025	3,473	3,473	3,473	1.33	%
Dresser Utility Solutions, LLC (Incremental)	(4) (6)	First Lien Term Loan	L+ 5.25%	9.64	%	10/1/2025	3,473	3,429	3,399	1.30	%
Marco APE Opco Holdings, LLC	(4)	Subordinated Debt	N/A	10.50% (Cash) 4.25% (PIK)		9/2/2026	8,633	8,103	7,458	2.87	%
Total Energy: Oil & Gas								21,951	21,275	8.17	%
Environmental Industries
North Haven Stack Buyer, LLC	(4) (6) (7)	First Lien Term Loan	S+ 5.50%	9.86	%	7/16/2027	6,947	6,918	6,845	2.63	%
Nutrition 101 Buyer LLC (a/k/a 101, Inc.)	(4) (6)	First Lien Term Loan	S+ 5.25%	9.61	%	8/31/2028	824	816	816	0.31	%
Total Environmental Industries								7,734	7,661	2.94	%
Healthcare & Pharmaceuticals
Heartland Veterinary Partners LLC (Incremental)	(4)	Subordinated Debt	S+ 7.50%	12.09	%	12/10/2027	1,000	982	980	0.38	%

91

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit	Cost	Fair Value		% of Net Assets (5)
Heartland Veterinary Partners LLC (Incremental) (Delayed Draw)	(4) (11)	Subordinated Debt	S+ 7.50%	12.09	%	12/10/2027	5,000	—	(100)		(0.04)	%
New You Bariatric Group, LLC	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	8/26/2024	6,946	6,946	6,838		2.63	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners)	(4) (6)	First Lien Term Loan	S+ 5.75%	10.34	%	10/5/2029	2,265	2,217	2,221		0.85	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S+ 5.75%	10.34	%	10/5/2029	735	—	(14)		(0.01)	%
Southern Veterinary Partners	(4) (6) (7)	First Lien Term Loan	S+ 5.50%	9.86	%	10/5/2027	3,085	3,026	3,022		1.16	%
US Radiology Specialists, Inc.	(6) (7) (12)	First Lien Term Loan	L+ 5.25%	10.02	%	12/15/2027	1,882	1,798	1,704		0.66	%
W2O Holdings, LLC	(4) (6)	First Lien Term Loan	L+ 4.75%	9.52	%	6/12/2025	6,947	6,947	6,905		2.65	%
Wellspring Pharmaceutical	(4) (6)	First Lien Term Loan	S+ 5.75%	10.53	%	8/22/2028	4,095	4,017	4,020		1.54	%
Wellspring Pharmaceutical (Delayed Draw)	(4) (11)	First Lien Term Loan	S+ 5.75%	10.53	%	8/22/2028	1,895	(14)	(35)		(0.01)	%
Total Healthcare & Pharmaceuticals								25,919	25,541	-	9.81	%
High Tech Industries
Infobase Acquisition, Inc.	(4) (6)	First Lien Term Loan	S+ 5.50%	10.09	%	6/14/2028	738	731	729		0.28	%
Infobase Acquisition, Inc. (Delayed Draw)	(4) (11)	First Lien Term Loan	S+ 5.50%	10.09	%	6/14/2028	122	—	(2)		0.00%
ITSavvy LLC	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	8/8/2028	1,793	1,776	1,793		0.69	%
ITSavvy LLC (Delayed Draw)	(4) (11)	First Lien Term Loan	S+ 5.25%	9.84	%	8/8/2028	480	(5)	—		0.00%
Specialist Resources Global Inc. (Delayed Draw)	(4) (6)	First Lien Term Loan	L+ 4.50%	8.89	%	9/23/2025	6,947	6,947	6,894		2.65	%
Total High Tech Industries								9,449	9,414		3.62	%
Media: Advertising, Printing & Publishing
Viking Target, LLC	(4) (6)	First Lien Term Loan	L+ 5.00%	9.77	%	8/9/2024	6,945	6,906	6,916		2.66	%
Total Media: Advertising, Printing & Publishing								6,906	6,916		2.66	%
Services: Business
BroadcastMed Holdco, LLC	(4)	Subordinated Debt	N/A	10.00% (Cash) 3.75% (PIK)		11/12/2027	2,649	2,597	2,598		1.00	%
Brown & Joseph, LLC	(4) (6)	First Lien Term Loan	S+ 5.75%	10.34	%	6/20/2024	6,945	6,896	6,920		2.66	%
Class Valuation	(4)	Subordinated Debt	N/A	11.00	%	9/30/2026	444	436	415		0.16	%
CrossCountry Consulting	(4) (6) (7)	First Lien Term Loan	S+ 5.75%	10.34	%	6/1/2029	1,393	1,367	1,376		0.53	%
CrossCountry Consulting (Delayed Draw)	(4) (7) (11)	First Lien Term Loan	S+ 5.75%	10.34	%	6/1/2029	560	(5)	(7)		—	%
CV Intermediate Holdco Corp.	(4)	Subordinated Debt	N/A	11.00	%	9/30/2026	10,000	9,848	9,333		3.59	%
Evergreen Services Group	(4) (6) (7)	First Lien Term Loan	S+ 6.00%	10.59	%	6/15/2029	4,068	3,991	3,971		1.52	%
Evergreen Services Group (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S+ 6.00%	10.59	%	6/15/2029	970	694	680		0.26	%
Kofile, Inc.	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.75% (PIK)		7/29/2026	10,128	10,128	9,987		3.84	%

92

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit	Cost	Fair Value	% of Net Assets (5)
Phaidon International	(4) (6) (10) (13)	First Lien Term Loan	S+ 5.50%	9.86	%	8/22/2029	7,000	6,932	6,916	2.66	%
Red Dawn SEI Buyer, Inc.	(4)	Subordinated Debt	L+ 8.25%	13.02	%	11/22/2026	6,650	6,650	6,650	2.54	%
Red Dawn SEI Buyer, Inc. (Incremental)	(4)	Subordinated Debt	L+ 8.50%	13.27	%	11/22/2026	3,350	3,350	3,350	1.29	%
Trilon Group, LLC	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	5/27/2029	2,993	2,964	2,881	1.11	%
Trilon Group, LLC	(4) (6)	First Lien Term Loan	S+ 6.25%	10.84	%	5/28/2029	600	594	593	0.23	%
Trilon Group, LLC (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S+ 6.25%	10.84	%	5/28/2029	400	37	32	0.01	%
Trilon Group, LLC (Delayed Draw)	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	5/27/2029	3,000	3,000	2,888	1.11	%
Total Services: Business								59,479	58,583	22.51	%
Services: Consumer
A Place for Mom, Inc.	(4) (6) (7)	First Lien Term Loan	S+ 4.50%	9.09	%	2/10/2026	6,936	6,936	6,657	2.56	%
ADPD Holdings, LLC (a/k/a NearU)	(4) (6) (7)	First Lien Term Loan	S+ 6.00%	10.59	%	8/16/2028	4,848	4,807	4,800	1.84	%
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S+ 6.00%	10.59	%	8/16/2028	1,000	—	(10)	—	%
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S+ 6.00%	10.59	%	8/16/2028	150	—	(1)	—	%
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S+ 6.00%	10.59	%	8/16/2028	1,000	—	(10)	—	%
Apex Services Partners, LLC (Incremental)	(4) (6) (7)	First Lien Term Loan	S+ 5.50%	10.09	%	7/31/2025	3,000	2,973	2,981	1.14	%
Apex Services Partners, LLC (Delayed Draw) (Incremental)	(4) (6) (7)	First Lien Term Loan	S+ 5.50%	10.09	%	7/31/2025	3,000	2,987	2,981	1.14	%
Excel Fitness	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	4/27/2029	5,985	5,920	5,690	2.19	%
Total Services: Consumer								23,623	23,088	8.87	%
Sovereign & Public Finance
LMI Consulting, LLC (LMI)	(4) (6)	First Lien Term Loan	S+ 6.50%	11.09	%	7/18/2028	742	728	718	0.28	%
LMI Consulting, LLC (LMI) (Incremental)	(4) (6)	First Lien Term Loan	S+ 6.50%	11.09	%	7/18/2028	2,985	2,889	2,889	1.11	%
Total Sovereign & Public Finance								3,617	3,607	1.39	%
Telecommunications
Arise Holdings Inc.	(4) (6)	First Lien Term Loan	S+ 4.25%	8.84	%	12/9/2025	6,946	6,894	6,720	2.58	%
Total Telecommunications								6,894	6,720	2.58	%
Transportation: Cargo
FSK Pallet Holding Corp. (DBA Kamps Pallets)	(4) (6)	First Lien Term Loan	L+ 5.00%	9.77	%	12/23/2026	5,985	5,870	5,869	2.25	%
Kenco Group, Inc.	(4) (6)	First Lien Term Loan	S+ 5.50%	10.09	%	11/15/2029	5,150	5,049	5,049	1.94	%
Kenco Group, Inc. (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S+ 5.50%	10.09	%	11/15/2029	850	(17)	(17)	(0.01)	%
Total Transportation: Cargo								10,902	10,901	4.18	%

93

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit	Cost	Fair Value	% of Net Assets (5)
Wholesale
AMC Buyer, LLC	(4) (6)	First Lien Term Loan	S+ 5.50%	10.09	%	11/2/2024	6,947	6,919	6,947	2.67	%
CDI AcquisitionCo, Inc.	(4) (6)	First Lien Term Loan	S+ 4.50%	9.28	%	12/24/2024	6,865	6,840	6,827	2.62	%
ISG Merger Sub, LLC (dba Industrial Service Group)	(4) (6)	First Lien Term Loan	S+ 6.25%	10.61	%	12/7/2028	2,479	2,429	2,429	0.93	%
ISG Merger Sub, LLC (dba Industrial Service Group) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S+ 6.25%	10.61	%	12/7/2028	1,282	(6)	(25)	(0.01)	%
New Era Technology, Inc	(4) (6) (7)	First Lien Term Loan	L+ 6.25%	11.02	%	10/31/2026	6,947	6,919	6,650	2.56	%
Solaray, LLC	(4) (6) (7)	First Lien Term Loan	S+ 5.75%	10.34	%	9/9/2023	6,963	6,955	6,878	2.64	%
Total Wholesale								30,056	29,706	11.41	%
Total Debt Investments								349,421	345,180	132.60	%
Equity Investments
Beverage, Food & Tobacco
Fresh Edge	(4) (8) (9)	Class A Preferred Units	N/A	—	%	N/A	—	454	454	0.17	%
Fresh Edge	(4) (8) (9)	Class B Common Units	N/A	—	%	N/A	—	—	—	—	%
Mr. Greens	(4) (8) (9)	Limited Partnership Interests	N/A	—	%	N/A	1	101	276	0.11	%
Spice World	(4) (8) (9)	LLC Common Units	N/A	—	%	N/A	1	126	101	0.04	%
Total Beverage, Food & Tobacco								681	831	0.32	%
Chemicals, Plastics & Rubber
SupplyOne, Inc.	(4) (8) (9)	LLC Common Units	N/A	—	%	N/A	1	504	980	0.38	%
Total Chemicals, Plastics & Rubber								504	980	0.38	%
Construction & Building
Gannett Fleming	(4) (8) (9)	Limited Partnership Interests	N/A	—	%	N/A	85	85	85	0.03	%
Trench Plate Rental Co.	(4) (8) (9)	Common Equity	N/A	—	%	N/A	1	127	134	0.05	%
Total Construction & Building								212	219	0.08	%
Consumer Goods: Non-Durable
RVGD Aggregator LP (Revision Skincare)	(4) (8) (9)	Limited Partnership Interests	N/A	—	%	N/A	—	98	133	0.05	%
Ultima Health Holdings, LLC	(4) (8) (9)	Preferred Units	N/A	—	%	N/A	—	130	130	0.05	%
Total Consumer Goods: Non-Durable								228	263	0.10	%
Containers, Packaging & Glass
Oliver Packaging	(4) (8) (9)	Class A Common Units	N/A	—	%	N/A	6	610	639	0.25	%

94

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit	Cost		Fair Value		% of Net Assets (5)
PG Aggregator, LLC	(4) (8) (9)	LLC Units	N/A	—	%	N/A	—	109		135		0.05	%
Total Containers, Packaging & Glass								719		774		0.30	%
High Tech Industries
ITSavvy LLC	(4) (8) (9)	Class A Common Units	N/A	—	%	N/A	—	119		158		0.06	%
Total High Tech Industries								119		158		0.06	%
Services: Business
BroadcastMed Holdco, LLC	(4) (8) (9)	Series A-3 Preferred Units	N/A	—	%	N/A	44	655		655		0.25	%
CV Holdco, LLC	(4) (8) (9)	Class A Common Units	N/A	—	%	N/A	1	102		49		0.02	%
Kofile, Inc.	(4) (8) (9)	Class A-2 Common Units	N/A	—	%	N/A	—	108		78		0.03	%
Total Services: Business								865		782		0.30	%
Services: Consumer
ADPD Holdings, LLC (a/k/a NearU)	(4) (8) (9)	Limited Partnership Interests	N/A	—	%	N/A	1	142		151		0.06	%
Total Services: Consumer								142		151		0.06	%
Sovereign & Public Finance
LMI Renaissance	(4) (8) (9)	Limited Partnership Interests	N/A	—	%	N/A	107	107		180		0.07	%
Total Sovereign & Public Finance								107		180		0.07	%
Total Equity Investments								3,577		4,338		1.67	%
Total Investments								$	352,998	$	349,518	134.27	%

____________________

(1)All investments are non-controlled/non-affiliated investments as defined by the Investment Company Act of 1940, as amended (the "1940 Act"). The 1940 Act classifies investments based on the level of control that the Fund maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally presumed to be “non-controlled” when the Fund owns 25% or less of the portfolio company’s voting securities and “controlled” when the Fund owns more than 25% of the portfolio company’s voting securities. The 1940 Act also classifies investments further based on the level of ownership that the Fund maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally deemed as “non-affiliated” when the Fund owns less than 5% of a portfolio company’s voting securities and “affiliated” when the Fund owns 5% or more of a portfolio company’s voting securities.

(2)Unless otherwise indicated, issuers of debt and equity held by the Fund are domiciled in the United States.

(3)The majority of the investments bear interest at rates that may be determined by reference to London Interbank Offered Rate (“LIBOR” or "L"), as well as Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Fund has provided the spread over LIBOR and SOFR and the current contractual interest rate in effect at December 31, 2022. As of December 31, 2022, effective rates for 1M L and 3M L are 4.39% and 4.77%, respectively. As of December 31, 2022, effective rates for 1M S, 3M S and 6M S are 4.36%, 4.59% and 4.78%, respectively. For portfolio companies with multiple interest rate contracts, the interest rate shown is a weighted average current interest rate in effect as of December 31, 2022. Certain investments are subject to a LIBOR or SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

(4)Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies - Valuation of Portfolio Investments” for more information.

(5)Percentage is based on net assets of $260,301 as of December 31, 2022.

95

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

(6)Denotes that all or a portion of the assets are owned by SPV I (as defined in Note 1 “Organization”). SPV I entered into a senior secured revolving credit facility (the “Bank of America Credit Facility”) on April 19, 2022. The lenders of the Bank of America Credit Facility have a first lien security interest in substantially all of the assets of SPV I. Accordingly, such assets are not available to creditors of the Fund. See Note 6 “Secured Borrowings”.

(7)Investment is a unitranche position.

(8)Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of December 31, 2022, the Fund held seventeen restricted securities with an aggregate fair value of $4,338, or 1.7% of the Fund’s net assets. The acquisition dates of these securities were as follows: CV Holdco, LLC - March 31, 2022, Kofile, Inc. - March 31, 2022, Mr. Greens - March 31, 2022, PG Aggregator, LLC - March 31, 2022, RVGD Aggregator LP (Revision Skincare) - March 31, 2022. Spice World - March 31, 2022, Supply One - March 31, 2022, Trench Plate Rental Co. - March 31, 2022, LMI Renaissance - June 30, 2022, Oliver Packaging - July 6, 2022, ITSavvy LLC- August 8, 2022, ADPD Holdings, LLC (a/k/a NearU) - August 11, 2022 and Ultima Health Holdings, LLC - September 12, 2022, Fresh Edge Class A and Fresh Edge Class B - October 3, 2022, BroadcastMed Holdco, LLC - October 4, 2022 and Gannett Fleming - December 20, 2022.

(9)Equity investments are non-income producing securities unless otherwise noted.

(10)This portfolio company is not domiciled in the United States. The principal place of business for Phaidon International is the United Kingdom. A portfolio company that is not domiciled in the United States is considered a non-qualifying asset under Section 55(a) of the 1940 Act.

(11)Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 7 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

(12)Investments valued using observable inputs (Level 2). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

(13)The investment is considered as a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Fund's total assets. As of December 31, 2022, total non-qualifying assets at fair value represented 1.64% of the Fund's total assets calculated in accordance with the 1940 Act.

96

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

1. ORGANIZATION

Nuveen Churchill Private Capital Income Fund (“PCAP”, and together with its consolidated subsidiaries, the “Fund”) is a Delaware statutory trust formed on February 8, 2022. PCAP is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Fund is externally managed by its adviser, Churchill Asset Management LLC (the “Adviser” or “Churchill”). Churchill is an indirect subsidiary of Nuveen, LLC (“Nuveen”), the investment management division of TIAA (as defined below). Churchill has engaged its affiliate, Nuveen Asset Management, LLC (“Nuveen Asset Management” or the “Sub-Adviser”), acting through its leveraged finance division, to manage certain of its Liquid Investments (defined below) pursuant to an investment sub-advisory agreement between the Adviser and Nuveen Asset Management (as discussed further in Note 5). The Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) as defined under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

The Fund’s investment objective is to generate attractive risk-adjusted returns primarily through current income and, secondarily, long-term capital appreciation, by investing in a diversified portfolio of private debt and equity investments in U.S. middle market companies owned by leading private equity firms, which the Fund defines as companies with approximately $10 million to $250 million of earnings before interest, taxes, depreciation and amortization (“EBITDA”). The Fund primarily focuses on investing in U.S. middle market companies with $10 to $100 million in EBITDA, which the Fund considers the core middle market. The Fund primarily invests in first-lien senior secured debt and first-out positions in unitranche loans (collectively “Senior Loan Investments”), as well as junior debt investments, such as second-lien loans, unsecured debt, subordinated debt and last-out positions in unitranche loans (including fixed- and floating-rate instruments and instruments with payment-in-kind income) (“Junior Capital Investments”). Senior Loan Investments and Junior Capital Investments may be originated alongside smaller related common equity positions to the same portfolio companies. The portfolio also will include larger, stand-alone direct equity co-investments in private-equity backed companies that may or may not be originated alongside or separately from Senior Loan Investments and/or Junior Capital Investments to the applicable portfolio company (“Equity Co-Investments”). We target an investment portfolio consisting, directly or indirectly, of 75% to 90% in Senior Loan Investments, 5% to 25% in Junior Capital Investments and up to 10% in Equity Co-Investments. To support the Fund’s share repurchase program (as discussed further in Note 8), the Fund also will invest 5% to 10% of its assets in cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments (“Liquid Investments”).

The Fund was established by Teachers Insurance and Annuity Association of America (“TIAA”), the ultimate parent of Churchill and Nuveen, and operated as a wholly owned subsidiary of TIAA until the Escrow Break Date (as defined below). On March 30, 2022, TIAA purchased 40 shares of the Fund’s Class I shares at $25.00 per share.

On March 31, 2022, prior to the Fund’s election to be regulated as a BDC under the 1940 Act, TIAA contributed certain portfolio investments to the Fund in the amount of $296,231 (fair value as of March 31, 2022). In addition, on March 31, 2022, the Fund entered into a promissory note with TIAA (the “Note”) as the lender. The principal amount of the Note equaled (i) the fair value of portfolio investments contributed as of March 31, 2022, minus (ii) $263,500 (as discussed further in Note 5). In connection therewith, the Fund issued to TIAA 10,540,000 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share. On June 3, 2022, the Fund fully repaid the balance on the Note to TIAA which was comprised of $32,731 and $226 of principal and interest, respectively.

NCPIF SPV I LLC (“SPV I”) and NCPIF Equity Holdings LLC (“Equity Holdings”) was formed on February 25, 2022 and April 1, 2022, respectively. Each of SPV I and Equity Holdings is a wholly owned subsidiary of the Fund and is consolidated in these consolidated financial statements commencing from the date of its formation. SPV I commenced operations on March 31, 2022, upon receipt of contribution of portfolio investments from TIAA to the Fund (as discussed further in Note 8). Equity Holdings commenced from the date of its formation.

The Fund is offering on a continuous basis up to $2.5 billion of any combination of three classes of common shares of beneficial interest (“Common Shares”), Class S shares, Class D shares and Class I shares. On May 17, 2022, the Securities and Exchange Commission (the “SEC”) granted an exemptive order permitting the Fund to offer multiple classes of Common Shares and to impose varying sales loads, asset-based service and/or distribution fees and early withdrawal fees. The share classes have different ongoing shareholder servicing and/or distribution fees. None of the share classes being offered will have early withdrawal fees. The purchase price per share for each class of Common Shares will equal the Fund’s net asset value (“NAV”) per share as of the effective date of the monthly share purchase date. Nuveen Securities, LLC (the “Intermediary Manager”) will use its best efforts to sell Common Shares, but is not obligated to purchase or sell any specific amount of Common Shares in the offering. As of June 1, 2023 (the “Escrow Break Date”), the Fund had satisfied the minimum offering requirement and the Fund’s Board of Trustees (the “Board”) authorized the release of proceeds from escrow.

97

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

2. SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Fund is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the period presented, have been included. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value unless otherwise disclosed within.

Consolidation

As provided under ASC 946, the Fund will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Fund. Accordingly, the consolidated financial statements include the accounts of the Fund and its wholly owned subsidiaries, SPV I and Equity Holdings. All significant intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Fund to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash, Restricted Cash and Cash Equivalents

Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value. As of December 31, 2023, the Fund did not hold any restricted cash.

Valuation of Portfolio Investments

Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”) and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value.

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

•Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

•Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

•Level 3 — Valuations are based on inputs that are unobservable and significant to the overall fair value measurement.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.

98

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price.

Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Fund’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs.

Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Fund's valuation designee (the “Valuation Designee”) to determine the fair value of the Fund's investments that do not have readily available market quotations, effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Fund's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Fund's assets for which market quotations are not readily available, subject to the oversight of the Board.

With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, undertakes a multi-step valuation process each quarter, as follows:

i.the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm;

ii.to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Board to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Fund will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value;

iii.the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Fund’s valuation policy, subject to the oversight of the Board; and

iv.the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Fund's valuation policy in connection with each quarterly Board meeting and discuss with the Board its determination of the fair value of each investment in good faith.

The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company’s credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are disclosed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources.

When determining NAV as of the last day of a month that is not also the last day of a calendar quarter, the Adviser updates the value of securities with “readily available market quotations” (as defined in Rule 2a-5 under the 1940 Act) to the most recent market quotation. For securities without readily available market quotations, the Adviser generally values such assets at the most recent quarterly valuation unless the Adviser determines that a significant observable change has occurred since the most recent quarter end with respect to the investment (which determination may be as a result of a material event at a portfolio company, material change in market spreads, secondary market transaction in the securities of an investment or otherwise). If the Adviser determines such a change has occurred with respect to one or more investments, the Adviser will determine whether to update the value for each relevant investment.

99

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such values do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material.

The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Fund’s assets for which market quotations are not readily available, taking into account the Fund’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Fund's investments.

Investment Transactions and Revenue Recognition

Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains or losses are measured by the difference between the net proceeds received and the amortized cost basis of the investment using the specific identification method without regard to unrealized appreciation or depreciation previously recognized and are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.

Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Fund accrues interest income if it expects that ultimately it will be able to collect such income.

The Fund may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. If at any point the Fund believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Fund to maintain its tax treatment as a RIC, even though the Fund has not yet collected cash. As of December 31, 2023 and December 31, 2022, the fair value of the loans in the portfolio with PIK income provisions was $76,082 and $70,361, respectively, which represents approximately 14.86% and 20.13% of total investments at fair value, respectively. For the year ended December 31, 2023 and the period from February 8, 2022 (inception) through December 31, 2022 the Fund earned $2,333 and $1,275, respectively, in PIK income. As of December 31, 2023 and December 31, 2022, there were no PIK loans in the Fund's portfolio on non-accrual status.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio companies and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the year ended December 31, 2023, the Fund earned $123 in dividend income. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund did not earn any dividend income on its equity investments.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Fund’s investment activities, as well as any fees for managerial assistance services rendered by the Fund to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the year ended December 31, 2023, the Fund earned other income of $178 primarily related to amendment fees. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund earned other income of $504, primarily related to prepayment and amendment fees.

Loans are generally placed on non-accrual status when a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Fund will cease recognizing interest income on that loan until all principal and interest is current through payment, or until a restructuring occurs such that the interest income is deemed to be collectible. However, the Fund remains contractually entitled to this interest. The Fund may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. As of December 31, 2023 and December 31, 2022, there were no loans in the Fund's portfolio on non-accrual status.

100

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

Deferred Financing Costs

Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities.

Allocation of Income, Expenses, Gains and Losses

Income, expenses (other than those attributable to a specific class), gains and losses are allocated to each class of shares based upon the relative proportion of net assets represented by such class. Operating expenses attributable to a specific class are charged against the operations of that class.

Organization and Offering Costs

Organization costs consist of primarily legal, incorporation and accounting fees incurred in connection with the organization of the Fund. Organization costs are expensed as incurred and are shown in the Fund's consolidated statements of operations. Refer to Note 5 for further details on the Expense Support Agreement.

Offering costs consist primarily of fees and expenses incurred in connection with the offering of Common Shares, as well as legal, printing and other costs associated with the preparation and filing of the registration statements and offering materials. Offering costs are recognized as a deferred charge, amortized on a straight-line basis over 12 months and are shown in the Fund's consolidated statements of operations. For the year ended December 31, 2023, offering costs of $775, were incurred, and $659, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. For the period February 8, 2022 (inception) through December 31, 2022, offering costs of $484, were incurred, and $228, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. Refer to Note 5 for further details on the Expense Support Agreement.

Income Taxes

For U.S. federal income tax purposes, the Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. In order to qualify as a RIC, the Fund must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Fund is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Fund to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Fund may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

In addition, based on the excise distribution requirements, the Fund is subject to a 4% nondeductible U.S. federal excise tax on undistributed income unless the Fund distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Fund that is subject to U.S. federal income tax is considered to have been distributed. The Fund intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Fund may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax.

The Fund evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. SPV I is a disregarded entity for tax purposes and will be consolidated with the tax return of the Fund. Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the year ended December 31, 2023, the Fund incurred $31 in excise tax expense. For the period February 8, 2022 (inception) through December 31, 2022, the Fund incurred $2 in excise tax expense.

101

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

Dividends and Distributions to Common Shareholders

The Fund has declared distributions each month beginning in September 2022 through the date of this Annual Report on Form 10-K, and expects to continue to pay regular monthly distributions to the extent the Fund has taxable income available. Distributions to shareholders are recorded on the record date. The amount to be distributed to shareholders is determined by the Board and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Fund may decide to retain such capital gains for investment. Although the gross distribution per share is generally equivalent for each share class, the net distribution for each share class is reduced for any class specific expenses, including distribution and shareholder servicing fees, if any.

Functional Currency

The functional currency of the Fund is the U.S. Dollar and all transactions were in U.S. Dollars.

102

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

3. INVESTMENTS

The composition of the Fund’s investment portfolio at cost and fair value was as follows:

	December 31, 2023						December 31, 2022
	Amortized Cost		Fair Value		% of Fair Value		Amortized Cost		Fair Value		% of Fair Value
First-Lien Term Loans	$	402,858	$	399,882	78.10	%	$	253,940	$	251,371	71.92	%
Subordinated Debt (1)	103,888		101,930		19.90	%	95,481		93,809		26.84	%
Equity Investments	9,422		10,224		2.00	%	3,577		4,338		1.24	%
Total	$	516,168	$	512,036	100.00	%	$	352,998	$	349,518	100.00	%
Largest portfolio company investment	$	10,731	$	10,986	2.15	%	$	10,617	$	11,093	3.17	%
Average portfolio company investment	$	3,246	$	3,220	0.63	%	$	5,516	$	5,461	1.56	%

_______________

(1)As of December 31, 2023, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $52,170 and mezzanine debt of $49,760 at fair value, and second lien term loans and/or second lien notes of $53,365 and mezzanine debt of $50,523 at amortized cost. As of December 31, 2022, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903 at fair value, and second lien term loans and/or second lien notes of $32,189 and mezzanine debt of $63,292 at amortized cost.

The industry composition of our portfolio as a percentage of fair value as of December 31, 2023 and December 31, 2022 was as follows:

Industry	December 31, 2023		December 31, 2022
Aerospace & Defense	2.07	%	—	%
Automotive	1.10	%	1.11	%
Banking, Finance, Insurance, Real Estate	1.49	%	0.08	%
Beverage, Food & Tobacco	10.39	%	12.54	%
Capital Equipment	4.28	%	1.98	%
Chemicals, Plastics & Rubber	3.80	%	4.28	%
Construction & Building	4.78	%	4.52	%
Consumer Goods: Durable	3.76	%	4.48	%
Consumer Goods: Non-durable	5.97	%	7.56	%
Containers, Packaging & Glass	3.49	%	4.89	%
Energy: Electricity	0.43	%	—	%
Energy: Oil & Gas	3.08	%	6.09	%
Environmental Industries	3.04	%	2.19	%
Healthcare & Pharmaceuticals	10.08	%	7.31	%
High Tech Industries	4.81	%	2.74	%
Hotel, Gaming & Leisure	0.44	%	—	%
Media: Advertising, Printing & Publishing	1.33	%	1.98	%
Media: Broadcasting & Subscription	0.80	%	—	%
Metals and Mining	0.10	%	—	%
Services: Business	16.82	%	16.98	%
Services: Consumer	5.73	%	6.65	%
Sovereign & Public Finance	0.77	%	1.08	%
Telecommunications	2.33	%	1.92	%
Transportation: Cargo	2.32	%	3.12	%
Transportation: Consumer	0.78	%	—	%
Utilities: Electric	0.51	%	—	%
Wholesale	5.50	%	8.50	%
Total	100.00	%	100.00	%

103

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

The geographic composition of investments at cost and fair value was as follows:

	December 31, 2023
	Cost		Fair Value		% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	$	496,774	$	492,518	96.19	%	138.80	%
Canada	6,374		6,376		1.25	%	1.80	%
United Kingdom	9,045		9,139		1.78	%	2.58	%
Ireland	1,741		1,750		0.34	%	0.49	%
Luxembourg	1,255		1,255		0.25	%	0.35	%
Netherlands	979		998		0.19	%	0.28	%
	$	516,168	$	512,036	100.00	%	144.30	%

	December 31, 2022
	Cost		Fair Value		% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	$	346,066	$	342,602	98.02	%	131.62	%
United Kingdom	6,932		6,916		1.98	%	2.66	%
	$	352,998	$	349,518	100.00	%	134.28	%

As of December 31, 2023 and December 31, 2022, on a fair value basis, 84.74% and 76.79%, respectively, of the Fund’s debt investments bore interest at a floating rate and 15.26% and 23.21%, respectively, of the Fund’s debt investments bore interest at a fixed rate.

104

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

4. FAIR VALUE MEASUREMENTS

Fair Value Disclosures

The following table presents fair value measurements of investments, by major class as of December 31, 2023 and December 31, 2022, according to the fair value hierarchy:

As of December 31, 2023	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	45,486	$	354,396	$	399,882
Subordinated Debt (1)	—		—		101,930		101,930
Equity Investments	—		—		10,224		10,224
Cash Equivalents	7,590		—		—		7,590
Total	$	7,590	$	45,486	$	466,550	$	519,626

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $52,170 and mezzanine debt of $49,760.

As of December 31, 2022	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	1,704	$	249,667	$	251,371
Subordinated Debt (1)	—		—		93,809		93,809
Equity Investments	—		—		4,338		4,338
Total	$	—	$	1,704	$	347,814	$	349,518

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903.

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2022	$	249,667	$	93,809	$	4,338	$	347,814
Purchase of investments	137,949		15,956		5,948		159,853
Proceeds from principal repayments and sales of investments	(35,224)		(10,216)		(392)		(45,832)
Payment-in-kind interest	71		2,117		—		2,188
Amortization of premium/accretion of discount, net	577		242		—		819
Net realized gain (loss) on investments	174		311		291		776
Net change in unrealized appreciation (depreciation) on investments	(522)		(289)		39		(772)
Transfers to Level 3 (1)	1,704		—		—		1,704
Balance as of December 31, 2023	$	354,396	$	101,930	$	10,224	$	466,550
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of December 31, 2023	$	(475)	$	36	$	215	$	(224)

________________

(1) Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the year ended December 31, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for one portfolio company.

105

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of February 8, 2022 (inception)	$	—	$	—	$	—	$	—
Purchase of investments	271,109		113,294		3,575		387,978
Proceeds from principal repayments and sales of investments	(19,207)		(19,000)		—		(38,207)
Payment-in-kind interest	—		1,275		—		1,275
Amortization of premium/accretion of discount, net	310		191		—		501
Net realized gain (loss) on investments	(66)		(281)		—		(347)
Net change in unrealized appreciation (depreciation) on investments	(2,479)		(1,670)		763		(3,386)
Balance as of December 31, 2022	$	249,667	$	93,809	$	4,338	$	347,814
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of December 31, 2022	$	(2,479)	$	(1,670)	$	763	$	(3,386)

Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the period from February 8, 2022 (inception) through December 31, 2022, there were no transfers into or out of Level 3.

Significant Unobservable Inputs

ASC Topic 820 requires disclosure of quantitative information about the significant unobservable inputs used in the valuation of assets and liabilities classified as Level 3 within the fair value hierarchy. The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of December 31, 2023 and December 31, 2022 were as follows:

Investment Type	Fair Value at December 31, 2023		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	282,615	Yield Method	Implied Discount Rate	6.13	%	16.48	%	10.88	%
First Lien Term Loans	68,615		Recent Transaction	Transaction Price	97.83		100.13		98.87
First Lien Term Loans	3,166		Market Approach	EBITDA Multiple	7.50		7.50		7.50
Subordinated Debt	100,086		Yield Method	Implied Discount Rate	11.57	%	20.63	%	13.96	%
Subordinated Debt	1,844		Recent Transaction	Transaction Price	98.01		98.01		98.01
Equity Investments	8,779		Market Approach	EBITDA Multiple	8.50		19.50		11.49
Equity Investments	57		Market Approach	EBITDA Multiple	9.00		9.00		9.00
			Market Approach	ARR Multiple	3.50		3.50		3.50
Equity Investments	528		Yield Method	Implied Discount Rate	8.36	%	15.16	%	8.35	%
Total	$	465,690

Equity investments in the amount of $860 at December 31, 2023 have been excluded from the table above as the investments are valued using recent transaction price.

Investment Type	Fair Value at December 31, 2022		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	228,304	Yield Method	Implied Discount Rate	8.98	%	13.37	%	10.63	%
First Lien Term Loans	21,363		Recent Transaction	Transaction Price	98.01		98.08		98.05
Subordinated Debt	88,391		Yield Method	Implied Discount Rate	8.88	%	17.94	%	13.39	%
Subordinated Debt	5,418		Recent Transaction	Transaction Price	97.58		98.08		97.82
Equity Investments	3,144		Enterprise Value	EBITDA Multiple	9.25x		13.50x		10.93x
Total	$	346,620

Equity investments in the amount of $1,194 at December 31, 2022 have been excluded from the table above as the investments are valued using recent transaction price.

106

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

Debt investments are generally valued using a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to the expected life, portfolio company performance since close, and other terms and risks associated with an investment. Among other factors, a determinant of risk is the amount of leverage used by the portfolio company relative to its total enterprise value, and the rights and remedies of the Fund’s investment within the portfolio company’s capital structure. A recent market trade, if applicable, will also be factored into the valuation.

Equity investments are generally valued using a market approach, which utilizes market value multiples (EBITDA or revenue) of publicly traded comparable companies and available precedent sales transactions of comparable companies. The selected multiple is used to estimate the enterprise value of the underlying investment.

The significant unobservable input used in the yield method is a discount rate based on comparable market yields. Significant increases in discount rates in isolation would result in a significantly lower fair value measurement. The significant unobservable input used in the market approach is the performance multiple, which may include a revenue multiple, EBITDA multiple, or forward-looking metrics. The multiple is used to estimate the enterprise value of the underlying investment. An increase or decrease in the multiple would result in an increase or decrease, respectively, in the fair value. A recent transaction, if applicable, may also be factored into the valuation if the transaction price is believed to be an indicator of value.

Alternative valuation methodologies may be used as deemed appropriate for debt or equity investments, and may include, but are not limited to, a market analysis, income analysis, or liquidation (recovery) analysis.

Weighted average inputs are calculated based on the relative fair value of the investments.

5. RELATED PARTY TRANSACTIONS

Advisory Agreement

On March 31, 2022, the Fund entered into the Advisory Agreement. The Board, including all of the trustees who are not “interested persons” (as defined under Section 2(a)(19) of the 1940 Act) of the Fund (the “Independent Trustees”), approved the Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such trustees as required by the 1940 Act. On August 3, 2022, the Board, including all of the Independent Trustees, approved Amendment No. 1 to the Advisory Agreement (the “Advisory Agreement Amendment”), which became effective immediately. The Advisory Agreement Amendment was entered into solely to extend the notice requirement for the Adviser to terminate the Advisory Agreement from 60 days to 120 days (as described below).

On January 10, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 2 (the “Second Advisory Agreement Amendment”) to the Investment Advisory Agreement, which became effective immediately. The Fund and the Adviser entered into the Second Advisory Agreement Amendment as a result of comments issued by securities regulators from various states in connection with their “blue sky” review of the Fund’s offering. The Second Advisory Agreement Amendment, among other things: (1) removed sunset provisions contingent upon recognition of the Common Shares as “covered securities”; (2) removed provisions entitling the Adviser to amounts owed under Sections 3 or Section 7 of the Advisory Agreement following a notice of termination of the Advisory Agreement; (3) specifies the conditions under which the Adviser may sell all or substantially all of the Fund’s assets; and (4) revised provisions to reflect conflicts of interest provisions set forth in the NASAA Omnibus Guidelines Statement of Policy adopted on March 29, 1992 and as amended on May 7, 2007 and from time to time (the “Omnibus Guidelines”).

On August 2, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 3 (the “Third Advisory Agreement Amendment”) to the Advisory Agreement, which became effective immediately. The Fund and the Adviser entered into Third Advisory Agreement Amendment as a result of comments issued by state securities regulators in connection with their “blue sky” review of the Fund’s offering, and reflects specific language in the Omnibus Guidelines required by a state securities regulator.

Unless terminated earlier as described below, the Advisory Agreement will remain in effect for a period of two years from March 31, 2022 and will remain in effect from year-to-year thereafter if approved annually by the Board or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of the Independent Trustees. The Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the Adviser and may be terminated by the Adviser without penalty upon not less than 120 days’ written notice to the Fund or by the Fund without penalty upon not less than 60 days’ written notice to the Adviser. The holders of a majority of the outstanding voting securities may also terminate either of the Advisory Agreement without penalty.

107

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

Base Management Fee

The management fee is payable monthly in arrears at an annual rate of 0.75% of the value of the Fund’s net assets as of the beginning of the first calendar day of the applicable month. For the first calendar month in which the Fund has operations, net assets will be measured using the beginning net assets as of the Escrow Break Date. In addition, the Adviser has agreed to waive its management fee until June 1, 2024, the expiry of twelve months from the Escrow Break Date.

For the year ended December 31, 2023, base management fees earned were $1,292, all of which were voluntarily waived by the Adviser. As of December 31, 2023, no amounts were payable to the Adviser related to management fees. For the the period from February 8, 2022 (inception) through December 31, 2022, no management fees were earned.

Incentive Fee

The incentive fee consists of two components that are independent of each other, with the result that one component may be payable even if the other is not: (i) incentive fee on income and (ii) an incentive fee on capital gains. Each part of the incentive fee is outlined below.

Incentive Fee Based on Income

The portion based on income is based on Pre-Incentive Fee Net Investment Income Returns. “Pre-Incentive Fee Net Investment Income Returns” means, as the context requires, either the dollar value of, or percentage rate of return on the value of net assets at the end of the immediate preceding quarter from, interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Fund receives from portfolio companies) accrued during the calendar quarter, minus our operating expenses accrued for the quarter (including the management fee, expenses payable under the Administration Agreement, and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred shares, but excluding the incentive fee and any shareholder servicing and/or distribution fees).

Pre-Incentive Fee Net Investment Income Returns include, in the case of investments with a deferred interest feature (such as OID, debt instruments with PIK interest and zero coupon securities), accrued income that has not yet been received in cash. Pre-Incentive Fee Net Investment Income Returns do not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The impact of expense support payments and recoupments (as discussed further below) are also excluded from Pre-Incentive Fee Net Investment Income Returns.

Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of the Fund’s net assets at the end of the immediate preceding quarter, is compared to a “hurdle rate” of return of 1.50% per quarter (6% annualized).

The Fund will pay the Adviser an incentive fee quarterly in arrears with respect to Pre-Incentive Fee Net Investment Income Returns in each calendar quarter as follows:

•No incentive fee based on Pre-Incentive Fee Net Investment Income Returns in any calendar quarter in which our Pre-Incentive Fee Net Investment Income Returns do not exceed the hurdle rate of 1.50% per quarter (6% annualized);

•100% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns with respect to that portion of such Pre-Incentive Fee Net Investment Income Returns, if any, that exceeds the hurdle rate but is less than a rate of return of 1.76% (7.06% annualized). The Fund refers to this portion of Pre-Incentive Fee Net Investment Income Returns (which exceeds the hurdle rate but is less than 1.76%) as the “catch-up.” The “catch-up” is meant to provide the Adviser with approximately 15% of our Pre-Incentive Fee Net Investment Income Returns as if a hurdle rate did not apply if this net investment income exceeds 1.76% in any calendar quarter; and

•15% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns, if any, that exceed a rate of return of 1.76% (7.06% annualized). This reflects that once the hurdle rate is reached and the catch-up is achieved, 15% of all Pre-Incentive Fee Net Investment Income Returns thereafter are allocated to the Adviser.

These calculations will be pro-rated for any period of less than three months and adjusted for any share issuances or repurchases during the relevant quarter.

The Adviser has agreed to waive the incentive fee based on income until June 1, 2024, the expiry of twelve months from the Escrow Break Date. For the year ended December 31, 2023, income based incentive fees were $3,108, which were voluntarily waived by the Adviser. As of December 31, 2023, no amounts were payable to the Adviser related to income based incentive fees. For the period from February 8, 2022 (inception) through December 31, 2022, no income based incentive fees were earned.

108

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

Incentive Fee Based on Capital Gains

The second component of the incentive fee, the capital gains incentive fee, will be payable at the end of each calendar year in arrears. The amount payable will equal:

•15% of cumulative realized capital gains from inception through the end of such calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid incentive fee on capital gains as calculated in accordance with U.S. GAAP.

Each year, the fee paid for the capital gains incentive fee will be net of the aggregate amount of any previously paid capital gains incentive fee for all prior periods. The Fund will accrue, but will not pay, a capital gains incentive fee with respect to unrealized appreciation because a capital gains incentive fee would be owed to the Adviser if the Fund was to sell the relevant investment and realize a capital gain. In no event will the capital gains incentive fee payable pursuant to the Advisory Agreement be in excess of the amount permitted by the Advisers Act, including Section 205 thereof.

The fees that are payable under the Advisory Agreement for any partial period will be appropriately prorated. For the year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022, the Fund did not incur any incentive fee based on capital gains.

Sub-Advisory Agreement

On March 31, 2022, the Adviser entered into the Investment Sub-Advisory Agreement with the Sub-Adviser (the “Sub-Advisory Agreement”). The Board, including all of the Independent Trustees, also approved the Sub-Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such trustees as required by the 1940 Act. The Sub-Adviser manages certain of the Liquid Investments pursuant to the Sub-Advisory Agreement. The Adviser has general oversight over the investment process on behalf of the Fund and manages the capital structure of the Fund, including, but not limited to, asset and liability management. The Adviser also has ultimate responsibility for the Fund’s performance under the terms of the Investment Advisory Agreement. The Adviser will pay the Sub-Adviser monthly in arrears, 0.375% of the daily weighted average principal amount of the Liquid Investments managed by the Sub-Adviser pursuant to the Sub-Advisory Agreement.

On August 3, 2022, the Board, including all of the Independent Trustees, approved Amendment No. 1 to the Sub-Advisory Agreement (the “Sub-Advisory Agreement Amendment”), which became effective immediately. The Sub-Advisory Agreement Amendment was entered into solely to extend the notice requirement applicable to both the Adviser and the Sub-Adviser to terminate the Sub-Advisory Agreement from 60 days to 120 days (as described below).

Unless terminated earlier as described below, the Sub-Advisory Agreement will remain in effect for a period of two years from March 31, 2022 and will remain in effect from year-to-year thereafter if approved annually by the Board or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of the Independent Trustees. The Sub-Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the Adviser and may be terminated by either the Adviser or the Sub-Adviser without penalty upon not less than 120 days’ written notice to the other.

Administration Agreement

On March 31, 2022, the Fund entered into an administration agreement with the Administrator (the “Administration Agreement”), which was approved by the Board. Pursuant to the Administration Agreement, the Administrator furnishes the Fund with office facilities and equipment and provides clerical, bookkeeping and record keeping and other administrative services at such facilities. The Administrator performs, or oversees the performance of, the required administrative services, which include, among other things, assisting the Fund with the preparation of the financial records that the Fund is required to maintain and with the preparation of reports to shareholders and reports filed with the SEC. At the request of the Adviser or the Sub-Adviser, the Administrator also may provide significant managerial assistance on the Fund’s behalf to those portfolio companies that have accepted the Fund’s offer to provide such assistance. U.S. Bancorp Fund Services, LLC will provide the Fund with certain fund administration and bookkeeping services pursuant to a sub-administration agreement (the “Sub-Administration Agreement”) with the Administrator.

On January 10, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 1 (the “Administration Agreement Amendment”) to the Administration Agreement, which became effective immediately. The Fund and the Administrator entered into the Administration Agreement Amendment as a result of comments issued by securities regulators from various states in connection with their “blue sky” review of the Fund’s offering. The Administration Agreement Amendment provides that the Indemnified Parties (as defined in the Administration Agreement) will not be entitled to indemnification for any loss or liability to the Fund or its shareholders by reason of the Indemnified Parties’ negligence or misconduct, in accordance with the Omnibus Guidelines.

109

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

For the year ended December 31, 2023, the Fund incurred $517, in fees under the Sub-Administrative Agreement, which are included in administration fees in the consolidated statement of operations. For the period February 8, 2022 (inception) through December 31, 2022, the Fund incurred $299 in fees under the Sub-Administration Agreement, which are included in administration fees in the accompanying consolidated statements of operations. As of December 31, 2023 and December 31, 2022, $614 and $246, respectively, was unpaid and included in accounts payable and accrued expenses in the consolidated statements of assets and liabilities.

Intermediary Manager Agreement

On March 31, 2022, the Fund entered into an Intermediary Manager Agreement (the “Intermediary Manager Agreement”) with the Intermediary Manager, an affiliate of the Adviser. Under the terms of the Intermediary Manager Agreement, the Intermediary Manager serves as the agent and principal distributor for the Fund’s public offering of its Common Shares. The Intermediary Manager is entitled to receive distribution and/or shareholder servicing fees monthly at an annual rate of 0.85% of the value of the Fund’s net assets attributable to Class S shares as of the beginning of the first calendar day of the month. The Intermediary Manager is entitled to receive distribution and/or shareholder servicing fees monthly at an annual rate of 0.25% of the value of the Fund’s net assets attributable to Class D shares as of the beginning of the first calendar day of the month. No distribution and/or shareholder servicing fees will be paid with respect to Class I shares.

The Fund will cease paying the distribution and/or shareholder servicing fees on any Class S share and Class D share in a shareholder’s account at the end of the month in which the Intermediary Manager in conjunction with the transfer agent determines that total brokerage commissions and distribution and/or shareholder servicing fees paid with respect to any such share held by such shareholder within such account would exceed, in the aggregate, 10% of the gross proceeds from the sale of such share. At the end of such month, each such Class S share or Class D share will convert into a number of Class I shares (including any fractional shares), with an equivalent aggregate NAV as such share. The total underwriting compensation and total organization and offering expenses will not exceed 10% and 15%, respectively, of the gross proceeds from the offering.

For the year ended December 31, 2023, the Fund accrued distribution and shareholder servicing fee of $5 and $1 that were attributable to Class S and Class D shares, respectively. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund did not incur any distribution and shareholder servicing fee.

The Intermediary Manager Agreement may be terminated at any time, without the payment of any penalty, by vote of a majority of the Independent Trustees and the trustees who have no direct or indirect financial interest in the operation of the Fund’s distribution plan or the Intermediary Manager Agreement or by vote a majority of the outstanding voting securities of the Fund, on not more than 60 days’ written notice to the Intermediary Manager or the Adviser. The Intermediary Manager Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act.

Expense Support and Conditional Reimbursement Agreement

On March 31, 2022, the Fund entered into an expense support and conditional reimbursement agreement (the “Expense Support Agreement”) with the Adviser. The Expense Support Agreement provides that, Nuveen Alternative Holdings, an affiliate of the Adviser may pay (or cause one or more of its affiliates to pay) certain expenses of the Fund, provided that no portion of the payment will be used to pay any interest expenses of the Fund and/or shareholder servicing fees of the Fund (each, an “Expense Payment’). Such expense payment will be made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from Nuveen Alternative Holdings to pay such expense, and/or by an offset against amounts due from the Fund to Nuveen Alternative Holdings.

Following any calendar quarter in which Available Operating Funds (as defined below) exceed the cumulative distributions accrued to the Fund’s shareholders based on distributions declared with respect to record dates occurring in such calendar quarter (such amount referred to as the “Excess Operating Funds”), the Fund will pay such Excess Operating Funds, or a portion thereof (each, a “Reimbursement Payment”), to Nuveen Alternative Holdings until such time as all Expense Payments made by the entity to the Fund within three years prior to the last business day of such calendar quarter have been reimbursed. Available Operating Funds means the sum of (i) the Fund’s net investment income (including net realized short-term capital gains reduced by net realized long-term capital losses), (ii) the Fund’s net capital gains (including the excess of net realized long-term capital gains over net realized short-term capital losses) and (iii) dividends and other distributions paid to the Fund on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above). The amount of the Reimbursement Payment for any calendar quarter will equal the lesser of (i) the Excess Operating Funds in such quarter and (ii) the aggregate amount of all Expense Payments made by Nuveen Alternative Holdings to the Fund within three years prior to the last business day of such calendar quarter that have not been previously reimbursed by the Fund to Nuveen Alternative Holdings.

110

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

No Reimbursement Payment for any month will be made if (1) the annualized rate of regular cash distributions declared by the Fund at the time of such Reimbursement Payment is less than the annualized rate of regular cash distributions declared by the Fund at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) the Fund’s Operating Expense Ratio (as defined below) at the time of such Reimbursement Payment is greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Reimbursement Payment relates. The Operating Expense Ratio is calculated by dividing the Fund’s operating costs and expenses incurred, less organizational and offering expenses, base management and incentive fees owed to the Adviser, and interest expense, by the Fund’s net assets. The Fund’s obligation to make a Reimbursement Payment will automatically become a liability of the Fund on the last business day of the applicable calendar month, except to the extent the Adviser has waived its right to receive such payment for the applicable month.

The following table presents a cumulative summary of the expense payments and reimbursement payments since the Fund’s commencement of operations, comprised primarily of organizational expenses, offering costs and professional fees:

For the Quarter Ended	Expense Payments by Adviser		Reimbursement Payments to Adviser		Unreimbursed Expense Payments		Effective Rate of Distribution per Share (1)		Reimbursement Eligibility Expiration	Operating Expense Ratio (2)
March 31, 2022	$	983	$	—	$	983	—	%	March 31, 2025	0.08	%
June 30, 2022	677		—		677		6.62	%	June 30, 2025	0.19	%
September 30, 2022	379		—		379		7.23	%	September 30, 2025	0.21	%
December 31, 2022	176		—		176		9.07	%	December 31, 2025	0.14	%
March 31, 2023	198		—		198		10.22	%	March 31, 2026	0.22	%
June 30, 2023	113		—		113		11.69	%	June 30, 2026	0.22	%
September 30, 2023	327		—		327		12.19	%	September 30, 2026	0.27	%
December 31, 2023	115		—		115		12.13	%	December 21, 2026	0.13	%
Total	$	2,968	$	—	$	2,968

__________

(1)The effective rate of distribution per share is expressed as a percentage equal to the projected annualized distribution amount as of the end of the applicable period (which is calculated by annualizing the regular monthly cash distributions per share as of such date without compounding), divided by the Fund’s gross offering price per share as of each quarter ended.

(2)The operating expense ratio is calculated by dividing the quarterly operating expenses, less organizational and offering expenses, base management fee and incentive fees owed to the Adviser, and interest expense, by the Fund’s net assets as of each quarter end.

Board of Trustees’ Fees

The Board consists of seven members, four of whom are Independent Trustees. On March 30, 2022, the Board established an Audit Committee, a Nominating and Corporate Governance Committee and a Special Transactions Committee, each consisting solely of the Independent Trustees, and may establish additional committees in the future. For the year ended December 31, 2023, the Fund incurred $508 in fees which are included in Board of Trustees’ fees in the accompanying consolidated statements of operations. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund incurred $385 in fees which are included in Board of Trustees’ fees in the accompanying consolidated statements of operations. As of December 31, 2023 and December 31, 2022, $128 and $128, respectively, were unpaid and are included in Board of Trustees’ fees payable in the accompanying consolidated statements of assets and liabilities.

Other Related Party Transactions

From time to time, the Adviser may pay amounts owed by the Fund to third-party providers of goods or services and the Fund will subsequently reimburse the Adviser for such amounts paid on its behalf. Amounts payable to the Adviser are settled in the normal course of business without formal payment terms. As of December 31, 2023 and December 31, 2022, the Fund owed the Adviser $361 and $231, respectively, for reimbursements including the Fund’s allocable portion of overhead, which is included in accounts payable and accrued expenses in the accompanying consolidated statement of assets and liabilities.

Promissory Note

On March 31, 2022, the Fund entered into the Note with TIAA as the lender. The Note is issued under the purchase and sales agreement, dated as of March 31, 2022, by and among the Fund, SPV I and TIAA in connection with the contribution of portfolio investments by TIAA to the Fund (as discussed further in Note 8). The principal amount of the Note equals (i) the fair value of

111

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

portfolio investments contributed as of March 31, 2022, minus (ii) $263,500. The Note was due to mature on March 30, 2023, with an interest rate of 4% per annum on the unpaid principal amount, compounded quarterly.

On June 3, 2022, the Fund fully repaid the balance on the Note which was comprised of $32,731 and $226 of principal and interest, respectively.

6. SECURED BORROWINGS

In accordance with the 1940 Act, the Fund is only permitted to borrow amounts such that its asset coverage, as defined in the 1940 Act, is maintained at a level of at least 150% after such borrowing. As of December 31, 2023 and December 31, 2022, the Fund’s asset coverage was 314.08% and 267.94%, respectively.

On April 19, 2022, SPV I entered into a credit agreement with the lenders from time to time parties thereto, Bank of America, N.A., as administrative agent, the Fund, as servicer, U.S. Bank Trust Company, National Association, as collateral administrator, and U.S. Bank National Association, as collateral custodian (the “Credit Agreement” and the revolving credit facility thereunder, the “Bank of America Credit Facility”).

On October 4, 2022, SPV I entered into Amendment No. 1 to the Credit Agreement (the “Amendment”). The Amendment, among other things: (i) increased the maximum amount available under the Bank of America Credit Facility from $200,000 to $250,000; and (ii) increased the rate to be paid from Daily SOFR (as defined below) +2.00% to Daily SOFR +2.15% with a “step up” on the one year anniversary of the Closing Date (as defined in the Amendment) increasing from Daily SOFR +2.15% to Daily SOFR +2.40%, as reflected in the Amendment.

Borrowings under the Credit Agreement are secured by all of the assets held by SPV I and bear interest based on either (x) an annual rate equal to SOFR determined for any day (“Daily SOFR”) for the relevant interest period, plus an applicable spread, or (y) the highest of (i) the Federal Funds Rate plus an applicable spread, (ii) the Prime Rate in effect for any day and (iii) Daily SOFR plus an applicable spread. Interest is payable monthly in arrears. Advances under the Credit Agreement are secured by a pool of broadly-syndicated and middle-market loans subject to eligibility criteria and advance rates specified in the Credit Agreement. Advances under the Credit Agreement may be prepaid and reborrowed at any time during the Availability Period (as defined therein), and SPV I may terminate or reduce the facility amount subject to certain conditions. As of December 31, 2023, the Bank of America Credit Facility bears interest at a rate of Daily SOFR plus 2.40% per annum. Interest is payable monthly in arrears. Any amounts borrowed under the Credit Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) April 19, 2027, the fifth anniversary of the effective date of April 19, 2022, or (ii) upon certain other events in connection with a refinancing under the Credit Agreement. Borrowing under the Credit Agreement is subject to certain restrictions contained in the 1940 Act.

Prior to entering into the Bank of America Credit Facility, the Fund contributed and/or sold certain assets to SPV I pursuant to a contribution and sale agreement and TIAA contributed and/or sold certain assets to SPV I pursuant to a master participation and assignment agreement, and the Fund expects to contribute and/or sell additional assets to SPV I pursuant to a contribution and sale agreement in the future. The Fund may, but will not be required to, repurchase and/or substitute certain assets previously transferred to SPV I subject to the conditions specified in the contribution and sale agreement and the Credit Agreement.

The fair value of the Bank of America Credit Facility, which would be categorized as Level 3 within the fair value hierarchy as of December 31, 2023, approximates its carrying value. The carrying amounts of the Fund’s assets and liabilities, including the credit facilities, other than investments at fair value, approximate fair value due to their short maturities. The borrowing consisted of the following as of December 31, 2023 and December 31, 2022:

	December 31, 2023
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	165,750		165,750
Unused Portion (2)	84,250		84,250
Amount Available (3)	51,883		51,883

_______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

112

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

	December 31, 2022
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	155,000		155,000
Unused Portion (2)	95,000		95,000
Amount Available (3)	81,855		81,855

______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

For the year ended December 31, 2023 and for the period February 8, 2022 (inception) through December 31, 2022, the components of interest expense and debt financing expenses were as follows:

	For the Years Ended December 31,
	2023			2022 (1)
Borrowing interest expense	$	10,144		$	3,697
Unused fees	434			312
Amortization of deferred financing costs (2)	174			74
Total interest and debt financing expenses	$	10,752		$	4,083
Average interest rate (3)	7.73		%	4.90		%
Average daily borrowings	$	136,894		$	116,212

_______________

(1)Period from February 8, 2022 (inception) through December 31, 2022

(2)For the year ended December 31, 2023, $2 of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement. For the period from February 8, 2022 (inception) through December 31, 2022, $462 of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement.

(3)Average interest rate includes interest expense and unused fees.

7. COMMITMENTS AND CONTINGENCIES

In the ordinary course of its business, the Fund enters into contracts or agreements that contain indemnifications or warranties. Future events could occur that might lead to the enforcement of these provisions against the Fund. The Fund believes that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in the consolidated financial statements as of December 31, 2023 and 2022 for any such exposure.

As of December 31, 2023 and December 31, 2022, the Fund had the following unfunded commitments to fund delayed draw loans:

113

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

Portfolio Company	December 31, 2023		December 31, 2022
Aramsco	$	520	$	—
ARMstrong	1,007		—
ASTP Holdings Co-Investment LP	26		—
Chroma Color	381		—
ClaimLogiq	891		—
CrossCountry Consulting	560		560
Elevation Labs	599		599
Engage	2,040		—
Ergotech (INS)	1,139		—
Evergreen Services Group	—		267
Evergreen Services Group II	923		—
EyeSouth	266		735
Health Management Associates	415		—
Heartland Veterinary Partners	—		5,000
Impact Environmental Group	1,832		—
Industrial Service Group	2,019		1,282
Infobase	122		122
ITSavvy	36		480
Kenco	850		850
Legacy Service Partners	306		—
LMI Consulting, LLC	2		—
Leo Facilities	2,571		—
MEI Buyer LLC	501		—
Mobile Communications America Inc	1,463		—
Motion & Control Enterprises	1,704		—
National Power	799		—
NearU	1,919		2,149
OMNIA Partners	129		—
Online Labels Group	237		—
Ovation Holdings	127		—
Palmetto Exterminators	503		—
Patriot Growth	—		5,568
Pinnacle Supply Partners, LLC	1,455		—
Precision Aviation Group	2,480		—
Propark Mobility	665		—
Randy's Worldwide Automotive	1,332		1,332
Rhino Tool House	306		—
Riveron	779		—
Sugar Foods	1,173		—
Sunny Sky Products	464		—
Tech24	919		—
TIDI Products	1,201		—
Trilon Group	—		363
Vertex Service Partners	1,777		—
Wellspring	—		1,895
WSB / EST	1,096		—
Young Innovations	1,431		—
Total unfunded commitments	$	38,965	$	21,202

114

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

The Fund believes its assets will provide adequate coverage to satisfy these unfunded commitments. As of December 31, 2023, the Fund had cash and cash equivalents of $8,679 and available borrowings under the Bank of America Credit Facility of $51,883.

8. NET ASSETS

In connection with its formation, the Fund has the authority to issue an unlimited number of Common Shares.

On March 30, 2022, an affiliate of the Adviser, TIAA, purchased 40 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share.

On March 31, 2022, TIAA contributed certain portfolio investments to the Fund in the amount of $296,231 (fair value as of March 31, 2022). In connection therewith, the Fund entered into the Note with TIAA as the lender (as described in Note 5), and issued to TIAA 10,540,000 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share. The Fund fully repaid the balance of the Note to TIAA on June 3, 2022.

On the Escrow Break Date, the Fund had satisfied the minimum offering requirement and the Board authorized the release of proceeds from escrow.

The following table presents transactions in common shares during the year ended December 31, 2023 (dollars in thousands except share amounts):

	December 31, 2023
	Shares	Amount
CLASS S
Subscriptions	149,441	$	3,671
Share transfers between classes	—	$	—
Distributions reinvested	397	$	10
Shares repurchases	—	$	—
Net increase (decrease)	149,838	$	3,681
CLASS D
Subscriptions	106,881	$	2,629
Share transfers between classes	—	$	—
Distributions reinvested	385	$	9
Shares repurchases	—	$	—
Net increase (decrease)	107,266	$	2,638
CLASS I
Subscriptions	3,517,694	$	86,550
Share transfers between classes	—	$	—
Distributions reinvested	33,652	$	828
Shares repurchases	—	$	—
Net increase (decrease)	3,551,346	$	87,378

The Fund determines NAV for each class of shares as of the last day of each calendar month. Share issuances related to monthly subscriptions are effective the first calendar day of each month. Shares are issued at an offering price equivalent to the most recent NAV per share available for each share class, which will be the prior calendar day NAV per share (i.e. the prior month-end NAV).

115

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

The following table presents each month-end net offering price for Class S, Class D, and Class I common shares, which approximately equals their respective NAV per share, for the year ended December 31, 2023:

	Net Offering Price Per Share
For the Months Ended	Class S (1)	Class D (1)	Class I
January 31, 2023	—	—	$24.70
February 28, 2023	—	—	$24.70
March 31, 2023	—	—	$24.65
April 30, 2023	—	—	$24.68
May 31, 2023	—	—	$24.66
June 30. 2023	—	—	$24.63
July 31, 2023	—	—	$24.60
August 31, 2023	—	—	$24.56
September 30, 2023	—	—	$24.61
October 31, 2023	$24.58	$24.59	$24.60
November 30, 2023	$24.59	$24.60	$24.60
December 31, 2023	$24.69	$24.73	$24.73

_______________

(1)Class S and Class D shares were first issued and sold in October 2023.

Distributions

The following table summarizes the Fund’s dividends declared from inception through December 31, 2023:

			Class S
Declaration Date	Record Date	Payment Date	Distribution per Share (1)	Distribution Amount
October 27, 2023	October 31, 2023	November 28, 2023	$0.233	$9
November 27, 2023	November 30, 2023	December 28, 2023	$0.233	$17
December 28, 2023	December 31, 2023	January 29, 2024	$0.233	$35

			Class D
Declaration Date	Record Date	Payment Date	Distribution per Share (1)	Distribution Amount
October 27, 2023	October 31, 2023	November 28, 2023	$0.245	$2
November 27, 2023	November 30, 2023	December 28, 2023	$0.245	$11
December 28, 2023	December 31, 2023	January 29, 2024	$0.245	$26

_______________

(1)Class S and Class D dividends are net of distribution and servicing fees.

116

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

			Class I
Declaration Date	Record Date	Payment Date	Distribution per Share		Distribution Amount
September 30, 2022	September 30, 2022	October 28, 2022	$0.870	(1)	$9,170
October 31, 2022	October 31, 2022	November 28, 2022	$0.180		$1,897
November 30, 2022	November 30, 2022	December 28, 2022	$0.190		$2,003
December 31, 2022	December 31, 2022	January 28, 2023	$0.295	(2)	$3,109
January 31, 2023	January 31, 2023	February 28, 2023	$0.200		$2,108
February 28, 2023	February 28, 2023	March 28, 2023	$0.200		$2,108
March 31, 2023	March 31, 2023	April 28, 2023	$0.230		$2,424
April 28, 2023	April 30, 2023	May 26, 2023	$0.240		$2,530
May 25, 2023	May 31, 2023	June 28, 2023	$0.240		$2,530
June 28, 2023	June 30, 2023	July 28, 2023	$0.240		$2,605
July 28, 2023	July 31, 2023	August 28, 2023	$0.270	(3)	$3,081
August 23, 2023	August 31, 2023	September 28, 2023	$0.270	(3)	$3,133
September 29, 2023	September 30, 2023	October 27, 2023	$0.250		$3,070
October 27, 2023	October 31, 2023	November 28, 2023	$0.250		$3,244
November 27, 2023	November 30, 2023	December 28, 2023	$0.250		$3,435
December 28, 2023	December 31, 2023	January 29, 2024	$0.250		$3,523

_______________

(1)Represents monthly dividend of $0.14 per share for each of April 2022, May 2022 and June 2022, and monthly dividend of $0.15 per share for each of July 2022, August 2022 and September 2022.

(2)Comprised of $0.19 regular dividend and $0.105 supplemental dividend attributable to accrued net investment income.

(3)Comprised of $0.25 regular dividend and $0.020 special dividend attributable to accrued net investment income.

Distribution Reinvestment Plan

The Fund has adopted a distribution reinvestment plan, pursuant to which it will reinvest all cash dividends declared by the Board on behalf of its shareholders who do not elect to receive their dividends in cash, except for shareholders in certain states. As a result, if the Board authorizes, and we declare, a cash dividend or other distribution, then our shareholders who have not opted out of our distribution reinvestment plan will have their cash distributions automatically reinvested in additional Common Shares, rather than receiving the cash dividend or other distribution. Alabama, Arkansas, Idaho, Kansas, Kentucky, Maine, Maryland, Massachusetts, Nebraska, New Jersey, North Carolina, Ohio, Oregon, Vermont and Washington investors and clients of certain participating brokers that do not permit automatic enrollment in our distribution reinvestment plan will automatically receive their distributions in cash unless they elect to have their cash distributions reinvested in additional Common Shares. Distributions on fractional shares will be credited to each participating shareholder’s account to three decimal places.

Character of Distributions

The Fund may fund its cash distributions to shareholders from any source of funds available to the Fund, including but not limited to offering proceeds, net investment income from operations, capital gain proceeds from the sale of assets, borrowings, dividends or other distributions paid to it on account of preferred and common equity investments in portfolio companies and expense support from the Adviser, which is subject to recoupment.

Through December 31, 2023, a portion of the Fund’s distributions resulted from expense support from the Adviser, and future distributions may result from expense support from the Adviser, each of which is subject to repayment by the Fund within three years from the date of payment. The purpose of this arrangement avoids distributions being characterized as a return of capital for U.S. federal income tax purposes. Shareholders should understand that any such distribution is not based solely on the Fund’s investment performance, and can only be sustained if the Company achieves positive investment performance in future periods and/or the Adviser continues to provide expense support. Shareholders should also understand that the Fund’s future repayments of expense support will reduce the distributions that they would otherwise receive. There can be no assurance that the Fund will achieve the performance necessary to sustain these distributions, or be able to pay distributions at all.

117

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

Sources of distributions, other than net investment income and realized gains on a U.S. GAAP basis, include required adjustments to U.S. GAAP net investment income in the current period to determine taxable income available for distributions. The following table reflects the source of cash distributions on a U.S. GAAP basis that the Fund has declared on its common shares for the year ended December 31, 2023:

	Class S (1)		Class D (1)		Class I
Sources of Distribution	Per Share	Amount	Per Share	Amount	Per Share	Amount
Net investment income	$0.699	$61	$0.735	$39	$2.890	$33,789
Net realized gains	$—	$—	$—	$—	$—	$—
Total	$0.699	$61	$0.735	$39	$2.890	$33,789

_______________

(1)Class S and Class D shares were first issued and sold in October 2023.

The following table reflects the source of cash distributions on a U.S. GAAP basis that the Fund has declared on its common shares for the period from February 8, 2022 (inception) through December 31, 2022:

	Class S (1)		Class D (1)		Class I
Sources of Distribution	Per Share	Amount	Per Share	Amount	Per Share	Amount
Net investment income	$—	$—	$—	$—	$1.535	$16,179
Net realized gains	$—	$—	$—	$—	$—	$—
Total	$—	$—	$—	$—	$1.535	$16,179

_______________

(1)Class S and Class D shares were first issued and sold in October 2023.

Share Repurchase Program

Beginning with the fiscal quarter ended September 30, 2023, the Fund commenced a share repurchase program in which it intends to repurchase in each quarter, at the discretion of the Board, up to 5% of its Common Shares outstanding (either by number of shares or aggregate NAV) as of the close of the previous calendar quarter. The Board, in its sole discretion, may amend, suspend or terminate the share repurchase program if it deems such action to be in the best interest of the Fund’s shareholders. As a result, share repurchases may not be available each quarter, such as when a repurchase offer would place an undue burden on our liquidity, adversely affect the Fund’s operations or risk having an adverse impact on the Fund that would outweigh the benefit of the repurchase offer. Following any such suspension, the Board will consider on at least a quarterly basis whether the continued suspension of the Share Repurchase Program is in the best interest of the Fund and shareholders, and will reinstate the Share Repurchase Program when and if appropriate and subject to its fiduciary duty to the Fund and shareholders. However, our Board is not required to authorize the recommencement of our Share Repurchase Program within any specified period of time. The Fund intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Securities Exchange Act of 1934, as amended, and the 1940 Act. All Common Shares purchased by the Fund pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued Common Shares.

Under the share repurchase program, to the extent the Fund offers to repurchase Common Shares in any particular quarter, the Fund expects to repurchase Common Shares pursuant to tender offers using a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter, except that Common Shares that have not been outstanding for at least one year will be repurchased at 98% of such NAV (an “Early Repurchase Deduction”). The one-year holding period is measured as of the subscription closing date immediately following the prospective repurchase date. The Early Repurchase Deduction may be waived in the case of repurchase requests arising from the death, divorce or qualified disability of the holder. The Early Repurchase Deduction will be retained by the Fund for the benefit of remaining shareholders.Common Shares. The repurchase of the Adviser’s shares, if any, will be on the same terms and subject to the same limitations as other shareholders under the Share Repurchase Program.

Payment for repurchased shares may require us to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. Our Adviser intends to take measures, subject to policies as may be established by our Board, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of shares. Class I shares owned by TIAA will be subject to the following restrictions. TIAA may submit its Class I shares for repurchase beginning on March 31, 2027. Beginning March 31, 2027, the total amount of TIAA shares eligible for repurchase will be limited to no more than 1.67% of our aggregate NAV

118

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

per calendar quarter; provided that, if in any quarter the total amount of aggregate repurchase requests of all classes of Common Shares does not exceed the Share Repurchase Plan limit of 5% of the aggregate NAV per calendar quarter, these redemption limits on the TIAA shares will not apply for that quarter, and TIAA will be entitled to submit its shares for repurchase up to the overall Share Repurchase Plan limits.

For the year ended December 31, 2023, no Common Shares were repurchased.

9. CONSOLIDATED FINANCIAL HIGHLIGHTS

The following is a schedule of financial highlights for the year ended December 31, 2023:

	For the Year Ended December 31, 2023
	Class S (7)			Class D (7)			Class I
Per share data:
Net asset value at beginning of period	$	—		$	—		$	24.70
Net investment income (loss)	0.73			0.76			2.97
Net realized gains (losses) (1)	—			—			0.07
Net change in unrealized appreciation (depreciation) (1)	0.17			0.22			(0.06)
Net increase (decrease) in net assets resulting from operations	0.90			0.98			2.98
Stockholder distributions from income (2)	(0.70)			(0.74)			(2.89)
Issuance of common shares	24.61			24.61			—
Other (3)	(0.12)			(0.12)			(0.06)
Net asset value at end of period	$	24.69		$	24.73		$	24.73
Supplemental Data:
Net assets at end of period	$	3,699		$	2,652		$	348,480
Shares outstanding at end of period (1)	149,838			107,266			14,091,386
Total return	3.21		%	3.53		%	12.52		%
Ratio to average net assets:
Ratio of net expenses to average net assets before expense support and waived fees (4)(5)	8.30		%	6.55		%	6.34		%
Ratio of net expenses to average net assets after expense support and waived fees (4)(5)	5.58		%	3.96		%	4.56		%
Ratio of net investment income (loss) to average net assets (4)	13.82		%	12.18		%	12.02		%
Portfolio turnover rate (6)	11.44		%	11.44		%	11.44		%
Asset coverage ratio	314.08		%	314.08		%	314.08		%

_______________

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Ratios are annualized except for management fees and incentive fees which were calculated from the Escrow Break Date, which were fully waived for the year ended December 31, 2023 (Refer to Note 5). Average net assets is calculated utilizing quarterly net assets. Ratio of net investment income (loss) to average net assets includes the effect of expense support and waived management fee and incentive fee.

(5)The ratio of interest and debt financing expenses to average net assets for the year ending December 31, 2023 was 3.96%, 3.21% and 3.73% for Class S, Class D, and Class I, respectively, Average net assets is calculated utilizing quarterly net assets.

(6)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

(7)Class S and Class D shares were first issued and sold in October 2023.

119

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

The following is a schedule of financial highlights for the period February 8, 2022 (inception) through December 31, 2022:

	Class I
Per share data:
Net asset value at beginning of period	$	—
Net investment income (loss)	1.60
Net realized gains (losses) (1)	(0.02)
Net change in unrealized appreciation (depreciation) (1)	(0.34)
Net increase (decrease) in net assets resulting from operations	1.24
Stockholder distributions from income (2)	(1.54)
Issuance of common shares	25.00
Other (3)	—
Net asset value at end of period	$	24.70
Supplemental Data:
Net assets at end of period	$	260,301
Shares outstanding at end of period (1)	10,540,040
Total return	4.91		%
Ratio to average net assets:
Ratio of net expenses to average net assets before expense support and waived fees (4)(5)	2.41		%
Ratio of net investment income (loss) to average net assets (4)	7.13		%
Portfolio turnover rate (6)	12.11		%
Asset coverage ratio	267.94		%

_______________

*For the period February 8, 2022 (inception) through December 31, 2022

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Ratios are annualized except for expense support amounts relating to organizational costs and interest expense on the Note. The ratio of total expenses to average net assets was 3.02% for the period February 8, 2022 (inception) through December 31, 2022 on an annualized basis, excluding the effect of expense support which represented (0.61)% of average net assets. Average net assets is calculated utilizing quarterly net assets.

(5)The ratio of interest and debt financing expenses to average net assets for the period February 8, 2022 (inception) through December 31, 2022 was 1.82%, Average net assets is calculated utilizing quarterly net assets.

(6)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

120

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

10. INCOME TAX

The Fund intends to elect to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code for the fiscal year ending December 31, 2023. As a result, the Fund generally must timely distribute substantially all of its net taxable income each tax year as dividends to its shareholders. Accordingly, no provision for U.S. federal income tax has been made in the consolidated financial statements.

The Fund will file income tax returns in U.S. federal and applicable state and local jurisdictions. The Fund’s U.S. federal income tax return is generally subject to examination for a period of three fiscal years after being filed. State and local tax returns may be subject to examination for an additional period of time depending on the jurisdiction. Management has analyzed the Funds’s tax positions taken for the open tax year and has concluded that no provision for income tax is required in the Fund’s consolidated financial statements.

Taxable income generally differs from net increase (decrease) in net assets resulting from operations for financial reporting purposes due to the timing of temporary and permanent differences in the recognition of gains and losses on investment transactions. Temporary differences do not require reclassification. As of December 31, 2023, permanent differences that resulted in reclassifications among the components of net assets resulting from operations relate primarily to paydowns, amendment fees and non-deductible excise tax. Temporary and permanent differences have no impact on the Fund’s net assets.

As of December 31, 2023 and December 31, 2022, the Fund’s cost of investments for U.S. federal income tax purposes and gross unrealized appreciation and depreciation on investments were as follows:

	December 31, 2023		December 31, 2022
Tax cost of investments	$	516,168	$	352,998
Gross unrealized appreciation on investments	3,128		1,389
Gross unrealized depreciation on investments	(7,260)		(4,869)
Net unrealized appreciation (depreciation) on investments	$	(4,132)	$	(3,480)

As of December 31, 2023 and December 31, 2022, the components of Accumulated Earnings (Losses) on a tax basis were as follows:

	December 31, 2023		December 31, 2022
Undistributed Ordinary Income - Net	$	884	$	370
Undistributed Long-Term Income - Net	634		—
Total Undistributed Earnings	$	1,518	370
Capital loss carryforward	$	—	(88)
Unrealized Earnings (Losses) - Net	(4,194)		(3,480)
Other book-to-tax differences	123		—
Total Accumulated Earnings (Losses) - Net	$	(2,553)	$	(3,198)

Capital losses in excess of capital gains earned in a tax year generally may be carried forward and used to offset capital gains, subject to certain limitations. Under the Regulated Investment Company Modernization Act of 2010, capital losses incurred after September 30, 2011 will not be subject to expiration. As of December 31, 2023, the Fund had $0 capital loss carryforward available for use in future tax years.

121

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

For income tax purposes, dividends paid and distributions made to the Fund's shareholders are reported by the Fund to the shareholders as ordinary income, capital gains, or a combination thereof. The tax character of the distributions paid for the year ended December 31, 2023 and December 31, 2022 was as follows:

	December 31, 2023		December 31, 2022
Distributions paid from:
Ordinary income	$	33,890	$	16,179
Net long-term capital gains	—		—
Total taxable distributions	$	33,890	$	16,179

The Fund is subject to a 4% nondeductible federal excise tax on certain undistributed income unless the Fund distributes, in a timely manner as required by the Code, an amount at least equal to the sum of (1) 98% of its respective net ordinary income earned for the calendar year and (2) 98.2% of its respective capital gain net income for the one-year period ending October 31 in the calendar year. For the year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022, the Fund incurred $31 and $2, respectively, in excise tax expense.

The Fund’s wholly owned subsidiary, Equity Holdings, is subject to U.S. federal and state corporate-level income taxes. As a result the Fund recorded a net deferred tax liability related to US GAAP to tax outside basis differences in Equity Holdings’ investments in certain partnership interests of $61 as of December 31, 2023, which are included in accounts payable and accrued expenses in the accompanying consolidated statements of assets and liabilities. For the year ended December 31, 2023, the Fund recorded a net tax provision of $61. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund did not record net tax benefit (provision).

The Fund accounts for income taxes in conformity with ASC Topic 740, Income Taxes ("ASC 740"). ASC 740 provides guidelines for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken in the course of preparing the Fund’s tax returns to determine whether the tax positions are "more-likely-than-not" to be sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Based on its analysis of its tax position for all open tax years (the current and prior years, as applicable), the Fund has concluded that it does not have any uncertain tax positions that met the recognition or measurement criteria of ASC 740.

122

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(dollar amounts in thousands, except per share data)

11. SUBSEQUENT EVENTS

The Fund’s management evaluated subsequent events through the date of issuance of the consolidated financial statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of December 31, 2023, except as discussed below.

Distributions

On January 26, 2024, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on February 28, 2024 to shareholders of record as of January 31, 2024.

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

On February 28, 2024, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on March 28, 2024 to shareholders of record as of February 29, 2024.

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

Since inception through the date of issuance of the consolidated financial statements, the Fund has accepted approximately $384.2 million net proceeds relating to the issuance of Class I shares, Class S shares, and Class D shares.

Chief Compliance Officer Appointment

On February 20, 2024, John D. McCally submitted his resignation as Chief Compliance Officer of the Fund to the Board, effective as of March 1, 2024. Mr. McCally will continue to serve as Vice President and Secretary of the Fund. In connection with the foregoing, on February 20, 2024, the Board appointed Charmagne Kukulka as the Chief Compliance Officer of the Fund, effective as of March 1, 2024.

Charmagne Kukulka, 34, has been a Principal and Deputy Chief Compliance Officer at Churchill since May 2023. Ms. Kukulka is responsible to managing Churchill’s compliance program and provides compliance support in connection with regulatory matters affecting the business. Prior to joining Churchill, Ms. Kukulka was the Chief Compliance Officer at 13D Management LLC, specializing in investment adviser and investment company act rules and regulations from January 2022 to May 2023. She began her compliance career at Blackstone Inc., where she held various roles within the legal and compliance teams administering the compliance program for Blackstone’s registered funds platform from August 2013 to January 2022. Ms. Kukulka received her B.A. in Business and Corporate Communications from Arizona State University’s W.P. Carey School of Business.

There are no family relationships between Ms. Kukulka and any of the Fund’s directors or executive officers, and she is not a party to any transaction that is required to be reported pursuant to Item 404(a) of Regulation S-K.

123

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

124

ITEM 9A. CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

In accordance with Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this Annual Report on Form 10-K.

Based on that evaluation, we, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective as of December 31, 2023 and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.

(b) Management’s Quarterly Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act). The Fund’s internal control over financial reporting is a process designed under the supervision of its Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) and effected by the Fund’s board of trustees, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of its consolidated financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles.

The Fund’s internal control over financial reporting includes policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect transactions and dispositions of the Fund’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the Fund are being made only in accordance with authorizations of management and the trustees; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Fund’s assets that could have a material effect on its consolidated financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Management (with the participation of our Chief Executive Officer and Chief Financial Officer) conducted an evaluation of the effectiveness of the Fund’s internal control over financial reporting as of December 31, 2023 based on the framework established in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, management concluded that the Fund’s internal control over financial reporting as of December 31, 2023 was effective. This Annual Report on Form 10-K does not include an attestation report of the Fund’s independent registered public accounting firm due to an exemption for emerging growth companies under the JOBS Act.

(c) Changes in Internal Controls Over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

125

ITEM 9B. OTHER INFORMATION

(a) None.

(b) During the fiscal quarter ended December 31, 2023, no director or officer of the Fund has entered into any (i) contract, instruction or written plan for the purchase or sale of securities of the Fund intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or (ii) any non-Rule 10b5-1 trading arrangement.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not applicable.

PART III.

We will file a definitive Proxy Statement for our 2024 Annual Meeting of Shareholders with the SEC, pursuant to Regulation 14A, within 120 days after the end of our fiscal year-end, which was December 31, 2023. Accordingly, information required by Part III has been omitted under General Instruction G(3) to Form 10-K. Only those sections of our definitive Proxy Statement that specifically address the items set forth herein are incorporated by reference herein.

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required by Item 10 is hereby incorporated by reference from our definitive Proxy Statement relating to our 2024 Annual Meeting of Shareholders, to be filed with the SEC within 120 days following the end of our fiscal year-end, which was December 31, 2023.

ITEM 11. EXECUTIVE COMPENSATION

The information required by Item 11 is hereby incorporated by reference from our definitive Proxy Statement relating to our 2024 Annual Meeting of Shareholders, to be filed with the SEC within 120 days following the end of our fiscal year-end, which was December 31, 2023.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information required by Item 12 is hereby incorporated by reference from our definitive Proxy Statement relating to our 2024 Annual Meeting of Shareholders, to be filed with the SEC within 120 days following the end of our fiscal year-end, which was December 31, 2023.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information required by Item 13 is hereby incorporated by reference from our definitive Proxy Statement relating to our 2024 Annual Meeting of Shareholders, to be filed with the SEC within 120 days following the end of our fiscal year-end, which was December 31, 2023.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required by Item 14 is hereby incorporated by reference from our definitive Proxy Statement relating to our 2024 Annual Meeting of Shareholders, to be filed with the SEC within 120 days following the end of our fiscal year-end, which was December 31, 2023.

126

ITEM 15. Exhibits and Financial Statement Schedules

a.Documents Filed as Part of this Report

The following financial statements are set forth in Item 8:

Nuveen Churchill Private Capital Income Fund

	Page
Consolidated Statement of Assets and Liabilities as of December 31, 2023 and 2022	85
Consolidated Statement of Operations for the Year Ended December 31, 2023 and for the Period from February 8, 2022 (inception) through December 31, 2022	86
Consolidated Statement of Changes in Net Assets for the Year Ended December 31, 2023 and for the Period from February 8, 2022 (inception) through December 31, 2022	87
Consolidated Statement of Cash Flows for the Year Ended December 31, 2023 and for the Period from February 8, 2022 (inception) through December 31, 2022	88
Consolidated Schedule of Investments as of December 31, 2023 and 2022	89
Notes to Consolidated Financial Statements	97

b.Exhibits

The following exhibits are filed as part of this Annual Report on Form 10-K or hereby incorporated by reference to exhibits previously filed with the United States Securities and Exchange Commission.

127

3.1	Fifth Amended and Restated Declaration of Trust of the Registrant(7)
3.2	Third Amended and Restated Bylaws of the Registrant(9)
4.1	Form of Subscription Agreement(6)
4.2	Distribution Reinvestment Plan(3)
4.3	Description of Securities(8)
10.1	Investment Advisory Agreement between Nuveen Churchill Private Capital Income Fund and Churchill Asset Management LLC(3)
10.2	Amendment No. 1, dated as of August 3, 2022, to the Investment Advisory Agreement between Nuveen Churchill Private Capital Income Fund and Churchill Asset Management LLC(2)
10.3	Amendment No. 2. dated as of January 10, 2023, to the Investment Advisory Agreement between Nuveen Churchill Private Capital Income Fund and Churchill Asset Management LLC(5)
10.4	Amendment No. 3 dated as of August 2, 2023, to the Investment Advisory Agreement between Nuveen Churchill Private Capital Income Fund and Churchill Asset Management LLC(10)
10.5	Investment Sub-Advisory Agreement by and between Churchill Asset Management LLC and Nuveen Asset Management, LLC(3)
10.6	Amendment No. 1, dated as of August 3, 2022, to the Investment Sub-Advisory Agreement by and between Churchill Asset Management LLC and Nuveen Asset Management, LLC(2)
10.7	Intermediary Manager Agreement by and between Nuveen Churchill Private Capital Income Fund and Nuveen Securities, LLC(1)
10.8	Form of Participating Dealer Agreement (included as Exhibit A to the Intermediary Manager Agreement attached hereto as Exhibit 10.6)
10.9	Distribution and Shareholder Servicing Plan of Nuveen Churchill Private Capital Income Fund(3)
10.10	Custody Agreement by and between Nuveen Churchill Private Capital Income Fund and U.S. Bank Trust Company, National Association(3)
10.11	Administration Agreement between Nuveen Churchill Private Capital Income Fund and Nuveen Churchill Administration LLC(3)
10.12	Amendment No. 1. dated as of January 10, 2023, to the Administration Agreement between Nuveen Churchill Private Capital Income Fund and Nuveen Churchill Administration LLC(5)
10.13	Form of Escrow Agreement by and among Nuveen Churchill Private Capital Income Fund, Nuveen Securities, LLC, and UMB Bank, N.A. (1)
10.14	Services Agreement between Nuveen Churchill private Capital income Fund and DST Systems, Inc.(3)
10.15	Expense Support and Conditional Reimbursement Agreement by and between Nuveen Churchill Private Capital income Fund and Churchill Asset Management LLC(3)
10.16	Credit Agreement, dated April 19, 2022, among NCPIF SPV I LLC, as borrower, the lenders party thereto, Bank of America, N.A., as administrative agent, Nuveen Churchill Private Capital Income Fund, as servicer, U.S. Bank Trust Company, National Association, as collateral administrator, U.S. Bank National Association, as a collateral custodian, and Bank of America, N.A., as sole lead arranger and sole book manager(3)
10.17	Amendment No. 1 to Credit Agreement, dated as of October 4, 2022, by and among NCPIF SPV I LLC, as the borrower, the lenders party thereto, Bank of America, N.A., as administrative agent, Nuveen Churchill Private Capital Income Fund, as servicer, U.S. Bank Trust Company, National Association, as collateral administrator and U.S. Bank National Association, as collateral custodian(4)
10.18	Multi-Class Plan(3)
14.1	Independent Director Code of Ethics of Nuveen Churchill Private Capital Income Fund *
14.2	Code of Ethics of Nuveen, LLC *
21.1	List of Subsidiaries*
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*
32	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as amended*

__________________

*Filed herewith

(1)Incorporated by reference to Pre-Effective Amendment No. 2 to the Registrant’s Registration Statement on Form N-2 (File No. 333-262771) filed on July 8, 2022.

(2)Incorporated by reference to Quarterly Report on Form 10-Q filed on August 8, 2022.

128

(3)Incorporated by reference to Post-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-2 (File No. 333-262771) filed on September 6, 2022.

(4)Incorporated by reference to Current Report on Form 8-K filed on October 6, 2022.

(5)Incorporated by reference to Current Report on Form 8-K filed on January 13, 2023.

(6)Incorporated by reference to Post-Effective Amendment No. 2 to the Registrant’s Registration Statement on Form N-2 (File No. 333-262771) filed on January 13, 2023.

(7)Incorporated by reference to Current Report on Form 8-K filed on March 3, 2023.

(8)Incorporated by reference to Annual Report on Form 10-K filed on March 9, 2023.

(9)Incorporated by reference to Current Report on 8-K filed on May 1, 2023.

(10)Incorporated by reference to Quarterly Report on Form 10-Q filed on August 4, 2023.

ITEM 16. FORM 10-K SUMMARY

None.

129

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND
By:	/s/ Kenneth Kencel
Name:	Kenneth Kencel
Title:	Chief Executive Officer, President, Trustee and Chairman

By:	/s/ Shai Vichness
Name:	Shai Vichness
Title:	Chief Financial Officer and Treasurer

Date: February 29, 2024

130

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Date: February 29, 2024

Nuveen Churchill Private Capital Income Fund
By:	/s/ Kenneth Kencel
	Name: Kenneth Kencel
	Title: Chief Executive Officer, President, Trustee, and Chairman
By:	/s/ Shaul Vichness
	Name: Shaul Vichness
	Title: Chief Financial Officer and Treasurer
By:	/s/ William Huffman
	Name: William Huffman
	Title: Trustee
By:	/s/ Stephen Potter
	Name: Stephen Potter
	Title: Trustee
By:	/s/ James Ritchie
	Name: James Ritchie
	Title: Trustee
By:	/s/ Dee Dee Sklar
	Name: Dee Dee Sklar
	Title: Trustee
By:	/s/ Sarah Smith
	Name: Sarah Smith
	Title: Trustee

131

EX-14.1

Exhibit 14.1

Joint Independent Director Code of Ethics

Summary  

Purpose

The purpose of this Code is to help to ensure that the Independent Directors (“Directors”) of each Company place the interests of the Company and its shareholders ahead of the Directors’ own personal interests. The terms the “Companies”, the “Company”, and the “Advisers” will each have the meaning ascribed to them in the Rule 38a-1 Compliance Manual. The term “Independent Director” refers to the directors or trustees of the respective Company’s board who are not “interested persons” (as defined in Section 2(a)(19) of the Investment Company Act of 1940, as amended) of the Company.

Rule 17j-1 under the Investment Company Act of 1940 (“Rule 17j-1”) makes it unlawful for any affiliated person of the Company, or any affiliated person of an investment adviser for the Company, in connection with the purchase or sale, directly or indirectly, by the person of a security held or to be acquired by the Company, to (i) employ any device, scheme or artifice to defraud the Company or its shareholders; (ii) make any untrue statement of a material fact to the Company or its shareholders or omit to state to the Company or its shareholders a material fact necessary in order to make the statements made, in light of the circumstances under which they are made, not misleading; (iii) engage in any act, practice or course of business that operates or would operate as a fraud or deceit upon the Company or its shareholders; or (iv) engage in any manipulative practice with respect to the Company or its shareholders. 

This Code has been adopted in recognition of the Directors’ fiduciary obligations to shareholders of the Companies and in accordance with various provisions of Rule 17j-1.  

Important to Understand

The securities industry is highly regulated and its participants are expected to adhere to high standards of behavior, including in their personal trading. A violation of the Code can have an adverse effect on you, your fellow Directors, the Advisers, and their commonly controlled affiliates, including Nuveen, LLC and its subsidiaries (“Churchill”), as well as the Companies and their shareholders.  The Code does not address every ethical issue that might arise.  

It is important for Directors to be sensitive to investments that may compromise your independence, directly or indirectly.  The Code applies to appearance as well as substance. Always consider how any action might appear to an outside observer such as a regulator. If you have any doubt after consulting the Code, contact the Churchill Legal Department. 

For purposes of this Policy, the obligations and requirements for Directors also apply to the Directors’ Household Members (as defined herein) as well as any account for which the Director or Household Member has Beneficial Ownership (also as defined herein).

Terms with Special Meanings 

Advisers: Churchill Asset Management LLC and Churchill DLC Adviser LLC

Beneficial Ownership:  Any interest by which you or any Household Member – directly or indirectly – derives a monetary benefit from purchasing, selling, or owning a security or account, or exercises investment discretion.  You have Beneficial Ownership of securities held in accounts in your own name, or any Household Member’s name, and in all other accounts over which you or any Household Member exercise or may exercise investment decision-making powers, or other influence or control, including trust, partnership, estate, and corporate accounts or other joint ownership or pooling arrangements. 

Code:  This Code of Ethics. 

Company: Nuveen Churchill Direct Lending Corp., Nuveen Churchill Private Capital Income Fund and NC SLF Inc.

Household Member:  Any of the following who reside, or are expected to reside for at least 90 days a year, in the same household as a Director:  Spouse or Domestic Partner, Sibling, Child, Stepchild, Grandchild, Parent, Stepparent, Grandparent, In-laws (mother, father, son, daughter, brother, sister). 

Inside Information:  Inside information is information that is both material and non-public.  Information is material if: (1) a reasonable investor would likely consider it important when making an investment decision; and (2) public release of the information would likely affect the price of a security.  Information is non-public if it has not been distributed through a widely used public medium such as a press release or a report, filing or other periodic communication. 

Nuveen:  Nuveen, LLC, and all of its direct or indirect subsidiaries. 

Restrictions and Requirements  

1.Do not purchase or sell shares of the Company without prior approval from the Company’s Chief Compliance Officer (the “CCO”) and/or Churchill Legal Department.   

2.Do not purchase and sell or sell and purchase shares of the Company within 6 months at a profit. 

3.Do not purchase or sell any securities if you know at the time of the proposed transaction that the Company has purchased or sold the same securities within the past 15 days, or is considering purchasing or selling the same securities within the next 15 days.  This is the “15 day window.” 

4.Avoid conflicts of interest. This applies not only to actual conflicts of interest, but also to any situation that might appear to an outside observer to be improper or a breach of fiduciary duty. 

5.Do not share or trade upon inside information about the Company.  

6.Never do anything indirectly that, if done directly, would violate the Code.  Such actions will be considered the equivalent of direct Code violations. 

7.Promptly alert the Churchill Legal Department of any actual or suspected wrongdoing.  

Actions to Take 

A.When you become a Director:  Sign an acknowledgement that you have received this Code.  The form of such acknowledgement is attached hereto as Exhibit G-1. 

B.If you want to purchase or sell shares of the Company: 

i.Seek prior approval before purchasing or selling shares of the Company via e-mail to BDC-Transaction@churchillam.com (the “BDC Transaction Mailbox”). The Company’s CCO and/or the Churchill Legal Department will review the pre-clearance request and respond with approval or disapproval of the request.   

ii.Immediately after you have purchased or sold the shares, provide transaction details (date of transaction, shares purchased or sold, and price) to the BDC Transaction Mailbox.   

C.Comply with the Company’s Section 16 Policy: Section 16 of the Securities Exchange Act of 1934 imposes reporting requirements on purchases and sales of shares of the Company by Directors and prohibits Directors from profiting on sales (purchases) of such shares purchased (sold) within the preceding six months.  The Company has adopted a separate Section 16 Policy to ensure compliance with these requirements.  

Administration of Code 

A.Training:  A Churchill representative will review this Code with you when you join the Board.   

B.Exceptions:  The Code exists to ensure that Directors place the interests of the Company and its shareholders ahead of Directors’ own personal interests.  No exceptions that would violate that principle will be granted. 

C.Reporting and Enforcement:   The CCO will alert the Audit Committee of any known potential violations of this Code.  The Audit Committee shall determine whether a violation of the Code occurred and what remedial action is appropriate for any such violation.   

Responsible Parties 

Churchill Legal Department 
Churchill Chief Compliance Officer  

Effective: December 9, 2019 

Amended: March 8, 2021 

Amended: March 30, 2022

Last Amended: December 28, 2023

APPENDIX G-1

ACKNOWLEDGMENT AND CERTIFICATION

I acknowledge receipt of the Joint Independent Director Code of Ethics (the “Code of Ethics”). I have read and understand the Code of Ethics and agree to be governed by it at all times. Further, if I have been subject to the Code of Ethics during the preceding year, I certify that I have complied with the requirements of the Code of Ethics and have disclosed or reported all personal securities transactions required to be disclosed or reported pursuant to the requirements of the Code of Ethics.

___________________________________

(Signature)

___________________________________

(Please print name)

Date:__________________________

EX-14.2

Confidential (C) Nuveen Compliance | 1 January 2024 Code of Ethics SUMMARY AND SCOPE What the Code is about Helping to ensure that Nuveen personnel place the interests of Nuveen clients ahead of their own personal interests. Who the Code applies to and what the implications are This Code applies to individuals in the following categories: • Nuveen Employees based in the US or Canada (except employees of Nuveen Natural Capital, unless the local/ designated Chief Compliance Officer and Nuveen Ethics Office determine otherwise). • Employees of any US-registered investment adviser who are based outside the US. • Consultants, interns, and temporary workers based in the US or Canada whose contract length is 90 days or more, unless the Nuveen Ethics Office determines otherwise. • TIAA Employees, consultants, interns, and temporary workers designated as Access Persons by the TIAA- CREF Funds Chief Compliance Officer or the Nuveen Ethics Office. Independent directors and trustees of the TIAA-CREF Funds Complex and Nuveen-sponsored or -branded funds have their own Code of Ethics and are not subject to this one. For individuals who are subject to the Code, there are two designations with different implications: Access Person and Investment Person. ACCESS PERSON All Nuveen Employees and TIAA Employees who are subject to the Code are considered Access Persons, since they have, or could have, access to non-public information about securities transactions and other investments, holdings, or recommendations for Affiliate-Advised Accounts or Portfolios. Key characteristics of this designation. An individual may be considered an Access Person of multiple advisers affiliated with Nuveen, or of only one. If your regular duties give you access to non-public information, or you are an officer of a Nuveen or TIAA-CREF sponsored or branded fund, your personal trading is generally monitored only against the trading activity of the specific adviser(s) or Affiliated Funds with which you are involved. For other employees, personal trading is typically monitored against the trading activities of all advisers affiliated with Nuveen. You will generally not be permitted to execute transactions in a security on any day when an Affiliate-Advised Account or Portfolio managed by the adviser(s) that you are monitored against has a pending buy or sell order for that security at the time of your pre- clearance request. INVESTMENT PERSON An Access Person who meets any of the following criteria will in addition be considered an Investment Person: • The Access Person is a Portfolio Manager, Research Analyst or Research Assistant, or they otherwise participate in making recommendations or decisions concerning the purchase or sale of securities in any Affiliate-Advised Account or Portfolio. • The Access Person has been designated an Investment Person by the affiliate Chief Compliance Officer or the Nuveen Ethics Office. Key characteristics of this designation. The vast majority of Investment Persons are employees of Nuveen’s affiliated investment advisers. An Investment Person is prohibited from transacting in securities during the period starting 7 calendar days before, and ending 7 calendar days after, any trade in an Affiliate-Advised Account or Portfolio for which he/she has responsibility. In addition, an Investment Person’s personal transactions will be reviewed for conflicts in the period starting 7 calendar days before, and ending 7 calendar days after, all trades by their associated investment adviser(s). In some cases, the Investment Person may be required to reverse a trade and/or forfeit an appropriate portion of any profit as determined by the Nuveen Ethics Office. These consequences can apply whether or not the trade was pre-cleared. The personal trading of Investment Persons is generally only monitored against the trading activity of the specific adviser(s) for which they have been designated an Investment Person.

Code of Ethics Page 2 of 9 Important to understand Some of our affiliated investment advisers may have supplemental policies of their own that impose additional rules on the same topics covered in this Code. Check with your manager or local/designated Chief Compliance Officer if you have questions. Personal trading is a privilege, not a right. Nuveen Employees are expected to follow the law and adhere to the highest standards of behavior—including with respect to personal trading. Any violation of the Code could have severe adverse effects on you, your co-workers, and Nuveen. You may be held personally liable for your conduct and be subject to fines, regulatory sanctions, and even criminal penalties. Because Nuveen can restrict your trading or take actions such as forcing you to hold a position or to disgorge profits, personal trading carries risks beyond normal market risks. Some requirements in this Code apply to Household Members. Each Household Member (see “Terms with Special Meanings” below) is subject to the same personal trading restrictions and requirements that apply to his/her related Nuveen Employee. The Code does not address every ethical issue that might arise. If you have any doubt at all after consulting the Code, contact the Nuveen Ethics Office for direction. The Code applies to appearance as well as substance. Always consider how any action might appear to an outside observer (such as a client or regulator). You are expected to follow the Code both in letter and in spirit. Literal compliance, such as pre-clearing a transaction, does not necessarily protect you from liability for conduct that violates the spirit of the Code. If you have questions about how to comply with this Code, consult the Nuveen Ethics Office. WHO TO CONTACT Nuveen Ethics Office (Americas) Hotline: 1 800 842 2733 extension 22-5599 nuveenethicsoffice@nuveen.com TERMS WITH SPECIAL MEANINGS Within this policy, these terms are defined as follows: Affiliate-Advised Account or Portfolio Any Affiliated Fund, or any portfolio or client account advised or sub- advised by Nuveen. Affiliated Fund Any TIAA-CREF or Nuveen branded or sponsored open-end fund, closed-end fund, or Exchange Traded Fund (ETF), and any third-party fund advised or sub-advised by Nuveen. Automatic Investment Plan Any program, such as a dividend reinvestment plan (DRIP), under which investment account purchases or withdrawals occur according to a predetermined schedule and allocation. Beneficial Ownership Any interest by which you or any Household Member—directly or indirectly—derives a monetary benefit from purchasing, selling, or owning a security or account, or exercises investment discretion. You have Beneficial Ownership of securities held in accounts in your own name, or any Household Member’s name, and in all other accounts over which you or any Household Member exercises or may exercise investment decision- making powers, or other influence or control, including trust, partnership, estate, and corporate accounts or other joint ownership or pooling arrangements. Code This Code of Ethics. Domestic Partner An individual who is neither a relative of nor legally married to a Nuveen Employee, but shares a residence and is in a mutual commitment similar to marriage with such Nuveen Employee. Federal Securities Laws The applicable portions of any of the following laws, as amended, and of any rules adopted under them by the Securities and Exchange Commission or the Department of the Treasury: • Securities Act of 1933. • Securities Exchange Act of 1934. • Investment Company Act of 1940. • Investment Advisers Act of 1940. • Sarbanes-Oxley Act of 2002. • Title V of the Gramm-Leach-Bliley Act. • The Bank Secrecy Act. Household Member Any of the following who reside, or are expected to reside for at least 90 days a year, in the same household as a Nuveen Employee: • Spouse or Domestic Partner. • Sibling. • Child, stepchild, grandchild. • Parent, stepparent, grandparent. • In-laws (mother, father, son, daughter, brother, sister). Independent Director Any director or trustee of an Affiliated Fund who is not an “interested person” within the meaning of Section 2(a)(19) of the Investment Company Act of 1940, as amended. Managed Account Any account, including robo-advised accounts, in which you or a Household Member has Beneficial Ownership and for which you have delegated full investment discretion in writing to a third- party broker or investment manager. Nuveen Nuveen, LLC and all of its direct or indirect subsidiaries worldwide. Confidential (C)

Code of Ethics Page 3 of 9 TERMS WITH SPECIAL MEANINGS (continued) Nuveen Employee Any full- or part-time employee of Nuveen, and any consultants, interns or temporary workers designated by the Nuveen Ethics Office. Private Placement Any offering exempt from registration under the Securities Act of 1933, such as a private equity investment, hedge fund, or limited partnership. A private investment in public equity (PIPE) is also considered a Private Placement. Reportable Account Any account for which you or a Household Member has Beneficial Ownership AND in which securities can be bought, sold or held. This includes, among others: • All brokerage, IRA, custodial and trust accounts. • All Managed Accounts. • All 529 College Savings Plan accounts. • Any TIAA 401(k) plan account. • Any 401(k) plan account that permits transactions in any Reportable Security. • Any direct holding in an Affiliated Fund. • Any health savings account (HSA) that permits the purchase of any security. • Any employee stock purchase plan (ESPP) or employee stock ownership plan (ESOP). The following are NOT considered Reportable Accounts: • Charitable giving accounts. • Any 401(k), 403(b), plan account, or any other account held directly with a mutual fund complex or mutual fund- only platform, and not held at a bank or broker-dealer, in which open-end, non-Affiliated Funds are the only possible investment. • Any cash management account with a broker in which a security cannot be purchased or sold. • Any accounts that can invest only in cryptocurrency such as Bitcoin or Ethereum. Reportable Security Any security EXCEPT: • Direct obligations of the US government (indirect obligations, such as Fannie Mae and Freddie Mac securities, are reportable). • Certificates of deposit, bankers’ acceptances, commercial paper, and high quality short-term debt (including repurchase agreements). • Money market funds. • Open-end funds that are not Affiliated Funds. • Note that closed-end funds are Reportable Securities. • Note that direct investments in cryptocurrency, such as Bitcoin, are not considered to be a security and are therefore not reportable. Reportable Transaction Any transaction involving a Reportable Security EXCEPT: • Transactions in Managed Accounts. Section 16 Persons: Transactions involving Nuveen closed-end funds in any of your Managed Accounts are reportable. • Transactions under an Automatic Investment Plan; note that transactions that override the pre-set schedule or allocation are reportable. • Dividends. • Interest Accrued. Section 16 Person Section 16 of the Exchange Act and the rules thereunder impose certain obligations on persons specified in section 30(h) of the Investment Company Act of 1940, as well as insiders of any public company that trades on a national stock exchange (such as a Nuveen closed-end fund). For purposes of Section 16, an “insider” is: • A director of a public company. • A designated officer of a public company. • A person who beneficially owns 10% or more of any class of equity security that is registered under Section 12 of the Exchange Act. • A portfolio manager of a Nuveen closed-end fund. Persons subject to Section 16 include, but are not limited to, portfolio managers of the Nuveen closed-end funds. TIAA Employee Any full- or part-time employee of TIAA, and any consultants, interns or temporary workers designated by the Nuveen Ethics Office. GENERAL RESTRICTIONS AND REQUIREMENTS BASIC PRINCIPLES 1. Never abuse a client’s trust, rights, or interests. This means you must never do any of the following: • Engage in any plan or action, or use any device, that would defraud or deceive a client. • Make any material statements of fact that are incorrect or misleading, either as to what they include or omit. • Engage in any manipulative practice. • Use your position (including any knowledge or access to opportunities you have gained by virtue of your position) to personal advantage or to a client’s disadvantage. This would include, for example, front-running or tailgating (trading directly before or after the execution of a large client trade order), or any attempt to influence a client’s trading to enhance the value of your personal holdings. • Conduct personal trading in any way that could be inconsistent with your fiduciary duties to a client (even if it does not technically violate the Code). 2. Handle conflicts of interest appropriately. This applies not only to actual conflicts of interest, but also to any situation that might appear to an outside observer to be improper or a breach of fiduciary duty. Confidential (C)

Code of Ethics Page 4 of 9 3. Keep confidential information confidential. Always properly safeguard any confidential information you obtain in the course of your work. This includes confidential information related to any of the following: • Any Affiliate-Advised Account or Portfolio and any other financial product offered or serviced by Nuveen. • New products, product changes, or business initiatives. • Past, current, and prospective clients, including their identities, investments, and account activity. “Keeping information confidential” means using discretion in disclosing information as well as guarding against unlawful or inappropriate access by others. This includes: • Making sure no confidential information is visible on your computer screen and desk when you are not there. • Not sharing passwords with others. • Using caution when discussing business in any location where your conversation could be overheard. Confidential information may be released only as required by law or as permitted under the applicable privacy policy(ies). Consult the Nuveen Ethics Office or your local/designated CCO before releasing any confidential information. 4. Handle Material Non-Public Information properly. Follow all terms described in “Material Non-Public Information” below. Be aware that any failure to handle such information properly is a serious offense and may lead to disciplinary action from Nuveen as well as serious civil or criminal liability. 5. Comply with Federal Securities Laws. Any violation of these laws is punishable as a violation of the Code. 6. Never do anything indirectly that, if done directly, would violate the Code. Such actions will be considered the equivalent of direct Code violations. 7. Promptly alert the Nuveen Ethics Office or your local/designated CCO of any actual or suspected wrongdoing. Examples of wrongdoing include violations of the Federal Securities Laws, misuse of corporate assets, misuse of confidential information, or other violations of the Code. If you prefer to report confidentially, call the TIAA Confidential Helpline at 1-877-774-6492. Note that failure to report suspected wrongdoing in a timely fashion is itself a violation of the Code. PRE-CLEARANCE AND HOLDING REQUIREMENTS 8. Pre-clear any trade in Reportable Securities, including certain Affiliated Funds (see box on next page for additional information). If your trade requires pre-clearance, request approval through the StarCompliance system (StarCompliance) before you or any Household Member places an order to buy or sell any Reportable Security. Any approval you receive expires at the end of the day it was granted; however, you may place after-hours trades in international markets until 11:59 PM local time on that day. When requesting pre-clearance, follow this process: • Request pre-clearance on the same day you want to trade, during standard US trading hours (9:30 AM to 4:00 PM ET). Be sure your pre-clearance request is accurate as to security and direction of trade. • Wait for approval to be displayed before trading. If you receive approval, you may only trade that same day, and only within the scope of approval. If you do not receive approval, do not trade • Place day orders only. Do not place good-till-canceled orders or limit orders that expire beyond the day of pre-clearance approval. You may place orders for an after-hours trading session or in foreign markets using that day’s pre-clearance approval, but you must not place any order that could remain open into the next day’s trading session. 9. Hold positions in securities that are subject to pre- clearance for 60 calendar days, or be prepared to forfeit any gains. Several things to note: • You may be required to surrender any gains realized (net of commissions) through a violation of this rule. • The 60-day holding requirement is tested on a last- in-first-out basis, across all of your holdings (not just within individual accounts). • The 60-day holding requirement extends to any options or other transactions that may have the same effect as a purchase or sale, and to all Reportable Securities except Exchange Traded Funds (ETFs), Exchange Traded Notes (ETNs), Unit Investment Trusts (UITs), and open-end Affiliated Funds. • Closed-end funds, including Nuveen branded or sponsored closed-end funds, are subject to the 60-day holding requirement. • You may sell the security on the 60th day after purchase, provided you obtain pre-clearance or an approved exemption applies. • You may re-purchase a security immediately after executing a sale of that same security subject to pre- clearance approval, which will trigger a new 60 calendar day holding period. • You may close a position at a loss at any time provided pre-clearance approval has been obtained, or an approved exemption applies. If your pre-clearance has been denied, it is advisable that you contact the Nuveen Ethics Office if you are seeking to sell at a loss within 60 days of your purchase. Note that if there are conflicts with any other provisions of the Code, your pre- clearance denial will not be overridden. Confidential (C)

Code of Ethics Page 5 of 9 10. Comply with trading restrictions described in the prospectuses for all Affiliated Funds. This includes restrictions on frequent trading in shares of any open-end Affiliated Fund. 11. Pre-clear any transaction in a Managed Account that involves your influence. You must also immediately consult with the Nuveen Ethics Office to discuss whether the account in question can properly remain classified as a Managed Account. 12. Obtain the required approvals before any transaction in a Private Placement, including PIPEs. Participation and approval for all transactions in Private Placements advised or sub-advised by Nuveen, is facilitated by the Nuveen Employee Investment Program (NuveenEIP@nuveen.com). For all other Private Placements, you must obtain approval for initial and subsequent commitments to invest but not sales/redemptions. Be aware that sales/ redemptions are Reportable Transactions. Approval is required even if the investment is made in a Managed Account. WHAT NEEDS TO BE PRE-CLEARED Pre-clearance required • All actively initiated trades in Reportable Securities, except those listed here under “No pre- clearance required.” • The sale of restricted stock or employee stock options accrued during prior employment or a Household Member’s employment require pre-clearance. If pre- clearance is denied, you may contact the Nuveen Ethics Office to request reconsideration. • You may liquidate a position recently acquired through inheritance or a spin-off, subject to pre-clearance approval. If your pre-clearance has been denied, you may contact the Nuveen Ethics Office to seek an exemption. Be aware that pre-clearance can be withdrawn even after it has been granted, and even after you have traded, if Nuveen later becomes aware of Affiliate-Advised Account or Portfolio trades whose existence would have resulted in denial of pre-clearance. In these cases, you may be required to reverse a trade and/or forfeit an appropriate portion of any profit, as determined by the Nuveen Ethics Office. Be aware that trades initiated by a broker to address the financial standing of an account can result in violations and will generally not be protected by the Code’s “actively initiated trade” language for trades requiring pre- clearances. Examples include, but are not limited to, brokers initiating trades in margin accounts, brokers initiating trades to cover account fees, and brokers initiating trades to remediate a minimum or negative cash balance in an account. Pre-clearance not required • Shares of any open-end mutual fund (including Affiliated Funds). Note that closed-end funds, including Nuveen branded or sponsored closed-end funds, require pre-clearance. • ETFs, ETNs, UITs (including options on ETFs and ETNs). • CDs and commercial paper. • Securities acquired or disposed of through actions outside your control or issued pro rata to all holders of the same class of investment, such as automatic dividend reinvestments, stock splits, mergers, spin-offs, or rights subscriptions. • The automatic exercise or liquidation by an exchange of a derivative instrument upon expiration or the delivery of securities pursuant to a written option that is exercised against you, and the assignment of options. • Sales pursuant to a bona fide tender offer. • Trades made through an Automatic Investment Plan that have been disclosed to the Nuveen Ethics Office in advance. • Trades in a Managed Account (except that you must pre-clear any trades that involve your influence, any initial purchases of Private Placements, purchases in any equity IPO, and any sales or redemptions of Private Placements that are branded, sponsored, advised or sub- advised by Nuveen). • Foreign currencies, including futures. • Commodity instruments. • Index options and index futures. • Direct investments in cryptocurrencies. • Crypto instruments that are comprised of and invest solely in cryptocurrencies. OTHER RESTRICTIONS 13. Never knowingly trade any security being traded or considered for trade by any Affiliate-Advised Account or Portfolio. This applies to employee transactions in securities that are exempt from pre- clearance and includes equivalent or related securities. For example, if a company’s common stock is being traded, you may face restrictions on trading any of the company’s debt, preferred, or foreign equivalent securities, and from trading or exercising any options based on the company’s securities. 14. Always prioritize client trades over personal trades. Your fiduciary duties to the client are far more important than your personal trading, which is a privilege and not a right. Never delay or in any way alter the timing or terms of a client trade for your personal benefit. 15. Do not engage in trading that involves single stock futures. 16. Do not engage in uncovered short sales of individual securities. Confidential (C)

Code of Ethics Page 6 of 9 17. You may trade options on individual securities, subject to the 60-day holding period. Options traded must have an expiration of at least 60 days from the date that you enter into the contract. You are not permitted to close an option at a profit within 60 days of having entered into the contract. The option contract can be closed in less than 60 days at a loss, provided pre- clearance approval has been obtained. 18. Never participate in an investment club or similar entity. 19. Do not engage in excessive or inappropriate trading activity. Never let personal trading interfere with your professional duties. The Nuveen Ethics Office will monitor for potentially excessive or inappropriate trading, and notify you, your manager, and your local/designated CCO for assessment. 20. Pre-clear the sale of securities in a margin account. Margin accounts are permitted, however you must obtain pre-clearance when selling to meet a margin call, even if the transaction is initiated by a broker. 21. Never purchase an IPO without advance approval. This includes Managed Accounts. Equity IPO participation is generally prohibited but approval may be granted in special circumstances, such as when: • You already have equity in the company and are offered shares. • You are a policy holder or depositor in a company that is demutualizing. • A Household Member has been offered shares as an employee. Purchases of initial offerings of SPACs, fixed income securities, convertible securities, preferred securities, open- and closed-end funds, commodity pools, and secondary equity offerings are generally permitted subject to prior approval from the Nuveen Ethics Office. MATERIAL NON-PUBLIC INFORMATION What is Material Non-Public Information? Material Non-Public Information is defined as information regarding any security, securities-based derivatives or issuer of a security that is both material and non-public. Information is material if both of the following are true: • A reasonable investor would likely consider it important when making an investment decision. • Public release of the information would likely affect the price of a security. Information is generally non-public if it has not been distributed through a widely used public medium, such as a press release or a report, filing or other periodic communication. Restrictions and requirements • Any time you think you might have, or may be about to, come into possession of Material Non-Public Information (whether in connection with your position at Nuveen or not), alert the Nuveen Ethics Office. Alternatively, you may alert your local/designated CCO or Legal office, who in turn must promptly notify the Nuveen Ethics Office. Follow the instructions you are given. • Until you receive further instructions from the Nuveen Ethics Office, your local/designated CCO, or Legal, do not take any action in relation to the information, including trading or recommending the relevant securities or communicating the information to anyone else. • Never make decisions on your own regarding potential Material Non-Public Information, including whether such information is actually Material Non-Public Information or what steps should be taken. • If the Nuveen Ethics Office, your local/designated CCO and/or Legal determine that you have Material Non- Public Information: – Do not buy, sell, gift, or otherwise dispose of the issuer’s securities, whether on behalf of an Affiliate-Advised Account or Portfolio, yourself, or anyone else. – Do not in any way recommend, encourage, or influence others to transact in the issuer’s securities, even if you do not specifically disclose or reference the Material Non- Public Information. – Do not communicate the Material Non-Public Information to anyone, whether inside or outside Nuveen, except in discussions with the Nuveen Ethics Office and Legal and as expressly permitted by any confidentiality agreement or supplemental policies and procedures of your business unit. • Please refer to Nuveen’s Material Non-Public Information and Insider Trading Policy for detailed information. Confidential (C)

Code of Ethics Page 7 of 9 REPORTING REQUIREMENTS UPON BECOMING A NUVEEN EMPLOYEE 22. Within 10 calendar days of starting at Nuveen, acknowledge receipt of the Code. This includes certifying that you have read the Code, understand it, recognize that you are subject to it, have complied with all of its applicable requirements, and have submitted all Code-required reports. 23. Within 10 calendar days of starting at Nuveen, use StarCompliance to report all of your Reportable Accounts and holdings in Reportable Securities. Report all Reportable Accounts using StarCompliance within 10 calendar days of starting at Nuveen, making sure that you include information about the broker, dealer, or bank through which the account is held and the type of account. You must report all holdings in Reportable Securities in StarCompliance within 10 calendar days by uploading the most recent statement. You must also enter each Reportable Security into StarCompliance as an initial holding if: 1) the account is an account type not required to be maintained with an approved broker as described in item 25 below (excluding Managed Accounts), or 2) you wish to sell a Reportable Security in an approved broker account, or in transition to an approved broker account, prior to the establishment of the broker’s electronic feed. For each Reportable Security, provide the security name and type, a ticker symbol or CUSIP, the number of shares or units held, and the principal amount (dollar value). This information must be no older than 45 calendar days before your first day of employment. Note that there are separate procedures for Managed Accounts, as described below in item 27. 24. Within 10 calendar days of starting at Nuveen, report all current investments in Private Placements (limited offerings). Limited offerings are Reportable Securities. 25. Within 30 calendar days of starting at Nuveen, move or close any Reportable Account that is not at an approved firm. This does not include Reportable Accounts that are 401(k), HSA, ESPP/ESOP, or 529 plans, or Reportable Accounts that cannot trade or hold Reportable Securities. Accounts held directly with a mutual fund complex or mutual fund only platform that are not held with a bank or broker-dealer, and in which open-end non-Affiliated Funds are the only possible investment are not reportable. Contact the Nuveen Ethics Office if you are unsure whether your account must be held with an approved firm. The list of approved firms is maintained by the Nuveen Ethics Office and may be accessed on StarCompliance. Under very limited circumstances, it may be possible to obtain a waiver to keep a Reportable Account at a non- approved firm. Examples include: • An account owned by a Household Member who works at another financial firm with comparable restrictions. • An account that holds securities that cannot be transferred. • An account that cannot be moved because of a trust agreement. To apply for an exception, contact the Nuveen Ethics Office. For any account granted an exception, you are required to upload statements for the account in StarCompliance based on the frequency with which a statement is generated for the account (e.g. monthly, quarterly). In all cases, if your accounts are not held at an approved firm, you must manually enter all Reportable Transactions in StarCompliance within 5 days of execution. Consultants and temporary workers are generally not required to move or close Reportable Accounts. 26. Within 30 calendar days of starting at Nuveen, seek approval to liquidate any securities held prior to starting at Nuveen that you do not wish to continue to hold. If you wish to liquidate securities that you held prior to joining Nuveen, seek approval by contacting the Nuveen Ethics Office within 30 calendar days of starting at Nuveen. If you do not liquidate securities during this time, you will generally forfeit this consideration for liquidation. WHEN OPENING ANY MANAGED ACCOUNT 27. Get pre-approval for any new Managed Account before any trading activity commences and report the account within 10 calendar days of the date you or a Household Member opens the account or an account becomes a Reportable Account through marriage, cohabitation, divorce, death, or another event. Using the appropriate form which may be accessed in StarCompliance, provide representations that support the classification of the account as a Managed Account. For an account to be classified as a Managed Account, the account owner must have no direct or indirect influence or control over the securities in the account. The form must be signed by the account’s broker or investment manager and by all account owners. The broker or investment manager may provide a Managed Account agreement or letter which substantiates the account as managed in lieu of signing the form. You may be asked periodically to confirm these representations or submit an updated form to confirm such. Confidential (C)

Code of Ethics Page 8 of 9 Note that upon request, you are also responsible for providing duplicate statements for the Managed Account to the Nuveen Ethics Office. WHEN OPENING ANY NEW REPORTABLE ACCOUNT 28. Report any new Reportable Account, including Managed Accounts. Do this in StarCompliance within 10 calendar days of the date you or a Household member opens the account or an account becomes a Reportable Account through marriage, cohabitation, divorce, death, or another event. EVERY QUARTER 29. Within 30 calendar days of the end of each calendar quarter, verify in StarCompliance that all Reportable Transactions made during that quarter have been reported. StarCompliance will display all transactions of yours for which it has received notice (except transactions in your TIAA pension and retirement plan accounts, which you are not required to report because the firm accesses this information directly). For any other Reportable Transactions not displayed, or displayed inaccurately, you are responsible for making any necessary revisions in StarCompliance prior to completing your certification. 30. For each Reportable Transaction, you must provide, as applicable, the transaction date, security name and type, ticker symbol or CUSIP, interest rate (coupon) and maturity date, number of shares, price at which the transaction was effected, principal amount (dollar value), the nature of the trade (buy or sell), and the name of the broker, dealer, or bank that effected the transaction. It is very important that you carefully review and verify the transactions and related details displayed in StarCompliance, checking for accuracy and completeness. Once again, if you find any errors or omissions, correct or add to your list of transactions in StarCompliance. EVERY YEAR 31. Within 45 calendar days of the end of each calendar year, acknowledge receipt of the most recent version of the Code and certify in StarCompliance as to your annual Reportable Security holdings and Reportable Accounts. The reporting must contain the information described in item 23 above and include your certification that you have reported all Reportable Accounts, and all holdings in Reportable Securities at year end. You are responsible for ensuring that all of your Reportable Accounts have been accurately reported in StarCompliance. If any of your holdings in Reportable Securities are not displayed in StarCompliance or are displayed inaccurately, you are responsible for entering adjustments and trade confirms or making any necessary revisions in StarCompliance to complete your certification. In addition, you must affirm each year through StarCompliance that each Managed Account is properly classified as a Managed Account, for yourself and on behalf of any Household Member. This affirmation does not require broker or investment manager involvement. You also must acknowledge any amendments to the Code that occur during the course of the year. ADDITIONAL RULES FOR SECTION 16 PERSONS • Pre-clear transactions in all closed-end funds through StarCompliance. Any requests involving Nuveen closed- end funds will be reviewed by Legal. • Pre-clear buy/sell transactions involving any Nuveen closed-end funds within your Managed Account(s). • When selling for a gain any securities you buy that are issued by the entity of which you are a Section 16 Person, make sure it is at least 6 months after your most recent purchase of that security. This rule extends to any options or other transactions that may have the same effect as a purchase or sale, and is tested on a last-in- first-out basis. You may be required to surrender any gains realized through a violation of this rule. Note that for any fund of which you are a Section 16 Person, no exception from pre-clearance is available. • Promptly email to the appropriate contact in Legal the details of all executed transactions in Nuveen closed-end funds of which you are a Section 16 Person. • See the Nuveen Funds Section 16 Policy and Procedures for additional information. If you are unsure whether you are a Section 16 Person, contact Legal or the Nuveen Ethics Office. Confidential (C)

Code of Ethics Page 9 of 9 CODE ADMINISTRATION Training You will be required to participate in training on the Code when joining Nuveen as well as periodically during the time you are subject to the Code. Exceptions The Code exists to prevent violations of law. The Nuveen Ethics Office may, under certain circumstances, grant waivers from a Code requirement. No waivers or exceptions that would violate any law will be granted. Monitoring The Nuveen Ethics Office is responsible for monitoring accounts, transactions, holdings and certifications for any violations of this Code. Consequences of violation Any individual who violates the Code is subject to penalty. Penalties could include, among other possibilities, a written warning, restriction of trading privileges, unwinding or reversing trades, disgorgement of trading profits, fines, and suspension or termination of employment. Applicable rules The Code has been adopted in recognition of Nuveen’s fiduciary obligations to clients and in accordance with various provisions of Rule 204A-1 under the Investment Advisers Act of 1940 and Rule 17j-1 under the Investment Company Act of 1940. This Code is also adopted by the Affiliated Funds advised by Nuveen Fund Advisors, LLC, TIAA-CREF Investment Management, LLC and Teachers Advisors, LLC under Rule 17j-1. Some elements of the Code also constitute part of Nuveen’s response to Financial Industry Regulatory Authority (FINRA) requirements that apply to registered personnel of Nuveen Securities, LLC. Confidential (C)

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kenneth Kencel, Chief Executive Officer of Nuveen Churchill Private Capital Income Fund, certify that:

1.I have reviewed this annual report on Form 10-K of Nuveen Churchill Private Capital Income Fund;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	February 29, 2024	By:	/s/ Kenneth Kencel
			Name: Kenneth Kencel
			Title: President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Shai Vichness, Chief Financial Officer of Nuveen Churchill Private Capital Income Fund, certify that:

1.I have reviewed this annual report on Form 10-K of Nuveen Churchill Private Capital Income Fund;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	February 29, 2024	By:	/s/ Shai Vichness
			Name: Shai Vichness
			Title: Chief Financial Officer and Treasurer

EX-32

Exhibit 32

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the annual report of Nuveen Churchill Private Capital Income Fund on Form 10-K for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned officers of Nuveen Churchill Private Capital Income Fund does hereby certify, to the best of such officer's knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Nuveen Churchill Private Capital Income Fund.

Date:	February 29, 2024
	/s/ Kenneth Kencel
	Name: Kenneth Kencel
	Title: President and Chief Executive Officer

Date:	February 29, 2024
	/s/ Shai Vichness
	Name: Shai Vichness
	Title: Chief Financial Officer and Treasurer

XML

Cover - USD ($)

12 Months Ended

Dec. 31, 2023

Feb. 29, 2024

Class of Stock [Line Items]

Document Type

10-K

Document Annual Report

true

Current Fiscal Year End Date

--12-31

Document Period End Date

Dec. 31, 2023

Document Transition Report

false

Securities Act File Number

001-04321

Entity Registrant Name

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

Entity Incorporation, State or Country Code

DE

Entity Tax Identification Number

88-6187397

Entity Address, Address Line One

375 Park Avenue, 9th Floor

Entity Address, City or Town

New York

Entity Address, State or Province

NY

Entity Address, Postal Zip Code

10152

City Area Code

212

Local Phone Number

478-9200

Entity Well-known Seasoned Issuer

No

Entity Voluntary Filers

No

Entity Current Reporting Status

Yes

Entity Interactive Data Current

Yes

Entity Filer Category

Non-accelerated Filer

Entity Small Business

false

Entity Emerging Growth Company

true

Entity Ex Transition Period

false

ICFR Auditor Attestation Flag

false

Document Financial Statement Error Correction [Flag]

false

Entity Shell Company

false

Entity Public Float

$ 0

Documents Incorporated by Reference

Portions of the registrant’s proxy statement to be filed with the U.S. Securities and Exchange Commission pursuant to Regulation 14A in connection with the registrant’s 2024 Annual Meeting of Shareholders, which will be filed subsequent to the date hereof, are incorporated by reference into Part III of this Form 10-K. Such proxy statement will be filed with the U.S. Securities and Exchange Commission not later than 120 days following the end of the registrant’s fiscal year ended December 31, 2023.

Entity Central Index Key

0001911066

Amendment Flag

false

Document Fiscal Year Focus

2023

Document Fiscal Period Focus

FY

Class S Common Shares

Class of Stock [Line Items]

Title of 12(g) Security

Class S common shares of beneficial interest, par value $0.01 per share

Entity Common Stock, Shares Outstanding

259,478

Class D Common Shares

Class of Stock [Line Items]

Title of 12(g) Security

Class D common shares of beneficial interest, par value $0.01 per share

Entity Common Stock, Shares Outstanding

241,439

Class I Common Shares

Class of Stock [Line Items]

Title of 12(g) Security

Class I common shares of beneficial interest, par value $0.01 per share

Entity Common Stock, Shares Outstanding

14,938,167

XML

Audit Information	12 Months Ended
	Dec. 31, 2023
Audit Information [Abstract]
Auditor Firm ID	238
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	New York, New York

XML

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Investments
Non-controlled/non-affiliate company investments, at fair value (amortized cost of $516,168 and $352,998, respectively)	$ 512,036	$ 349,518
Cash and cash equivalents	8,679	65,785
Due from affiliate expense support (See Note 5)	2,968	2,215
Interest receivable	5,758	4,282
Receivable for investments sold	161	196
Prepaid expenses	41	29
Total assets	529,643	422,025
Liabilities (See Note 6)
Secured Debt	165,001	154,353
Distributions payable	3,584	3,109
Payable for investments purchased	338	0
Interest payable	630	533
Due to affiliate expense support (See Note 5)	2,968	2,215
Board of Trustees' fees payable	128	128
Accounts payable and accrued expenses	2,163	1,386
Total liabilities	174,812	161,724
Commitments and contingencies (See Note 7)
Net Assets: (See Note 8)
Paid-in-capital in excess of par value	357,241	263,396
Total distributable earnings (loss)	(2,553)	(3,200)
Total net assets	354,831	260,301	[1]
Total liabilities and net assets	529,643	422,025
Class S Common Shares
Net Assets: (See Note 8)
Common Stock, Value, Issued	$ 1	$ 0
Net asset value per share (in dollars per share)	$ 24.69	$ 0
Class D Common Shares
Net Assets: (See Note 8)
Common Stock, Value, Issued	$ 1	$ 0
Net asset value per share (in dollars per share)	$ 24.73	$ 0
Class I Common Shares
Net Assets: (See Note 8)
Common Stock, Value, Issued	$ 141	$ 105
Net asset value per share (in dollars per share)	$ 24.73	$ 24.70
Non-controlled/Non-affiliated
Investments
Non-controlled/non-affiliate company investments, at fair value (amortized cost of $516,168 and $352,998, respectively)	$ 512,036	$ 349,518

[1] Period from February 8, 2022 (inception) through December 31, 2022

XML

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Cost	$ 516,168	$ 352,998
Deferred financing costs	$ 749	$ 647
Class S Common Shares
Common stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Common shares, shares issued (in shares)	149,838	0
Common shares, shares outstanding (in shares)	149,838	0
Class D Common Shares
Common stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Common shares, shares issued (in shares)	107,266	0
Common shares, shares outstanding (in shares)	107,266	0
Class I Common Shares
Common stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Common shares, shares issued (in shares)	14,091,386	10,540,040
Common shares, shares outstanding (in shares)	14,091,386	10,540,040
Non-controlled/Non-affiliated
Cost	$ 516,168	$ 352,998

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)		11 Months Ended		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2023
Investment income:
Payment-in-kind interest income				$ 2,333,000
Dividend income		$ 0		123,000
Other income		504,000		178,000
Expenses:
Organizational expenses		1,081,000	[1]	0
Interest and debt financing expenses		4,083,000	[1]	10,752,000
Interest expense on Note (See Note 5)		226,000	[1]	0
Professional fees		708,000	[1]	762,000
Management fees		0	[1]	1,292,000
Income based incentive fees		0	[1]	3,108,000
Board of Trustees’ fees		385,000	[1]	508,000
Administration fees		299,000	[1]	517,000
Other general and administrative expenses		260,000	[1]	682,000
Distribution and shareholder servicing fees		0
Offering costs		228,000	[1]	659,000
Total expenses		7,270,000	[1]	18,286,000
Expense support (See Note 5)		(1,558,000)	[1]	(750,000)
Management fees waived (Note 4)		0	[1]	(1,292,000)
Incentive fees waived (Note 4)		0	[1]	(3,108,000)
Net expenses		5,712,000	[1]	13,136,000
Net investment income before excise taxes		16,808,000	[1]	34,698,000
Excise taxes		2,000	[1]	31,000
Net investment income (loss)		16,806,000	[1],[2]	34,667,000
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments		(347,000)	[3]	768,000
Net change in unrealized appreciation (depreciation):
Non-controlled/non-affiliated company investments		(3,480,000)	[3]	(652,000)
Income tax (provision) benefit		0		61,000
Net increase (decrease) in net assets resulting from operations		$ 12,979,000	[1],[2]	$ 34,722,000
Per share data:
Weighted average common shares outstanding - basic (in shares)		0	[1]	11,644,451
Weighted average common shares outstanding - diluted (in shares)				53,295
Class S Common Shares
Expenses:
Distribution and shareholder servicing fees		$ 0	[1]	$ 5,000
Per share data:
Net investment income (loss) per share - basic (in dollars per share)		$ 0	[1]	$ 0.73
Net investment income (loss) per share - diluted (in dollars per share)		0	[1]	0.73
Net increase (decrease) in net assets resulting from operations per share (in dollars per share)		$ 0	[1]	$ 0.90
Weighted average common shares outstanding - basic (in shares)		0	[1]	88,660
Weighted average common shares outstanding - diluted (in shares)		0	[1]	88,660
Class D Common Shares
Expenses:
Distribution and shareholder servicing fees		$ 0	[1]	$ 1,000
Per share data:
Net investment income (loss) per share - basic (in dollars per share)		$ 0	[1]	$ 0.76
Net investment income (loss) per share - diluted (in dollars per share)		0		0.76
Net increase (decrease) in net assets resulting from operations per share (in dollars per share)		$ 0	[1]	$ 0.98
Weighted average common shares outstanding - basic (in shares)				53,295
Weighted average common shares outstanding - diluted (in shares)	[1]	0
Class I Common Shares
Per share data:
Net investment income (loss) per share - basic (in dollars per share)		$ 1.60		$ 2.97
Net investment income (loss) per share - diluted (in dollars per share)		1.60		2.97
Net increase (decrease) in net assets resulting from operations per share (in dollars per share)		$ 1.24	[1]	$ 2.98
Weighted average common shares outstanding - basic (in shares)	[1]	10,501,989
Weighted average common shares outstanding - diluted (in shares)		10,501,989	[1]	11,644,451
Non-controlled/Non-affiliated
Investment income:
Interest income		$ 20,741,000	[1]	$ 45,200,000
Payment-in-kind interest income		1,275,000	[1]	2,333,000
Dividend income		0	[1]	123,000
Other income		504,000	[1]	178,000
Total investment income		22,520,000	[1]	47,834,000
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments		(347,000)	[1]	768,000
Net change in unrealized appreciation (depreciation):
Non-controlled/non-affiliated company investments		(3,480,000)	[1]	(652,000)
Income tax (provision) benefit		0	[1]	(61,000)
Total net change in unrealized gain (loss)		(3,480,000)	[1]	(713,000)
Total net realized and unrealized gain (loss) on investments		$ (3,827,000)	[1]	$ 55,000

[1] Period from February 8, 2022 (inception) through December 31, 2022

[2] Period from February 8, 2022 (inception) through December 31, 2022

[3] Period from February 8, 2022 (inception) through December 31, 2022

XML

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS - USD ($) $ in Thousands		11 Months Ended		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2023
Increase (decrease) in net assets resulting from operations:
Net investment income (loss)		$ 16,806	[1],[2]	$ 34,667
Net realized gain (loss) on investments		(347)	[1]	768
Total net change in unrealized gain (loss)		(3,480)	[1]	(713)
Net increase (decrease) in net assets resulting from operations		12,979	[1],[2]	34,722
Shareholder Distributions:
Net increase (decrease) in net assets resulting from shareholder distributions		(16,179)	[1]	(33,889)
Capital share transactions:
Total increase (decrease) in net assets		260,301	[1]	94,530
Net assets, at beginning of period	[1]	0		260,301
Net assets, at end of period		260,301	[1]	354,831
Class S Common Shares
Shareholder Distributions:
Shareholder distributions		0	[1]	(61)
Capital share transactions:
Issuance of common shares, net		0	[1]	3,671
Reinvestment of shareholder distributions		0	[1]	10
Net increase (decrease) in net assets resulting from capital share transactions		0	[1]	3,681
Class D Common Shares
Shareholder Distributions:
Shareholder distributions		0	[1]	(39)
Capital share transactions:
Issuance of common shares, net		0	[1]	2,629
Reinvestment of shareholder distributions		0	[1]	9
Net increase (decrease) in net assets resulting from capital share transactions		0	[1]	2,638
Class I Common Shares
Shareholder Distributions:
Shareholder distributions		(16,179)	[1]	(33,789)
Capital share transactions:
Issuance of common shares, net		263,501	[1]	86,550
Reinvestment of shareholder distributions		0	[1]	828
Net increase (decrease) in net assets resulting from capital share transactions		$ 263,501	[1]	$ 87,378

[1] Period from February 8, 2022 (inception) through December 31, 2022

[2] Period from February 8, 2022 (inception) through December 31, 2022

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		11 Months Ended		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2023
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations		$ 12,979	[1],[2]	$ 34,722
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities
Purchase of investments		(93,554)	[3]	(206,879)
Proceeds from principal repayments and sales of investments		38,221	[3]	47,485
Payment-in-kind interest		(1,275)	[3]	(2,333)
Amortization of premium/accretion of discount, net		(506)	[3]	(820)
Net realized (gain) loss on investments		347	[3]	(768)
Net change in unrealized (appreciation) depreciation on investments		3,480	[3]	652
Amortization of deferred financing costs		14	[3]	174
Changes in operating assets and liabilities:
Due from affiliate expense support		(2,215)	[3]	(753)
Receivable for investments sold		(196)	[3]	35
Interest receivable		(4,282)	[3]	(1,330)
Prepaid expenses		(29)	[3]	(12)
Payable for investments purchased		0	[3]	338
Interest payable		533	[3]	97
Due to affiliate expense support		2,215	[3]	753
Board of Trustees' fees payable		128	[3]	0
Accounts payable and accrued expenses		985	[3]	777
Net cash provided by (used in) operating activities		(43,155)	[3]	(127,862)
Cash flows from financing activities:
Proceeds from issuance of common shares		1	[3]	92,850
Proceeds from secured borrowings		162,500	[3]	135,250
Repayments of secured borrowings		(7,500)	[3]	(124,500)
Repayments of Note		(32,731)	[3]	0
Distributions paid		(13,070)	[3]	(32,568)
Payments of deferred financing costs		(260)	[3]	(276)
Net cash provided by (used in) financing activities		108,940	[3]	70,756
Net increase (decrease) in cash and cash equivalents		65,785	[3]	(57,106)
Cash and cash equivalents, beginning of period	[3]	0		65,785
Cash and cash equivalents, end of period		65,785	[3]	8,679
Supplemental information and non-cash activities:
Purchases of investments		(296,231)	[3]	0
Cash paid during the period for interest		3,702	[3]	10,482
Financing costs paid through expense support		462	[3]	2
Amortization of deferred financing costs paid through expense support		60	[3]	0
Cash paid during the period for excise taxes		0	[3]	2
Issuance of Class I common shares, net		263,500	[3]	0
Reinvestment of Shareholder Distributions		$ 0	[3]	$ 847

[1] Period from February 8, 2022 (inception) through December 31, 2022

[2] Period from February 8, 2022 (inception) through December 31, 2022

[3] Period from February 8, 2022 (inception) through December 31, 2022

XML

CONSOLIDATED SCHEDULE OF INVESTMENTS - USD ($) shares in Thousands, $ in Thousands		Dec. 31, 2023		Dec. 31, 2022
Schedule of Investments [Line Items]
Cost		$ 523,758		$ 352,998
Fair Value		$ 519,626		$ 349,518
Fair Value as % of Net Assets		146.43%	[1]	134.27%	[2]
Debt Securities
Schedule of Investments [Line Items]
Cost		$ 506,746		$ 349,421
Fair Value		$ 501,812		$ 345,180
Fair Value as % of Net Assets		141.42%	[1]	132.60%	[2]
Equity Investments
Schedule of Investments [Line Items]
Cost		$ 9,422		$ 3,577
Fair Value		$ 10,224		$ 4,338
Fair Value as % of Net Assets		2.88%	[1]	1.67%	[2]
Cash Equivalents
Schedule of Investments [Line Items]
Cost		$ 7,590
Fair Value		$ 7,590
Fair Value as % of Net Assets	[1]	2.13%
Aerospace & Defense | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 9,270
Fair Value		$ 9,258
Fair Value as % of Net Assets	[1]	2.61%
Aerospace & Defense | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 1,256
Fair Value		$ 1,322
Fair Value as % of Net Assets	[1]	0.37%
Automotive | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 5,640		$ 3,918
Fair Value		$ 5,643		$ 3,893
Fair Value as % of Net Assets		1.59%	[1]	1.50%	[2]
Automotive | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 160
Fair Value		$ 208
Fair Value as % of Net Assets		0.05%
Banking, Finance, Insurance, Real Estate | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 7,647		$ 375
Fair Value		$ 7,558		$ 266
Fair Value as % of Net Assets		2.13%	[1]	0.10%	[2]
Banking, Finance, Insurance, Real Estate | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 77
Fair Value		$ 80
Fair Value as % of Net Assets	[1]	0.02%
Beverage, Food & Tobacco | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 52,250		$ 43,357
Fair Value		$ 51,892		$ 43,015
Fair Value as % of Net Assets		14.62%	[1]	16.53%	[2]
Beverage, Food & Tobacco | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 1,180		$ 681
Fair Value		$ 1,325		$ 831
Fair Value as % of Net Assets		0.38%	[1]	0.32%	[2]
Capital Equipment | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 21,670		$ 6,891
Fair Value		$ 21,704		$ 6,937
Fair Value as % of Net Assets		6.12%	[1]	2.66%	[2]
Chemicals, Plastics, & Rubber | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 19,468		$ 14,083
Fair Value		$ 18,707		$ 13,976
Fair Value as % of Net Assets		5.27%	[1]	5.37%	[2]
Chemicals, Plastics, & Rubber | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 504		$ 504
Fair Value		$ 759		$ 980
Fair Value as % of Net Assets		0.21%	[1]	0.38%	[2]
Construction & Building | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 24,086		$ 15,713
Fair Value		$ 24,107		$ 15,568
Fair Value as % of Net Assets		6.79%	[1]	5.98%	[2]
Construction & Building | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 330		$ 212
Fair Value		$ 387		$ 219
Fair Value as % of Net Assets		0.11%	[1]	0.08%	[2]
Consumer Goods: Durable | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 19,577		$ 15,875
Fair Value		$ 19,237		$ 15,653
Fair Value as % of Net Assets		5.42%	[1]	6.01%	[2]
Consumer Goods: Non-Durable | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 29,979		$ 26,344
Fair Value		$ 29,773		$ 26,157
Fair Value as % of Net Assets		8.39%	[1]	10.05%	[2]
Consumer Goods: Non-Durable | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 763		$ 228
Fair Value		$ 810		$ 263
Fair Value as % of Net Assets		0.22%	[1]	0.10%	[2]
Containers, Packaging & Glass | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 17,357		$ 16,335
Fair Value		$ 17,312		$ 16,303
Fair Value as % of Net Assets		4.89%	[1]	6.26%	[2]
Containers, Packaging & Glass | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 780		$ 719
Fair Value		$ 555		$ 774
Fair Value as % of Net Assets		0.16%	[1]	0.30%	[2]
Energy: Electricity | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 2,206
Fair Value		$ 2,201
Fair Value as % of Net Assets	[1]	0.62%
Energy: Oil & Gas | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 16,313		$ 21,951
Fair Value		$ 15,767		$ 21,275
Fair Value as % of Net Assets		4.44%	[1]	8.17%	[2]
Environmental Industries | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 15,574		$ 7,734
Fair Value		$ 15,570		$ 7,661
Fair Value as % of Net Assets		4.39%	[1]	2.94%	[2]
Healthcare & Pharmaceuticals | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 51,863		$ 25,919
Fair Value		$ 51,446		$ 25,541
Fair Value as % of Net Assets		14.50%	[1]	9.81%	[2]
Healthcare & Pharmaceuticals | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 162
Fair Value		$ 173
Fair Value as % of Net Assets	[1]	0.05%
High Tech Industries | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 24,343		$ 9,449
Fair Value		$ 24,352		$ 9,414
Fair Value as % of Net Assets		6.87%	[1]	3.62%	[2]
High Tech Industries | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 119		$ 119
Fair Value		$ 285		$ 158
Fair Value as % of Net Assets		0.08%	[1]	0.06%	[2]
Hotel, Gaming & Leisure | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 2,252
Fair Value		$ 2,253
Fair Value as % of Net Assets	[1]	0.63%
Media: Advertising, Printing & Publishing | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 6,844		$ 6,906
Fair Value		$ 6,833		$ 6,916
Fair Value as % of Net Assets		1.93%	[1]	2.66%	[2]
Media: Broadcasting & Subscription | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 4,087
Fair Value		$ 4,092
Fair Value as % of Net Assets	[1]	1.15%
Metals and Mining | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 501
Fair Value		$ 502
Fair Value as % of Net Assets	[1]	0.14%
Services: Business | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 84,946		$ 59,479
Fair Value		$ 83,907		$ 58,583
Fair Value as % of Net Assets		23.64%	[1]	22.51%	[2]
Services: Business | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 2,262		$ 865
Fair Value		$ 2,223		$ 782
Fair Value as % of Net Assets		0.63%	[1]	0.30%	[2]
Services: Consumer | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 28,194		$ 23,623
Fair Value		$ 27,747		$ 23,088
Fair Value as % of Net Assets		7.82%	[1]	8.87%	[2]
Services: Consumer | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 1,473		$ 142
Fair Value		$ 1,573		$ 151
Fair Value as % of Net Assets		0.45%	[1]	0.06%	[2]
Sovereign & Public Finance | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 3,596		$ 3,617
Fair Value		$ 3,705		$ 3,607
Fair Value as % of Net Assets		1.04%	[1]	1.39%	[2]
Sovereign & Public Finance | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 107		$ 107
Fair Value		$ 237		$ 180
Fair Value as % of Net Assets		0.07%	[1]	0.07%	[2]
Telecommunications | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 12,301		$ 6,894
Fair Value		$ 11,907		$ 6,720
Fair Value as % of Net Assets		3.36%	[1]	2.58%	[2]
Transportation: Cargo | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 11,828		$ 10,902
Fair Value		$ 11,867		$ 10,901
Fair Value as % of Net Assets		3.34%	[1]	4.18%	[2]
Transportation: Consumer | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 3,813
Fair Value		$ 3,816
Fair Value as % of Net Assets	[1]	1.08%
Transportation: Consumer | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 137
Fair Value		$ 175
Fair Value as % of Net Assets	[1]	0.05%
Utilities: Electric | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 2,474
Fair Value		$ 2,505
Fair Value as % of Net Assets	[1]	0.71%
Utilities: Electric | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 112
Fair Value		$ 112
Fair Value as % of Net Assets	[1]	0.03%
Wholesale | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 28,667		$ 30,056
Fair Value		$ 28,151		$ 29,706
Fair Value as % of Net Assets		7.93%	[1]	11.41%	[2]
Investment, Identifier [Axis]: A Place for Mom, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[3],[4],[5]	4.50%	[6],[7],[8],[9]
Interest Rate		9.97%	[3],[4],[5]	9.09%	[6],[7],[8],[9]
Par Amount / Unit		$ 6,851	[3],[4]	$ 6,936	[6],[7],[8]
Cost		6,851	[3],[4]	6,936	[6],[7],[8]
Fair Value		$ 6,764	[3],[4]	$ 6,657	[6],[7],[8]
Fair Value as % of Net Assets		1.90%	[1],[3],[4]	2.56%	[2],[6],[7],[8]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[3],[4],[5],[10]	6.00%	[6],[7],[8],[9]
Interest Rate		11.68%	[3],[4],[5],[10]	10.59%	[6],[7],[8],[9]
Par Amount / Unit		$ 4,941	[3],[4],[10]	$ 4,848	[6],[7],[8]
Cost		4,904	[3],[4],[10]	4,807	[6],[7],[8]
Fair Value		$ 4,618	[3],[4],[10]	$ 4,800	[6],[7],[8]
Fair Value as % of Net Assets		1.30%	[1],[3],[4],[10]	1.84%	[2],[6],[7],[8]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[3],[4],[5],[10],[11]	6.00%	[6],[7],[8],[9],[12]
Interest Rate		11.68%	[3],[4],[5],[10],[11]	10.59%	[6],[7],[8],[9],[12]
Par Amount / Unit		$ 920	[3],[4],[10],[11]	$ 1,000	[6],[7],[8],[12]
Cost		0	[3],[4],[10],[11]	0	[6],[7],[8],[12]
Fair Value		$ (60)	[3],[4],[10],[11]	$ (10)	[6],[7],[8],[12]
Fair Value as % of Net Assets		(0.02%)	[1],[3],[4],[10],[11]	0.00%	[2],[6],[7],[8],[12]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[3],[4],[5],[10],[11]	6.00%	[6],[7],[8],[9],[12]
Interest Rate		11.68%	[3],[4],[5],[10],[11]	10.59%	[6],[7],[8],[9],[12]
Par Amount / Unit		$ 1,000	[3],[4],[10],[11]	$ 150	[6],[7],[8],[12]
Cost		0	[3],[4],[10],[11]	0	[6],[7],[8],[12]
Fair Value		$ (65)	[3],[4],[10],[11]	$ (1)	[6],[7],[8],[12]
Fair Value as % of Net Assets		(0.02%)	[1],[3],[4],[10],[11]	0.00%	[2],[6],[7],[8],[12]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 3
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[7],[8],[9],[12]			6.00%
Interest Rate	[6],[7],[8],[9],[12]			10.59%
Par Amount / Unit	[6],[7],[8],[12]			$ 1,000
Cost	[6],[7],[8],[12]			0
Fair Value	[6],[7],[8],[12]			$ (10)
Fair Value as % of Net Assets	[2],[6],[7],[8],[12]			0.00%
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) 1
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 142	[4],[10],[15],[16]	$ 142	[8],[13],[14]
Fair Value		$ 91	[4],[10],[15],[16]	$ 151	[8],[13],[14]
Fair Value as % of Net Assets		0.03%	[1],[4],[10],[15],[16]	0.06%	[2],[8],[13],[14]
Share / Unit		1,419	[4],[10],[15],[16]	1	[8],[13],[14]
Investment, Identifier [Axis]: ALKU Intermediate Holdings, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4],[5]	6.25%
Interest Rate	[1],[3],[4],[5]	11.61%
Par Amount / Unit	[1],[3],[4]	$ 2,711
Cost	[1],[3],[4]	2,660
Fair Value	[1],[3],[4]	$ 2,688
Fair Value as % of Net Assets	[1],[3],[4]	0.75%
Investment, Identifier [Axis]: AMC Buyer, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[8],[9]			5.50%
Interest Rate	[6],[8],[9]			10.09%
Par Amount / Unit	[6],[8]			$ 6,947
Cost	[6],[8]			6,919
Fair Value	[6],[8]			$ 6,947
Fair Value as % of Net Assets	[2],[6],[8]			2.67%
Investment, Identifier [Axis]: ARMstrong
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.25%
Interest Rate	[3],[4],[5]	11.70%
Par Amount / Unit	[3],[4]	$ 2,996
Cost	[3],[4]	2,953
Fair Value	[3],[4]	$ 2,954
Fair Value as % of Net Assets	[1],[3],[4]	0.83%
Investment, Identifier [Axis]: ARMstrong (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.25%
Interest Rate	[3],[4],[5],[11]	11.70%
Par Amount / Unit	[3],[4],[11]	$ 1,007
Cost	[3],[4],[11]	(7)
Fair Value	[3],[4],[11]	$ (14)
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.00%
Investment, Identifier [Axis]: ASTP Holdings Co-Investment LP
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 137
Fair Value	[4],[15],[16]	$ 175
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.05%
Share / Unit	[4],[15],[16]	160,609
Investment, Identifier [Axis]: Acclaim MidCo, LLC (dba ClaimLogiQ)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.00%
Interest Rate	[3],[4],[5]	11.35%
Par Amount / Unit	[3],[4]	$ 2,216
Cost	[3],[4]	2,174
Fair Value	[3],[4]	$ 2,196
Fair Value as % of Net Assets	[1],[3],[4]	0.62%
Investment, Identifier [Axis]: Acclaim MidCo, LLC (dba ClaimLogiQ) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.00%
Interest Rate	[3],[4],[5],[11]	11.35%
Par Amount / Unit	[3],[4],[11]	$ 891
Cost	[3],[4],[11]	(4)
Fair Value	[3],[4],[11]	$ (8)
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.00%
Investment, Identifier [Axis]: Accupac, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[3],[4],[5],[10]	5.50%	[6],[7],[8],[9]
Interest Rate		11.52%	[3],[4],[5],[10]	10.09%	[6],[7],[8],[9]
Par Amount / Unit		$ 6,875	[3],[4],[10]	$ 6,946	[6],[7],[8]
Cost		6,859	[3],[4],[10]	6,923	[6],[7],[8]
Fair Value		$ 6,625	[3],[4],[10]	$ 6,815	[6],[7],[8]
Fair Value as % of Net Assets		1.87%	[1],[3],[4],[10]	2.62%	[2],[6],[7],[8]
Investment, Identifier [Axis]: Adient US LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.25%
Interest Rate	[3],[5],[17],[18]	8.72%
Par Amount / Unit	[3],[17],[18]	$ 875
Cost	[3],[17],[18]	878
Fair Value	[3],[17],[18]	$ 879
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.25%
Investment, Identifier [Axis]: Air Canada
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.50%
Interest Rate	[3],[5],[17],[18]	9.14%
Par Amount / Unit	[3],[17],[18]	$ 996
Cost	[3],[17],[18]	999
Fair Value	[3],[17],[18]	$ 1,001
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.28%
Investment, Identifier [Axis]: AirX Climate Solutions Company
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 77
Fair Value	[4],[15],[16]	$ 96
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.03%
Share / Unit	[4],[15],[16]	96
Investment, Identifier [Axis]: AmSpec Group, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[7],[8],[9]			5.75%
Interest Rate	[6],[7],[8],[9]			10.52%
Par Amount / Unit	[6],[7],[8]			$ 6,946
Cost	[6],[7],[8]			6,946
Fair Value	[6],[7],[8]			$ 6,945
Fair Value as % of Net Assets	[2],[6],[7],[8]			2.67%
Investment, Identifier [Axis]: American Student Transportaton Partners, Inc
Schedule of Investments [Line Items]
Interest Rate	[4],[5]	10.00%
Interest Rate, PIK	[4],[5]	3.50%
Par Amount / Unit	[4]	$ 1,606
Cost	[4]	1,564
Fair Value	[4]	$ 1,564
Fair Value as % of Net Assets	[1],[4]	0.44%
Investment, Identifier [Axis]: Apex Services Partners, LLC (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[7],[8],[9]			5.50%
Interest Rate	[6],[7],[8],[9]			10.09%
Par Amount / Unit	[6],[7],[8]			$ 3,000
Cost	[6],[7],[8]			2,987
Fair Value	[6],[7],[8]			$ 2,981
Fair Value as % of Net Assets	[2],[6],[7],[8]			1.14%
Investment, Identifier [Axis]: Apex Services Partners, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[7],[8],[9]			5.50%
Interest Rate	[6],[7],[8],[9]			10.09%
Par Amount / Unit	[6],[7],[8]			$ 3,000
Cost	[6],[7],[8]			2,973
Fair Value	[6],[7],[8]			$ 2,981
Fair Value as % of Net Assets	[2],[6],[7],[8]			1.14%
Investment, Identifier [Axis]: Aramsco
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10]	4.75%
Interest Rate	[3],[4],[5],[10]	10.10%
Par Amount / Unit	[3],[4],[10]	$ 2,980
Cost	[3],[4],[10]	2,921
Fair Value	[3],[4],[10]	$ 2,923
Fair Value as % of Net Assets	[1],[3],[4],[10]	0.82%
Investment, Identifier [Axis]: Aramsco (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10],[11]	4.75%
Interest Rate	[3],[4],[5],[10],[11]	10.10%
Par Amount / Unit	[3],[4],[10],[11]	$ 520
Cost	[3],[4],[10],[11]	0
Fair Value	[3],[4],[10],[11]	$ (10)
Fair Value as % of Net Assets	[1],[3],[4],[10],[11]	0.00%
Investment, Identifier [Axis]: Arise Holdings Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.25%	[3],[4],[5]	4.25%	[6],[8],[9]
Interest Rate		9.73%	[3],[4],[5]	8.84%	[6],[8],[9]
Par Amount / Unit		$ 6,875	[3],[4]	$ 6,946	[6],[8]
Cost		6,840	[3],[4]	6,894	[6],[8]
Fair Value		$ 6,452	[3],[4]	$ 6,720	[6],[8]
Fair Value as % of Net Assets		1.83%	[1],[3],[4]	2.58%	[2],[6],[8]
Investment, Identifier [Axis]: Arsenal AIC Parent LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17]	4.50%
Interest Rate	[3],[5],[17]	9.86%
Par Amount / Unit	[3],[17]	$ 499
Cost	[3],[17]	501
Fair Value	[3],[17]	$ 502
Fair Value as % of Net Assets	[1],[3],[17]	0.14%
Investment, Identifier [Axis]: BPC Kodiak LLC (Turbine Engine Specialist, Inc)
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 1,180
Fair Value	[4],[15],[16]	$ 1,245
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.35%
Share / Unit	[4],[15],[16]	1,180,000
Investment, Identifier [Axis]: Bakeovations Intermediate, LLC (d/b/a Commercial Bakeries)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[18],[19]	6.25%
Interest Rate	[3],[4],[5],[18],[19]	11.60%
Par Amount / Unit	[3],[4],[18],[19]	$ 4,236
Cost	[3],[4],[18],[19]	4,156
Fair Value	[3],[4],[18],[19]	$ 4,152
Fair Value as % of Net Assets	[1],[3],[4],[18],[19]	1.17%
Investment, Identifier [Axis]: Belron Finance US LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.43%
Interest Rate	[3],[5],[17],[18]	8.07%
Par Amount / Unit	[3],[17],[18]	$ 871
Cost	[3],[17],[18]	874
Fair Value	[3],[17],[18]	$ 874
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.24%
Investment, Identifier [Axis]: BroadcastMed Holdco, LLC
Schedule of Investments [Line Items]
Interest Rate		10.00%	[4],[5]	10.00%	[8],[9]
Interest Rate, PIK		3.75%	[4],[5]	3.75%	[8],[9]
Par Amount / Unit		$ 2,673	[4]	$ 2,649	[8]
Cost		2,627	[4]	2,597	[8]
Fair Value		$ 2,587	[4]	$ 2,598	[8]
Fair Value as % of Net Assets		0.73%	[1],[4]	1.00%	[2],[8]
Investment, Identifier [Axis]: BroadcastMed Holdco, LLC 1
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 655	[4],[16]	$ 655	[8],[13],[14]
Fair Value		$ 682	[4],[16]	$ 655	[8],[13],[14]
Fair Value as % of Net Assets		0.19%	[1],[4],[16]	0.25%	[2],[8],[13],[14]
Share / Unit		43,679	[4],[16]	44	[8],[13],[14]
Investment, Identifier [Axis]: Brown & Joseph, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[8],[9]			5.75%
Interest Rate	[6],[8],[9]			10.34%
Par Amount / Unit	[6],[8]			$ 6,945
Cost	[6],[8]			6,896
Fair Value	[6],[8]			$ 6,920
Fair Value as % of Net Assets	[2],[6],[8]			2.66%
Investment, Identifier [Axis]: CDI AcquisitionCo, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.25%	[3],[4],[5]	4.50%	[6],[8],[9]
Interest Rate		9.55%	[3],[4],[5]	9.28%	[6],[8],[9]
Par Amount / Unit		$ 6,684	[3],[4]	$ 6,865	[6],[8]
Cost		6,672	[3],[4]	6,840	[6],[8]
Fair Value		$ 6,679	[3],[4]	$ 6,827	[6],[8]
Fair Value as % of Net Assets		1.88%	[1],[3],[4]	2.62%	[2],[6],[8]
Investment, Identifier [Axis]: COP Exterminators Acquisition, Inc.
Schedule of Investments [Line Items]
Interest Rate	[4],[5]	9.00%
Interest Rate, PIK	[4],[5]	4.00%
Par Amount / Unit	[4]	$ 647
Cost	[4]	630
Fair Value	[4]	$ 630
Fair Value as % of Net Assets	[1],[4]	0.18%
Investment, Identifier [Axis]: COP Exterminators Acquisition, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate	[4],[5],[11]	9.00%
Interest Rate, PIK	[4],[5],[11]	4.00%
Par Amount / Unit	[4],[11]	$ 503
Cost	[4],[11]	(6)
Fair Value	[4],[11]	$ (13)
Fair Value as % of Net Assets	[1],[4],[11]	0.00%
Investment, Identifier [Axis]: COP Exterminators Investment, LLC
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 862
Fair Value	[4],[15],[16]	$ 898
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.25%
Share / Unit	[4],[15],[16]	770,000
Investment, Identifier [Axis]: CV Holdco, LLC
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost	[8],[13],[14]			$ 102
Fair Value	[8],[13],[14]			$ 49
Fair Value as % of Net Assets	[2],[8],[13],[14]			0.02%
Share / Unit	[8],[13],[14]			1
Investment, Identifier [Axis]: CV Intermediate Holdco Corp.
Schedule of Investments [Line Items]
Interest Rate		11.00%	[4],[5]	11.00%	[8],[9]
Par Amount / Unit		$ 10,000	[4]	$ 10,000	[8]
Cost		9,882	[4]	9,848	[8]
Fair Value		$ 9,278	[4]	$ 9,333	[8]
Fair Value as % of Net Assets		2.61%	[1],[4]	3.59%	[2],[8]
Investment, Identifier [Axis]: Chroma Color Corporation (dba Chroma Color)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.00%
Interest Rate	[3],[4],[5]	11.41%
Par Amount / Unit	[3],[4]	$ 1,744
Cost	[3],[4]	1,712
Fair Value	[3],[4]	$ 1,712
Fair Value as % of Net Assets	[1],[3],[4]	0.49%
Investment, Identifier [Axis]: Chroma Color Corporation (dba Chroma Color) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.00%
Interest Rate	[3],[4],[5],[11]	11.41%
Par Amount / Unit	[3],[4],[11]	$ 381
Cost	[3],[4],[11]	(3)
Fair Value	[3],[4],[11]	$ (7)
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.00%
Investment, Identifier [Axis]: Cinemark USA Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.75%
Interest Rate	[3],[5],[17],[18]	9.14%
Par Amount / Unit	[3],[17],[18]	$ 996
Cost	[3],[17],[18]	997
Fair Value	[3],[17],[18]	$ 998
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.28%
Investment, Identifier [Axis]: Clarios Global LP (f/k/a Johnson Controls Inc)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18],[19]	3.75%
Interest Rate	[3],[5],[17],[18],[19]	9.11%
Par Amount / Unit	[3],[17],[18],[19]	$ 998
Cost	[3],[17],[18],[19]	998
Fair Value	[3],[17],[18],[19]	$ 1,001
Fair Value as % of Net Assets	[1],[3],[17],[18],[19]	0.28%
Investment, Identifier [Axis]: Clarity Innovations, Inc.
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 76
Fair Value	[4],[15],[16]	$ 77
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.02%
Share / Unit	[4],[15],[16]	77,000
Investment, Identifier [Axis]: Class Valuation
Schedule of Investments [Line Items]
Interest Rate		11.00%	[4],[5]	11.00%	[8],[9]
Par Amount / Unit		$ 444	[4]	$ 444	[8]
Cost		438	[4]	436	[8]
Fair Value		$ 412	[4]	$ 415	[8]
Fair Value as % of Net Assets		0.12%	[1],[4]	0.16%	[2],[8]
Investment, Identifier [Axis]: Class Valuation 1
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 105
Fair Value	[4],[15],[16]	$ 34
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.01%
Share / Unit	[4],[15],[16]	1,038
Investment, Identifier [Axis]: Cold Spring Brewing Company
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[3],[4],[5]	4.75%	[6],[8],[9]
Interest Rate		10.11%	[3],[4],[5]	9.11%	[6],[8],[9]
Par Amount / Unit		$ 6,188	[3],[4]	$ 6,805	[6],[8]
Cost		6,188	[3],[4]	6,805	[6],[8]
Fair Value		$ 6,188	[3],[4]	$ 6,804	[6],[8]
Fair Value as % of Net Assets		1.75%	[1],[3],[4]	2.61%	[2],[6],[8]
Investment, Identifier [Axis]: Colibri (McKissock LLC)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10]	5.00%
Interest Rate	[3],[4],[5],[10]	10.38%
Par Amount / Unit	[3],[4],[10]	$ 6,000
Cost	[3],[4],[10]	5,853
Fair Value	[3],[4],[10]	$ 6,007
Fair Value as % of Net Assets	[1],[3],[4],[10]	1.69%
Investment, Identifier [Axis]: Copeland (Emerson Climate Technologies)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.00%
Interest Rate	[3],[5],[17],[18]	8.36%
Par Amount / Unit	[3],[17],[18]	$ 1,247
Cost	[3],[17],[18]	1,250
Fair Value	[3],[17],[18]	$ 1,253
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.35%
Investment, Identifier [Axis]: Covanta Holding Corp 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.50%
Interest Rate	[3],[5],[17],[18]	7.86%
Par Amount / Unit	[3],[17],[18]	$ 53
Cost	[3],[17],[18]	53
Fair Value	[3],[17],[18]	$ 53
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.01%
Investment, Identifier [Axis]: Covanta Holding Corp 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.50%
Interest Rate	[3],[5],[17],[18]	7.86%
Par Amount / Unit	[3],[17],[18]	$ 694
Cost	[3],[17],[18]	692
Fair Value	[3],[17],[18]	$ 695
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.20%
Investment, Identifier [Axis]: CrossCountry Consulting
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[3],[4],[5],[10]	5.75%	[6],[7],[8],[9]
Interest Rate		11.21%	[3],[4],[5],[10]	10.34%	[6],[7],[8],[9]
Par Amount / Unit		$ 1,379	[3],[4],[10]	$ 1,393	[6],[7],[8]
Cost		1,356	[3],[4],[10]	1,367	[6],[7],[8]
Fair Value		$ 1,387	[3],[4],[10]	$ 1,376	[6],[7],[8]
Fair Value as % of Net Assets		0.39%	[1],[3],[4],[10]	0.53%	[2],[6],[7],[8]
Investment, Identifier [Axis]: CrossCountry Consulting (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[10],[11]	5.75%	[7],[8],[9],[12]
Interest Rate		11.21%	[4],[5],[10],[11]	10.34%	[7],[8],[9],[12]
Par Amount / Unit		$ 560	[4],[10],[11]	$ 560	[7],[8],[12]
Cost		(5)	[4],[10],[11]	(5)	[7],[8],[12]
Fair Value		$ 3	[4],[10],[11]	$ (7)	[7],[8],[12]
Fair Value as % of Net Assets		0.00%	[1],[4],[10],[11]	0.00%	[2],[7],[8],[12]
Investment, Identifier [Axis]: DIRECTV (AKA DIRECTV Financing LLC)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	5.00%
Interest Rate	[3],[5],[17],[18]	10.65%
Par Amount / Unit	[3],[17],[18]	$ 379
Cost	[3],[17],[18]	375
Fair Value	[3],[17],[18]	$ 379
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.11%
Investment, Identifier [Axis]: Delta 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18],[19]	2.25%
Interest Rate	[3],[5],[17],[18],[19]	7.60%
Par Amount / Unit	[3],[17],[18],[19]	$ 1,250
Cost	[3],[17],[18],[19]	1,255
Fair Value	[3],[17],[18],[19]	$ 1,255
Fair Value as % of Net Assets	[1],[3],[17],[18],[19]	0.35%
Investment, Identifier [Axis]: Dresser Utility Solutions, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[3],[4],[5]	4.25%	[6],[8],[9]
Interest Rate		10.71%	[3],[4],[5]	8.64%	[6],[8],[9]
Par Amount / Unit		$ 3,438	[3],[4]	$ 3,473	[6],[8]
Cost		3,438	[3],[4]	3,473	[6],[8]
Fair Value		$ 3,438	[3],[4]	$ 3,473	[6],[8]
Fair Value as % of Net Assets		0.97%	[1],[3],[4]	1.33%	[2],[6],[8]
Investment, Identifier [Axis]: Dresser Utility Solutions, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.00%	[3],[4],[5]	5.25%	[6],[8],[9]
Interest Rate		9.46%	[3],[4],[5]	9.64%	[6],[8],[9]
Par Amount / Unit		$ 3,437	[3],[4]	$ 3,473	[6],[8]
Cost		3,408	[3],[4]	3,429	[6],[8]
Fair Value		$ 3,402	[3],[4]	$ 3,399	[6],[8]
Fair Value as % of Net Assets		0.96%	[1],[3],[4]	1.30%	[2],[6],[8]
Investment, Identifier [Axis]: EFC Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate	[4],[5]	11.00%
Interest Rate, PIK	[4],[5]	2.50%
Par Amount / Unit	[4]	$ 2,436
Cost	[4]	2,372
Fair Value	[4]	$ 2,413
Fair Value as % of Net Assets	[1],[4]	0.68%
Investment, Identifier [Axis]: EFC Holdings, LLC 1
Schedule of Investments [Line Items]
Cost	[4],[15],[16],[18]	$ 114
Fair Value	[4],[15],[16],[18]	$ 121
Fair Value as % of Net Assets	[1],[4],[15],[16],[18]	0.03%
Share / Unit	[4],[15],[16],[18]	114
Investment, Identifier [Axis]: EFC Holdings, LLC 2
Schedule of Investments [Line Items]
Cost	[4],[15],[16],[18]	$ 46
Fair Value	[4],[15],[16],[18]	$ 87
Fair Value as % of Net Assets	[1],[4],[15],[16],[18]	0.02%
Share / Unit	[4],[15],[16],[18]	114
Investment, Identifier [Axis]: Elevation Labs
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[3],[4],[5]	5.25%	[6],[8],[9]
Interest Rate		11.23%	[3],[4],[5]	9.84%	[6],[8],[9]
Par Amount / Unit		$ 1,302	[3],[4]	$ 1,315	[6],[8]
Cost		1,292	[3],[4]	1,303	[6],[8]
Fair Value		$ 1,215	[3],[4]	$ 1,301	[6],[8]
Fair Value as % of Net Assets		0.34%	[1],[3],[4]	0.50%	[2],[6],[8]
Investment, Identifier [Axis]: Elevation Labs (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[3],[4],[5],[11]	5.25%	[6],[8],[9],[12]
Interest Rate		11.23%	[3],[4],[5],[11]	9.84%	[6],[8],[9],[12]
Par Amount / Unit		$ 599	[3],[4],[11]	$ 599	[6],[8],[12]
Cost		(2)	[3],[4],[11]	(3)	[6],[8],[12]
Fair Value		$ (40)	[3],[4],[11]	$ (6)	[6],[8],[12]
Fair Value as % of Net Assets		(0.01%)	[1],[3],[4],[11]	0.00%	[2],[6],[8],[12]
Investment, Identifier [Axis]: Evergreen Services Group
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[3],[4],[5],[10]	6.00%	[6],[7],[8],[9]
Interest Rate		11.70%	[3],[4],[5],[10]	10.59%	[6],[7],[8],[9]
Par Amount / Unit		$ 4,027	[3],[4],[10]	$ 4,068	[6],[7],[8]
Cost		3,959	[3],[4],[10]	3,991	[6],[7],[8]
Fair Value		$ 3,948	[3],[4],[10]	$ 3,971	[6],[7],[8]
Fair Value as % of Net Assets		1.11%	[1],[3],[4],[10]	1.52%	[2],[6],[7],[8]
Investment, Identifier [Axis]: Evergreen Services Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[3],[4],[5],[10]	6.00%	[6],[7],[8],[9],[12]
Interest Rate		11.70%	[3],[4],[5],[10]	10.59%	[6],[7],[8],[9]
Par Amount / Unit		$ 963	[3],[4],[10]	$ 970	[6],[7],[8]
Cost		955	[3],[4],[10]	694	[6],[7],[8]
Fair Value		$ 945	[3],[4],[10]	$ 680	[6],[7],[8]
Fair Value as % of Net Assets		0.27%	[1],[3],[4],[10]	0.26%	[2],[6],[7],[8]
Investment, Identifier [Axis]: Evergreen Services Group II
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10]	6.00%
Interest Rate	[3],[4],[5],[10]	11.35%
Par Amount / Unit	[3],[4],[10]	$ 3,323
Cost	[3],[4],[10]	3,274
Fair Value	[3],[4],[10]	$ 3,276
Fair Value as % of Net Assets	[1],[3],[4],[10]	0.92%
Investment, Identifier [Axis]: Evergreen Services Group II (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10],[11]	6.00%
Interest Rate	[3],[4],[5],[10],[11]	11.35%
Par Amount / Unit	[3],[4],[10],[11]	$ 2,677
Cost	[3],[4],[10],[11]	1,747
Fair Value	[3],[4],[10],[11]	$ 1,716
Fair Value as % of Net Assets	[1],[3],[4],[10],[11]	0.48%
Investment, Identifier [Axis]: Excel Fitness
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[3],[5]	5.25%	[6],[8],[9]
Interest Rate		10.75%	[3],[5]	9.84%	[6],[8],[9]
Par Amount / Unit		$ 5,925	[3],[4]	$ 5,985	[6],[8]
Cost		5,867	[3],[4]	5,920	[6],[8]
Fair Value		$ 5,769	[3],[4]	$ 5,690	[6],[8]
Fair Value as % of Net Assets		1.63%	[1],[3],[4]	2.19%	[2],[6],[8]
Investment, Identifier [Axis]: FCP-Cranium Holdings P/S A
Schedule of Investments [Line Items]
Cost	[4],[15],[16],[18],[19]	$ 0
Fair Value	[4],[15],[16],[18],[19]	$ 0
Fair Value as % of Net Assets	[1],[4],[15],[16],[18],[19]	0.00%
Share / Unit	[4],[15],[16],[18],[19]	375
Investment, Identifier [Axis]: FCP-Cranium Holdings, LLC (Brain labs) 1
Schedule of Investments [Line Items]
Cost	[4],[15],[16],[18],[19]	$ 389
Fair Value	[4],[15],[16],[18],[19]	$ 407
Fair Value as % of Net Assets	[1],[4],[15],[16],[18],[19]	0.11%
Share / Unit	[4],[15],[16],[18],[19]	1,026
Investment, Identifier [Axis]: FCP-Cranium Holdings, LLC (Brain labs) 2
Schedule of Investments [Line Items]
Cost	[4],[15],[16],[18],[19]	$ 600
Fair Value	[4],[15],[16],[18],[19]	$ 600
Fair Value as % of Net Assets	[1],[4],[15],[16],[18],[19]	0.17%
Share / Unit	[4],[15],[16],[18],[19]	375
Investment, Identifier [Axis]: FSK Pallet Holding Corp. (DBA Kamps Pallets)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[3],[4],[5]	5.00%	[6],[8],[9]
Interest Rate		11.53%	[3],[4],[5]	9.77%	[6],[8],[9]
Par Amount / Unit		$ 5,925	[3],[4]	$ 5,985	[6],[8]
Cost		5,835	[3],[4]	5,870	[6],[8]
Fair Value		$ 5,770	[3],[4]	$ 5,869	[6],[8]
Fair Value as % of Net Assets		1.62%	[1],[3],[4]	2.25%	[2],[6],[8]
Investment, Identifier [Axis]: First American Government Obligations Fund
Schedule of Investments [Line Items]
Interest Rate		526.00%
Cost		$ 15
Fair Value		$ 15
Fair Value as % of Net Assets	[1]	0.00%
Share / Unit		15
Investment, Identifier [Axis]: Fortune International, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[3],[4],[5]	4.75%	[6],[8],[9]
Interest Rate		10.20%	[3],[4],[5]	9.52%	[6],[8],[9]
Par Amount / Unit		$ 6,878	[3],[4]	$ 6,948	[6],[8]
Cost		6,839	[3],[4]	6,891	[6],[8]
Fair Value		$ 6,812	[3],[4]	$ 6,802	[6],[8]
Fair Value as % of Net Assets		1.92%	[1],[3],[4]	2.61%	[2],[6],[8]
Investment, Identifier [Axis]: Freedom U.S. Acquisition Corporation
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[3],[4],[5]	4.50%	[6],[8],[9]
Interest Rate		11.25%	[3],[4],[5]	9.27%	[6],[8],[9]
Par Amount / Unit		$ 6,980	[3],[4]	$ 7,000	[6],[8]
Cost		6,980	[3],[4]	7,000	[6],[8]
Fair Value		$ 6,935	[3],[4]	$ 6,955	[6],[8]
Fair Value as % of Net Assets		1.96%	[1],[3],[4]	2.67%	[2],[6],[8]
Investment, Identifier [Axis]: Fresh Edge
Schedule of Investments [Line Items]
Spread Above Reference Rate	[8],[9]			9.00%
Interest Rate		15.20%	[3],[4],[5]	13.36%	[8],[9]
Interest Rate, PIK	[3],[4],[5]	5.13%
Par Amount / Unit		$ 2,954	[3],[4]	$ 2,890	[8]
Cost		2,888	[3],[4]	2,820	[8]
Fair Value		$ 2,886	[3],[4]	$ 2,820	[8]
Fair Value as % of Net Assets		0.81%	[1],[3],[4]	1.08%	[2],[8]
Investment, Interest Rate, Paid in Cash	[3],[4],[5]	4.50%
Investment, Identifier [Axis]: Fresh Edge - Common
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 0
Fair Value	[4],[15],[16]	$ 67
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.02%
Share / Unit	[4],[15],[16]	454
Investment, Identifier [Axis]: Fresh Edge - Preferred
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 454
Fair Value	[4],[15],[16]	$ 507
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.14%
Share / Unit	[4],[15],[16]	454
Investment, Identifier [Axis]: Fresh Edge 1
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost	[8],[13],[14]			$ 454
Fair Value	[8],[13],[14]			$ 454
Fair Value as % of Net Assets	[2],[8],[13],[14]			0.17%
Share / Unit	[8],[13],[14]			0
Investment, Identifier [Axis]: Fresh Edge 2
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost	[8],[13],[14]			$ 0
Fair Value	[8],[13],[14]			$ 0
Fair Value as % of Net Assets	[2],[8],[13],[14]			0.00%
Share / Unit	[8],[13],[14]			0
Investment, Identifier [Axis]: GFL Environmental
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.50%
Interest Rate	[3],[5],[17],[18]	7.91%
Par Amount / Unit	[3],[17],[18]	$ 1,247
Cost	[3],[17],[18]	1,251
Fair Value	[3],[17],[18]	$ 1,253
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.35%
Investment, Identifier [Axis]: GTCR W Merger Sub LLC (Worldpay)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.00%
Interest Rate	[3],[5],[17],[18]	8.33%
Par Amount / Unit	[3],[17],[18]	$ 340
Cost	[3],[17],[18]	338
Fair Value	[3],[17],[18]	$ 342
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.10%
Investment, Identifier [Axis]: Gannett Fleming
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.60%	[3],[4],[5]	6.50%	[6],[8],[9]
Interest Rate		11.95%	[3],[4],[5]	11.09%	[6],[8],[9]
Par Amount / Unit		$ 1,980	[3],[4]	$ 2,000	[6],[8]
Cost		1,946	[3],[4]	1,960	[6],[8]
Fair Value		$ 1,982	[3],[4]	$ 1,960	[6],[8]
Fair Value as % of Net Assets		0.55%	[1],[3],[4]	0.76%	[2],[6],[8]
Investment, Identifier [Axis]: Gannett Fleming 1
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 85	[4],[15],[16],[20]	$ 85	[8],[13],[14]
Fair Value		$ 124	[4],[15],[16],[20]	$ 85	[8],[13],[14]
Fair Value as % of Net Assets		0.03%	[1],[4],[15],[16],[20]	0.03%	[2],[8],[13],[14]
Share / Unit		84,949	[4],[15],[16],[20]	85	[8],[13],[14]
Investment, Identifier [Axis]: Gannett Fleming 2
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 118
Fair Value	[4],[15],[16]	$ 166
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.05%
Share / Unit	[4],[15],[16]	113,901
Investment, Identifier [Axis]: GenServe LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[3],[4],[5],[10]	5.25%	[6],[7],[8],[9]
Interest Rate		11.21%	[3],[4],[5],[10]	9.84%	[6],[7],[8],[9]
Par Amount / Unit		$ 6,878	[3],[4],[10]	$ 6,947	[6],[7],[8]
Cost		6,865	[3],[4],[10]	6,891	[6],[7],[8]
Fair Value		$ 6,843	[3],[4],[10]	$ 6,937	[6],[7],[8]
Fair Value as % of Net Assets		1.93%	[1],[3],[4],[10]	2.66%	[2],[6],[7],[8]
Investment, Identifier [Axis]: Getty Images Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17]	4.50%
Interest Rate	[3],[5],[17]	9.95%
Par Amount / Unit	[3],[17]	$ 496
Cost	[3],[17]	498
Fair Value	[3],[17]	$ 499
Fair Value as % of Net Assets	[1],[3],[17]	0.14%
Investment, Identifier [Axis]: Gray Television, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.50%
Interest Rate	[3],[5],[17],[18]	7.96%
Par Amount / Unit	[3],[17],[18]	$ 500
Cost	[3],[17],[18]	498
Fair Value	[3],[17],[18]	$ 500
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.14%
Investment, Identifier [Axis]: Grifols Worldwide Operations LTD
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18],[19]	2.00%
Interest Rate	[3],[5],[17],[18],[19]	7.54%
Par Amount / Unit	[3],[17],[18],[19]	$ 499
Cost	[3],[17],[18],[19]	495
Fair Value	[3],[17],[18],[19]	$ 499
Fair Value as % of Net Assets	[1],[3],[17],[18],[19]	0.14%
Investment, Identifier [Axis]: Harvest Hill Beverage Company
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5]	9.00%
Interest Rate	[4],[5]	14.46%
Par Amount / Unit	[4]	$ 2,800
Cost	[4]	2,723
Fair Value	[4]	$ 2,749
Fair Value as % of Net Assets	[1],[4]	0.77%
Investment, Identifier [Axis]: Hayward Industries, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.75%
Interest Rate	[3],[5],[17],[18]	8.22%
Par Amount / Unit	[3],[17],[18]	$ 747
Cost	[3],[17],[18]	741
Fair Value	[3],[17],[18]	$ 748
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.21%
Investment, Identifier [Axis]: Health Management Associates
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.50%
Interest Rate	[3],[4],[5]	11.73%
Par Amount / Unit	[3],[4]	$ 3,364
Cost	[3],[4]	3,302
Fair Value	[3],[4]	$ 3,334
Fair Value as % of Net Assets	[1],[3],[4]	0.94%
Investment, Identifier [Axis]: Health Management Associates (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.50%
Interest Rate	[3],[4],[5],[11]	11.73%
Par Amount / Unit	[3],[4],[11]	$ 607
Cost	[3],[4],[11]	180
Fair Value	[3],[4],[11]	$ 186
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.05%
Investment, Identifier [Axis]: Health Management Associates 3
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 162
Fair Value	[4],[15],[16]	$ 173
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.05%
Share / Unit	[4],[15],[16]	161,953
Investment, Identifier [Axis]: Heartland Veterinary Partners LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		7.50%	[4],[5]	7.50%	[8],[9]
Interest Rate		12.96%	[4],[5]	12.09%	[8],[9]
Par Amount / Unit		$ 1,000	[4]	$ 1,000	[8]
Cost		985	[4]	982	[8]
Fair Value		$ 987	[4]	$ 980	[8]
Fair Value as % of Net Assets		0.28%	[1],[4]	0.38%	[2],[8]
Investment, Identifier [Axis]: Heartland Veterinary Partners LLC (Incremental) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		7.50%	[4],[5]	7.50%	[8],[9],[12]
Interest Rate		12.96%	[4],[5]	12.09%	[8],[9],[12]
Par Amount / Unit		$ 5,000	[4]	$ 5,000	[8],[12]
Cost		5,000	[4]	0	[8],[12]
Fair Value		$ 4,936	[4]	$ (100)	[8],[12]
Fair Value as % of Net Assets		1.39%	[1],[4]	(0.04%)	[2],[8],[12]
Investment, Identifier [Axis]: Hyphen Solutions, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[3],[4],[5],[10]	5.50%	[6],[7],[8],[9]
Interest Rate		10.98%	[3],[4],[5],[10]	9.89%	[6],[7],[8],[9]
Par Amount / Unit		$ 6,877	[3],[4],[10]	$ 6,947	[6],[7],[8]
Cost		6,839	[3],[4],[10]	6,898	[6],[7],[8]
Fair Value		$ 6,752	[3],[4],[10]	$ 6,804	[6],[7],[8]
Fair Value as % of Net Assets		1.90%	[1],[3],[4],[10]	2.61%	[2],[6],[7],[8]
Investment, Identifier [Axis]: ICON Publishing Ltd 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18],[19]	2.25%
Par Amount / Unit	[3],[17],[18],[19]	$ 342
Cost	[3],[17],[18],[19]	343
Fair Value	[3],[17],[18],[19]	$ 344
Fair Value as % of Net Assets	[1],[3],[17],[18],[19]	0.10%
Investment, Identifier [Axis]: ICON Publishing Ltd 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17]	2.25%
Interest Rate	[3],[5],[17]	7.86%
Par Amount / Unit	[3],[17]	$ 85
Cost	[3],[17]	86
Fair Value	[3],[17]	$ 86
Fair Value as % of Net Assets	[1],[3],[17]	0.02%
Investment, Identifier [Axis]: II-VI Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.75%
Interest Rate	[3],[5],[17],[18]	8.22%
Par Amount / Unit	[3],[17],[18]	$ 726
Cost	[3],[17],[18]	728
Fair Value	[3],[17],[18]	$ 730
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.21%
Investment, Identifier [Axis]: INEOS US Finance LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.75%
Interest Rate	[3],[5],[17],[18]	9.21%
Par Amount / Unit	[3],[17],[18]	$ 497
Cost	[3],[17],[18]	497
Fair Value	[3],[17],[18]	$ 500
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.14%
Investment, Identifier [Axis]: INEOS US Petrochem LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	4.25%
Interest Rate	[3],[5],[17],[18]	9.71%
Par Amount / Unit	[3],[17],[18]	$ 874
Cost	[3],[17],[18]	874
Fair Value	[3],[17],[18]	$ 869
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.24%
Investment, Identifier [Axis]: INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.50%
Interest Rate	[3],[4],[5]	12.03%
Par Amount / Unit	[3],[4]	$ 4,583
Cost	[3],[4]	4,504
Fair Value	[3],[4]	$ 4,590
Fair Value as % of Net Assets	[1],[3],[4]	1.29%
Investment, Identifier [Axis]: INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.50%
Interest Rate	[3],[4],[5],[11]	12.03%
Par Amount / Unit	[3],[4],[11]	$ 1,139
Cost	[3],[4],[11]	(19)
Fair Value	[3],[4],[11]	$ 2
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.00%
Investment, Identifier [Axis]: ISG Merger Sub, LLC (dba Industrial Service Group)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[3],[4],[5]	6.25%	[6],[8],[9]
Interest Rate		11.60%	[3],[4],[5]	10.61%	[6],[8],[9]
Par Amount / Unit		$ 2,454	[3],[4]	$ 2,479	[6],[8]
Cost		2,411	[3],[4]	2,429	[6],[8]
Fair Value		$ 2,470	[3],[4]	$ 2,429	[6],[8]
Fair Value as % of Net Assets		0.70%	[1],[3],[4]	0.93%	[2],[6],[8]
Investment, Identifier [Axis]: ISG Merger Sub, LLC (dba Industrial Service Group) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[3],[4],[5]	6.25%	[6],[8],[9],[12]
Interest Rate		11.60%	[3],[4],[5]	10.61%	[6],[8],[9],[12]
Par Amount / Unit		$ 1,277	[3],[4]	$ 1,282	[6],[8],[12]
Cost		1,272	[3],[4]	(6)	[6],[8],[12]
Fair Value		$ 1,286	[3],[4]	$ (25)	[6],[8],[12]
Fair Value as % of Net Assets		0.36%	[1],[3],[4]	(0.01%)	[2],[6],[8],[12]
Investment, Identifier [Axis]: ITSavvy LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[3],[4],[5]	5.25%	[6],[8],[9]
Interest Rate		10.89%	[3],[4],[5]	9.84%	[6],[8],[9]
Par Amount / Unit		$ 1,775	[3],[4]	$ 1,793	[6],[8]
Cost		1,761	[3],[4]	1,776	[6],[8]
Fair Value		$ 1,775	[3],[4]	$ 1,793	[6],[8]
Fair Value as % of Net Assets		0.50%	[1],[3],[4]	0.69%	[2],[6],[8]
Investment, Identifier [Axis]: ITSavvy LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[11]	5.25%	[8],[9],[12]
Interest Rate		10.89%	[4],[5],[11]	9.84%	[8],[9],[12]
Par Amount / Unit		$ 239	[4],[11]	$ 480	[8],[12]
Cost		201	[4],[11]	(5)	[8],[12]
Fair Value		$ 203	[4],[11]	$ 0	[8],[12]
Fair Value as % of Net Assets		0.06%	[1],[4],[11]	0.00%	[2],[8],[12]
Investment, Identifier [Axis]: ITSavvy LLC 1
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 119	[4],[15],[16]	$ 119	[8],[13],[14]
Fair Value		$ 285	[4],[15],[16]	$ 158	[8],[13],[14]
Fair Value as % of Net Assets		0.08%	[1],[4],[15],[16]	0.06%	[2],[8],[13],[14]
Share / Unit		119	[4],[15],[16]	0	[8],[13],[14]
Investment, Identifier [Axis]: Image International Intermediate Holdco II, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[3],[4],[5],[10]	5.50%	[6],[7],[8],[9]
Interest Rate		11.03%	[3],[4],[5],[10]	10.27%	[6],[7],[8],[9]
Par Amount / Unit		$ 6,992	[3],[4],[10]	$ 6,992	[6],[7],[8]
Cost		6,967	[3],[4],[10]	6,950	[6],[7],[8]
Fair Value		$ 6,882	[3],[4],[10]	$ 6,873	[6],[7],[8]
Fair Value as % of Net Assets		1.94%	[1],[3],[4],[10]	2.64%	[2],[6],[7],[8]
Investment, Identifier [Axis]: Impact Environmental Group
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.00%
Interest Rate	[3],[4],[5]	11.28%
Par Amount / Unit	[3],[4]	$ 2,076
Cost	[3],[4]	2,037
Fair Value	[3],[4]	$ 2,059
Fair Value as % of Net Assets	[1],[3],[4]	0.58%
Investment, Identifier [Axis]: Impact Environmental Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.00%
Interest Rate	[3],[4],[5],[11]	11.28%
Par Amount / Unit	[3],[4],[11]	$ 970
Cost	[3],[4],[11]	849
Fair Value	[3],[4],[11]	$ 845
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.24%
Investment, Identifier [Axis]: Impact Environmental Group (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.00%
Interest Rate	[3],[4],[5],[11]	11.28%
Par Amount / Unit	[3],[4],[11]	$ 1,716
Cost	[3],[4],[11]	(8)
Fair Value	[3],[4],[11]	$ (14)
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.00%
Investment, Identifier [Axis]: Impact Environmental Group (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.00%
Interest Rate	[3],[4],[5]	11.28%
Par Amount / Unit	[3],[4]	$ 425
Cost	[3],[4]	418
Fair Value	[3],[4]	$ 422
Fair Value as % of Net Assets	[1],[3],[4]	0.12%
Investment, Identifier [Axis]: Industrial Service Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	5.75%
Interest Rate	[3],[4],[5],[11]	11.11%
Par Amount / Unit	[3],[4],[11]	$ 2,259
Cost	[3],[4],[11]	238
Fair Value	[3],[4],[11]	$ 213
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.06%
Investment, Identifier [Axis]: Infinite Electronics (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10]	6.25%
Interest Rate	[3],[4],[5],[10]	11.88%
Par Amount / Unit	[3],[4],[10]	$ 1,967
Cost	[3],[4],[10]	1,917
Fair Value	[3],[4],[10]	$ 1,901
Fair Value as % of Net Assets	[1],[3],[4],[10]	0.54%
Investment, Identifier [Axis]: Infobase Acquisition, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[3],[4],[5]	5.50%	[6],[8],[9]
Interest Rate		10.93%	[3],[4],[5]	10.09%	[6],[8],[9]
Par Amount / Unit		$ 731	[3],[4]	$ 738	[6],[8]
Cost		725	[3],[4]	731	[6],[8]
Fair Value		$ 725	[3],[4]	$ 729	[6],[8]
Fair Value as % of Net Assets		0.20%	[1],[3],[4]	0.28%	[2],[6],[8]
Investment, Identifier [Axis]: Infobase Acquisition, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[11]	5.50%	[8],[9],[12]
Interest Rate		10.93%	[4],[5],[11]	10.09%	[8],[9],[12]
Par Amount / Unit		$ 122	[4],[11]	$ 122	[8],[12]
Cost		0	[4],[11]	0	[8],[12]
Fair Value		$ (1)	[4],[11]	$ (2)	[8],[12]
Fair Value as % of Net Assets		0.00%	[1],[4],[11]	0.00%	[2],[8],[12]
Investment, Identifier [Axis]: Informatica LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.75%
Interest Rate	[3],[5],[17],[18]	8.22%
Par Amount / Unit	[3],[17],[18]	$ 1,245
Cost	[3],[17],[18]	1,250
Fair Value	[3],[17],[18]	$ 1,249
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.35%
Investment, Identifier [Axis]: Ingram Micro T/L (09/23) TARGET FACILITY
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.00%
Interest Rate	[3],[5],[17],[18]	8.61%
Par Amount / Unit	[3],[17],[18]	$ 875
Cost	[3],[17],[18]	876
Fair Value	[3],[17],[18]	$ 879
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.25%
Investment, Identifier [Axis]: Instructure Holdings Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.75%
Interest Rate	[3],[5],[17],[18]	8.68%
Par Amount / Unit	[3],[17],[18]	$ 996
Cost	[3],[17],[18]	999
Fair Value	[3],[17],[18]	$ 1,002
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.28%
Investment, Identifier [Axis]: Inszone
Schedule of Investments [Line Items]
Cost	[4],[15],[16],[18]	$ 77
Fair Value	[4],[15],[16],[18]	$ 80
Fair Value as % of Net Assets	[1],[4],[15],[16],[18]	0.02%
Share / Unit	[4],[15],[16],[18]	80,208
Investment, Identifier [Axis]: Iridium Satellite LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.50%
Interest Rate	[3],[5],[17],[18]	7.86%
Par Amount / Unit	[3],[17],[18]	$ 1,000
Cost	[3],[17],[18]	1,002
Fair Value	[3],[17],[18]	$ 1,004
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.28%
Investment, Identifier [Axis]: Jazz Pharmaceuticals plc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18],[19]	3.50%
Interest Rate	[3],[5],[17],[18],[19]	8.97%
Par Amount / Unit	[3],[17],[18],[19]	$ 1,244
Cost	[3],[17],[18],[19]	1,246
Fair Value	[3],[17],[18],[19]	$ 1,251
Fair Value as % of Net Assets	[1],[3],[17],[18],[19]	0.35%
Investment, Identifier [Axis]: KRIV Acquisition, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.50%
Interest Rate	[3],[4],[5]	11.85%
Par Amount / Unit	[3],[4]	$ 5,221
Cost	[3],[4]	5,081
Fair Value	[3],[4]	$ 5,070
Fair Value as % of Net Assets	[1],[3],[4]	1.43%
Investment, Identifier [Axis]: KRIV Acquisition, Inc (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.50%
Interest Rate	[3],[4],[5],[11]	11.85%
Par Amount / Unit	[3],[4],[11]	$ 779
Cost	[3],[4],[11]	(9)
Fair Value	[3],[4],[11]	$ (23)
Fair Value as % of Net Assets	[1],[3],[4],[11]	(0.01%)
Investment, Identifier [Axis]: KRIV Acquisition, Inc 1
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 200
Fair Value	[4],[15],[16]	$ 236
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.07%
Share / Unit	[4],[15],[16]	200
Investment, Identifier [Axis]: Kenco Group, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[3],[4],[5]	5.50%	[6],[8],[9]
Interest Rate		10.39%	[3],[4],[5]	10.09%	[6],[8],[9]
Par Amount / Unit		$ 5,099	[3],[4]	$ 5,150	[6],[8]
Cost		5,010	[3],[4]	5,049	[6],[8]
Fair Value		$ 5,099	[3],[4]	$ 5,049	[6],[8]
Fair Value as % of Net Assets		1.44%	[1],[3],[4]	1.94%	[2],[6],[8]
Investment, Identifier [Axis]: Kenco Group, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[3],[4],[5],[11]	5.50%	[6],[8],[9],[12]
Interest Rate		10.39%	[3],[4],[5],[11]	10.09%	[6],[8],[9],[12]
Par Amount / Unit		$ 850	[3],[4],[11]	$ 850	[6],[8],[12]
Cost		(14)	[3],[4],[11]	(17)	[6],[8],[12]
Fair Value		$ 0	[3],[4],[11]	$ (17)	[6],[8],[12]
Fair Value as % of Net Assets		0.00%	[1],[3],[4],[11]	(0.01%)	[2],[6],[8],[12]
Investment, Identifier [Axis]: Keng Acquisition, Inc. (Engage Group Holdings, LLC)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10]	6.25%
Interest Rate	[3],[4],[5],[10]	11.60%
Par Amount / Unit	[3],[4],[10]	$ 2,431
Cost	[3],[4],[10]	2,395
Fair Value	[3],[4],[10]	$ 2,396
Fair Value as % of Net Assets	[1],[3],[4],[10]	0.68%
Investment, Identifier [Axis]: Keng Acquisition, Inc. (Engage Group Holdings, LLC) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[10],[11]	6.25%
Interest Rate	[3],[4],[5],[10],[11]	11.60%
Par Amount / Unit	[3],[4],[10],[11]	$ 2,342
Cost	[3],[4],[10],[11]	296
Fair Value	[3],[4],[10],[11]	$ 268
Fair Value as % of Net Assets	[1],[3],[4],[10],[11]	0.08%
Investment, Identifier [Axis]: Kofile, Inc.
Schedule of Investments [Line Items]
Interest Rate		10.00%	[4],[5]	10.00%	[8],[9]
Interest Rate, PIK		1.75%	[4],[5]	1.75%	[8],[9]
Par Amount / Unit		$ 10,308	[4]	$ 10,128	[8]
Cost		10,308	[4]	10,128	[8]
Fair Value		$ 9,720	[4]	$ 9,987	[8]
Fair Value as % of Net Assets		2.74%	[1],[4]	3.84%	[2],[8]
Investment, Identifier [Axis]: Kofile, Inc. 1
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost	[8],[13],[14]			$ 108
Fair Value	[8],[13],[14]			$ 78
Fair Value as % of Net Assets	[2],[8],[13],[14]			0.03%
Share / Unit	[8],[13],[14]			0
Investment, Identifier [Axis]: Kofile, Inc.1
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 108
Fair Value	[4],[15],[16]	$ 57
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.02%
Share / Unit	[4],[15],[16]	100
Investment, Identifier [Axis]: Kraton Polymers LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.25%
Interest Rate	[3],[5],[17],[18]	8.90%
Par Amount / Unit	[3],[17],[18]	$ 497
Cost	[3],[17],[18]	491
Fair Value	[3],[17],[18]	$ 488
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.14%
Investment, Identifier [Axis]: LMI Consulting, LLC (LMI)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[3],[4],[5]	6.50%	[6],[8],[9]
Interest Rate		11.90%	[3],[4],[5]	11.09%	[6],[8],[9]
Par Amount / Unit		$ 734	[3],[4]	$ 742	[6],[8]
Cost		722	[3],[4]	728	[6],[8]
Fair Value		$ 737	[3],[4]	$ 718	[6],[8]
Fair Value as % of Net Assets		0.21%	[1],[3],[4]	0.28%	[2],[6],[8]
Investment, Identifier [Axis]: LMI Consulting, LLC (LMI) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[3],[4],[5]	6.50%	[6],[8],[9]
Interest Rate		11.89%	[3],[4],[5]	11.09%	[6],[8],[9]
Par Amount / Unit		$ 2,955	[3],[4]	$ 2,985	[6],[8]
Cost		2,874	[3],[4]	2,889	[6],[8]
Fair Value		$ 2,968	[3],[4]	$ 2,889	[6],[8]
Fair Value as % of Net Assets		0.83%	[1],[3],[4]	1.11%	[2],[6],[8]
Investment, Identifier [Axis]: LMI Renaissance
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 107	[4],[15],[16]	$ 107	[8],[13],[14]
Fair Value		$ 237	[4],[15],[16]	$ 180	[8],[13],[14]
Fair Value as % of Net Assets		0.07%	[1],[4],[15],[16]	0.07%	[2],[8],[13],[14]
Share / Unit		109,456	[4],[15],[16]	107	[8],[13],[14]
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.50%
Interest Rate	[3],[4],[5]	12.00%
Par Amount / Unit	[3],[4]	$ 4,065
Cost	[3],[4]	3,993
Fair Value	[3],[4]	$ 4,122
Fair Value as % of Net Assets	[1],[3],[4]	1.16%
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.50%
Interest Rate	[3],[4],[5],[11]	12.00%
Par Amount / Unit	[3],[4],[11]	$ 1,894
Cost	[3],[4],[11]	1,579
Fair Value	[3],[4],[11]	$ 1,615
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.46%
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”) 1
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 196
Fair Value	[4],[15],[16]	$ 217
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.06%
Share / Unit	[4],[15],[16]	1,963
Investment, Identifier [Axis]: MEI Rigging & Crating (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.50%
Interest Rate	[3],[4],[5],[11]	11.86%
Par Amount / Unit	[3],[4],[11]	$ 501
Cost	[3],[4],[11]	(2)
Fair Value	[3],[4],[11]	$ (4)
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.00%
Investment, Identifier [Axis]: MEI Rigging & Crating 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.50%
Interest Rate	[3],[4],[5]	11.86%
Par Amount / Unit	[3],[4]	$ 3,158
Cost	[3],[4]	3,097
Fair Value	[3],[4]	$ 3,130
Fair Value as % of Net Assets	[1],[3],[4]	0.88%
Investment, Identifier [Axis]: MKS Instruments Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.50%
Interest Rate	[3],[5],[17],[18]	7.84%
Par Amount / Unit	[3],[17],[18]	$ 996
Cost	[3],[17],[18]	998
Fair Value	[3],[17],[18]	$ 1,000
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.28%
Investment, Identifier [Axis]: Marco APE Opco Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate	[8],[9]			10.50%
Interest Rate, PIK	[9]	15.00%	[4]	4.25%	[8]
Par Amount / Unit		$ 9,888	[4]	$ 8,633	[8]
Cost		9,467	[4]	8,103	[8]
Fair Value		$ 8,927	[4]	$ 7,458	[8]
Fair Value as % of Net Assets		2.51%	[1],[4]	2.87%	[2],[8]
Investment, Identifier [Axis]: Marlin Coinvest LP
Schedule of Investments [Line Items]
Cost	[4],[15],[16],[18]	$ 200
Fair Value	[4],[15],[16],[18]	$ 236
Fair Value as % of Net Assets	[1],[4],[15],[16],[18]	0.07%
Share / Unit	[4],[15],[16],[18]	200,000
Investment, Identifier [Axis]: Micronics
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5]	5.25%
Interest Rate	[4],[5]	10.00%
Par Amount / Unit	[4]	$ 1,880
Cost	[4]	1,842
Fair Value	[4]	$ 1,843
Fair Value as % of Net Assets	[1],[4]	0.52%
Investment, Identifier [Axis]: Mobile Communications America Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.00%
Interest Rate	[3],[4],[5]	11.35%
Par Amount / Unit	[3],[4]	$ 4,537
Cost	[3],[4]	4,470
Fair Value	[3],[4]	$ 4,472
Fair Value as % of Net Assets	[1],[3],[4]	1.26%
Investment, Identifier [Axis]: Mobile Communications America Inc (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.00%
Interest Rate	[3],[4],[5],[11]	11.35%
Par Amount / Unit	[3],[4],[11]	$ 1,463
Cost	[3],[4],[11]	(11)
Fair Value	[3],[4],[11]	$ (21)
Fair Value as % of Net Assets	[1],[3],[4],[11]	(0.01%)
Investment, Identifier [Axis]: Motion & Control Enterprises
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	5.50%
Interest Rate	[3],[4],[5]	11.03%
Par Amount / Unit	[3],[4]	$ 1,600
Cost	[3],[4]	1,581
Fair Value	[3],[4]	$ 1,581
Fair Value as % of Net Assets	[1],[3],[4]	0.45%
Investment, Identifier [Axis]: Motion & Control Enterprises (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	5.50%
Interest Rate	[3],[4],[5],[11]	11.03%
Par Amount / Unit	[3],[4],[11]	$ 4,400
Cost	[3],[4],[11]	2,691
Fair Value	[3],[4],[11]	$ 2,643
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.74%
Investment, Identifier [Axis]: Mr. Greens
Schedule of Investments [Line Items]
Interest Rate	[8],[9]			10.00%
Interest Rate, PIK	[8],[9]			2.00%
Par Amount / Unit	[8]			$ 10,153
Cost	[8]			9,807
Fair Value	[8]			$ 10,153
Fair Value as % of Net Assets	[2],[8]			3.90%
Investment, Identifier [Axis]: Mr. Greens 1
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost	[8],[13],[14]			$ 101
Fair Value	[8],[13],[14]			$ 276
Fair Value as % of Net Assets	[2],[8],[13],[14]			0.11%
Share / Unit	[8],[13],[14]			1
Investment, Identifier [Axis]: NMC Skincare Intermediate Holdings II, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10]	6.00%
Interest Rate	[3],[4],[5],[10]	10.44%
Interest Rate, PIK	[3],[4],[5],[10]	1.00%
Par Amount / Unit	[3],[4],[10]	$ 6,630
Cost	[3],[4],[10]	6,586
Fair Value	[3],[4],[10]	$ 6,294
Fair Value as % of Net Assets	[1],[3],[4],[10]	1.77%
Investment, Identifier [Axis]: NMC Skincare Intermediate Holdings II, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[7],[8],[9]			5.00%
Interest Rate	[6],[7],[8],[9]			9.77%
Par Amount / Unit	[6],[7],[8]			$ 6,946
Cost	[6],[7],[8]			6,849
Fair Value	[6],[7],[8]			$ 6,672
Fair Value as % of Net Assets	[2],[6],[7],[8]			2.56%
Investment, Identifier [Axis]: National Power
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.00%
Interest Rate	[3],[4],[5]	11.36%
Par Amount / Unit	[3],[4]	$ 1,485
Cost	[3],[4]	1,463
Fair Value	[3],[4]	$ 1,464
Fair Value as % of Net Assets	[1],[3],[4]	0.41%
Investment, Identifier [Axis]: National Power (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.00%
Interest Rate	[3],[4],[5],[11]	11.36%
Par Amount / Unit	[3],[4],[11]	$ 799
Cost	[3],[4],[11]	(2)
Fair Value	[3],[4],[11]	$ (11)
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.00%
Investment, Identifier [Axis]: New Era Technology, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[3],[4],[5],[10]	6.25%	[6],[7],[8],[9]
Interest Rate		11.78%	[3],[4],[5],[10]	11.02%	[6],[7],[8],[9]
Par Amount / Unit		$ 6,723	[3],[4],[10]	$ 6,947	[6],[7],[8]
Cost		6,703	[3],[4],[10]	6,919	[6],[7],[8]
Fair Value		$ 6,512	[3],[4],[10]	$ 6,650	[6],[7],[8]
Fair Value as % of Net Assets		1.84%	[1],[3],[4],[10]	2.56%	[2],[6],[7],[8]
Investment, Identifier [Axis]: New ILC Dover, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[3],[4],[5],[10]	5.00%	[6],[7],[8],[9]
Interest Rate		10.70%	[3],[4],[5],[10]	9.77%	[6],[7],[8],[9]
Par Amount / Unit		$ 6,875	[3],[4],[10]	$ 6,947	[6],[7],[8]
Cost		6,868	[3],[4],[10]	6,935	[6],[7],[8]
Fair Value		$ 6,875	[3],[4],[10]	$ 6,946	[6],[7],[8]
Fair Value as % of Net Assets		1.95%	[1],[3],[4],[10]	2.67%	[2],[6],[7],[8]
Investment, Identifier [Axis]: New You Bariatric Group, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[3],[4],[5]	5.25%	[6],[8],[9]
Interest Rate		10.75%	[3],[4],[5]	9.84%	[6],[8],[9]
Par Amount / Unit		$ 6,874	[3],[4]	$ 6,946	[6],[8]
Cost		6,874	[3],[4]	6,946	[6],[8]
Fair Value		$ 6,491	[3],[4]	$ 6,838	[6],[8]
Fair Value as % of Net Assets		1.83%	[1],[3],[4]	2.63%	[2],[6],[8]
Investment, Identifier [Axis]: Nexstar Media Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.50%
Interest Rate	[3],[5],[17],[18]	7.97%
Par Amount / Unit	[3],[17],[18]	$ 1,000
Cost	[3],[17],[18]	1,001
Fair Value	[3],[17],[18]	$ 1,002
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.28%
Investment, Identifier [Axis]: Nonni's Foods, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[3],[4],[5]	5.00%	[6],[8],[9]
Interest Rate		11.10%	[3],[4],[5]	9.39%	[6],[8],[9]
Par Amount / Unit		$ 6,890	[3],[4]	$ 6,963	[6],[8]
Cost		6,887	[3],[4]	6,958	[6],[8]
Fair Value		$ 6,849	[3],[4]	$ 6,915	[6],[8]
Fair Value as % of Net Assets		1.93%	[1],[3],[4]	2.66%	[2],[6],[8]
Investment, Identifier [Axis]: North Haven Stack Buyer, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[3],[4],[5],[10]	5.50%	[6],[7],[8],[9]
Interest Rate		11.03%	[3],[4],[5],[10]	9.86%	[6],[7],[8],[9]
Par Amount / Unit		$ 6,877	[3],[4],[10]	$ 6,947	[6],[7],[8]
Cost		6,853	[3],[4],[10]	6,918	[6],[7],[8]
Fair Value		$ 6,871	[3],[4],[10]	$ 6,845	[6],[7],[8]
Fair Value as % of Net Assets		1.93%	[1],[3],[4],[10]	2.63%	[2],[6],[7],[8]
Investment, Identifier [Axis]: Norton Lifelock Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.00%
Interest Rate	[3],[5],[17],[18]	7.46%
Par Amount / Unit	[3],[17],[18]	$ 467
Cost	[3],[17],[18]	467
Fair Value	[3],[17],[18]	$ 468
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.13%
Investment, Identifier [Axis]: Nouryon Finance B.V.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	4.00%
Interest Rate	[3],[5],[17],[18]	9.35%
Par Amount / Unit	[3],[17],[18]	$ 747
Cost	[3],[17],[18]	744
Fair Value	[3],[17],[18]	$ 751
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.21%
Investment, Identifier [Axis]: Nutrition 101 Buyer LLC (a/k/a 101, Inc.)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[3],[4],[5]	5.25%	[6],[8],[9]
Interest Rate		10.73%	[3],[4],[5]	9.61%	[6],[8],[9]
Par Amount / Unit		$ 816	[3],[4]	$ 824	[6],[8]
Cost		810	[3],[4]	816	[6],[8]
Fair Value		$ 800	[3],[4]	$ 816	[6],[8]
Fair Value as % of Net Assets		0.23%	[1],[3],[4]	0.31%	[2],[6],[8]
Investment, Identifier [Axis]: OMNIA Partners, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[10],[17]	4.25%
Interest Rate	[3],[5],[10],[17]	9.63%
Par Amount / Unit	[3],[10],[17]	$ 1,371
Cost	[3],[10],[17]	1,358
Fair Value	[3],[10],[17]	$ 1,381
Fair Value as % of Net Assets	[1],[3],[10],[17]	0.39%
Investment, Identifier [Axis]: Oliver Packaging
Schedule of Investments [Line Items]
Interest Rate		10.00%	[4],[5]	10.00%	[8],[9]
Interest Rate, PIK		1.00%	[4],[5]	1.00%	[8],[9]
Par Amount / Unit		$ 1,326	[4]	$ 1,332	[8]
Cost		1,305	[4]	1,308	[8]
Fair Value		$ 1,255	[4]	$ 1,265	[8]
Fair Value as % of Net Assets		0.35%	[1],[4]	0.48%	[2],[8]
Investment, Identifier [Axis]: Oliver Packaging 1
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 671	[4],[15],[16]	$ 610	[8],[13],[14]
Fair Value		$ 420	[4],[15],[16]	$ 639	[8],[13],[14]
Fair Value as % of Net Assets		0.12%	[1],[4],[15],[16]	0.25%	[2],[8],[13],[14]
Share / Unit		6,710	[4],[15],[16]	6	[8],[13],[14]
Investment, Identifier [Axis]: Omnia Partners (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[10],[11],[17]	4.25%
Interest Rate	[3],[5],[10],[11],[17]	9.63%
Par Amount / Unit	[3],[10],[11],[17]	$ 129
Cost	[3],[10],[11],[17]	(1)
Fair Value	[3],[10],[11],[17]	$ 1
Fair Value as % of Net Assets	[1],[3],[10],[11],[17]	0.00%
Investment, Identifier [Axis]: Online Labels Group
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	5.25%
Interest Rate	[3],[4],[5]	10.61%
Par Amount / Unit	[3],[4]	$ 979
Cost	[3],[4]	969
Fair Value	[3],[4]	$ 969
Fair Value as % of Net Assets	[1],[3],[4]	0.27%
Investment, Identifier [Axis]: Online Labels Group (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[11]	5.25%
Interest Rate	[4],[5],[11]	10.61%
Par Amount / Unit	[4],[11]	$ 119
Cost	[4],[11]	0
Fair Value	[4],[11]	$ (1)
Fair Value as % of Net Assets	[1],[4],[11]	0.00%
Investment, Identifier [Axis]: Online Labels Group (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[11]	5.25%
Interest Rate	[4],[5],[11]	10.61%
Par Amount / Unit	[4],[11]	$ 119
Cost	[4],[11]	0
Fair Value	[4],[11]	$ (1)
Fair Value as % of Net Assets	[1],[4],[11]	0.00%
Investment, Identifier [Axis]: Open Text Corp
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18],[19]	2.75%
Interest Rate	[3],[5],[17],[18],[19]	8.21%
Par Amount / Unit	[3],[17],[18],[19]	$ 1,219
Cost	[3],[17],[18],[19]	1,220
Fair Value	[3],[17],[18],[19]	$ 1,223
Fair Value as % of Net Assets	[1],[3],[17],[18],[19]	0.34%
Investment, Identifier [Axis]: Organon & Co
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.00%
Interest Rate	[3],[5],[17],[18]	8.47%
Par Amount / Unit	[3],[17],[18]	$ 1,250
Cost	[3],[17],[18]	1,255
Fair Value	[3],[17],[18]	$ 1,255
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.35%
Investment, Identifier [Axis]: Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.25%
Interest Rate	[3],[4],[5]	11.65%
Par Amount / Unit	[3],[4]	$ 3,420
Cost	[3],[4]	3,370
Fair Value	[3],[4]	$ 3,371
Fair Value as % of Net Assets	[1],[3],[4]	0.95%
Investment, Identifier [Axis]: Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.25%
Interest Rate	[3],[4],[5],[11]	11.65%
Par Amount / Unit	[3],[4],[11]	$ 2,571
Cost	[3],[4],[11]	(6)
Fair Value	[3],[4],[11]	$ (37)
Fair Value as % of Net Assets	[1],[3],[4],[11]	(0.01%)
Investment, Identifier [Axis]: Ovation Holdings, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.25%
Interest Rate	[3],[4],[5]	11.78%
Par Amount / Unit	[3],[4]	$ 2,973
Cost	[3],[4]	2,914
Fair Value	[3],[4]	$ 2,941
Fair Value as % of Net Assets	[1],[3],[4]	0.83%
Investment, Identifier [Axis]: Ovation Holdings, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.25%
Interest Rate	[3],[4],[5],[11]	11.78%
Par Amount / Unit	[3],[4],[11]	$ 703
Cost	[3],[4],[11]	568
Fair Value	[3],[4],[11]	$ 568
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.16%
Investment, Identifier [Axis]: PG Aggregator, LLC
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 109	[4],[15],[16],[18]	$ 109	[8],[13],[14]
Fair Value		$ 135	[4],[15],[16],[18]	$ 135	[8],[13],[14]
Fair Value as % of Net Assets		0.04%	[1],[4],[15],[16],[18]	0.05%	[2],[8],[13],[14]
Share / Unit		100	[4],[15],[16],[18]	0	[8],[13],[14]
Investment, Identifier [Axis]: PG Buyer, LLC
Schedule of Investments [Line Items]
Interest Rate		10.00%	[3],[4],[5]	10.00%
Interest Rate, PIK		1.50%	[3],[4],[5]	1.50%
Par Amount / Unit		$ 8,215	[3],[4]	$ 8,092	[8]
Cost		8,215	[3],[4]	8,092	[8]
Fair Value		$ 8,215	[3],[4]	$ 8,092	[8]
Fair Value as % of Net Assets		2.32%	[1],[3],[4]	3.11%	[2],[8]
Investment, Identifier [Axis]: Palmetto Acquisitionco, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5]	5.75%
Interest Rate	[3],[5]	11.10%
Par Amount / Unit	[3],[4]	$ 3,348
Cost	[3],[4]	3,292
Fair Value	[3],[4]	$ 3,291
Fair Value as % of Net Assets	[1],[3],[4]	0.93%
Investment, Identifier [Axis]: Palmetto Acquisitionco, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	5.75%
Interest Rate	[3],[4],[5],[11]	11.10%
Par Amount / Unit	[3],[4],[11]	$ 1,217
Cost	[3],[4],[11]	294
Fair Value	[3],[4],[11]	$ 277
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.08%
Investment, Identifier [Axis]: Patriot Growth Insurance Service (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[3],[4],[5],[10]	5.75%	[6],[7],[8],[9],[12]
Interest Rate		11.25%	[3],[4],[5],[10]	10.52%	[6],[7],[8],[9],[12]
Par Amount / Unit		$ 5,972	[3],[4],[10]	$ 5,999	[6],[7],[8],[12]
Cost		5,924	[3],[4],[10]	375	[6],[7],[8],[12]
Fair Value		$ 5,836	[3],[4],[10]	$ 266	[6],[7],[8],[12]
Fair Value as % of Net Assets		1.65%	[1],[3],[4],[10]	0.10%	[2],[6],[7],[8],[12]
Investment, Identifier [Axis]: Perennial Services Investors LLC
Schedule of Investments [Line Items]
Cost	[4],[15],[16],[18]	$ 196
Fair Value	[4],[15],[16],[18]	$ 271
Fair Value as % of Net Assets	[1],[4],[15],[16],[18]	0.08%
Share / Unit	[4],[15],[16],[18]	1,957
Investment, Identifier [Axis]: Perennial Services, Group, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.00%
Interest Rate	[3],[4],[5]	11.49%
Par Amount / Unit	[3],[4]	$ 1,693
Cost	[3],[4]	1,669
Fair Value	[3],[4]	$ 1,668
Fair Value as % of Net Assets	[1],[3],[4]	0.47%
Investment, Identifier [Axis]: Perennial Services, Group, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.00%
Interest Rate	[3],[4],[5]	11.49%
Par Amount / Unit	[3],[4]	$ 1,515
Cost	[3],[4]	1,512
Fair Value	[3],[4]	$ 1,493
Fair Value as % of Net Assets	[1],[3],[4]	0.42%
Investment, Identifier [Axis]: Perrigo Company plc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.25%
Interest Rate	[3],[5],[17],[18]	7.71%
Par Amount / Unit	[3],[17],[18]	$ 999
Cost	[3],[17],[18]	998
Fair Value	[3],[17],[18]	$ 999
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.28%
Investment, Identifier [Axis]: Phaidon International
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[3],[4],[5],[18],[19]	5.50%	[6],[8],[9]
Interest Rate		10.96%	[3],[4],[5],[18],[19]	9.86%	[6],[8],[9],[21],[22]
Par Amount / Unit		$ 6,538	[3],[4],[18],[19]	$ 7,000	[6],[8],[21],[22]
Cost		6,483	[3],[4],[18],[19]	6,932	[6],[8],[21],[22]
Fair Value		$ 6,538	[3],[4],[18],[19]	$ 6,916	[6],[8],[21],[22]
Fair Value as % of Net Assets		1.84%	[1],[3],[4],[18],[19]	2.66%	[2],[6],[8],[21],[22]
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.00%
Interest Rate	[3],[4],[5]	11.47%
Par Amount / Unit	[3],[4]	$ 2,533
Cost	[3],[4]	2,486
Fair Value	[3],[4]	$ 2,515
Fair Value as % of Net Assets	[1],[3],[4]	0.71%
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.00%
Interest Rate	[3],[4],[5],[11]	11.47%
Par Amount / Unit	[3],[4],[11]	$ 1,455
Cost	[3],[4],[11]	(12)
Fair Value	[3],[4],[11]	$ (10)
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.00%
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC 1
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 112
Fair Value	[4],[15],[16]	$ 112
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.03%
Share / Unit	[4],[15],[16]	111,875
Investment, Identifier [Axis]: Precision Aviation Group
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	5.75%
Interest Rate	[3],[4],[5]	11.12%
Par Amount / Unit	[3],[4]	$ 7,520
Cost	[3],[4]	7,370
Fair Value	[3],[4]	$ 7,370
Fair Value as % of Net Assets	[1],[3],[4]	2.08%
Investment, Identifier [Axis]: Precision Aviation Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[11]	5.75%
Interest Rate	[4],[5],[11]	11.12%
Par Amount / Unit	[4],[11]	$ 2,480
Cost	[4],[11]	(25)
Fair Value	[4],[11]	$ (49)
Fair Value as % of Net Assets	[1],[4],[11]	(0.01%)
Investment, Identifier [Axis]: Prime Security Services
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.50%
Interest Rate	[3],[5],[17],[18]	7.84%
Par Amount / Unit	[3],[17],[18]	$ 735
Cost	[3],[17],[18]	728
Fair Value	[3],[17],[18]	$ 738
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.21%
Investment, Identifier [Axis]: Protective Industrial Products (“PIP”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10]	5.00%
Interest Rate	[3],[4],[5],[10]	10.47%
Par Amount / Unit	[3],[4],[10]	$ 1,343
Cost	[3],[4],[10]	1,294
Fair Value	[3],[4],[10]	$ 1,356
Fair Value as % of Net Assets	[1],[3],[4],[10]	0.38%
Investment, Identifier [Axis]: Quikrete Holdings, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17]	2.75%
Interest Rate	[3],[5],[17]	8.22%
Par Amount / Unit	[3],[17]	$ 996
Cost	[3],[17]	998
Fair Value	[3],[17]	$ 1,000
Fair Value as % of Net Assets	[1],[3],[17]	0.28%
Investment, Identifier [Axis]: RTH Buyer LLC (dba Rhino Tool House)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.25%
Interest Rate	[3],[4],[5]	11.97%
Par Amount / Unit	[3],[4]	$ 2,673
Cost	[3],[4]	2,623
Fair Value	[3],[4]	$ 2,651
Fair Value as % of Net Assets	[1],[3],[4]	0.75%
Investment, Identifier [Axis]: RTH Buyer LLC (dba Rhino Tool House) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.25%
Interest Rate	[3],[4],[5],[11]	11.97%
Par Amount / Unit	[3],[4],[11]	$ 626
Cost	[3],[4],[11]	317
Fair Value	[3],[4],[11]	$ 315
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.09%
Investment, Identifier [Axis]: RVGD Aggregator LP (Revision Skincare)
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 98	[4],[15],[16]	$ 98	[8],[13],[14]
Fair Value		$ 108	[4],[15],[16]	$ 133	[8],[13],[14]
Fair Value as % of Net Assets		0.03%	[1],[4],[15],[16]	0.05%	[2],[8],[13],[14]
Share / Unit		100	[4],[15],[16]	0	[8],[13],[14]
Investment, Identifier [Axis]: Randys Holdings, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[3],[4],[5],[10]	6.50%	[6],[7],[8],[9]
Interest Rate		11.88%	[3],[4],[5],[10]	11.09%	[6],[7],[8],[9]
Par Amount / Unit		$ 3,957	[3],[4],[10]	$ 3,996	[6],[7],[8]
Cost		3,888	[3],[4],[10]	3,918	[6],[7],[8]
Fair Value		$ 3,907	[3],[4],[10]	$ 3,919	[6],[7],[8]
Fair Value as % of Net Assets		1.10%	[1],[3],[4],[10]	1.51%	[2],[6],[7],[8]
Investment, Identifier [Axis]: Randys Holdings, Inc (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[3],[4],[5],[10],[11]	6.50%	[6],[7],[8],[9],[12]
Interest Rate		11.88%	[3],[4],[5],[10],[11]	11.09%	[6],[7],[8],[9],[12]
Par Amount / Unit		$ 1,332	[3],[4],[10],[11]	$ 1,332	[6],[7],[8],[12]
Cost		0	[3],[4],[10],[11]	0	[6],[7],[8],[12]
Fair Value		$ (17)	[3],[4],[10],[11]	$ (26)	[6],[7],[8],[12]
Fair Value as % of Net Assets		0.00%	[1],[3],[4],[10],[11]	(0.01%)	[2],[6],[7],[8],[12]
Investment, Identifier [Axis]: Red Dawn SEI Buyer, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		8.25%	[4],[5]	8.25%	[8],[9]
Interest Rate		13.60%	[4],[5]	13.02%	[8],[9]
Par Amount / Unit		$ 6,650	[4]	$ 6,650	[8]
Cost		6,650	[4]	6,650	[8]
Fair Value		$ 6,650	[4]	$ 6,650	[8]
Fair Value as % of Net Assets		1.87%	[1],[4]	2.54%	[2],[8]
Investment, Identifier [Axis]: Red Dawn SEI Buyer, Inc. (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		8.50%	[4],[5]	8.50%	[8],[9]
Interest Rate		13.95%	[4],[5]	13.27%	[8],[9]
Par Amount / Unit		$ 3,350	[4]	$ 3,350	[8]
Cost		3,350	[4]	3,350	[8]
Fair Value		$ 3,350	[4]	$ 3,350	[8]
Fair Value as % of Net Assets		0.94%	[1],[4]	1.29%	[2],[8]
Investment, Identifier [Axis]: Red Ventures LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17]	3.00%
Interest Rate	[3],[5],[17]	8.36%
Par Amount / Unit	[3],[17]	$ 872
Cost	[3],[17]	870
Fair Value	[3],[17]	$ 871
Fair Value as % of Net Assets	[1],[3],[17]	0.25%
Investment, Identifier [Axis]: Revision Buyer LLC
Schedule of Investments [Line Items]
Interest Rate		10.00%	[4],[5]	10.00%	[8],[9]
Interest Rate, PIK		1.00%	[4],[5]	1.00%	[8],[9]
Par Amount / Unit		$ 10,176	[4]	$ 10,075	[8]
Cost		10,013	[4]	9,889	[8]
Fair Value		$ 10,176	[4]	$ 9,896	[8]
Fair Value as % of Net Assets		2.87%	[1],[4]	3.80%	[2],[8]
Investment, Identifier [Axis]: Ryan Specialty Group LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.00%
Interest Rate	[3],[5],[17],[18]	8.46%
Par Amount / Unit	[3],[17],[18]	$ 1,245
Cost	[3],[17],[18]	1,248
Fair Value	[3],[17],[18]	$ 1,247
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.35%
Investment, Identifier [Axis]: SCP Eye Care Holdco, LLC (DBA EyeSouth Partners)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[3],[4],[5]	5.75%	[6],[8],[9]
Interest Rate		11.21%	[3],[4],[5]	10.34%	[6],[8],[9]
Par Amount / Unit		$ 2,242	[3],[4]	$ 2,265	[6],[8]
Cost		2,199	[3],[4]	2,217	[6],[8]
Fair Value		$ 2,215	[3],[4]	$ 2,221	[6],[8]
Fair Value as % of Net Assets		0.62%	[1],[3],[4]	0.85%	[2],[6],[8]
Investment, Identifier [Axis]: SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[3],[4],[5],[11]	5.75%	[6],[8],[9],[12]
Interest Rate		11.21%	[3],[4],[5],[11]	10.34%	[6],[8],[9],[12]
Par Amount / Unit		$ 733	[3],[4],[11]	$ 735	[6],[8],[12]
Cost		467	[3],[4],[11]	0	[6],[8],[12]
Fair Value		$ 459	[3],[4],[11]	$ (14)	[6],[8],[12]
Fair Value as % of Net Assets		0.13%	[1],[3],[4],[11]	(0.01%)	[2],[6],[8],[12]
Investment, Identifier [Axis]: SPI LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[3],[4],[5],[10]	5.00%	[6],[7],[8],[9]
Interest Rate		10.46%	[3],[4],[5],[10]	9.59%	[6],[7],[8],[9]
Par Amount / Unit		$ 6,878	[3],[4],[10]	$ 6,948	[6],[7],[8]
Cost		6,800	[3],[4],[10]	6,855	[6],[7],[8]
Fair Value		$ 6,878	[3],[4],[10]	$ 6,804	[6],[7],[8]
Fair Value as % of Net Assets		1.94%	[1],[3],[4],[10]	2.61%	[2],[6],[7],[8]
Investment, Identifier [Axis]: SRAM LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17]	2.75%
Interest Rate	[3],[5],[17]	6.00%
Par Amount / Unit	[3],[17]	$ 750
Cost	[3],[17]	751
Fair Value	[3],[17]	$ 750
Fair Value as % of Net Assets	[1],[3],[17]	0.21%
Investment, Identifier [Axis]: SS&C Technology Holdings Inc 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.25%
Interest Rate	[3],[5],[17],[18]	7.71%
Par Amount / Unit	[3],[17],[18]	$ 297
Cost	[3],[17],[18]	298
Fair Value	[3],[17],[18]	$ 298
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.08%
Investment, Identifier [Axis]: SS&C Technology Holdings Inc 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.25%
Interest Rate	[3],[5],[17],[18]	7.71%
Par Amount / Unit	[3],[17],[18]	$ 177
Cost	[3],[17],[18]	177
Fair Value	[3],[17],[18]	$ 177
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.05%
Investment, Identifier [Axis]: SW Ingredients Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate		10.50%	[4],[5]	10.50%	[8],[9]
Interest Rate, PIK		1.00%	[4],[5]	1.00%	[8],[9]
Par Amount / Unit		$ 10,179	[4]	$ 10,076	[8]
Cost		10,179	[4]	10,076	[8]
Fair Value		$ 9,898	[4]	$ 9,521	[8]
Fair Value as % of Net Assets		2.79%	[1],[4]	3.67%	[2],[8]
Investment, Identifier [Axis]: Select Medical Corporation
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.00%
Interest Rate	[3],[5],[17],[18]	8.36%
Par Amount / Unit	[3],[17],[18]	$ 1,245
Cost	[3],[17],[18]	1,248
Fair Value	[3],[17],[18]	$ 1,248
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.35%
Investment, Identifier [Axis]: Smith System
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 84
Fair Value	[4],[15],[16]	$ 84
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.03%
Share / Unit	[4],[15],[16]	84,000
Investment, Identifier [Axis]: Solaray, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[3],[4],[5],[10]	5.75%	[6],[7],[8],[9]
Interest Rate		11.97%	[3],[4],[5],[10]	10.34%	[6],[7],[8],[9]
Par Amount / Unit		$ 6,889	[3],[4],[10]	$ 6,963	[6],[7],[8]
Cost		6,886	[3],[4],[10]	6,955	[6],[7],[8]
Fair Value		$ 6,399	[3],[4],[10]	$ 6,878	[6],[7],[8]
Fair Value as % of Net Assets		1.80%	[1],[3],[4],[10]	2.64%	[2],[6],[7],[8]
Investment, Identifier [Axis]: Southern Veterinary Partners
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[7],[8],[9]			5.50%
Interest Rate	[6],[7],[8],[9]			9.86%
Par Amount / Unit	[6],[7],[8]			$ 3,085
Cost	[6],[7],[8]			3,026
Fair Value	[6],[7],[8]			$ 3,022
Fair Value as % of Net Assets	[2],[6],[7],[8]			1.16%
Investment, Identifier [Axis]: Spartech
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[3],[4],[5],[10]	4.75%	[6],[7],[8],[9]
Interest Rate		10.16%	[3],[4],[5],[10]	9.52%	[6],[7],[8],[9]
Par Amount / Unit		$ 3,930	[3],[4],[10]	$ 3,970	[6],[7],[8]
Cost		3,930	[3],[4],[10]	3,970	[6],[7],[8]
Fair Value		$ 3,166	[3],[4],[10]	$ 3,863	[6],[7],[8]
Fair Value as % of Net Assets		0.89%	[1],[3],[4],[10]	1.48%	[2],[6],[7],[8]
Investment, Identifier [Axis]: Specialist Resources Global Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[3],[4],[5]	4.50%	[6],[8],[9]
Interest Rate		10.46%	[3],[4],[5]	8.89%	[6],[8],[9]
Par Amount / Unit		$ 6,876	[3],[4]	$ 6,947	[6],[8]
Cost		6,876	[3],[4]	6,947	[6],[8]
Fair Value		$ 6,876	[3],[4]	$ 6,894	[6],[8]
Fair Value as % of Net Assets		1.94%	[1],[3],[4]	2.65%	[2],[6],[8]
Investment, Identifier [Axis]: Spice World
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 126	[4],[15],[16]	$ 126	[8],[13],[14]
Fair Value		$ 115	[4],[15],[16]	$ 101	[8],[13],[14]
Fair Value as % of Net Assets		0.03%	[1],[4],[15],[16]	0.04%	[2],[8],[13],[14]
Share / Unit		1,000	[4],[15],[16]	1	[8],[13],[14]
Investment, Identifier [Axis]: Sugar Foods
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10]	6.00%
Interest Rate	[3],[4],[5],[10]	11.34%
Par Amount / Unit	[3],[4],[10]	$ 4,221
Cost	[3],[4],[10]	4,128
Fair Value	[3],[4],[10]	$ 4,130
Fair Value as % of Net Assets	[1],[3],[4],[10]	1.16%
Investment, Identifier [Axis]: Sugar Foods (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10],[11]	6.00%
Interest Rate	[3],[4],[5],[10],[11]	11.34%
Par Amount / Unit	[3],[4],[10],[11]	$ 1,173
Cost	[3],[4],[10],[11]	(13)
Fair Value	[3],[4],[10],[11]	$ (25)
Fair Value as % of Net Assets	[1],[3],[4],[10],[11]	(0.01%)
Investment, Identifier [Axis]: Sugar PPC Holdings LLC
Schedule of Investments [Line Items]
Cost	[4],[15],[16],[18]	$ 200
Fair Value	[4],[15],[16],[18]	$ 200
Fair Value as % of Net Assets	[1],[4],[15],[16],[18]	0.06%
Share / Unit	[4],[15],[16],[18]	2,000
Investment, Identifier [Axis]: Summit Hill Foods
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.00%
Interest Rate	[3],[4],[5]	11.39%
Par Amount / Unit	[3],[4]	$ 2,893
Cost	[3],[4]	2,850
Fair Value	[3],[4]	$ 2,850
Fair Value as % of Net Assets	[1],[3],[4]	0.80%
Investment, Identifier [Axis]: Summit Materials, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.00%
Interest Rate	[3],[5],[17],[18]	8.57%
Par Amount / Unit	[3],[17],[18]	$ 996
Cost	[3],[17],[18]	1,002
Fair Value	[3],[17],[18]	$ 999
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.28%
Investment, Identifier [Axis]: Sunny Sky Products
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	5.25%
Interest Rate	[3],[4],[5]	10.60%
Par Amount / Unit	[3],[4]	$ 1,857
Cost	[3],[4]	1,839
Fair Value	[3],[4]	$ 1,839
Fair Value as % of Net Assets	[1],[3],[4]	0.52%
Investment, Identifier [Axis]: Sunny Sky Products (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	5.25%
Interest Rate	[3],[4],[5],[11]	10.60%
Par Amount / Unit	[3],[4],[11]	$ 464
Cost	[3],[4],[11]	0
Fair Value	[3],[4],[11]	$ (4)
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.00%
Investment, Identifier [Axis]: SupplyOne, Inc.
Schedule of Investments [Line Items]
Interest Rate		10.00%	[4],[5]	10.00%	[8],[9]
Interest Rate, PIK		1.50%	[4],[5]	1.50%	[8],[9]
Par Amount / Unit		$ 10,227	[4]	$ 10,113	[8]
Cost		10,227	[4]	10,113	[8]
Fair Value		$ 10,227	[4]	$ 10,113	[8]
Fair Value as % of Net Assets		2.88%	[1],[4]	3.89%	[2],[8]
Investment, Identifier [Axis]: SupplyOne, Inc. 1
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 504	[4],[15],[16]	$ 504	[8],[13],[14]
Fair Value		$ 759	[4],[15],[16]	$ 980	[8],[13],[14]
Fair Value as % of Net Assets		0.21%	[1],[4],[15],[16]	0.38%	[2],[8],[13],[14]
Share / Unit		1,000	[4],[15],[16]	1	[8],[13],[14]
Investment, Identifier [Axis]: TIDI Products
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10]	5.50%
Interest Rate	[3],[4],[5],[10]	10.86%
Par Amount / Unit	[3],[4],[10]	$ 4,566
Cost	[3],[4],[10]	4,521
Fair Value	[3],[4],[10]	$ 4,520
Fair Value as % of Net Assets	[1],[3],[4],[10]	1.27%
Investment, Identifier [Axis]: TIDI Products (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[10],[11]	5.50%
Interest Rate	[4],[5],[10],[11]	10.86%
Par Amount / Unit	[4],[10],[11]	$ 1,201
Cost	[4],[10],[11]	0
Fair Value	[4],[10],[11]	$ (12)
Fair Value as % of Net Assets	[1],[4],[10],[11]	0.00%
Investment, Identifier [Axis]: Tech24
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 200
Fair Value	[4],[15],[16]	$ 200
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.06%
Share / Unit	[4],[15],[16]	200
Investment, Identifier [Axis]: Tempo Acquisition LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.75%
Interest Rate	[3],[5],[17],[18]	8.11%
Par Amount / Unit	[3],[17],[18]	$ 1,223
Cost	[3],[17],[18]	1,225
Fair Value	[3],[17],[18]	$ 1,230
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.35%
Investment, Identifier [Axis]: Thorne HealthTech
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	5.75%
Interest Rate	[3],[4],[5]	11.10%
Par Amount / Unit	[3],[4]	$ 2,788
Cost	[3],[4]	2,761
Fair Value	[3],[4]	$ 2,763
Fair Value as % of Net Assets	[1],[3],[4]	0.78%
Investment, Identifier [Axis]: Topgolf Callaway Brands Corp
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.50%
Interest Rate	[3],[5],[17],[18]	8.96%
Par Amount / Unit	[3],[17],[18]	$ 497
Cost	[3],[17],[18]	499
Fair Value	[3],[17],[18]	$ 498
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.14%
Investment, Identifier [Axis]: Transit Buyer LLC (dba“Propark”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.25%
Interest Rate	[3],[4],[5]	11.69%
Par Amount / Unit	[3],[4]	$ 2,526
Cost	[3],[4]	2,482
Fair Value	[3],[4]	$ 2,518
Fair Value as % of Net Assets	[1],[3],[4]	0.71%
Investment, Identifier [Axis]: Transit Buyer LLC (dba“Propark”) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.25%
Interest Rate	[3],[4],[5],[11]	11.69%
Par Amount / Unit	[3],[4],[11]	$ 1,157
Cost	[3],[4],[11]	472
Fair Value	[3],[4],[11]	$ 488
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.14%
Investment, Identifier [Axis]: Trench Plate Rental Co.
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 127	[4],[15],[16]	$ 127	[8],[13],[14]
Fair Value		$ 97	[4],[15],[16]	$ 134	[8],[13],[14]
Fair Value as % of Net Assets		0.03%	[1],[4],[15],[16]	0.05%	[2],[8],[13],[14]
Share / Unit		1,000	[4],[15],[16]	1	[8],[13],[14]
Investment, Identifier [Axis]: Trilon Group, LLC (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[3],[4],[5]	6.25%	[6],[8],[9],[12]
Interest Rate		11.78%	[3],[4],[5]	10.84%	[6],[8],[9],[12]
Par Amount / Unit		$ 2,970	[3],[4]	$ 400	[6],[8],[12]
Cost		2,970	[3],[4]	37	[6],[8],[12]
Fair Value		$ 2,932	[3],[4]	$ 32	[6],[8],[12]
Fair Value as % of Net Assets		0.83%	[1],[3],[4]	0.01%	[2],[6],[8],[12]
Investment, Identifier [Axis]: Trilon Group, LLC (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[3],[4],[5]	5.25%	[6],[8],[9]
Interest Rate		11.78%	[3],[4],[5]	9.84%	[6],[8],[9]
Par Amount / Unit		$ 397	[3],[4]	$ 3,000	[6],[8]
Cost		397	[3],[4]	3,000	[6],[8]
Fair Value		$ 392	[3],[4]	$ 2,888	[6],[8]
Fair Value as % of Net Assets		0.11%	[1],[3],[4]	1.11%	[2],[6],[8]
Investment, Identifier [Axis]: Trilon Group, LLC 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[3],[4],[5]	5.25%	[6],[8],[9]
Interest Rate		11.78%	[3],[4],[5]	9.84%	[6],[8],[9]
Par Amount / Unit		$ 596	[3],[4]	$ 2,993	[6],[8]
Cost		592	[3],[4]	2,964	[6],[8]
Fair Value		$ 588	[3],[4]	$ 2,881	[6],[8]
Fair Value as % of Net Assets		0.17%	[1],[3],[4]	1.11%	[2],[6],[8]
Investment, Identifier [Axis]: Trilon Group, LLC 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[3],[4],[5]	6.25%	[6],[8],[9]
Interest Rate		11.75%	[3],[4],[5]	10.84%	[6],[8],[9]
Par Amount / Unit		$ 2,963	[3],[4]	$ 600	[6],[8]
Cost		2,938	[3],[4]	594	[6],[8]
Fair Value		$ 2,925	[3],[4]	$ 593	[6],[8]
Fair Value as % of Net Assets		0.82%	[1],[3],[4]	0.23%	[2],[6],[8]
Investment, Identifier [Axis]: Tronox Finance LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.50%
Interest Rate	[3],[5],[17],[18]	8.85%
Par Amount / Unit	[3],[17],[18]	$ 1,000
Cost	[3],[17],[18]	996
Fair Value	[3],[17],[18]	$ 1,001
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.28%
Investment, Identifier [Axis]: Turbine Engine Specialist, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5]	9.50%
Interest Rate	[4],[5]	14.96%
Par Amount / Unit	[4]	$ 1,973
Cost	[4]	1,925
Fair Value	[4]	$ 1,937
Fair Value as % of Net Assets	[1],[4]	0.54%
Investment, Identifier [Axis]: U.S. Bank National Association Money Market Deposit Account 1
Schedule of Investments [Line Items]
Interest Rate		472.00%
Cost		$ 1,989
Fair Value		$ 1,989
Fair Value as % of Net Assets	[1]	0.56%
Share / Unit		1,989
Investment, Identifier [Axis]: U.S. Bank National Association Money Market Deposit Account 2
Schedule of Investments [Line Items]
Interest Rate		205.00%
Cost		$ 5,586
Fair Value		$ 5,586
Fair Value as % of Net Assets	[1]	1.57%
Share / Unit		5,586
Investment, Identifier [Axis]: UPC Finance Partnership
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18],[19]	3.00%
Interest Rate	[3],[5],[17],[18],[19]	8.48%
Par Amount / Unit	[3],[17],[18],[19]	$ 500
Cost	[3],[17],[18],[19]	489
Fair Value	[3],[17],[18],[19]	$ 499
Fair Value as % of Net Assets	[1],[3],[17],[18],[19]	0.14%
Investment, Identifier [Axis]: US Foods, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.50%
Interest Rate	[3],[5],[17],[18]	7.97%
Par Amount / Unit	[3],[17],[18]	$ 1,250
Cost	[3],[17],[18]	1,254
Fair Value	[3],[17],[18]	$ 1,257
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.35%
Investment, Identifier [Axis]: US Radiology Specialists, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[3],[4],[5],[10]	5.25%	[6],[7],[9],[23]
Interest Rate		10.75%	[3],[4],[5],[10]	10.02%	[6],[7],[9],[23]
Par Amount / Unit		$ 1,863	[3],[4],[10]	$ 1,882	[6],[7],[23]
Cost		1,793	[3],[4],[10]	1,798	[6],[7],[23]
Fair Value		$ 1,851	[3],[4],[10]	$ 1,704	[6],[7],[23]
Fair Value as % of Net Assets		0.52%	[1],[3],[4],[10]	0.66%	[2],[6],[7],[23]
Investment, Identifier [Axis]: Uber Technologies Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	2.75%
Interest Rate	[3],[5],[17],[18]	8.13%
Par Amount / Unit	[3],[17],[18]	$ 995
Cost	[3],[17],[18]	997
Fair Value	[3],[17],[18]	$ 998
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.28%
Investment, Identifier [Axis]: Ultima Health Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate		11.00%	[4],[5]	11.00%	[8],[9]
Interest Rate, PIK		1.50%	[4],[5]	1.50%	[8],[9]
Par Amount / Unit		$ 1,326	[4]	$ 1,306	[8]
Cost		1,304	[4]	1,282	[8]
Fair Value		$ 1,303	[4]	$ 1,278	[8]
Fair Value as % of Net Assets		0.37%	[1],[4]	0.49%	[2],[8]
Investment, Identifier [Axis]: Ultima Health Holdings, LLC 1
Schedule of Investments [Line Items]
Interest Rate	[8],[9],[13],[14]			0.00%
Cost		$ 130	[4],[15],[16]	$ 130	[8],[13],[14]
Fair Value		$ 121	[4],[15],[16]	$ 130	[8],[13],[14]
Fair Value as % of Net Assets		0.03%	[1],[4],[15],[16]	0.05%	[2],[8],[13],[14]
Share / Unit		11	[4],[15],[16]	0	[8],[13],[14]
Investment, Identifier [Axis]: United Airlines Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.75%
Interest Rate	[3],[5],[17],[18]	9.22%
Par Amount / Unit	[3],[17],[18]	$ 1,245
Cost	[3],[17],[18]	1,250
Fair Value	[3],[17],[18]	$ 1,251
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.36%
Investment, Identifier [Axis]: Vertex Service Partners
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	5.50%
Interest Rate	[3],[4],[5]	10.90%
Par Amount / Unit	[3],[4]	$ 1,230
Cost	[3],[4]	1,212
Fair Value	[3],[4]	$ 1,212
Fair Value as % of Net Assets	[1],[3],[4]	0.34%
Investment, Identifier [Axis]: Vertex Service Partners (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	5.50%
Interest Rate	[3],[4],[5],[11]	10.90%
Par Amount / Unit	[3],[4],[11]	$ 2,369
Cost	[3],[4],[11]	586
Fair Value	[3],[4],[11]	$ 558
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.16%
Investment, Identifier [Axis]: Viking Target, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[3],[4],[5]	5.00%	[6],[8],[9]
Interest Rate		10.47%	[3],[4],[5]	9.77%	[6],[8],[9]
Par Amount / Unit		$ 6,360	[3],[4]	$ 6,945	[6],[8]
Cost		6,346	[3],[4]	6,906	[6],[8]
Fair Value		$ 6,334	[3],[4]	$ 6,916	[6],[8]
Fair Value as % of Net Assets		1.79%	[1],[3],[4]	2.66%	[2],[6],[8]
Investment, Identifier [Axis]: Virgin Media Bristol LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18],[19]	3.25%
Interest Rate	[3],[5],[17],[18],[19]	8.73%
Par Amount / Unit	[3],[17],[18],[19]	$ 1,250
Cost	[3],[17],[18],[19]	1,230
Fair Value	[3],[17],[18],[19]	$ 1,250
Fair Value as % of Net Assets	[1],[3],[17],[18],[19]	0.35%
Investment, Identifier [Axis]: W2O Holdings, Inc.(Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	5.25%
Interest Rate	[3],[4],[5]	10.82%
Par Amount / Unit	[3],[4]	$ 6,877
Cost	[3],[4]	6,877
Fair Value	[3],[4]	$ 6,877
Fair Value as % of Net Assets	[1],[3],[4]	1.94%
Investment, Identifier [Axis]: W2O Holdings, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[8],[9]			4.75%
Interest Rate	[6],[8],[9]			9.52%
Par Amount / Unit	[6],[8]			$ 6,947
Cost	[6],[8]			6,947
Fair Value	[6],[8]			$ 6,905
Fair Value as % of Net Assets	[2],[6],[8]			2.65%
Investment, Identifier [Axis]: WCI Holdings LLC
Schedule of Investments [Line Items]
Cost	[4],[15],[16],[18]	$ 535
Fair Value	[4],[15],[16],[18]	$ 581
Fair Value as % of Net Assets	[1],[4],[15],[16],[18]	0.16%
Share / Unit	[4],[15],[16],[18]	534,934
Investment, Identifier [Axis]: WSB Engineering Holdings Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	6.00%
Interest Rate	[3],[4],[5]	11.39%
Par Amount / Unit	[3],[4]	$ 1,639
Cost	[3],[4]	1,616
Fair Value	[3],[4]	$ 1,616
Fair Value as % of Net Assets	[1],[3],[4]	0.46%
Investment, Identifier [Axis]: WSB Engineering Holdings Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[11]	6.00%
Interest Rate	[3],[4],[5],[11]	11.39%
Par Amount / Unit	[3],[4],[11]	$ 1,096
Cost	[3],[4],[11]	(8)
Fair Value	[3],[4],[11]	$ (16)
Fair Value as % of Net Assets	[1],[3],[4],[11]	0.00%
Investment, Identifier [Axis]: Wellspring Pharmaceutical
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[3],[4],[5]	5.75%	[6],[8],[9]
Interest Rate		11.03%	[3],[4],[5]	10.53%	[6],[8],[9]
Par Amount / Unit		$ 4,054	[3],[4]	$ 4,095	[6],[8]
Cost		3,988	[3],[4]	4,017	[6],[8]
Fair Value		$ 3,958	[3],[4]	$ 4,020	[6],[8]
Fair Value as % of Net Assets		1.12%	[1],[3],[4]	1.54%	[2],[6],[8]
Investment, Identifier [Axis]: Wellspring Pharmaceutical (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5]	5.75%	[8],[9],[12]
Interest Rate		11.03%	[4],[5]	10.53%	[8],[9],[12]
Par Amount / Unit		$ 1,885	[4]	$ 1,895	[8],[12]
Cost		1,873	[4]	(14)	[8],[12]
Fair Value		$ 1,841	[4]	$ (35)	[8],[12]
Fair Value as % of Net Assets		0.52%	[1],[4]	(0.01%)	[2],[8],[12]
Investment, Identifier [Axis]: WideOpenWest Finance LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18]	3.00%
Interest Rate	[3],[5],[17],[18]	8.35%
Par Amount / Unit	[3],[17],[18]	$ 497
Cost	[3],[17],[18]	493
Fair Value	[3],[17],[18]	$ 462
Fair Value as % of Net Assets	[1],[3],[17],[18]	0.13%
Investment, Identifier [Axis]: Worldwide Clinical Trials 1
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 74
Fair Value	[4],[15],[16]	$ 74
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.02%
Share / Unit	[4],[15],[16]	7
Investment, Identifier [Axis]: Worldwide Clinical Trials 2
Schedule of Investments [Line Items]
Cost	[4],[15],[16]	$ 47
Fair Value	[4],[15],[16]	$ 49
Fair Value as % of Net Assets	[1],[4],[15],[16]	0.01%
Share / Unit	[4],[15],[16]	49
Investment, Identifier [Axis]: Xpressmyself.com LLC (a/k/a SmartSign)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[8],[9]			5.00%
Interest Rate	[6],[8],[9]			9.59%
Par Amount / Unit	[6],[8]			$ 2,045
Cost	[6],[8]			2,026
Fair Value	[6],[8]			$ 2,026
Fair Value as % of Net Assets	[2],[6],[8]			0.78%
Investment, Identifier [Axis]: Xpressmyself.com LLC (a/k/a SmartSign) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	5.75%
Interest Rate	[3],[4],[5]	11.22%
Par Amount / Unit	[3],[4]	$ 1,531
Cost	[3],[4]	1,503
Fair Value	[3],[4]	$ 1,518
Fair Value as % of Net Assets	[1],[3],[4]	0.43%
Investment, Identifier [Axis]: Xpressmyself.com LLC (a/k/a SmartSign) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5]	5.50%
Interest Rate	[3],[4],[5]	10.98%
Par Amount / Unit	[3],[4]	$ 2,024
Cost	[3],[4]	2,008
Fair Value	[3],[4]	$ 1,989
Fair Value as % of Net Assets	[1],[3],[4]	0.56%
Investment, Identifier [Axis]: Young Innovations
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[5],[10]	5.75%
Interest Rate	[3],[4],[5],[10]	11.09%
Par Amount / Unit	[3],[4],[10]	$ 6,867
Cost	[3],[4],[10]	6,799
Fair Value	[3],[4],[10]	$ 6,801
Fair Value as % of Net Assets	[1],[3],[4],[10]	1.92%
Investment, Identifier [Axis]: Young Innovations (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[10],[11]	5.75%
Interest Rate	[4],[5],[10],[11]	11.09%
Par Amount / Unit	[4],[10],[11]	$ 1,431
Cost	[4],[10],[11]	0
Fair Value	[4],[10],[11]	$ (14)
Fair Value as % of Net Assets	[1],[4],[10],[11]	0.00%
Investment, Identifier [Axis]: Ziggo Financing Partnership
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[5],[17],[18],[19]	2.50%
Interest Rate	[3],[5],[17],[18],[19]	7.98%
Par Amount / Unit	[3],[17],[18],[19]	$ 500
Cost	[3],[17],[18],[19]	490
Fair Value	[3],[17],[18],[19]	$ 499
Fair Value as % of Net Assets	[1],[3],[17],[18],[19]	0.14%

[1] Percentage is based on net assets of $354,831 as of December 31, 2023.

[2] Percentage is based on net assets of $260,301 as of December 31, 2022.

[3] Denotes that all or a portion of the assets are owned by SPV I (as defined in Note 1 “Organization”). SPV I entered into a senior secured revolving credit facility (the “Bank of America Credit Facility”) on April 19, 2022. The lenders of the Bank of America Credit Facility have a first lien security interest in substantially all of the assets of SPV I. Accordingly, such assets are not available to creditors of the Fund. See Note 6 “Secured Borrowings” for more information.

[4] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies - Valuation of Portfolio Investments” for more information.

[5] The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Fund has provided the spread over SOFR and the current contractual interest rate in effect at December 31, 2023. As of December 31, 2023, effective rates for 1M S, 3M S, 6M S and 12M S are 5.35%, 5.33%, 5.16% and 4.77%, respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

[6] Denotes that all or a portion of the assets are owned by SPV I (as defined in Note 1 “Organization”). SPV I entered into a senior secured revolving credit facility (the “Bank of America Credit Facility”) on April 19, 2022. The lenders of the Bank of America Credit Facility have a first lien security interest in substantially all of the assets of SPV I. Accordingly, such assets are not available to creditors of the Fund. See Note 6 “Secured Borrowings”.

[7] Investment is a unitranche position.

[8] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies - Valuation of Portfolio Investments” for more information.

[9] The majority of the investments bear interest at rates that may be determined by reference to London Interbank Offered Rate (“LIBOR” or "L"), as well as Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Fund has provided the spread over LIBOR and SOFR and the current contractual interest rate in effect at December 31, 2022. As of December 31, 2022, effective rates for 1M L and 3M L are 4.39% and 4.77%, respectively. As of December 31, 2022, effective rates for 1M S, 3M S and 6M S are 4.36%, 4.59% and 4.78%, respectively. For portfolio companies with multiple interest rate contracts, the interest rate shown is a weighted average current interest rate in effect as of December 31, 2022. Certain investments are subject to a LIBOR or SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

[10] Investment is a unitranche position.

[11] Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 7 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

[12] Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 7 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

[13] Equity investments are non-income producing securities unless otherwise noted.

[14] Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of December 31, 2022, the Fund held seventeen restricted securities with an aggregate fair value of $4,338, or 1.7% of the Fund’s net assets. The acquisition dates of these securities were as follows: CV Holdco, LLC - March 31, 2022, Kofile, Inc. - March 31, 2022, Mr. Greens - March 31, 2022, PG Aggregator, LLC - March 31, 2022, RVGD Aggregator LP (Revision Skincare) - March 31, 2022. Spice World - March 31, 2022, Supply One - March 31, 2022, Trench Plate Rental Co. - March 31, 2022, LMI Renaissance - June 30, 2022, Oliver Packaging - July 6, 2022, ITSavvy LLC- August 8, 2022, ADPD Holdings, LLC (a/k/a NearU) - August 11, 2022 and Ultima Health Holdings, LLC - September 12, 2022, Fresh Edge Class A and Fresh Edge Class B - October 3, 2022, BroadcastMed Holdco, LLC - October 4, 2022 and Gannett Fleming - December 20, 2022.

[15] Equity investments are non-income producing securities unless otherwise noted.

[16] Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of December 31, 2023, the Fund held forty restricted securities with an aggregate fair value of $10,224, or 2.88% of the Fund’s net assets.

[17] Investments valued using observable inputs (Level 2), if applicable. See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

[18] The investment is considered as a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Fund's total assets. As of December 31, 2023, total non-qualifying assets at fair value represented 10.16% of the Fund's total assets calculated in accordance with the 1940 Act.

[19] This portfolio company is not domiciled in the United States. A portfolio company that is not domiciled in the United States is considered a non-qualifying asset under Section 55(a) of the 1940 Act. See Note 3 "Investments" for more information.

[20] Represents an investment held through an aggregator vehicle organized as a pooled investment vehicle.

[21] The investment is considered as a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Fund's total assets. As of December 31, 2022, total non-qualifying assets at fair value represented 1.64% of the Fund's total assets calculated in accordance with the 1940 Act.

[22] This portfolio company is not domiciled in the United States. The principal place of business for Phaidon International is the United Kingdom. A portfolio company that is not domiciled in the United States is considered a non-qualifying asset under Section 55(a) of the 1940 Act.

[23] Investments valued using observable inputs (Level 2). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

XML

CONSOLIDATED SCHEDULE OF INVESTMENTS (Parenthetical) $ in Thousands	Dec. 31, 2023 USD ($) investment		Dec. 31, 2022 USD ($) investment
Schedule of Investments [Line Items]
Net assets	$ 354,831		$ 260,301
Aggregate fair value	$ 10,224		$ 4,338
Percent of net assets	146.43%	[1]	134.27%	[2]
Restricted Security
Schedule of Investments [Line Items]
Number of investments | investment	40		17
Percent of net assets	2.88%		1.70%
Qualifying Assets
Schedule of Investments [Line Items]
Percent of net assets	70.00%		70.00%
Non Qualifying Assets
Schedule of Investments [Line Items]
Percent of net assets	10.16%		1.64%
One Month Libor
Schedule of Investments [Line Items]
Effective interest rate			4.39%
Three Month Libor
Schedule of Investments [Line Items]
Effective interest rate			4.77%
One Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	5.35%		4.36%
Three Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	5.33%		4.59%
Six Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	5.16%		4.78%
Twelve Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	4.77%

[1] Percentage is based on net assets of $354,831 as of December 31, 2023.

[2] Percentage is based on net assets of $260,301 as of December 31, 2022.

XML

ORGANIZATION

12 Months Ended

Dec. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

ORGANIZATION

ORGANIZATION

Nuveen Churchill Private Capital Income Fund (“PCAP”, and together with its consolidated subsidiaries, the “Fund”) is a Delaware statutory trust formed on February 8, 2022. PCAP is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Fund is externally managed by its adviser, Churchill Asset Management LLC (the “Adviser” or “Churchill”). Churchill is an indirect subsidiary of Nuveen, LLC (“Nuveen”), the investment management division of TIAA (as defined below). Churchill has engaged its affiliate, Nuveen Asset Management, LLC (“Nuveen Asset Management” or the “Sub-Adviser”), acting through its leveraged finance division, to manage certain of its Liquid Investments (defined below) pursuant to an investment sub-advisory agreement between the Adviser and Nuveen Asset Management (as discussed further in Note 5). The Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) as defined under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

The Fund’s investment objective is to generate attractive risk-adjusted returns primarily through current income and, secondarily, long-term capital appreciation, by investing in a diversified portfolio of private debt and equity investments in U.S. middle market companies owned by leading private equity firms, which the Fund defines as companies with approximately $10 million to $250 million of earnings before interest, taxes, depreciation and amortization (“EBITDA”). The Fund primarily focuses on investing in U.S. middle market companies with $10 to $100 million in EBITDA, which the Fund considers the core middle market. The Fund primarily invests in first-lien senior secured debt and first-out positions in unitranche loans (collectively “Senior Loan Investments”), as well as junior debt investments, such as second-lien loans, unsecured debt, subordinated debt and last-out positions in unitranche loans (including fixed- and floating-rate instruments and instruments with payment-in-kind income) (“Junior Capital Investments”). Senior Loan Investments and Junior Capital Investments may be originated alongside smaller related common equity positions to the same portfolio companies. The portfolio also will include larger, stand-alone direct equity co-investments in private-equity backed companies that may or may not be originated alongside or separately from Senior Loan Investments and/or Junior Capital Investments to the applicable portfolio company (“Equity Co-Investments”). We target an investment portfolio consisting, directly or indirectly, of 75% to 90% in Senior Loan Investments, 5% to 25% in Junior Capital Investments and up to 10% in Equity Co-Investments. To support the Fund’s share repurchase program (as discussed further in Note 8), the Fund also will invest 5% to 10% of its assets in cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments (“Liquid Investments”).

The Fund was established by Teachers Insurance and Annuity Association of America (“TIAA”), the ultimate parent of Churchill and Nuveen, and operated as a wholly owned subsidiary of TIAA until the Escrow Break Date (as defined below). On March 30, 2022, TIAA purchased 40 shares of the Fund’s Class I shares at $25.00 per share.

On March 31, 2022, prior to the Fund’s election to be regulated as a BDC under the 1940 Act, TIAA contributed certain portfolio investments to the Fund in the amount of $296,231 (fair value as of March 31, 2022). In addition, on March 31, 2022, the Fund entered into a promissory note with TIAA (the “Note”) as the lender. The principal amount of the Note equaled (i) the fair value of portfolio investments contributed as of March 31, 2022, minus (ii) $263,500 (as discussed further in Note 5). In connection therewith, the Fund issued to TIAA 10,540,000 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share. On June 3, 2022, the Fund fully repaid the balance on the Note to TIAA which was comprised of $32,731 and $226 of principal and interest, respectively.

NCPIF SPV I LLC (“SPV I”) and NCPIF Equity Holdings LLC (“Equity Holdings”) was formed on February 25, 2022 and April 1, 2022, respectively. Each of SPV I and Equity Holdings is a wholly owned subsidiary of the Fund and is consolidated in these consolidated financial statements commencing from the date of its formation. SPV I commenced operations on March 31, 2022, upon receipt of contribution of portfolio investments from TIAA to the Fund (as discussed further in Note 8). Equity Holdings commenced from the date of its formation.

The Fund is offering on a continuous basis up to $2.5 billion of any combination of three classes of common shares of beneficial interest (“Common Shares”), Class S shares, Class D shares and Class I shares. On May 17, 2022, the Securities and Exchange Commission (the “SEC”) granted an exemptive order permitting the Fund to offer multiple classes of Common Shares and to impose varying sales loads, asset-based service and/or distribution fees and early withdrawal fees. The share classes have different ongoing shareholder servicing and/or distribution fees. None of the share classes being offered will have early withdrawal fees. The purchase price per share for each class of Common Shares will equal the Fund’s net asset value (“NAV”) per share as of the effective date of the monthly share purchase date. Nuveen Securities, LLC (the “Intermediary Manager”) will use its best efforts to sell Common Shares, but is not obligated to purchase or sell any specific amount of Common Shares in the offering. As of June 1, 2023 (the “Escrow Break Date”), the Fund had satisfied the minimum offering requirement and the Fund’s Board of Trustees (the “Board”) authorized the release of proceeds from escrow.

XML

SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Fund is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the period presented, have been included. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value unless otherwise disclosed within.

Consolidation

As provided under ASC 946, the Fund will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Fund. Accordingly, the consolidated financial statements include the accounts of the Fund and its wholly owned subsidiaries, SPV I and Equity Holdings. All significant intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Fund to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash, Restricted Cash and Cash Equivalents

Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value. As of December 31, 2023, the Fund did not hold any restricted cash.

Valuation of Portfolio Investments

Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”) and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value.

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

•Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

•Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

•Level 3 — Valuations are based on inputs that are unobservable and significant to the overall fair value measurement.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.

Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price.

Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Fund’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs.

Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Fund's valuation designee (the “Valuation Designee”) to determine the fair value of the Fund's investments that do not have readily available market quotations, effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Fund's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Fund's assets for which market quotations are not readily available, subject to the oversight of the Board.

With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, undertakes a multi-step valuation process each quarter, as follows:

i.the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm;

ii.to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Board to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Fund will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value;

iii.the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Fund’s valuation policy, subject to the oversight of the Board; and

iv.the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Fund's valuation policy in connection with each quarterly Board meeting and discuss with the Board its determination of the fair value of each investment in good faith.

The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company’s credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are disclosed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources.

When determining NAV as of the last day of a month that is not also the last day of a calendar quarter, the Adviser updates the value of securities with “readily available market quotations” (as defined in Rule 2a-5 under the 1940 Act) to the most recent market quotation. For securities without readily available market quotations, the Adviser generally values such assets at the most recent quarterly valuation unless the Adviser determines that a significant observable change has occurred since the most recent quarter end with respect to the investment (which determination may be as a result of a material event at a portfolio company, material change in market spreads, secondary market transaction in the securities of an investment or otherwise). If the Adviser determines such a change has occurred with respect to one or more investments, the Adviser will determine whether to update the value for each relevant investment.

The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such values do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material.

The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Fund’s assets for which market quotations are not readily available, taking into account the Fund’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Fund's investments.

Investment Transactions and Revenue Recognition

Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains or losses are measured by the difference between the net proceeds received and the amortized cost basis of the investment using the specific identification method without regard to unrealized appreciation or depreciation previously recognized and are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.

Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Fund accrues interest income if it expects that ultimately it will be able to collect such income.

The Fund may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. If at any point the Fund believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Fund to maintain its tax treatment as a RIC, even though the Fund has not yet collected cash. As of December 31, 2023 and December 31, 2022, the fair value of the loans in the portfolio with PIK income provisions was $76,082 and $70,361, respectively, which represents approximately 14.86% and 20.13% of total investments at fair value, respectively. For the year ended December 31, 2023 and the period from February 8, 2022 (inception) through December 31, 2022 the Fund earned $2,333 and $1,275, respectively, in PIK income. As of December 31, 2023 and December 31, 2022, there were no PIK loans in the Fund's portfolio on non-accrual status.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio companies and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the year ended December 31, 2023, the Fund earned $123 in dividend income. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund did not earn any dividend income on its equity investments.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Fund’s investment activities, as well as any fees for managerial assistance services rendered by the Fund to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the year ended December 31, 2023, the Fund earned other income of $178 primarily related to amendment fees. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund earned other income of $504, primarily related to prepayment and amendment fees.

Loans are generally placed on non-accrual status when a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Fund will cease recognizing interest income on that loan until all principal and interest is current through payment, or until a restructuring occurs such that the interest income is deemed to be collectible. However, the Fund remains contractually entitled to this interest. The Fund may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. As of December 31, 2023 and December 31, 2022, there were no loans in the Fund's portfolio on non-accrual status.

Deferred Financing Costs

Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities.

Allocation of Income, Expenses, Gains and Losses

Income, expenses (other than those attributable to a specific class), gains and losses are allocated to each class of shares based upon the relative proportion of net assets represented by such class. Operating expenses attributable to a specific class are charged against the operations of that class.

Organization and Offering Costs

Organization costs consist of primarily legal, incorporation and accounting fees incurred in connection with the organization of the Fund. Organization costs are expensed as incurred and are shown in the Fund's consolidated statements of operations. Refer to Note 5 for further details on the Expense Support Agreement.

Offering costs consist primarily of fees and expenses incurred in connection with the offering of Common Shares, as well as legal, printing and other costs associated with the preparation and filing of the registration statements and offering materials. Offering costs are recognized as a deferred charge, amortized on a straight-line basis over 12 months and are shown in the Fund's consolidated statements of operations. For the year ended December 31, 2023, offering costs of $775, were incurred, and $659, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. For the period February 8, 2022 (inception) through December 31, 2022, offering costs of $484, were incurred, and $228, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. Refer to Note 5 for further details on the Expense Support Agreement.

Income Taxes

For U.S. federal income tax purposes, the Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. In order to qualify as a RIC, the Fund must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Fund is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Fund to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Fund may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

In addition, based on the excise distribution requirements, the Fund is subject to a 4% nondeductible U.S. federal excise tax on undistributed income unless the Fund distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Fund that is subject to U.S. federal income tax is considered to have been distributed. The Fund intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Fund may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax.

The Fund evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. SPV I is a disregarded entity for tax purposes and will be consolidated with the tax return of the Fund. Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the year ended December 31, 2023, the Fund incurred $31 in excise tax expense. For the period February 8, 2022 (inception) through December 31, 2022, the Fund incurred $2 in excise tax expense.

Dividends and Distributions to Common Shareholders

The Fund has declared distributions each month beginning in September 2022 through the date of this Annual Report on Form 10-K, and expects to continue to pay regular monthly distributions to the extent the Fund has taxable income available. Distributions to shareholders are recorded on the record date. The amount to be distributed to shareholders is determined by the Board and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Fund may decide to retain such capital gains for investment. Although the gross distribution per share is generally equivalent for each share class, the net distribution for each share class is reduced for any class specific expenses, including distribution and shareholder servicing fees, if any.

Functional Currency

The functional currency of the Fund is the U.S. Dollar and all transactions were in U.S. Dollars.

XML

INVESTMENTS

12 Months Ended

Dec. 31, 2023

Investments, Debt and Equity Securities [Abstract]

INVESTMENTS

INVESTMENTS

The composition of the Fund’s investment portfolio at cost and fair value was as follows:

	December 31, 2023						December 31, 2022
	Amortized Cost		Fair Value		% of Fair Value		Amortized Cost		Fair Value		% of Fair Value
First-Lien Term Loans	$	402,858	$	399,882	78.10	%	$	253,940	$	251,371	71.92	%
Subordinated Debt (1)	103,888		101,930		19.90	%	95,481		93,809		26.84	%
Equity Investments	9,422		10,224		2.00	%	3,577		4,338		1.24	%
Total	$	516,168	$	512,036	100.00	%	$	352,998	$	349,518	100.00	%
Largest portfolio company investment	$	10,731	$	10,986	2.15	%	$	10,617	$	11,093	3.17	%
Average portfolio company investment	$	3,246	$	3,220	0.63	%	$	5,516	$	5,461	1.56	%

_______________

(1)As of December 31, 2023, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $52,170 and mezzanine debt of $49,760 at fair value, and second lien term loans and/or second lien notes of $53,365 and mezzanine debt of $50,523 at amortized cost. As of December 31, 2022, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903 at fair value, and second lien term loans and/or second lien notes of $32,189 and mezzanine debt of $63,292 at amortized cost.

The industry composition of our portfolio as a percentage of fair value as of December 31, 2023 and December 31, 2022 was as follows:

Industry	December 31, 2023		December 31, 2022
Aerospace & Defense	2.07	%	—	%
Automotive	1.10	%	1.11	%
Banking, Finance, Insurance, Real Estate	1.49	%	0.08	%
Beverage, Food & Tobacco	10.39	%	12.54	%
Capital Equipment	4.28	%	1.98	%
Chemicals, Plastics & Rubber	3.80	%	4.28	%
Construction & Building	4.78	%	4.52	%
Consumer Goods: Durable	3.76	%	4.48	%
Consumer Goods: Non-durable	5.97	%	7.56	%
Containers, Packaging & Glass	3.49	%	4.89	%
Energy: Electricity	0.43	%	—	%
Energy: Oil & Gas	3.08	%	6.09	%
Environmental Industries	3.04	%	2.19	%
Healthcare & Pharmaceuticals	10.08	%	7.31	%
High Tech Industries	4.81	%	2.74	%
Hotel, Gaming & Leisure	0.44	%	—	%
Media: Advertising, Printing & Publishing	1.33	%	1.98	%
Media: Broadcasting & Subscription	0.80	%	—	%
Metals and Mining	0.10	%	—	%
Services: Business	16.82	%	16.98	%
Services: Consumer	5.73	%	6.65	%
Sovereign & Public Finance	0.77	%	1.08	%
Telecommunications	2.33	%	1.92	%
Transportation: Cargo	2.32	%	3.12	%
Transportation: Consumer	0.78	%	—	%
Utilities: Electric	0.51	%	—	%
Wholesale	5.50	%	8.50	%
Total	100.00	%	100.00	%

The geographic composition of investments at cost and fair value was as follows:

	December 31, 2023
	Cost		Fair Value		% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	$	496,774	$	492,518	96.19	%	138.80	%
Canada	6,374		6,376		1.25	%	1.80	%
United Kingdom	9,045		9,139		1.78	%	2.58	%
Ireland	1,741		1,750		0.34	%	0.49	%
Luxembourg	1,255		1,255		0.25	%	0.35	%
Netherlands	979		998		0.19	%	0.28	%
	$	516,168	$	512,036	100.00	%	144.30	%

	December 31, 2022
	Cost		Fair Value		% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	$	346,066	$	342,602	98.02	%	131.62	%
United Kingdom	6,932		6,916		1.98	%	2.66	%
	$	352,998	$	349,518	100.00	%	134.28	%

As of December 31, 2023 and December 31, 2022, on a fair value basis, 84.74% and 76.79%, respectively, of the Fund’s debt investments bore interest at a floating rate and 15.26% and 23.21%, respectively, of the Fund’s debt investments bore interest at a fixed rate.

XML

FAIR VALUE MEASUREMENTS

12 Months Ended

Dec. 31, 2023

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

Fair Value Disclosures

The following table presents fair value measurements of investments, by major class as of December 31, 2023 and December 31, 2022, according to the fair value hierarchy:

As of December 31, 2023	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	45,486	$	354,396	$	399,882
Subordinated Debt (1)	—		—		101,930		101,930
Equity Investments	—		—		10,224		10,224
Cash Equivalents	7,590		—		—		7,590
Total	$	7,590	$	45,486	$	466,550	$	519,626

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $52,170 and mezzanine debt of $49,760.

As of December 31, 2022	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	1,704	$	249,667	$	251,371
Subordinated Debt (1)	—		—		93,809		93,809
Equity Investments	—		—		4,338		4,338
Total	$	—	$	1,704	$	347,814	$	349,518

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903.

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2022	$	249,667	$	93,809	$	4,338	$	347,814
Purchase of investments	137,949		15,956		5,948		159,853
Proceeds from principal repayments and sales of investments	(35,224)		(10,216)		(392)		(45,832)
Payment-in-kind interest	71		2,117		—		2,188
Amortization of premium/accretion of discount, net	577		242		—		819
Net realized gain (loss) on investments	174		311		291		776
Net change in unrealized appreciation (depreciation) on investments	(522)		(289)		39		(772)
Transfers to Level 3 (1)	1,704		—		—		1,704
Balance as of December 31, 2023	$	354,396	$	101,930	$	10,224	$	466,550
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of December 31, 2023	$	(475)	$	36	$	215	$	(224)

________________

(1) Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the year ended December 31, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for one portfolio company.

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of February 8, 2022 (inception)	$	—	$	—	$	—	$	—
Purchase of investments	271,109		113,294		3,575		387,978
Proceeds from principal repayments and sales of investments	(19,207)		(19,000)		—		(38,207)
Payment-in-kind interest	—		1,275		—		1,275
Amortization of premium/accretion of discount, net	310		191		—		501
Net realized gain (loss) on investments	(66)		(281)		—		(347)
Net change in unrealized appreciation (depreciation) on investments	(2,479)		(1,670)		763		(3,386)
Balance as of December 31, 2022	$	249,667	$	93,809	$	4,338	$	347,814
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of December 31, 2022	$	(2,479)	$	(1,670)	$	763	$	(3,386)

Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the period from February 8, 2022 (inception) through December 31, 2022, there were no transfers into or out of Level 3.

Significant Unobservable Inputs

ASC Topic 820 requires disclosure of quantitative information about the significant unobservable inputs used in the valuation of assets and liabilities classified as Level 3 within the fair value hierarchy. The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of December 31, 2023 and December 31, 2022 were as follows:

Investment Type	Fair Value at December 31, 2023		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	282,615	Yield Method	Implied Discount Rate	6.13	%	16.48	%	10.88	%
First Lien Term Loans	68,615		Recent Transaction	Transaction Price	97.83		100.13		98.87
First Lien Term Loans	3,166		Market Approach	EBITDA Multiple	7.50		7.50		7.50
Subordinated Debt	100,086		Yield Method	Implied Discount Rate	11.57	%	20.63	%	13.96	%
Subordinated Debt	1,844		Recent Transaction	Transaction Price	98.01		98.01		98.01
Equity Investments	8,779		Market Approach	EBITDA Multiple	8.50		19.50		11.49
Equity Investments	57		Market Approach	EBITDA Multiple	9.00		9.00		9.00
			Market Approach	ARR Multiple	3.50		3.50		3.50
Equity Investments	528		Yield Method	Implied Discount Rate	8.36	%	15.16	%	8.35	%
Total	$	465,690

Equity investments in the amount of $860 at December 31, 2023 have been excluded from the table above as the investments are valued using recent transaction price.

Investment Type	Fair Value at December 31, 2022		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	228,304	Yield Method	Implied Discount Rate	8.98	%	13.37	%	10.63	%
First Lien Term Loans	21,363		Recent Transaction	Transaction Price	98.01		98.08		98.05
Subordinated Debt	88,391		Yield Method	Implied Discount Rate	8.88	%	17.94	%	13.39	%
Subordinated Debt	5,418		Recent Transaction	Transaction Price	97.58		98.08		97.82
Equity Investments	3,144		Enterprise Value	EBITDA Multiple	9.25x		13.50x		10.93x
Total	$	346,620

Equity investments in the amount of $1,194 at December 31, 2022 have been excluded from the table above as the investments are valued using recent transaction price.

Debt investments are generally valued using a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to the expected life, portfolio company performance since close, and other terms and risks associated with an investment. Among other factors, a determinant of risk is the amount of leverage used by the portfolio company relative to its total enterprise value, and the rights and remedies of the Fund’s investment within the portfolio company’s capital structure. A recent market trade, if applicable, will also be factored into the valuation.

Equity investments are generally valued using a market approach, which utilizes market value multiples (EBITDA or revenue) of publicly traded comparable companies and available precedent sales transactions of comparable companies. The selected multiple is used to estimate the enterprise value of the underlying investment.

The significant unobservable input used in the yield method is a discount rate based on comparable market yields. Significant increases in discount rates in isolation would result in a significantly lower fair value measurement. The significant unobservable input used in the market approach is the performance multiple, which may include a revenue multiple, EBITDA multiple, or forward-looking metrics. The multiple is used to estimate the enterprise value of the underlying investment. An increase or decrease in the multiple would result in an increase or decrease, respectively, in the fair value. A recent transaction, if applicable, may also be factored into the valuation if the transaction price is believed to be an indicator of value.

Alternative valuation methodologies may be used as deemed appropriate for debt or equity investments, and may include, but are not limited to, a market analysis, income analysis, or liquidation (recovery) analysis.

Weighted average inputs are calculated based on the relative fair value of the investments.

XML

RELATED PARTY TRANSACTIONS

12 Months Ended

Dec. 31, 2023

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

Advisory Agreement

On March 31, 2022, the Fund entered into the Advisory Agreement. The Board, including all of the trustees who are not “interested persons” (as defined under Section 2(a)(19) of the 1940 Act) of the Fund (the “Independent Trustees”), approved the Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such trustees as required by the 1940 Act. On August 3, 2022, the Board, including all of the Independent Trustees, approved Amendment No. 1 to the Advisory Agreement (the “Advisory Agreement Amendment”), which became effective immediately. The Advisory Agreement Amendment was entered into solely to extend the notice requirement for the Adviser to terminate the Advisory Agreement from 60 days to 120 days (as described below).

On January 10, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 2 (the “Second Advisory Agreement Amendment”) to the Investment Advisory Agreement, which became effective immediately. The Fund and the Adviser entered into the Second Advisory Agreement Amendment as a result of comments issued by securities regulators from various states in connection with their “blue sky” review of the Fund’s offering. The Second Advisory Agreement Amendment, among other things: (1) removed sunset provisions contingent upon recognition of the Common Shares as “covered securities”; (2) removed provisions entitling the Adviser to amounts owed under Sections 3 or Section 7 of the Advisory Agreement following a notice of termination of the Advisory Agreement; (3) specifies the conditions under which the Adviser may sell all or substantially all of the Fund’s assets; and (4) revised provisions to reflect conflicts of interest provisions set forth in the NASAA Omnibus Guidelines Statement of Policy adopted on March 29, 1992 and as amended on May 7, 2007 and from time to time (the “Omnibus Guidelines”).

On August 2, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 3 (the “Third Advisory Agreement Amendment”) to the Advisory Agreement, which became effective immediately. The Fund and the Adviser entered into Third Advisory Agreement Amendment as a result of comments issued by state securities regulators in connection with their “blue sky” review of the Fund’s offering, and reflects specific language in the Omnibus Guidelines required by a state securities regulator.

Unless terminated earlier as described below, the Advisory Agreement will remain in effect for a period of two years from March 31, 2022 and will remain in effect from year-to-year thereafter if approved annually by the Board or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of the Independent Trustees. The Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the Adviser and may be terminated by the Adviser without penalty upon not less than 120 days’ written notice to the Fund or by the Fund without penalty upon not less than 60 days’ written notice to the Adviser. The holders of a majority of the outstanding voting securities may also terminate either of the Advisory Agreement without penalty.

Base Management Fee

The management fee is payable monthly in arrears at an annual rate of 0.75% of the value of the Fund’s net assets as of the beginning of the first calendar day of the applicable month. For the first calendar month in which the Fund has operations, net assets will be measured using the beginning net assets as of the Escrow Break Date. In addition, the Adviser has agreed to waive its management fee until June 1, 2024, the expiry of twelve months from the Escrow Break Date.

For the year ended December 31, 2023, base management fees earned were $1,292, all of which were voluntarily waived by the Adviser. As of December 31, 2023, no amounts were payable to the Adviser related to management fees. For the the period from February 8, 2022 (inception) through December 31, 2022, no management fees were earned.

Incentive Fee

The incentive fee consists of two components that are independent of each other, with the result that one component may be payable even if the other is not: (i) incentive fee on income and (ii) an incentive fee on capital gains. Each part of the incentive fee is outlined below.

Incentive Fee Based on Income

The portion based on income is based on Pre-Incentive Fee Net Investment Income Returns. “Pre-Incentive Fee Net Investment Income Returns” means, as the context requires, either the dollar value of, or percentage rate of return on the value of net assets at the end of the immediate preceding quarter from, interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Fund receives from portfolio companies) accrued during the calendar quarter, minus our operating expenses accrued for the quarter (including the management fee, expenses payable under the Administration Agreement, and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred shares, but excluding the incentive fee and any shareholder servicing and/or distribution fees).

Pre-Incentive Fee Net Investment Income Returns include, in the case of investments with a deferred interest feature (such as OID, debt instruments with PIK interest and zero coupon securities), accrued income that has not yet been received in cash. Pre-Incentive Fee Net Investment Income Returns do not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The impact of expense support payments and recoupments (as discussed further below) are also excluded from Pre-Incentive Fee Net Investment Income Returns.

Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of the Fund’s net assets at the end of the immediate preceding quarter, is compared to a “hurdle rate” of return of 1.50% per quarter (6% annualized).

The Fund will pay the Adviser an incentive fee quarterly in arrears with respect to Pre-Incentive Fee Net Investment Income Returns in each calendar quarter as follows:

•No incentive fee based on Pre-Incentive Fee Net Investment Income Returns in any calendar quarter in which our Pre-Incentive Fee Net Investment Income Returns do not exceed the hurdle rate of 1.50% per quarter (6% annualized);

•100% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns with respect to that portion of such Pre-Incentive Fee Net Investment Income Returns, if any, that exceeds the hurdle rate but is less than a rate of return of 1.76% (7.06% annualized). The Fund refers to this portion of Pre-Incentive Fee Net Investment Income Returns (which exceeds the hurdle rate but is less than 1.76%) as the “catch-up.” The “catch-up” is meant to provide the Adviser with approximately 15% of our Pre-Incentive Fee Net Investment Income Returns as if a hurdle rate did not apply if this net investment income exceeds 1.76% in any calendar quarter; and

•15% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns, if any, that exceed a rate of return of 1.76% (7.06% annualized). This reflects that once the hurdle rate is reached and the catch-up is achieved, 15% of all Pre-Incentive Fee Net Investment Income Returns thereafter are allocated to the Adviser.

These calculations will be pro-rated for any period of less than three months and adjusted for any share issuances or repurchases during the relevant quarter.

The Adviser has agreed to waive the incentive fee based on income until June 1, 2024, the expiry of twelve months from the Escrow Break Date. For the year ended December 31, 2023, income based incentive fees were $3,108, which were voluntarily waived by the Adviser. As of December 31, 2023, no amounts were payable to the Adviser related to income based incentive fees. For the period from February 8, 2022 (inception) through December 31, 2022, no income based incentive fees were earned.

Incentive Fee Based on Capital Gains

The second component of the incentive fee, the capital gains incentive fee, will be payable at the end of each calendar year in arrears. The amount payable will equal:

•15% of cumulative realized capital gains from inception through the end of such calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid incentive fee on capital gains as calculated in accordance with U.S. GAAP.

Each year, the fee paid for the capital gains incentive fee will be net of the aggregate amount of any previously paid capital gains incentive fee for all prior periods. The Fund will accrue, but will not pay, a capital gains incentive fee with respect to unrealized appreciation because a capital gains incentive fee would be owed to the Adviser if the Fund was to sell the relevant investment and realize a capital gain. In no event will the capital gains incentive fee payable pursuant to the Advisory Agreement be in excess of the amount permitted by the Advisers Act, including Section 205 thereof.

The fees that are payable under the Advisory Agreement for any partial period will be appropriately prorated. For the year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022, the Fund did not incur any incentive fee based on capital gains.

Sub-Advisory Agreement

On March 31, 2022, the Adviser entered into the Investment Sub-Advisory Agreement with the Sub-Adviser (the “Sub-Advisory Agreement”). The Board, including all of the Independent Trustees, also approved the Sub-Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such trustees as required by the 1940 Act. The Sub-Adviser manages certain of the Liquid Investments pursuant to the Sub-Advisory Agreement. The Adviser has general oversight over the investment process on behalf of the Fund and manages the capital structure of the Fund, including, but not limited to, asset and liability management. The Adviser also has ultimate responsibility for the Fund’s performance under the terms of the Investment Advisory Agreement. The Adviser will pay the Sub-Adviser monthly in arrears, 0.375% of the daily weighted average principal amount of the Liquid Investments managed by the Sub-Adviser pursuant to the Sub-Advisory Agreement.

On August 3, 2022, the Board, including all of the Independent Trustees, approved Amendment No. 1 to the Sub-Advisory Agreement (the “Sub-Advisory Agreement Amendment”), which became effective immediately. The Sub-Advisory Agreement Amendment was entered into solely to extend the notice requirement applicable to both the Adviser and the Sub-Adviser to terminate the Sub-Advisory Agreement from 60 days to 120 days (as described below).

Unless terminated earlier as described below, the Sub-Advisory Agreement will remain in effect for a period of two years from March 31, 2022 and will remain in effect from year-to-year thereafter if approved annually by the Board or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of the Independent Trustees. The Sub-Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the Adviser and may be terminated by either the Adviser or the Sub-Adviser without penalty upon not less than 120 days’ written notice to the other.

Administration Agreement

On March 31, 2022, the Fund entered into an administration agreement with the Administrator (the “Administration Agreement”), which was approved by the Board. Pursuant to the Administration Agreement, the Administrator furnishes the Fund with office facilities and equipment and provides clerical, bookkeeping and record keeping and other administrative services at such facilities. The Administrator performs, or oversees the performance of, the required administrative services, which include, among other things, assisting the Fund with the preparation of the financial records that the Fund is required to maintain and with the preparation of reports to shareholders and reports filed with the SEC. At the request of the Adviser or the Sub-Adviser, the Administrator also may provide significant managerial assistance on the Fund’s behalf to those portfolio companies that have accepted the Fund’s offer to provide such assistance. U.S. Bancorp Fund Services, LLC will provide the Fund with certain fund administration and bookkeeping services pursuant to a sub-administration agreement (the “Sub-Administration Agreement”) with the Administrator.

On January 10, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 1 (the “Administration Agreement Amendment”) to the Administration Agreement, which became effective immediately. The Fund and the Administrator entered into the Administration Agreement Amendment as a result of comments issued by securities regulators from various states in connection with their “blue sky” review of the Fund’s offering. The Administration Agreement Amendment provides that the Indemnified Parties (as defined in the Administration Agreement) will not be entitled to indemnification for any loss or liability to the Fund or its shareholders by reason of the Indemnified Parties’ negligence or misconduct, in accordance with the Omnibus Guidelines.

For the year ended December 31, 2023, the Fund incurred $517, in fees under the Sub-Administrative Agreement, which are included in administration fees in the consolidated statement of operations. For the period February 8, 2022 (inception) through December 31, 2022, the Fund incurred $299 in fees under the Sub-Administration Agreement, which are included in administration fees in the accompanying consolidated statements of operations. As of December 31, 2023 and December 31, 2022, $614 and $246, respectively, was unpaid and included in accounts payable and accrued expenses in the consolidated statements of assets and liabilities.

Intermediary Manager Agreement

On March 31, 2022, the Fund entered into an Intermediary Manager Agreement (the “Intermediary Manager Agreement”) with the Intermediary Manager, an affiliate of the Adviser. Under the terms of the Intermediary Manager Agreement, the Intermediary Manager serves as the agent and principal distributor for the Fund’s public offering of its Common Shares. The Intermediary Manager is entitled to receive distribution and/or shareholder servicing fees monthly at an annual rate of 0.85% of the value of the Fund’s net assets attributable to Class S shares as of the beginning of the first calendar day of the month. The Intermediary Manager is entitled to receive distribution and/or shareholder servicing fees monthly at an annual rate of 0.25% of the value of the Fund’s net assets attributable to Class D shares as of the beginning of the first calendar day of the month. No distribution and/or shareholder servicing fees will be paid with respect to Class I shares.

The Fund will cease paying the distribution and/or shareholder servicing fees on any Class S share and Class D share in a shareholder’s account at the end of the month in which the Intermediary Manager in conjunction with the transfer agent determines that total brokerage commissions and distribution and/or shareholder servicing fees paid with respect to any such share held by such shareholder within such account would exceed, in the aggregate, 10% of the gross proceeds from the sale of such share. At the end of such month, each such Class S share or Class D share will convert into a number of Class I shares (including any fractional shares), with an equivalent aggregate NAV as such share. The total underwriting compensation and total organization and offering expenses will not exceed 10% and 15%, respectively, of the gross proceeds from the offering.

For the year ended December 31, 2023, the Fund accrued distribution and shareholder servicing fee of $5 and $1 that were attributable to Class S and Class D shares, respectively. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund did not incur any distribution and shareholder servicing fee.

The Intermediary Manager Agreement may be terminated at any time, without the payment of any penalty, by vote of a majority of the Independent Trustees and the trustees who have no direct or indirect financial interest in the operation of the Fund’s distribution plan or the Intermediary Manager Agreement or by vote a majority of the outstanding voting securities of the Fund, on not more than 60 days’ written notice to the Intermediary Manager or the Adviser. The Intermediary Manager Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act.

Expense Support and Conditional Reimbursement Agreement

On March 31, 2022, the Fund entered into an expense support and conditional reimbursement agreement (the “Expense Support Agreement”) with the Adviser. The Expense Support Agreement provides that, Nuveen Alternative Holdings, an affiliate of the Adviser may pay (or cause one or more of its affiliates to pay) certain expenses of the Fund, provided that no portion of the payment will be used to pay any interest expenses of the Fund and/or shareholder servicing fees of the Fund (each, an “Expense Payment’). Such expense payment will be made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from Nuveen Alternative Holdings to pay such expense, and/or by an offset against amounts due from the Fund to Nuveen Alternative Holdings.

Following any calendar quarter in which Available Operating Funds (as defined below) exceed the cumulative distributions accrued to the Fund’s shareholders based on distributions declared with respect to record dates occurring in such calendar quarter (such amount referred to as the “Excess Operating Funds”), the Fund will pay such Excess Operating Funds, or a portion thereof (each, a “Reimbursement Payment”), to Nuveen Alternative Holdings until such time as all Expense Payments made by the entity to the Fund within three years prior to the last business day of such calendar quarter have been reimbursed. Available Operating Funds means the sum of (i) the Fund’s net investment income (including net realized short-term capital gains reduced by net realized long-term capital losses), (ii) the Fund’s net capital gains (including the excess of net realized long-term capital gains over net realized short-term capital losses) and (iii) dividends and other distributions paid to the Fund on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above). The amount of the Reimbursement Payment for any calendar quarter will equal the lesser of (i) the Excess Operating Funds in such quarter and (ii) the aggregate amount of all Expense Payments made by Nuveen Alternative Holdings to the Fund within three years prior to the last business day of such calendar quarter that have not been previously reimbursed by the Fund to Nuveen Alternative Holdings.

No Reimbursement Payment for any month will be made if (1) the annualized rate of regular cash distributions declared by the Fund at the time of such Reimbursement Payment is less than the annualized rate of regular cash distributions declared by the Fund at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) the Fund’s Operating Expense Ratio (as defined below) at the time of such Reimbursement Payment is greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Reimbursement Payment relates. The Operating Expense Ratio is calculated by dividing the Fund’s operating costs and expenses incurred, less organizational and offering expenses, base management and incentive fees owed to the Adviser, and interest expense, by the Fund’s net assets. The Fund’s obligation to make a Reimbursement Payment will automatically become a liability of the Fund on the last business day of the applicable calendar month, except to the extent the Adviser has waived its right to receive such payment for the applicable month.

The following table presents a cumulative summary of the expense payments and reimbursement payments since the Fund’s commencement of operations, comprised primarily of organizational expenses, offering costs and professional fees:

For the Quarter Ended	Expense Payments by Adviser		Reimbursement Payments to Adviser		Unreimbursed Expense Payments		Effective Rate of Distribution per Share (1)		Reimbursement Eligibility Expiration	Operating Expense Ratio (2)
March 31, 2022	$	983	$	—	$	983	—	%	March 31, 2025	0.08	%
June 30, 2022	677		—		677		6.62	%	June 30, 2025	0.19	%
September 30, 2022	379		—		379		7.23	%	September 30, 2025	0.21	%
December 31, 2022	176		—		176		9.07	%	December 31, 2025	0.14	%
March 31, 2023	198		—		198		10.22	%	March 31, 2026	0.22	%
June 30, 2023	113		—		113		11.69	%	June 30, 2026	0.22	%
September 30, 2023	327		—		327		12.19	%	September 30, 2026	0.27	%
December 31, 2023	115		—		115		12.13	%	December 21, 2026	0.13	%
Total	$	2,968	$	—	$	2,968

__________

(1)The effective rate of distribution per share is expressed as a percentage equal to the projected annualized distribution amount as of the end of the applicable period (which is calculated by annualizing the regular monthly cash distributions per share as of such date without compounding), divided by the Fund’s gross offering price per share as of each quarter ended.

(2)The operating expense ratio is calculated by dividing the quarterly operating expenses, less organizational and offering expenses, base management fee and incentive fees owed to the Adviser, and interest expense, by the Fund’s net assets as of each quarter end.

Board of Trustees’ Fees

The Board consists of seven members, four of whom are Independent Trustees. On March 30, 2022, the Board established an Audit Committee, a Nominating and Corporate Governance Committee and a Special Transactions Committee, each consisting solely of the Independent Trustees, and may establish additional committees in the future. For the year ended December 31, 2023, the Fund incurred $508 in fees which are included in Board of Trustees’ fees in the accompanying consolidated statements of operations. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund incurred $385 in fees which are included in Board of Trustees’ fees in the accompanying consolidated statements of operations. As of December 31, 2023 and December 31, 2022, $128 and $128, respectively, were unpaid and are included in Board of Trustees’ fees payable in the accompanying consolidated statements of assets and liabilities.

Other Related Party Transactions

From time to time, the Adviser may pay amounts owed by the Fund to third-party providers of goods or services and the Fund will subsequently reimburse the Adviser for such amounts paid on its behalf. Amounts payable to the Adviser are settled in the normal course of business without formal payment terms. As of December 31, 2023 and December 31, 2022, the Fund owed the Adviser $361 and $231, respectively, for reimbursements including the Fund’s allocable portion of overhead, which is included in accounts payable and accrued expenses in the accompanying consolidated statement of assets and liabilities.

Promissory Note

On March 31, 2022, the Fund entered into the Note with TIAA as the lender. The Note is issued under the purchase and sales agreement, dated as of March 31, 2022, by and among the Fund, SPV I and TIAA in connection with the contribution of portfolio investments by TIAA to the Fund (as discussed further in Note 8). The principal amount of the Note equals (i) the fair value of

portfolio investments contributed as of March 31, 2022, minus (ii) $263,500. The Note was due to mature on March 30, 2023, with an interest rate of 4% per annum on the unpaid principal amount, compounded quarterly.

On June 3, 2022, the Fund fully repaid the balance on the Note which was comprised of $32,731 and $226 of principal and interest, respectively.

XML

SECURED BORROWINGS

12 Months Ended

Dec. 31, 2023

Debt Disclosure [Abstract]

SECURED BORROWINGS

SECURED BORROWINGS

In accordance with the 1940 Act, the Fund is only permitted to borrow amounts such that its asset coverage, as defined in the 1940 Act, is maintained at a level of at least 150% after such borrowing. As of December 31, 2023 and December 31, 2022, the Fund’s asset coverage was 314.08% and 267.94%, respectively.

On April 19, 2022, SPV I entered into a credit agreement with the lenders from time to time parties thereto, Bank of America, N.A., as administrative agent, the Fund, as servicer, U.S. Bank Trust Company, National Association, as collateral administrator, and U.S. Bank National Association, as collateral custodian (the “Credit Agreement” and the revolving credit facility thereunder, the “Bank of America Credit Facility”).

On October 4, 2022, SPV I entered into Amendment No. 1 to the Credit Agreement (the “Amendment”). The Amendment, among other things: (i) increased the maximum amount available under the Bank of America Credit Facility from $200,000 to $250,000; and (ii) increased the rate to be paid from Daily SOFR (as defined below) +2.00% to Daily SOFR +2.15% with a “step up” on the one year anniversary of the Closing Date (as defined in the Amendment) increasing from Daily SOFR +2.15% to Daily SOFR +2.40%, as reflected in the Amendment.

Borrowings under the Credit Agreement are secured by all of the assets held by SPV I and bear interest based on either (x) an annual rate equal to SOFR determined for any day (“Daily SOFR”) for the relevant interest period, plus an applicable spread, or (y) the highest of (i) the Federal Funds Rate plus an applicable spread, (ii) the Prime Rate in effect for any day and (iii) Daily SOFR plus an applicable spread. Interest is payable monthly in arrears. Advances under the Credit Agreement are secured by a pool of broadly-syndicated and middle-market loans subject to eligibility criteria and advance rates specified in the Credit Agreement. Advances under the Credit Agreement may be prepaid and reborrowed at any time during the Availability Period (as defined therein), and SPV I may terminate or reduce the facility amount subject to certain conditions. As of December 31, 2023, the Bank of America Credit Facility bears interest at a rate of Daily SOFR plus 2.40% per annum. Interest is payable monthly in arrears. Any amounts borrowed under the Credit Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) April 19, 2027, the fifth anniversary of the effective date of April 19, 2022, or (ii) upon certain other events in connection with a refinancing under the Credit Agreement. Borrowing under the Credit Agreement is subject to certain restrictions contained in the 1940 Act.

Prior to entering into the Bank of America Credit Facility, the Fund contributed and/or sold certain assets to SPV I pursuant to a contribution and sale agreement and TIAA contributed and/or sold certain assets to SPV I pursuant to a master participation and assignment agreement, and the Fund expects to contribute and/or sell additional assets to SPV I pursuant to a contribution and sale agreement in the future. The Fund may, but will not be required to, repurchase and/or substitute certain assets previously transferred to SPV I subject to the conditions specified in the contribution and sale agreement and the Credit Agreement.

The fair value of the Bank of America Credit Facility, which would be categorized as Level 3 within the fair value hierarchy as of December 31, 2023, approximates its carrying value. The carrying amounts of the Fund’s assets and liabilities, including the credit facilities, other than investments at fair value, approximate fair value due to their short maturities. The borrowing consisted of the following as of December 31, 2023 and December 31, 2022:

	December 31, 2023
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	165,750		165,750
Unused Portion (2)	84,250		84,250
Amount Available (3)	51,883		51,883

_______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

	December 31, 2022
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	155,000		155,000
Unused Portion (2)	95,000		95,000
Amount Available (3)	81,855		81,855

______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

For the year ended December 31, 2023 and for the period February 8, 2022 (inception) through December 31, 2022, the components of interest expense and debt financing expenses were as follows:

	For the Years Ended December 31,
	2023			2022 (1)
Borrowing interest expense	$	10,144		$	3,697
Unused fees	434			312
Amortization of deferred financing costs (2)	174			74
Total interest and debt financing expenses	$	10,752		$	4,083
Average interest rate (3)	7.73		%	4.90		%
Average daily borrowings	$	136,894		$	116,212

_______________

(1)Period from February 8, 2022 (inception) through December 31, 2022

(2)For the year ended December 31, 2023, $2 of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement. For the period from February 8, 2022 (inception) through December 31, 2022, $462 of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement.

(3)Average interest rate includes interest expense and unused fees.

XML

COMMITMENTS AND CONTINGENCIES

12 Months Ended

Dec. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

In the ordinary course of its business, the Fund enters into contracts or agreements that contain indemnifications or warranties. Future events could occur that might lead to the enforcement of these provisions against the Fund. The Fund believes that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in the consolidated financial statements as of December 31, 2023 and 2022 for any such exposure.

As of December 31, 2023 and December 31, 2022, the Fund had the following unfunded commitments to fund delayed draw loans:

Portfolio Company	December 31, 2023		December 31, 2022
Aramsco	$	520	$	—
ARMstrong	1,007		—
ASTP Holdings Co-Investment LP	26		—
Chroma Color	381		—
ClaimLogiq	891		—
CrossCountry Consulting	560		560
Elevation Labs	599		599
Engage	2,040		—
Ergotech (INS)	1,139		—
Evergreen Services Group	—		267
Evergreen Services Group II	923		—
EyeSouth	266		735
Health Management Associates	415		—
Heartland Veterinary Partners	—		5,000
Impact Environmental Group	1,832		—
Industrial Service Group	2,019		1,282
Infobase	122		122
ITSavvy	36		480
Kenco	850		850
Legacy Service Partners	306		—
LMI Consulting, LLC	2		—
Leo Facilities	2,571		—
MEI Buyer LLC	501		—
Mobile Communications America Inc	1,463		—
Motion & Control Enterprises	1,704		—
National Power	799		—
NearU	1,919		2,149
OMNIA Partners	129		—
Online Labels Group	237		—
Ovation Holdings	127		—
Palmetto Exterminators	503		—
Patriot Growth	—		5,568
Pinnacle Supply Partners, LLC	1,455		—
Precision Aviation Group	2,480		—
Propark Mobility	665		—
Randy's Worldwide Automotive	1,332		1,332
Rhino Tool House	306		—
Riveron	779		—
Sugar Foods	1,173		—
Sunny Sky Products	464		—
Tech24	919		—
TIDI Products	1,201		—
Trilon Group	—		363
Vertex Service Partners	1,777		—
Wellspring	—		1,895
WSB / EST	1,096		—
Young Innovations	1,431		—
Total unfunded commitments	$	38,965	$	21,202

The Fund believes its assets will provide adequate coverage to satisfy these unfunded commitments. As of December 31, 2023, the Fund had cash and cash equivalents of $8,679 and available borrowings under the Bank of America Credit Facility of $51,883.

XML

NET ASSETS

12 Months Ended

Dec. 31, 2023

Stockholders' Equity Note [Abstract]

NET ASSETS

NET ASSETS

In connection with its formation, the Fund has the authority to issue an unlimited number of Common Shares.

On March 30, 2022, an affiliate of the Adviser, TIAA, purchased 40 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share.

On March 31, 2022, TIAA contributed certain portfolio investments to the Fund in the amount of $296,231 (fair value as of March 31, 2022). In connection therewith, the Fund entered into the Note with TIAA as the lender (as described in Note 5), and issued to TIAA 10,540,000 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share. The Fund fully repaid the balance of the Note to TIAA on June 3, 2022.

On the Escrow Break Date, the Fund had satisfied the minimum offering requirement and the Board authorized the release of proceeds from escrow.

The following table presents transactions in common shares during the year ended December 31, 2023 (dollars in thousands except share amounts):

	December 31, 2023
	Shares	Amount
CLASS S
Subscriptions	149,441	$	3,671
Share transfers between classes	—	$	—
Distributions reinvested	397	$	10
Shares repurchases	—	$	—
Net increase (decrease)	149,838	$	3,681
CLASS D
Subscriptions	106,881	$	2,629
Share transfers between classes	—	$	—
Distributions reinvested	385	$	9
Shares repurchases	—	$	—
Net increase (decrease)	107,266	$	2,638
CLASS I
Subscriptions	3,517,694	$	86,550
Share transfers between classes	—	$	—
Distributions reinvested	33,652	$	828
Shares repurchases	—	$	—
Net increase (decrease)	3,551,346	$	87,378

The Fund determines NAV for each class of shares as of the last day of each calendar month. Share issuances related to monthly subscriptions are effective the first calendar day of each month. Shares are issued at an offering price equivalent to the most recent NAV per share available for each share class, which will be the prior calendar day NAV per share (i.e. the prior month-end NAV).

The following table presents each month-end net offering price for Class S, Class D, and Class I common shares, which approximately equals their respective NAV per share, for the year ended December 31, 2023:

	Net Offering Price Per Share
For the Months Ended	Class S (1)	Class D (1)	Class I
January 31, 2023	—	—	$24.70
February 28, 2023	—	—	$24.70
March 31, 2023	—	—	$24.65
April 30, 2023	—	—	$24.68
May 31, 2023	—	—	$24.66
June 30. 2023	—	—	$24.63
July 31, 2023	—	—	$24.60
August 31, 2023	—	—	$24.56
September 30, 2023	—	—	$24.61
October 31, 2023	$24.58	$24.59	$24.60
November 30, 2023	$24.59	$24.60	$24.60
December 31, 2023	$24.69	$24.73	$24.73

_______________

(1)Class S and Class D shares were first issued and sold in October 2023.

Distributions

The following table summarizes the Fund’s dividends declared from inception through December 31, 2023:

			Class S
Declaration Date	Record Date	Payment Date	Distribution per Share (1)	Distribution Amount
October 27, 2023	October 31, 2023	November 28, 2023	$0.233	$9
November 27, 2023	November 30, 2023	December 28, 2023	$0.233	$17
December 28, 2023	December 31, 2023	January 29, 2024	$0.233	$35

			Class D
Declaration Date	Record Date	Payment Date	Distribution per Share (1)	Distribution Amount
October 27, 2023	October 31, 2023	November 28, 2023	$0.245	$2
November 27, 2023	November 30, 2023	December 28, 2023	$0.245	$11
December 28, 2023	December 31, 2023	January 29, 2024	$0.245	$26

_______________

(1)Class S and Class D dividends are net of distribution and servicing fees.

			Class I
Declaration Date	Record Date	Payment Date	Distribution per Share		Distribution Amount
September 30, 2022	September 30, 2022	October 28, 2022	$0.870	(1)	$9,170
October 31, 2022	October 31, 2022	November 28, 2022	$0.180		$1,897
November 30, 2022	November 30, 2022	December 28, 2022	$0.190		$2,003
December 31, 2022	December 31, 2022	January 28, 2023	$0.295	(2)	$3,109
January 31, 2023	January 31, 2023	February 28, 2023	$0.200		$2,108
February 28, 2023	February 28, 2023	March 28, 2023	$0.200		$2,108
March 31, 2023	March 31, 2023	April 28, 2023	$0.230		$2,424
April 28, 2023	April 30, 2023	May 26, 2023	$0.240		$2,530
May 25, 2023	May 31, 2023	June 28, 2023	$0.240		$2,530
June 28, 2023	June 30, 2023	July 28, 2023	$0.240		$2,605
July 28, 2023	July 31, 2023	August 28, 2023	$0.270	(3)	$3,081
August 23, 2023	August 31, 2023	September 28, 2023	$0.270	(3)	$3,133
September 29, 2023	September 30, 2023	October 27, 2023	$0.250		$3,070
October 27, 2023	October 31, 2023	November 28, 2023	$0.250		$3,244
November 27, 2023	November 30, 2023	December 28, 2023	$0.250		$3,435
December 28, 2023	December 31, 2023	January 29, 2024	$0.250		$3,523

_______________

(1)Represents monthly dividend of $0.14 per share for each of April 2022, May 2022 and June 2022, and monthly dividend of $0.15 per share for each of July 2022, August 2022 and September 2022.

(2)Comprised of $0.19 regular dividend and $0.105 supplemental dividend attributable to accrued net investment income.

(3)Comprised of $0.25 regular dividend and $0.020 special dividend attributable to accrued net investment income.

Distribution Reinvestment Plan

The Fund has adopted a distribution reinvestment plan, pursuant to which it will reinvest all cash dividends declared by the Board on behalf of its shareholders who do not elect to receive their dividends in cash, except for shareholders in certain states. As a result, if the Board authorizes, and we declare, a cash dividend or other distribution, then our shareholders who have not opted out of our distribution reinvestment plan will have their cash distributions automatically reinvested in additional Common Shares, rather than receiving the cash dividend or other distribution. Alabama, Arkansas, Idaho, Kansas, Kentucky, Maine, Maryland, Massachusetts, Nebraska, New Jersey, North Carolina, Ohio, Oregon, Vermont and Washington investors and clients of certain participating brokers that do not permit automatic enrollment in our distribution reinvestment plan will automatically receive their distributions in cash unless they elect to have their cash distributions reinvested in additional Common Shares. Distributions on fractional shares will be credited to each participating shareholder’s account to three decimal places.

Character of Distributions

The Fund may fund its cash distributions to shareholders from any source of funds available to the Fund, including but not limited to offering proceeds, net investment income from operations, capital gain proceeds from the sale of assets, borrowings, dividends or other distributions paid to it on account of preferred and common equity investments in portfolio companies and expense support from the Adviser, which is subject to recoupment.

Through December 31, 2023, a portion of the Fund’s distributions resulted from expense support from the Adviser, and future distributions may result from expense support from the Adviser, each of which is subject to repayment by the Fund within three years from the date of payment. The purpose of this arrangement avoids distributions being characterized as a return of capital for U.S. federal income tax purposes. Shareholders should understand that any such distribution is not based solely on the Fund’s investment performance, and can only be sustained if the Company achieves positive investment performance in future periods and/or the Adviser continues to provide expense support. Shareholders should also understand that the Fund’s future repayments of expense support will reduce the distributions that they would otherwise receive. There can be no assurance that the Fund will achieve the performance necessary to sustain these distributions, or be able to pay distributions at all.

Sources of distributions, other than net investment income and realized gains on a U.S. GAAP basis, include required adjustments to U.S. GAAP net investment income in the current period to determine taxable income available for distributions. The following table reflects the source of cash distributions on a U.S. GAAP basis that the Fund has declared on its common shares for the year ended December 31, 2023:

	Class S (1)		Class D (1)		Class I
Sources of Distribution	Per Share	Amount	Per Share	Amount	Per Share	Amount
Net investment income	$0.699	$61	$0.735	$39	$2.890	$33,789
Net realized gains	$—	$—	$—	$—	$—	$—
Total	$0.699	$61	$0.735	$39	$2.890	$33,789

_______________

(1)Class S and Class D shares were first issued and sold in October 2023.

The following table reflects the source of cash distributions on a U.S. GAAP basis that the Fund has declared on its common shares for the period from February 8, 2022 (inception) through December 31, 2022:

	Class S (1)		Class D (1)		Class I
Sources of Distribution	Per Share	Amount	Per Share	Amount	Per Share	Amount
Net investment income	$—	$—	$—	$—	$1.535	$16,179
Net realized gains	$—	$—	$—	$—	$—	$—
Total	$—	$—	$—	$—	$1.535	$16,179

_______________

(1)Class S and Class D shares were first issued and sold in October 2023.

Share Repurchase Program

Beginning with the fiscal quarter ended September 30, 2023, the Fund commenced a share repurchase program in which it intends to repurchase in each quarter, at the discretion of the Board, up to 5% of its Common Shares outstanding (either by number of shares or aggregate NAV) as of the close of the previous calendar quarter. The Board, in its sole discretion, may amend, suspend or terminate the share repurchase program if it deems such action to be in the best interest of the Fund’s shareholders. As a result, share repurchases may not be available each quarter, such as when a repurchase offer would place an undue burden on our liquidity, adversely affect the Fund’s operations or risk having an adverse impact on the Fund that would outweigh the benefit of the repurchase offer. Following any such suspension, the Board will consider on at least a quarterly basis whether the continued suspension of the Share Repurchase Program is in the best interest of the Fund and shareholders, and will reinstate the Share Repurchase Program when and if appropriate and subject to its fiduciary duty to the Fund and shareholders. However, our Board is not required to authorize the recommencement of our Share Repurchase Program within any specified period of time. The Fund intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Securities Exchange Act of 1934, as amended, and the 1940 Act. All Common Shares purchased by the Fund pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued Common Shares.

Under the share repurchase program, to the extent the Fund offers to repurchase Common Shares in any particular quarter, the Fund expects to repurchase Common Shares pursuant to tender offers using a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter, except that Common Shares that have not been outstanding for at least one year will be repurchased at 98% of such NAV (an “Early Repurchase Deduction”). The one-year holding period is measured as of the subscription closing date immediately following the prospective repurchase date. The Early Repurchase Deduction may be waived in the case of repurchase requests arising from the death, divorce or qualified disability of the holder. The Early Repurchase Deduction will be retained by the Fund for the benefit of remaining shareholders.Common Shares. The repurchase of the Adviser’s shares, if any, will be on the same terms and subject to the same limitations as other shareholders under the Share Repurchase Program.

Payment for repurchased shares may require us to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. Our Adviser intends to take measures, subject to policies as may be established by our Board, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of shares. Class I shares owned by TIAA will be subject to the following restrictions. TIAA may submit its Class I shares for repurchase beginning on March 31, 2027. Beginning March 31, 2027, the total amount of TIAA shares eligible for repurchase will be limited to no more than 1.67% of our aggregate NAV

per calendar quarter; provided that, if in any quarter the total amount of aggregate repurchase requests of all classes of Common Shares does not exceed the Share Repurchase Plan limit of 5% of the aggregate NAV per calendar quarter, these redemption limits on the TIAA shares will not apply for that quarter, and TIAA will be entitled to submit its shares for repurchase up to the overall Share Repurchase Plan limits.

For the year ended December 31, 2023, no Common Shares were repurchased.

XML

CONSOLIDATED FINANCIAL HIGHLIGHTS

12 Months Ended

Dec. 31, 2023

Investment Company [Abstract]

CONSOLIDATED FINANCIAL HIGHLIGHTS

CONSOLIDATED FINANCIAL HIGHLIGHTS

The following is a schedule of financial highlights for the year ended December 31, 2023:

	For the Year Ended December 31, 2023
	Class S (7)			Class D (7)			Class I
Per share data:
Net asset value at beginning of period	$	—		$	—		$	24.70
Net investment income (loss)	0.73			0.76			2.97
Net realized gains (losses) (1)	—			—			0.07
Net change in unrealized appreciation (depreciation) (1)	0.17			0.22			(0.06)
Net increase (decrease) in net assets resulting from operations	0.90			0.98			2.98
Stockholder distributions from income (2)	(0.70)			(0.74)			(2.89)
Issuance of common shares	24.61			24.61			—
Other (3)	(0.12)			(0.12)			(0.06)
Net asset value at end of period	$	24.69		$	24.73		$	24.73
Supplemental Data:
Net assets at end of period	$	3,699		$	2,652		$	348,480
Shares outstanding at end of period (1)	149,838			107,266			14,091,386
Total return	3.21		%	3.53		%	12.52		%
Ratio to average net assets:
Ratio of net expenses to average net assets before expense support and waived fees (4)(5)	8.30		%	6.55		%	6.34		%
Ratio of net expenses to average net assets after expense support and waived fees (4)(5)	5.58		%	3.96		%	4.56		%
Ratio of net investment income (loss) to average net assets (4)	13.82		%	12.18		%	12.02		%
Portfolio turnover rate (6)	11.44		%	11.44		%	11.44		%
Asset coverage ratio	314.08		%	314.08		%	314.08		%

_______________

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Ratios are annualized except for management fees and incentive fees which were calculated from the Escrow Break Date, which were fully waived for the year ended December 31, 2023 (Refer to Note 5). Average net assets is calculated utilizing quarterly net assets. Ratio of net investment income (loss) to average net assets includes the effect of expense support and waived management fee and incentive fee.

(5)The ratio of interest and debt financing expenses to average net assets for the year ending December 31, 2023 was 3.96%, 3.21% and 3.73% for Class S, Class D, and Class I, respectively, Average net assets is calculated utilizing quarterly net assets.

(6)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

(7)Class S and Class D shares were first issued and sold in October 2023.

The following is a schedule of financial highlights for the period February 8, 2022 (inception) through December 31, 2022:

	Class I
Per share data:
Net asset value at beginning of period	$	—
Net investment income (loss)	1.60
Net realized gains (losses) (1)	(0.02)
Net change in unrealized appreciation (depreciation) (1)	(0.34)
Net increase (decrease) in net assets resulting from operations	1.24
Stockholder distributions from income (2)	(1.54)
Issuance of common shares	25.00
Other (3)	—
Net asset value at end of period	$	24.70
Supplemental Data:
Net assets at end of period	$	260,301
Shares outstanding at end of period (1)	10,540,040
Total return	4.91		%
Ratio to average net assets:
Ratio of net expenses to average net assets before expense support and waived fees (4)(5)	2.41		%
Ratio of net investment income (loss) to average net assets (4)	7.13		%
Portfolio turnover rate (6)	12.11		%
Asset coverage ratio	267.94		%

_______________

*For the period February 8, 2022 (inception) through December 31, 2022

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Ratios are annualized except for expense support amounts relating to organizational costs and interest expense on the Note. The ratio of total expenses to average net assets was 3.02% for the period February 8, 2022 (inception) through December 31, 2022 on an annualized basis, excluding the effect of expense support which represented (0.61)% of average net assets. Average net assets is calculated utilizing quarterly net assets.

(5)The ratio of interest and debt financing expenses to average net assets for the period February 8, 2022 (inception) through December 31, 2022 was 1.82%, Average net assets is calculated utilizing quarterly net assets.

(6)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

XML

INCOME TAX

12 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

INCOME TAX

INCOME TAX

The Fund intends to elect to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code for the fiscal year ending December 31, 2023. As a result, the Fund generally must timely distribute substantially all of its net taxable income each tax year as dividends to its shareholders. Accordingly, no provision for U.S. federal income tax has been made in the consolidated financial statements.

The Fund will file income tax returns in U.S. federal and applicable state and local jurisdictions. The Fund’s U.S. federal income tax return is generally subject to examination for a period of three fiscal years after being filed. State and local tax returns may be subject to examination for an additional period of time depending on the jurisdiction. Management has analyzed the Funds’s tax positions taken for the open tax year and has concluded that no provision for income tax is required in the Fund’s consolidated financial statements.

Taxable income generally differs from net increase (decrease) in net assets resulting from operations for financial reporting purposes due to the timing of temporary and permanent differences in the recognition of gains and losses on investment transactions. Temporary differences do not require reclassification. As of December 31, 2023, permanent differences that resulted in reclassifications among the components of net assets resulting from operations relate primarily to paydowns, amendment fees and non-deductible excise tax. Temporary and permanent differences have no impact on the Fund’s net assets.

As of December 31, 2023 and December 31, 2022, the Fund’s cost of investments for U.S. federal income tax purposes and gross unrealized appreciation and depreciation on investments were as follows:

	December 31, 2023		December 31, 2022
Tax cost of investments	$	516,168	$	352,998
Gross unrealized appreciation on investments	3,128		1,389
Gross unrealized depreciation on investments	(7,260)		(4,869)
Net unrealized appreciation (depreciation) on investments	$	(4,132)	$	(3,480)

As of December 31, 2023 and December 31, 2022, the components of Accumulated Earnings (Losses) on a tax basis were as follows:

	December 31, 2023		December 31, 2022
Undistributed Ordinary Income - Net	$	884	$	370
Undistributed Long-Term Income - Net	634		—
Total Undistributed Earnings	$	1,518	370
Capital loss carryforward	$	—	(88)
Unrealized Earnings (Losses) - Net	(4,194)		(3,480)
Other book-to-tax differences	123		—
Total Accumulated Earnings (Losses) - Net	$	(2,553)	$	(3,198)

Capital losses in excess of capital gains earned in a tax year generally may be carried forward and used to offset capital gains, subject to certain limitations. Under the Regulated Investment Company Modernization Act of 2010, capital losses incurred after September 30, 2011 will not be subject to expiration. As of December 31, 2023, the Fund had $0 capital loss carryforward available for use in future tax years.

For income tax purposes, dividends paid and distributions made to the Fund's shareholders are reported by the Fund to the shareholders as ordinary income, capital gains, or a combination thereof. The tax character of the distributions paid for the year ended December 31, 2023 and December 31, 2022 was as follows:

	December 31, 2023		December 31, 2022
Distributions paid from:
Ordinary income	$	33,890	$	16,179
Net long-term capital gains	—		—
Total taxable distributions	$	33,890	$	16,179

The Fund is subject to a 4% nondeductible federal excise tax on certain undistributed income unless the Fund distributes, in a timely manner as required by the Code, an amount at least equal to the sum of (1) 98% of its respective net ordinary income earned for the calendar year and (2) 98.2% of its respective capital gain net income for the one-year period ending October 31 in the calendar year. For the year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022, the Fund incurred $31 and $2, respectively, in excise tax expense.

The Fund’s wholly owned subsidiary, Equity Holdings, is subject to U.S. federal and state corporate-level income taxes. As a result the Fund recorded a net deferred tax liability related to US GAAP to tax outside basis differences in Equity Holdings’ investments in certain partnership interests of $61 as of December 31, 2023, which are included in accounts payable and accrued expenses in the accompanying consolidated statements of assets and liabilities. For the year ended December 31, 2023, the Fund recorded a net tax provision of $61. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund did not record net tax benefit (provision).

The Fund accounts for income taxes in conformity with ASC Topic 740, Income Taxes ("ASC 740"). ASC 740 provides guidelines for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken in the course of preparing the Fund’s tax returns to determine whether the tax positions are "more-likely-than-not" to be sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Based on its analysis of its tax position for all open tax years (the current and prior years, as applicable), the Fund has concluded that it does not have any uncertain tax positions that met the recognition or measurement criteria of ASC 740.

XML

SUBSEQUENT EVENTS

12 Months Ended

Dec. 31, 2023

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

The Fund’s management evaluated subsequent events through the date of issuance of the consolidated financial statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of December 31, 2023, except as discussed below.

Distributions

On January 26, 2024, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on February 28, 2024 to shareholders of record as of January 31, 2024.

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

On February 28, 2024, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on March 28, 2024 to shareholders of record as of February 29, 2024.

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

Since inception through the date of issuance of the consolidated financial statements, the Fund has accepted approximately $384.2 million net proceeds relating to the issuance of Class I shares, Class S shares, and Class D shares.

Chief Compliance Officer Appointment

On February 20, 2024, John D. McCally submitted his resignation as Chief Compliance Officer of the Fund to the Board, effective as of March 1, 2024. Mr. McCally will continue to serve as Vice President and Secretary of the Fund. In connection with the foregoing, on February 20, 2024, the Board appointed Charmagne Kukulka as the Chief Compliance Officer of the Fund, effective as of March 1, 2024.

Charmagne Kukulka, 34, has been a Principal and Deputy Chief Compliance Officer at Churchill since May 2023. Ms. Kukulka is responsible to managing Churchill’s compliance program and provides compliance support in connection with regulatory matters affecting the business. Prior to joining Churchill, Ms. Kukulka was the Chief Compliance Officer at 13D Management LLC, specializing in investment adviser and investment company act rules and regulations from January 2022 to May 2023. She began her compliance career at Blackstone Inc., where she held various roles within the legal and compliance teams administering the compliance program for Blackstone’s registered funds platform from August 2013 to January 2022. Ms. Kukulka received her B.A. in Business and Corporate Communications from Arizona State University’s W.P. Carey School of Business.

There are no family relationships between Ms. Kukulka and any of the Fund’s directors or executive officers, and she is not a party to any transaction that is required to be reported pursuant to Item 404(a) of Regulation S-K.

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	11 Months Ended		12 Months Ended
	Dec. 31, 2022		Dec. 31, 2023
Pay vs Performance Disclosure
Net increase (decrease) in net assets resulting from operations	$ 12,979	[1],[2]	$ 34,722

[1] Period from February 8, 2022 (inception) through December 31, 2022

[2] Period from February 8, 2022 (inception) through December 31, 2022

XML

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Fund is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the period presented, have been included. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value unless otherwise disclosed within.

Consolidation

Consolidation

As provided under ASC 946, the Fund will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Fund. Accordingly, the consolidated financial statements include the accounts of the Fund and its wholly owned subsidiaries, SPV I and Equity Holdings. All significant intercompany balances and transactions have been eliminated.

Use of Estimates

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Fund to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash, Restricted Cash and Cash Equivalents

Cash, Restricted Cash and Cash Equivalents

Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value. As of December 31, 2023, the Fund did not hold any restricted cash.

Valuation of Portfolio Investments

Valuation of Portfolio Investments

Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”) and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value.

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

•Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

•Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

•Level 3 — Valuations are based on inputs that are unobservable and significant to the overall fair value measurement.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.

Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price.

Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Fund’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs.

Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Fund's valuation designee (the “Valuation Designee”) to determine the fair value of the Fund's investments that do not have readily available market quotations, effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Fund's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Fund's assets for which market quotations are not readily available, subject to the oversight of the Board.

With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, undertakes a multi-step valuation process each quarter, as follows:

i.the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm;

ii.to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Board to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Fund will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value;

iii.the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Fund’s valuation policy, subject to the oversight of the Board; and

iv.the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Fund's valuation policy in connection with each quarterly Board meeting and discuss with the Board its determination of the fair value of each investment in good faith.

The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company’s credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are disclosed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources.

When determining NAV as of the last day of a month that is not also the last day of a calendar quarter, the Adviser updates the value of securities with “readily available market quotations” (as defined in Rule 2a-5 under the 1940 Act) to the most recent market quotation. For securities without readily available market quotations, the Adviser generally values such assets at the most recent quarterly valuation unless the Adviser determines that a significant observable change has occurred since the most recent quarter end with respect to the investment (which determination may be as a result of a material event at a portfolio company, material change in market spreads, secondary market transaction in the securities of an investment or otherwise). If the Adviser determines such a change has occurred with respect to one or more investments, the Adviser will determine whether to update the value for each relevant investment.

The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such values do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material.

The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Fund’s assets for which market quotations are not readily available, taking into account the Fund’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Fund's investments.

Investment Transactions

Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains or losses are measured by the difference between the net proceeds received and the amortized cost basis of the investment using the specific identification method without regard to unrealized appreciation or depreciation previously recognized and are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.

Revenue Recognition

Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Fund accrues interest income if it expects that ultimately it will be able to collect such income.

The Fund may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. If at any point the Fund believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Fund to maintain its tax treatment as a RIC, even though the Fund has not yet collected cash. As of December 31, 2023 and December 31, 2022, the fair value of the loans in the portfolio with PIK income provisions was $76,082 and $70,361, respectively, which represents approximately 14.86% and 20.13% of total investments at fair value, respectively. For the year ended December 31, 2023 and the period from February 8, 2022 (inception) through December 31, 2022 the Fund earned $2,333 and $1,275, respectively, in PIK income. As of December 31, 2023 and December 31, 2022, there were no PIK loans in the Fund's portfolio on non-accrual status.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio companies and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the year ended December 31, 2023, the Fund earned $123 in dividend income. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund did not earn any dividend income on its equity investments.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Fund’s investment activities, as well as any fees for managerial assistance services rendered by the Fund to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the year ended December 31, 2023, the Fund earned other income of $178 primarily related to amendment fees. For the period from February 8, 2022 (inception) through December 31, 2022, the Fund earned other income of $504, primarily related to prepayment and amendment fees.

Loans are generally placed on non-accrual status when a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Fund will cease recognizing interest income on that loan until all principal and interest is current through payment, or until a restructuring occurs such that the interest income is deemed to be collectible. However, the Fund remains contractually entitled to this interest. The Fund may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. As of December 31, 2023 and December 31, 2022, there were no loans in the Fund's portfolio on non-accrual status.

Deferred Financing Costs

Deferred Financing Costs

Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities.

Allocation of Income, Expenses, Gains and Losses

Allocation of Income, Expenses, Gains and Losses

Income, expenses (other than those attributable to a specific class), gains and losses are allocated to each class of shares based upon the relative proportion of net assets represented by such class. Operating expenses attributable to a specific class are charged against the operations of that class.

Organization and Offering Costs

Organization and Offering Costs

Organization costs consist of primarily legal, incorporation and accounting fees incurred in connection with the organization of the Fund. Organization costs are expensed as incurred and are shown in the Fund's consolidated statements of operations. Refer to Note 5 for further details on the Expense Support Agreement.

Offering costs consist primarily of fees and expenses incurred in connection with the offering of Common Shares, as well as legal, printing and other costs associated with the preparation and filing of the registration statements and offering materials. Offering costs are recognized as a deferred charge, amortized on a straight-line basis over 12 months and are shown in the Fund's consolidated statements of operations. For the year ended December 31, 2023, offering costs of $775, were incurred, and $659, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. For the period February 8, 2022 (inception) through December 31, 2022, offering costs of $484, were incurred, and $228, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. Refer to Note 5 for further details on the Expense Support Agreement.

Income Taxes

Income Taxes

For U.S. federal income tax purposes, the Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. In order to qualify as a RIC, the Fund must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Fund is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Fund to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Fund may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

In addition, based on the excise distribution requirements, the Fund is subject to a 4% nondeductible U.S. federal excise tax on undistributed income unless the Fund distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Fund that is subject to U.S. federal income tax is considered to have been distributed. The Fund intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Fund may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax.

The Fund evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. SPV I is a disregarded entity for tax purposes and will be consolidated with the tax return of the Fund. Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the year ended December 31, 2023, the Fund incurred $31 in excise tax expense. For the period February 8, 2022 (inception) through December 31, 2022, the Fund incurred $2 in excise tax expense.

Dividends and Distributions to Common Shareholders

Dividends and Distributions to Common Shareholders

The Fund has declared distributions each month beginning in September 2022 through the date of this Annual Report on Form 10-K, and expects to continue to pay regular monthly distributions to the extent the Fund has taxable income available. Distributions to shareholders are recorded on the record date. The amount to be distributed to shareholders is determined by the Board and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Fund may decide to retain such capital gains for investment. Although the gross distribution per share is generally equivalent for each share class, the net distribution for each share class is reduced for any class specific expenses, including distribution and shareholder servicing fees, if any.

Functional Currency

Functional Currency

The functional currency of the Fund is the U.S. Dollar and all transactions were in U.S. Dollars.

XML

INVESTMENTS (Tables)

12 Months Ended

Dec. 31, 2023

Investments, Debt and Equity Securities [Abstract]

Schedule of Fair Value Measurements of Investments

The following table presents fair value measurements of investments, by major class as of December 31, 2023 and December 31, 2022, according to the fair value hierarchy:

As of December 31, 2023	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	45,486	$	354,396	$	399,882
Subordinated Debt (1)	—		—		101,930		101,930
Equity Investments	—		—		10,224		10,224
Cash Equivalents	7,590		—		—		7,590
Total	$	7,590	$	45,486	$	466,550	$	519,626

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $52,170 and mezzanine debt of $49,760.

As of December 31, 2022	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	1,704	$	249,667	$	251,371
Subordinated Debt (1)	—		—		93,809		93,809
Equity Investments	—		—		4,338		4,338
Total	$	—	$	1,704	$	347,814	$	349,518

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903.

Schedules of Portfolio Composition at Fair Value

The composition of the Fund’s investment portfolio at cost and fair value was as follows:

	December 31, 2023						December 31, 2022
	Amortized Cost		Fair Value		% of Fair Value		Amortized Cost		Fair Value		% of Fair Value
First-Lien Term Loans	$	402,858	$	399,882	78.10	%	$	253,940	$	251,371	71.92	%
Subordinated Debt (1)	103,888		101,930		19.90	%	95,481		93,809		26.84	%
Equity Investments	9,422		10,224		2.00	%	3,577		4,338		1.24	%
Total	$	516,168	$	512,036	100.00	%	$	352,998	$	349,518	100.00	%
Largest portfolio company investment	$	10,731	$	10,986	2.15	%	$	10,617	$	11,093	3.17	%
Average portfolio company investment	$	3,246	$	3,220	0.63	%	$	5,516	$	5,461	1.56	%

_______________

(1)As of December 31, 2023, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $52,170 and mezzanine debt of $49,760 at fair value, and second lien term loans and/or second lien notes of $53,365 and mezzanine debt of $50,523 at amortized cost. As of December 31, 2022, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903 at fair value, and second lien term loans and/or second lien notes of $32,189 and mezzanine debt of $63,292 at amortized cost.

The industry composition of our portfolio as a percentage of fair value as of December 31, 2023 and December 31, 2022 was as follows:

Industry	December 31, 2023		December 31, 2022
Aerospace & Defense	2.07	%	—	%
Automotive	1.10	%	1.11	%
Banking, Finance, Insurance, Real Estate	1.49	%	0.08	%
Beverage, Food & Tobacco	10.39	%	12.54	%
Capital Equipment	4.28	%	1.98	%
Chemicals, Plastics & Rubber	3.80	%	4.28	%
Construction & Building	4.78	%	4.52	%
Consumer Goods: Durable	3.76	%	4.48	%
Consumer Goods: Non-durable	5.97	%	7.56	%
Containers, Packaging & Glass	3.49	%	4.89	%
Energy: Electricity	0.43	%	—	%
Energy: Oil & Gas	3.08	%	6.09	%
Environmental Industries	3.04	%	2.19	%
Healthcare & Pharmaceuticals	10.08	%	7.31	%
High Tech Industries	4.81	%	2.74	%
Hotel, Gaming & Leisure	0.44	%	—	%
Media: Advertising, Printing & Publishing	1.33	%	1.98	%
Media: Broadcasting & Subscription	0.80	%	—	%
Metals and Mining	0.10	%	—	%
Services: Business	16.82	%	16.98	%
Services: Consumer	5.73	%	6.65	%
Sovereign & Public Finance	0.77	%	1.08	%
Telecommunications	2.33	%	1.92	%
Transportation: Cargo	2.32	%	3.12	%
Transportation: Consumer	0.78	%	—	%
Utilities: Electric	0.51	%	—	%
Wholesale	5.50	%	8.50	%
Total	100.00	%	100.00	%

The geographic composition of investments at cost and fair value was as follows:

	December 31, 2023
	Cost		Fair Value		% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	$	496,774	$	492,518	96.19	%	138.80	%
Canada	6,374		6,376		1.25	%	1.80	%
United Kingdom	9,045		9,139		1.78	%	2.58	%
Ireland	1,741		1,750		0.34	%	0.49	%
Luxembourg	1,255		1,255		0.25	%	0.35	%
Netherlands	979		998		0.19	%	0.28	%
	$	516,168	$	512,036	100.00	%	144.30	%

	December 31, 2022
	Cost		Fair Value		% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	$	346,066	$	342,602	98.02	%	131.62	%
United Kingdom	6,932		6,916		1.98	%	2.66	%
	$	352,998	$	349,518	100.00	%	134.28	%

XML

FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Dec. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Fair Value Measurements of Investments

The following table presents fair value measurements of investments, by major class as of December 31, 2023 and December 31, 2022, according to the fair value hierarchy:

As of December 31, 2023	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	45,486	$	354,396	$	399,882
Subordinated Debt (1)	—		—		101,930		101,930
Equity Investments	—		—		10,224		10,224
Cash Equivalents	7,590		—		—		7,590
Total	$	7,590	$	45,486	$	466,550	$	519,626

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $52,170 and mezzanine debt of $49,760.

As of December 31, 2022	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	1,704	$	249,667	$	251,371
Subordinated Debt (1)	—		—		93,809		93,809
Equity Investments	—		—		4,338		4,338
Total	$	—	$	1,704	$	347,814	$	349,518

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903.

Schedule of Reconciliation of the Beginning and Ending Balances for Investments and Fair value Debt Obligations

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended December 31, 2023 and for the period from February 8, 2022 (inception) through December 31, 2022:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2022	$	249,667	$	93,809	$	4,338	$	347,814
Purchase of investments	137,949		15,956		5,948		159,853
Proceeds from principal repayments and sales of investments	(35,224)		(10,216)		(392)		(45,832)
Payment-in-kind interest	71		2,117		—		2,188
Amortization of premium/accretion of discount, net	577		242		—		819
Net realized gain (loss) on investments	174		311		291		776
Net change in unrealized appreciation (depreciation) on investments	(522)		(289)		39		(772)
Transfers to Level 3 (1)	1,704		—		—		1,704
Balance as of December 31, 2023	$	354,396	$	101,930	$	10,224	$	466,550
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of December 31, 2023	$	(475)	$	36	$	215	$	(224)

________________

(1) Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the year ended December 31, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for one portfolio company.

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of February 8, 2022 (inception)	$	—	$	—	$	—	$	—
Purchase of investments	271,109		113,294		3,575		387,978
Proceeds from principal repayments and sales of investments	(19,207)		(19,000)		—		(38,207)
Payment-in-kind interest	—		1,275		—		1,275
Amortization of premium/accretion of discount, net	310		191		—		501
Net realized gain (loss) on investments	(66)		(281)		—		(347)
Net change in unrealized appreciation (depreciation) on investments	(2,479)		(1,670)		763		(3,386)
Balance as of December 31, 2022	$	249,667	$	93,809	$	4,338	$	347,814
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of December 31, 2022	$	(2,479)	$	(1,670)	$	763	$	(3,386)

Schedule of Fair Value Measurement Inputs and Valuation Techniques

The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of December 31, 2023 and December 31, 2022 were as follows:

Investment Type	Fair Value at December 31, 2023		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	282,615	Yield Method	Implied Discount Rate	6.13	%	16.48	%	10.88	%
First Lien Term Loans	68,615		Recent Transaction	Transaction Price	97.83		100.13		98.87
First Lien Term Loans	3,166		Market Approach	EBITDA Multiple	7.50		7.50		7.50
Subordinated Debt	100,086		Yield Method	Implied Discount Rate	11.57	%	20.63	%	13.96	%
Subordinated Debt	1,844		Recent Transaction	Transaction Price	98.01		98.01		98.01
Equity Investments	8,779		Market Approach	EBITDA Multiple	8.50		19.50		11.49
Equity Investments	57		Market Approach	EBITDA Multiple	9.00		9.00		9.00
			Market Approach	ARR Multiple	3.50		3.50		3.50
Equity Investments	528		Yield Method	Implied Discount Rate	8.36	%	15.16	%	8.35	%
Total	$	465,690

Equity investments in the amount of $860 at December 31, 2023 have been excluded from the table above as the investments are valued using recent transaction price.

Investment Type	Fair Value at December 31, 2022		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	228,304	Yield Method	Implied Discount Rate	8.98	%	13.37	%	10.63	%
First Lien Term Loans	21,363		Recent Transaction	Transaction Price	98.01		98.08		98.05
Subordinated Debt	88,391		Yield Method	Implied Discount Rate	8.88	%	17.94	%	13.39	%
Subordinated Debt	5,418		Recent Transaction	Transaction Price	97.58		98.08		97.82
Equity Investments	3,144		Enterprise Value	EBITDA Multiple	9.25x		13.50x		10.93x
Total	$	346,620

Equity investments in the amount of $1,194 at December 31, 2022 have been excluded from the table above as the investments are valued using recent transaction price.

XML

RELATED PARTY TRANSACTIONS (Tables)

12 Months Ended

Dec. 31, 2023

Related Party Transactions [Abstract]

Schedule of Expenses Reimbursed by the Advisor

The following table presents a cumulative summary of the expense payments and reimbursement payments since the Fund’s commencement of operations, comprised primarily of organizational expenses, offering costs and professional fees:

For the Quarter Ended	Expense Payments by Adviser		Reimbursement Payments to Adviser		Unreimbursed Expense Payments		Effective Rate of Distribution per Share (1)		Reimbursement Eligibility Expiration	Operating Expense Ratio (2)
March 31, 2022	$	983	$	—	$	983	—	%	March 31, 2025	0.08	%
June 30, 2022	677		—		677		6.62	%	June 30, 2025	0.19	%
September 30, 2022	379		—		379		7.23	%	September 30, 2025	0.21	%
December 31, 2022	176		—		176		9.07	%	December 31, 2025	0.14	%
March 31, 2023	198		—		198		10.22	%	March 31, 2026	0.22	%
June 30, 2023	113		—		113		11.69	%	June 30, 2026	0.22	%
September 30, 2023	327		—		327		12.19	%	September 30, 2026	0.27	%
December 31, 2023	115		—		115		12.13	%	December 21, 2026	0.13	%
Total	$	2,968	$	—	$	2,968

__________

(1)The effective rate of distribution per share is expressed as a percentage equal to the projected annualized distribution amount as of the end of the applicable period (which is calculated by annualizing the regular monthly cash distributions per share as of such date without compounding), divided by the Fund’s gross offering price per share as of each quarter ended.

(2)The operating expense ratio is calculated by dividing the quarterly operating expenses, less organizational and offering expenses, base management fee and incentive fees owed to the Adviser, and interest expense, by the Fund’s net assets as of each quarter end.

XML

SECURED BORROWINGS (Tables)

12 Months Ended

Dec. 31, 2023

Debt Disclosure [Abstract]

Schedule of Borrowings

The borrowing consisted of the following as of December 31, 2023 and December 31, 2022:

	December 31, 2023
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	165,750		165,750
Unused Portion (2)	84,250		84,250
Amount Available (3)	51,883		51,883

_______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

	December 31, 2022
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	155,000		155,000
Unused Portion (2)	95,000		95,000
Amount Available (3)	81,855		81,855

______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

For the year ended December 31, 2023 and for the period February 8, 2022 (inception) through December 31, 2022, the components of interest expense and debt financing expenses were as follows:

	For the Years Ended December 31,
	2023			2022 (1)
Borrowing interest expense	$	10,144		$	3,697
Unused fees	434			312
Amortization of deferred financing costs (2)	174			74
Total interest and debt financing expenses	$	10,752		$	4,083
Average interest rate (3)	7.73		%	4.90		%
Average daily borrowings	$	136,894		$	116,212

_______________

(1)Period from February 8, 2022 (inception) through December 31, 2022

(2)For the year ended December 31, 2023, $2 of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement. For the period from February 8, 2022 (inception) through December 31, 2022, $462 of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement.

(3)Average interest rate includes interest expense and unused fees.

XML

COMMITMENTS AND CONTINGENCIES (Tables)

12 Months Ended

Dec. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of Unfunded Commitments to Fund Delayed Draw Loans

As of December 31, 2023 and December 31, 2022, the Fund had the following unfunded commitments to fund delayed draw loans:

Portfolio Company	December 31, 2023		December 31, 2022
Aramsco	$	520	$	—
ARMstrong	1,007		—
ASTP Holdings Co-Investment LP	26		—
Chroma Color	381		—
ClaimLogiq	891		—
CrossCountry Consulting	560		560
Elevation Labs	599		599
Engage	2,040		—
Ergotech (INS)	1,139		—
Evergreen Services Group	—		267
Evergreen Services Group II	923		—
EyeSouth	266		735
Health Management Associates	415		—
Heartland Veterinary Partners	—		5,000
Impact Environmental Group	1,832		—
Industrial Service Group	2,019		1,282
Infobase	122		122
ITSavvy	36		480
Kenco	850		850
Legacy Service Partners	306		—
LMI Consulting, LLC	2		—
Leo Facilities	2,571		—
MEI Buyer LLC	501		—
Mobile Communications America Inc	1,463		—
Motion & Control Enterprises	1,704		—
National Power	799		—
NearU	1,919		2,149
OMNIA Partners	129		—
Online Labels Group	237		—
Ovation Holdings	127		—
Palmetto Exterminators	503		—
Patriot Growth	—		5,568
Pinnacle Supply Partners, LLC	1,455		—
Precision Aviation Group	2,480		—
Propark Mobility	665		—
Randy's Worldwide Automotive	1,332		1,332
Rhino Tool House	306		—
Riveron	779		—
Sugar Foods	1,173		—
Sunny Sky Products	464		—
Tech24	919		—
TIDI Products	1,201		—
Trilon Group	—		363
Vertex Service Partners	1,777		—
Wellspring	—		1,895
WSB / EST	1,096		—
Young Innovations	1,431		—
Total unfunded commitments	$	38,965	$	21,202

XML

NET ASSETS (Tables)

12 Months Ended

Dec. 31, 2023

Stockholders' Equity Note [Abstract]

Schedule of Shares Issued

The following table presents transactions in common shares during the year ended December 31, 2023 (dollars in thousands except share amounts):

	December 31, 2023
	Shares	Amount
CLASS S
Subscriptions	149,441	$	3,671
Share transfers between classes	—	$	—
Distributions reinvested	397	$	10
Shares repurchases	—	$	—
Net increase (decrease)	149,838	$	3,681
CLASS D
Subscriptions	106,881	$	2,629
Share transfers between classes	—	$	—
Distributions reinvested	385	$	9
Shares repurchases	—	$	—
Net increase (decrease)	107,266	$	2,638
CLASS I
Subscriptions	3,517,694	$	86,550
Share transfers between classes	—	$	—
Distributions reinvested	33,652	$	828
Shares repurchases	—	$	—
Net increase (decrease)	3,551,346	$	87,378

Schedule of Net Offering Price Per Share

The following table presents each month-end net offering price for Class S, Class D, and Class I common shares, which approximately equals their respective NAV per share, for the year ended December 31, 2023:

	Net Offering Price Per Share
For the Months Ended	Class S (1)	Class D (1)	Class I
January 31, 2023	—	—	$24.70
February 28, 2023	—	—	$24.70
March 31, 2023	—	—	$24.65
April 30, 2023	—	—	$24.68
May 31, 2023	—	—	$24.66
June 30. 2023	—	—	$24.63
July 31, 2023	—	—	$24.60
August 31, 2023	—	—	$24.56
September 30, 2023	—	—	$24.61
October 31, 2023	$24.58	$24.59	$24.60
November 30, 2023	$24.59	$24.60	$24.60
December 31, 2023	$24.69	$24.73	$24.73

_______________

(1)Class S and Class D shares were first issued and sold in October 2023.

Schedule of Fund's Dividends Declared

The following table summarizes the Fund’s dividends declared from inception through December 31, 2023:

			Class S
Declaration Date	Record Date	Payment Date	Distribution per Share (1)	Distribution Amount
October 27, 2023	October 31, 2023	November 28, 2023	$0.233	$9
November 27, 2023	November 30, 2023	December 28, 2023	$0.233	$17
December 28, 2023	December 31, 2023	January 29, 2024	$0.233	$35

			Class D
Declaration Date	Record Date	Payment Date	Distribution per Share (1)	Distribution Amount
October 27, 2023	October 31, 2023	November 28, 2023	$0.245	$2
November 27, 2023	November 30, 2023	December 28, 2023	$0.245	$11
December 28, 2023	December 31, 2023	January 29, 2024	$0.245	$26

_______________

(1)Class S and Class D dividends are net of distribution and servicing fees.

			Class I
Declaration Date	Record Date	Payment Date	Distribution per Share		Distribution Amount
September 30, 2022	September 30, 2022	October 28, 2022	$0.870	(1)	$9,170
October 31, 2022	October 31, 2022	November 28, 2022	$0.180		$1,897
November 30, 2022	November 30, 2022	December 28, 2022	$0.190		$2,003
December 31, 2022	December 31, 2022	January 28, 2023	$0.295	(2)	$3,109
January 31, 2023	January 31, 2023	February 28, 2023	$0.200		$2,108
February 28, 2023	February 28, 2023	March 28, 2023	$0.200		$2,108
March 31, 2023	March 31, 2023	April 28, 2023	$0.230		$2,424
April 28, 2023	April 30, 2023	May 26, 2023	$0.240		$2,530
May 25, 2023	May 31, 2023	June 28, 2023	$0.240		$2,530
June 28, 2023	June 30, 2023	July 28, 2023	$0.240		$2,605
July 28, 2023	July 31, 2023	August 28, 2023	$0.270	(3)	$3,081
August 23, 2023	August 31, 2023	September 28, 2023	$0.270	(3)	$3,133
September 29, 2023	September 30, 2023	October 27, 2023	$0.250		$3,070
October 27, 2023	October 31, 2023	November 28, 2023	$0.250		$3,244
November 27, 2023	November 30, 2023	December 28, 2023	$0.250		$3,435
December 28, 2023	December 31, 2023	January 29, 2024	$0.250		$3,523

_______________

(1)Represents monthly dividend of $0.14 per share for each of April 2022, May 2022 and June 2022, and monthly dividend of $0.15 per share for each of July 2022, August 2022 and September 2022.

(2)Comprised of $0.19 regular dividend and $0.105 supplemental dividend attributable to accrued net investment income.

(3)Comprised of $0.25 regular dividend and $0.020 special dividend attributable to accrued net investment income.

The following table reflects the source of cash distributions on a U.S. GAAP basis that the Fund has declared on its common shares for the year ended December 31, 2023:

	Class S (1)		Class D (1)		Class I
Sources of Distribution	Per Share	Amount	Per Share	Amount	Per Share	Amount
Net investment income	$0.699	$61	$0.735	$39	$2.890	$33,789
Net realized gains	$—	$—	$—	$—	$—	$—
Total	$0.699	$61	$0.735	$39	$2.890	$33,789

_______________

(1)Class S and Class D shares were first issued and sold in October 2023.

The following table reflects the source of cash distributions on a U.S. GAAP basis that the Fund has declared on its common shares for the period from February 8, 2022 (inception) through December 31, 2022:

	Class S (1)		Class D (1)		Class I
Sources of Distribution	Per Share	Amount	Per Share	Amount	Per Share	Amount
Net investment income	$—	$—	$—	$—	$1.535	$16,179
Net realized gains	$—	$—	$—	$—	$—	$—
Total	$—	$—	$—	$—	$1.535	$16,179

_______________

(1)Class S and Class D shares were first issued and sold in October 2023.

XML

CONSOLIDATED FINANCIAL HIGHLIGHTS (Tables)

12 Months Ended

Dec. 31, 2023

Investment Company [Abstract]

Schedule of Financial Highlights

The following is a schedule of financial highlights for the year ended December 31, 2023:

	For the Year Ended December 31, 2023
	Class S (7)			Class D (7)			Class I
Per share data:
Net asset value at beginning of period	$	—		$	—		$	24.70
Net investment income (loss)	0.73			0.76			2.97
Net realized gains (losses) (1)	—			—			0.07
Net change in unrealized appreciation (depreciation) (1)	0.17			0.22			(0.06)
Net increase (decrease) in net assets resulting from operations	0.90			0.98			2.98
Stockholder distributions from income (2)	(0.70)			(0.74)			(2.89)
Issuance of common shares	24.61			24.61			—
Other (3)	(0.12)			(0.12)			(0.06)
Net asset value at end of period	$	24.69		$	24.73		$	24.73
Supplemental Data:
Net assets at end of period	$	3,699		$	2,652		$	348,480
Shares outstanding at end of period (1)	149,838			107,266			14,091,386
Total return	3.21		%	3.53		%	12.52		%
Ratio to average net assets:
Ratio of net expenses to average net assets before expense support and waived fees (4)(5)	8.30		%	6.55		%	6.34		%
Ratio of net expenses to average net assets after expense support and waived fees (4)(5)	5.58		%	3.96		%	4.56		%
Ratio of net investment income (loss) to average net assets (4)	13.82		%	12.18		%	12.02		%
Portfolio turnover rate (6)	11.44		%	11.44		%	11.44		%
Asset coverage ratio	314.08		%	314.08		%	314.08		%

_______________

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Ratios are annualized except for management fees and incentive fees which were calculated from the Escrow Break Date, which were fully waived for the year ended December 31, 2023 (Refer to Note 5). Average net assets is calculated utilizing quarterly net assets. Ratio of net investment income (loss) to average net assets includes the effect of expense support and waived management fee and incentive fee.

(5)The ratio of interest and debt financing expenses to average net assets for the year ending December 31, 2023 was 3.96%, 3.21% and 3.73% for Class S, Class D, and Class I, respectively, Average net assets is calculated utilizing quarterly net assets.

(6)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

(7)Class S and Class D shares were first issued and sold in October 2023.

The following is a schedule of financial highlights for the period February 8, 2022 (inception) through December 31, 2022:

	Class I
Per share data:
Net asset value at beginning of period	$	—
Net investment income (loss)	1.60
Net realized gains (losses) (1)	(0.02)
Net change in unrealized appreciation (depreciation) (1)	(0.34)
Net increase (decrease) in net assets resulting from operations	1.24
Stockholder distributions from income (2)	(1.54)
Issuance of common shares	25.00
Other (3)	—
Net asset value at end of period	$	24.70
Supplemental Data:
Net assets at end of period	$	260,301
Shares outstanding at end of period (1)	10,540,040
Total return	4.91		%
Ratio to average net assets:
Ratio of net expenses to average net assets before expense support and waived fees (4)(5)	2.41		%
Ratio of net investment income (loss) to average net assets (4)	7.13		%
Portfolio turnover rate (6)	12.11		%
Asset coverage ratio	267.94		%

_______________

*For the period February 8, 2022 (inception) through December 31, 2022

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Ratios are annualized except for expense support amounts relating to organizational costs and interest expense on the Note. The ratio of total expenses to average net assets was 3.02% for the period February 8, 2022 (inception) through December 31, 2022 on an annualized basis, excluding the effect of expense support which represented (0.61)% of average net assets. Average net assets is calculated utilizing quarterly net assets.

(5)The ratio of interest and debt financing expenses to average net assets for the period February 8, 2022 (inception) through December 31, 2022 was 1.82%, Average net assets is calculated utilizing quarterly net assets.

(6)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

XML

INCOME TAX (Tables)

12 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

Schedule of Tax-basis Cost for Federal Income Tax Purposes

As of December 31, 2023 and December 31, 2022, the Fund’s cost of investments for U.S. federal income tax purposes and gross unrealized appreciation and depreciation on investments were as follows:

	December 31, 2023		December 31, 2022
Tax cost of investments	$	516,168	$	352,998
Gross unrealized appreciation on investments	3,128		1,389
Gross unrealized depreciation on investments	(7,260)		(4,869)
Net unrealized appreciation (depreciation) on investments	$	(4,132)	$	(3,480)

Schedule of Components of Accumulated Earnings (Losses)

As of December 31, 2023 and December 31, 2022, the components of Accumulated Earnings (Losses) on a tax basis were as follows:

	December 31, 2023		December 31, 2022
Undistributed Ordinary Income - Net	$	884	$	370
Undistributed Long-Term Income - Net	634		—
Total Undistributed Earnings	$	1,518	370
Capital loss carryforward	$	—	(88)
Unrealized Earnings (Losses) - Net	(4,194)		(3,480)
Other book-to-tax differences	123		—
Total Accumulated Earnings (Losses) - Net	$	(2,553)	$	(3,198)

Schedule of Tax Character of Distributions

The tax character of the distributions paid for the year ended December 31, 2023 and December 31, 2022 was as follows:

	December 31, 2023		December 31, 2022
Distributions paid from:
Ordinary income	$	33,890	$	16,179
Net long-term capital gains	—		—
Total taxable distributions	$	33,890	$	16,179

XML

SUBSEQUENT EVENTS (Tables)

12 Months Ended

Dec. 31, 2023

Subsequent Events [Abstract]

Schedule of Aggregate Distributions Declared for Each Class of Common Share

On January 26, 2024, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on February 28, 2024 to shareholders of record as of January 31, 2024.

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

On February 28, 2024, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on March 28, 2024 to shareholders of record as of February 29, 2024.

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

XML

ORGANIZATION (Details) - USD ($) $ / shares in Units, $ in Thousands				12 Months Ended
	Jun. 03, 2022	Mar. 31, 2022	Mar. 30, 2022	Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]
Sale of stock				$ 2,500,000
Class I Common Shares
Schedule of Equity Method Investments [Line Items]
Issuance of shares (in shares)				3,517,694
TIAA
Schedule of Equity Method Investments [Line Items]
Portfolio investments to the fund amount		$ 296,231
TIAA | Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Capital commitments		$ 263,500
Debt instrument, periodic payment, principal	$ 32,731
Debt instrument, periodic payment, interest	$ 226
TIAA | Class I Common Shares
Schedule of Equity Method Investments [Line Items]
Purchased and sold shares (in share)			40
Issuance Price per share (in dollars per share)			$ 25.00
Issuance of shares (in shares)		10,540,000
Shares issued price per share (in dollars per share)		$ 25.00

XML

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	11 Months Ended		12 Months Ended
	Dec. 31, 2022		Dec. 31, 2023	Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Fair Value	$ 349,518,000		$ 519,626,000	$ 349,518,000
Payment-in-kind interest income			2,333,000	1,275,000
Dividend income	0		123,000
Other income	504,000		178,000
Offering costs	484,000		775,000
Noninterest expense offering cost	228,000	[1]	659,000
Excise taxes	2,000	[1]	31,000
Payment in Kind (PIK) Note
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Fair Value	70,361,000		76,082,000	70,361,000
Non-Accrual Loans
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Fair Value	$ 0		$ 0	$ 0
Investment Type Concentration Risk | Investments At Fair Value
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
% of Fair Value			100.00%	100.00%
Investment Type Concentration Risk | Investments At Fair Value | Payment in Kind (PIK) Note
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
% of Fair Value			14.86%	20.13%

[1] Period from February 8, 2022 (inception) through December 31, 2022

XML

INVESTMENTS - Schedule of Fair Value Measurements of Investments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Cost	$ 516,168	$ 352,998
Fair Value	512,036	349,518
Investment owned, fair value	519,626	349,518
Cost	$ 523,758	$ 352,998
Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	100.00%	100.00%
Second Lien Term Loans
Schedule of Investments [Line Items]
Investment owned, fair value	$ 52,170	$ 30,906
Cost	53,365	32,189
Mezzanine Debt
Schedule of Investments [Line Items]
Investment owned, fair value	49,760	62,903
Cost	50,523	63,292
First Lien Term Loans
Schedule of Investments [Line Items]
Cost	402,858	253,940
Fair Value	$ 399,882	$ 251,371
First Lien Term Loans | Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	78.10%	71.92%
Subordinated Debt
Schedule of Investments [Line Items]
Cost	$ 103,888	$ 95,481
Fair Value	$ 101,930	$ 93,809
Subordinated Debt | Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	19.90%	26.84%
Equity Investments
Schedule of Investments [Line Items]
Cost	$ 9,422	$ 3,577
Fair Value	10,224	4,338
Investment owned, fair value	10,224	4,338
Cost	$ 9,422	$ 3,577
Equity Investments | Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	2.00%	1.24%
Largest portfolio company investment
Schedule of Investments [Line Items]
Cost	$ 10,731	$ 10,617
Fair Value	$ 10,986	$ 11,093
Largest portfolio company investment | Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	2.15%	3.17%
Average portfolio company investment
Schedule of Investments [Line Items]
Cost	$ 3,246	$ 5,516
Fair Value	$ 3,220	$ 5,461
Average portfolio company investment | Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	0.63%	1.56%

XML

INVESTMENTS - Schedule of Portfolio Composition by Industry at Fair Value (Details) - Investments At Fair Value - Industry Concentration Risk	11 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2023
Schedule of Investments [Line Items]
% of Fair Value	100.00%	100.00%
Aerospace & Defense
Schedule of Investments [Line Items]
% of Fair Value	0.00%	2.07%
Automotive
Schedule of Investments [Line Items]
% of Fair Value	1.11%	1.10%
Banking, Finance, Insurance, Real Estate
Schedule of Investments [Line Items]
% of Fair Value	0.08%	1.49%
Beverage, Food & Tobacco
Schedule of Investments [Line Items]
% of Fair Value	12.54%	10.39%
Capital Equipment
Schedule of Investments [Line Items]
% of Fair Value	1.98%	4.28%
Chemicals, Plastics, & Rubber
Schedule of Investments [Line Items]
% of Fair Value	4.28%	3.80%
Construction & Building
Schedule of Investments [Line Items]
% of Fair Value	4.52%	4.78%
Consumer Goods: Durable
Schedule of Investments [Line Items]
% of Fair Value	4.48%	3.76%
Consumer Goods: Non-Durable
Schedule of Investments [Line Items]
% of Fair Value	7.56%	5.97%
Containers, Packaging & Glass
Schedule of Investments [Line Items]
% of Fair Value	4.89%	3.49%
Energy: Electricity
Schedule of Investments [Line Items]
% of Fair Value	0.00%	0.43%
Energy: Oil & Gas
Schedule of Investments [Line Items]
% of Fair Value	6.09%	3.08%
Environmental Industries
Schedule of Investments [Line Items]
% of Fair Value	2.19%	3.04%
Healthcare & Pharmaceuticals
Schedule of Investments [Line Items]
% of Fair Value	7.31%	10.08%
High Tech Industries
Schedule of Investments [Line Items]
% of Fair Value	2.74%	4.81%
Hotel, Gaming & Leisure
Schedule of Investments [Line Items]
% of Fair Value	0.00%	0.44%
Media: Advertising, Printing & Publishing
Schedule of Investments [Line Items]
% of Fair Value	1.98%	1.33%
Media: Broadcasting & Subscription
Schedule of Investments [Line Items]
% of Fair Value	0.00%	0.80%
Metals and Mining
Schedule of Investments [Line Items]
% of Fair Value	0.00%	0.10%
Services: Business
Schedule of Investments [Line Items]
% of Fair Value	16.98%	16.82%
Services: Consumer
Schedule of Investments [Line Items]
% of Fair Value	6.65%	5.73%
Sovereign & Public Finance
Schedule of Investments [Line Items]
% of Fair Value	1.08%	0.77%
Telecommunications
Schedule of Investments [Line Items]
% of Fair Value	1.92%	2.33%
Transportation: Cargo
Schedule of Investments [Line Items]
% of Fair Value	3.12%	2.32%
Transportation: Consumer
Schedule of Investments [Line Items]
% of Fair Value	0.00%	0.78%
Utilities: Electric
Schedule of Investments [Line Items]
% of Fair Value	0.00%	0.51%
Wholesale
Schedule of Investments [Line Items]
% of Fair Value	8.50%	5.50%

XML

INVESTMENTS - Schedules of Portfolio Composition by Geographic Region at Amortization Cost and Fair Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Cost	$ 516,168	$ 352,998
Fair Value	$ 512,036	$ 349,518
Fair Value as % of Net Assets	144.30%	134.28%
Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	100.00%	100.00%
USA
Schedule of Investments [Line Items]
Cost	$ 496,774	$ 346,066
Fair Value	$ 492,518	$ 342,602
Fair Value as % of Net Assets	138.80%	131.62%
USA | Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	96.19%	98.02%
Canada
Schedule of Investments [Line Items]
Cost	$ 6,374
Fair Value	$ 6,376
Fair Value as % of Net Assets	1.80%
Canada | Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	1.25%
United Kingdom
Schedule of Investments [Line Items]
Cost	$ 9,045	$ 6,932
Fair Value	$ 9,139	$ 6,916
Fair Value as % of Net Assets	2.58%	2.66%
United Kingdom | Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	1.78%	1.98%
Ireland
Schedule of Investments [Line Items]
Cost	$ 1,741
Fair Value	$ 1,750
Fair Value as % of Net Assets	0.49%
Ireland | Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	0.34%
Luxembourg
Schedule of Investments [Line Items]
Cost	$ 1,255
Fair Value	$ 1,255
Fair Value as % of Net Assets	0.35%
Luxembourg | Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	0.25%
Netherlands
Schedule of Investments [Line Items]
Cost	$ 979
Fair Value	$ 998
Fair Value as % of Net Assets	0.28%
Netherlands | Investments At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Fair Value	0.19%

XML

INVESTMENTS - Narrative (Details) - Investments At Fair Value - Investment Type Concentration Risk	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Concentration risk, percentage	100.00%	100.00%
Debt Securities, Variable Rate
Schedule of Investments [Line Items]
Concentration risk, percentage	84.74%	76.79%
Debt Securities, Fixed Rate
Schedule of Investments [Line Items]
Concentration risk, percentage	15.26%	23.21%

XML

FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurements of Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 519,626	$ 349,518
First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	399,882	251,371
Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	101,930	93,809
Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	10,224	4,338
Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	7,590
Second Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	52,170	30,906
Mezzanine Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	49,760	62,903
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	7,590	0
Level 1 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	7,590
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	45,486	1,704
Level 2 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	45,486	1,704
Level 2 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 2 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 2 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	466,550	347,814
Level 3 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	354,396	249,667
Level 3 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	101,930	93,809
Level 3 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	10,224	$ 4,338
Level 3 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 0

XML

FAIR VALUE MEASUREMENTS - Schedule of Reconciliation of the Beginning and Ending Balances for Investments (Details) - USD ($) $ in Thousands	11 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2023
Total
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 0	$ 347,814
Purchase of investments	387,978	159,853
Proceeds from principal repayments and sales of investments	(38,207)	(45,832)
Payment-in-kind interest	1,275	2,188
Amortization of premium/accretion of discount, net	501	819
Transfers to Level 3		1,704
Ending balance	347,814	466,550
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	(3,386)	(224)
Total | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(347)	776
Total | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(3,386)	(772)
First Lien Term Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	0	249,667
Purchase of investments	271,109	137,949
Proceeds from principal repayments and sales of investments	(19,207)	(35,224)
Payment-in-kind interest	0	71
Amortization of premium/accretion of discount, net	310	577
Transfers to Level 3		1,704
Ending balance	249,667	354,396
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	(2,479)	(475)
First Lien Term Loans | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(66)	174
First Lien Term Loans | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(2,479)	(522)
Subordinated Debt
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	0	93,809
Purchase of investments	113,294	15,956
Proceeds from principal repayments and sales of investments	(19,000)	(10,216)
Payment-in-kind interest	1,275	2,117
Amortization of premium/accretion of discount, net	191	242
Transfers to Level 3		0
Ending balance	93,809	101,930
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	(1,670)	36
Subordinated Debt | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(281)	311
Subordinated Debt | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(1,670)	(289)
Equity Investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	0	4,338
Purchase of investments	3,575	5,948
Proceeds from principal repayments and sales of investments	0	(392)
Payment-in-kind interest	0	0
Amortization of premium/accretion of discount, net	0	0
Transfers to Level 3		0
Ending balance	4,338	10,224
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	763	215
Equity Investments | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	291
Equity Investments | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	$ 763	$ 39

XML

FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details) - Level 3	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 465,690,000	$ 346,620,000
First Lien Term Loans | Yield Method
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 282,615,000	$ 228,304,000
First Lien Term Loans | Yield Method | Low | Implied Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0613	0.0898
First Lien Term Loans | Yield Method | High | Implied Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1648	0.1337
First Lien Term Loans | Yield Method | Weighted Average | Implied Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1088	0.1063
First Lien Term Loans | Recent Transaction
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 68,615,000	$ 21,363,000
First Lien Term Loans | Recent Transaction | Low | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	97.83	98.01
First Lien Term Loans | Recent Transaction | High | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	100.13	98.08
First Lien Term Loans | Recent Transaction | Weighted Average | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	98.87	98.05
First Lien Term Loans | Market Approach
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 3,166,000
First Lien Term Loans | Market Approach | Low | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	7.50
First Lien Term Loans | Market Approach | High | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	7.50
First Lien Term Loans | Market Approach | Weighted Average | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	7.50
Subordinated Debt | Yield Method
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 100,086,000	$ 88,391,000
Subordinated Debt | Yield Method | Low | Implied Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1157	0.0888
Subordinated Debt | Yield Method | High | Implied Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.2063	0.1794
Subordinated Debt | Yield Method | Weighted Average | Implied Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1396	0.1339
Subordinated Debt | Recent Transaction
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 1,844,000	$ 5,418,000
Subordinated Debt | Recent Transaction | Low | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	98.01	97.58
Subordinated Debt | Recent Transaction | High | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	98.01	98.08
Subordinated Debt | Recent Transaction | Weighted Average | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	98.01	97.82
Equity Investments
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments valued using recent transactions	$ 860,000	$ 1,194,000
Equity Investments | Yield Method
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 528,000
Equity Investments | Yield Method | Low | Implied Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0836
Equity Investments | Yield Method | High | Implied Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1516
Equity Investments | Yield Method | Weighted Average | Implied Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0835
Equity Investments | Market Approach
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 8,779,000
Equity Investments | Market Approach | Low | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	8.50
Equity Investments | Market Approach | Low | ARR Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	3.50
Equity Investments | Market Approach | High | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	19.50
Equity Investments | Market Approach | High | ARR Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	3.50
Equity Investments | Market Approach | Weighted Average | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	11.49
Equity Investments | Market Approach | Weighted Average | ARR Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	3.50
Equity Investments | Enterprise Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value		$ 3,144,000
Equity Investments | Enterprise Value | Low | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		9.25
Equity Investments | Enterprise Value | High | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		13.5
Equity Investments | Enterprise Value | Weighted Average | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		10.93
Equity Investments | Market Approach
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 57,000
Equity Investments | Market Approach | Low | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	9.00
Equity Investments | Market Approach | High | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	9.00
Equity Investments | Market Approach | Weighted Average | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	9.00

XML

RELATED PARTY TRANSACTIONS - Narrative (Details)						3 Months Ended		11 Months Ended		12 Months Ended
	Jan. 10, 2023	Aug. 03, 2022	Aug. 02, 2022	Jun. 03, 2022 USD ($)	Mar. 31, 2022 USD ($)	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2022 USD ($)		Dec. 31, 2023 USD ($) member part
Related Party Transaction [Line Items]
Management fees								$ 0	[1]	$ 1,292,000
Income based incentive fees								0	[1]	3,108,000
Administration fees								299,000	[1]	$ 517,000
Distribution and shareholder servicing fees								0
Number of board members | member										7
Number of independent directors | member										4
Directors' fees								385,000	[1]	$ 508,000
Board of Trustees' fees payable								128,000		128,000
Accounts payable and accrued expenses								1,386,000		2,163,000
Class S Common Shares
Related Party Transaction [Line Items]
Distribution and shareholder servicing fees								0	[1]	5,000
Class D Common Shares
Related Party Transaction [Line Items]
Distribution and shareholder servicing fees								0	[1]	1,000
Affiliated Entity
Related Party Transaction [Line Items]
Income based incentive fees								0		3,108,000
Income based incentive fee payable										$ 0
Affiliated Entity | TIAA
Related Party Transaction [Line Items]
Capital commitments					$ 263,500,000
Interest rate, stated percentage					4.00%		4.00%
Debt instrument, periodic payment, principal				$ 32,731,000
Debt instrument, periodic payment, interest				$ 226,000
Investment Advisory Agreements | Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction, period of written notice		120 days	60 days
Related party transaction, initial term					2 years
Related party transaction period of written notice by fund	60 days
Number of components | part										2
Base Management Fee | Affiliated Entity
Related Party Transaction [Line Items]
Base management fee percentage							0.75%
Management fees								0		$ 1,292,000
Management fees payable										0
Quarterly Hurdle Rate | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage						1.50%	1.50%
Annualized Hurdle Rate | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage						6.00%	6.00%
Pre-Incentive Fee Net Investment Income below catch-up threshold | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage							100.00%
Quarterly Catch-Up Threshold | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage							1.76%
Investment Advisory Agreement - Incentive Rate, Annualized Catch-Up Threshold | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage							7.06%
Pre-Incentive Fee Net Investment Income Exceeds Catch-Up Threshold | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage							15.00%
Realized Capital Gains | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage							15.00%
Sub-Advisory Agreement | Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction, period of written notice		120 days	60 days
Related party transaction, initial term		2 years
Management and service fees, rate					0.375%
Administrative Agreement | Affiliated Entity
Related Party Transaction [Line Items]
Administration fees								299,000		517,000
Administration fees payable								246,000		614,000
Intermediary Manager Agreement | Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction period of written notice by fund					60 days
Percentage of shareholder servicing fees, proceeds from sale of such share					10.00%		10.00%
Percentage of underwriting compensation, net					10.00%		10.00%
Percentage of expense, proceeds from offering					15.00%		15.00%
Intermediary Manager Agreement | Affiliated Entity | Class S Common Shares
Related Party Transaction [Line Items]
Shareholder servicing fees monthly, annual rate					0.85%		0.85%
Intermediary Manager Agreement | Affiliated Entity | Class D Common Shares
Related Party Transaction [Line Items]
Shareholder servicing fees monthly, annual rate					0.25%		0.25%
Expense Support Agreement
Related Party Transaction [Line Items]
Related party transaction, expense payment period					45 days
Expense Support Agreement | Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction, period of reimbursement payment					3 years
Advisor And Administrator | Affiliated Entity
Related Party Transaction [Line Items]
Accounts payable and accrued expenses								$ 231,000		$ 361,000

[1] Period from February 8, 2022 (inception) through December 31, 2022

XML

RELATED PARTY TRANSACTIONS - Schedule of Expenses Reimbursed by the Adviser (Details) - Expense Support Agreement - Affiliated Entity - USD ($) $ in Thousands	3 Months Ended								24 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023
Related Party Transaction [Line Items]
Expense Payments by Adviser	$ 115	$ 327	$ 113	$ 198	$ 176	$ 379	$ 677	$ 983	$ 2,968
Reimbursement Payments to Adviser	0	0	0	0	0	0	0	0	0
Unreimbursed Expense Payments	$ 115	$ 327	$ 113	$ 198	$ 176	$ 379	$ 677	$ 983	$ 2,968
Effective Rate of Distribution per Share	12.13%	12.19%	11.69%	10.22%	9.07%	7.23%	6.62%	0.00%
Operating Expense Ratio	0.13%	0.27%	0.22%	0.22%	0.14%	0.21%	0.19%	0.08%

XML

SECURED BORROWINGS - Narrative (Details) - USD ($)			12 Months Ended
	Oct. 04, 2022	Oct. 03, 2022	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Asset coverage ratio			314.08%	267.94%
Maximum facility amount available			$ 250,000,000	$ 250,000,000
Bank of America Credit Facility | Secured Borrowings | Credit Facility
Debt Instrument [Line Items]
Maximum facility amount available	$ 250,000,000	$ 200,000,000	$ 250,000,000	$ 250,000,000
Bank of America Credit Facility | Secured Borrowings | Secured Overnight Financing Rate (SOFR) | Credit Facility
Debt Instrument [Line Items]
Percentage of interest rate	2.15%	2.00%	2.40%
Bank of America Credit Facility | Secured Borrowings | Secured Overnight Financing Rate (SOFR) | Credit Facility | One Year After Closing Date
Debt Instrument [Line Items]
Percentage of interest rate	2.40%

XML

SECURED BORROWINGS - Schedule of Borrowings (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Oct. 04, 2022	Oct. 03, 2022
Debt Instrument [Line Items]
Total Commitment	$ 250,000,000	$ 250,000,000
Borrowings Outstanding	165,750,000	155,000,000
Unused Portion	84,250,000	95,000,000
Amount Available	51,883,000	81,855,000
Bank of America Credit Facility | Secured Borrowings | Credit Facility
Debt Instrument [Line Items]
Total Commitment	250,000,000	250,000,000	$ 250,000,000	$ 200,000,000
Borrowings Outstanding	165,750,000	155,000,000
Unused Portion	84,250,000	95,000,000
Amount Available	$ 51,883,000	$ 81,855,000

XML

SECURED BORROWINGS - Schedule of Components of Interest Expense and Debt Financing Expenses (Details) - USD ($) $ in Thousands	8 Months Ended	11 Months Ended		12 Months Ended
	Sep. 30, 2022	Dec. 31, 2022		Dec. 31, 2023
Debt Disclosure [Abstract]
Borrowing interest expense		$ 3,697		$ 10,144
Unused fees		312		434
Amortization of deferred financing costs		74		174
Total interest and debt financing expenses		$ 4,083	[1]	$ 10,752
Average interest rate		4.90%		7.73%
Average daily borrowings		$ 116,212		$ 136,894
Deferred financing costs were designated for reimbursement	$ 462			$ 2

[1] Period from February 8, 2022 (inception) through December 31, 2022

XML

COMMITMENTS AND CONTINGENCIES - Schedule of Unfunded Commitments (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	$ 38,965	$ 21,202
Investment, Identifier [Axis]: ARMstrong
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,007	0
Investment, Identifier [Axis]: ASTP Holdings Co-Investment LP
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	26	0
Investment, Identifier [Axis]: Aramsco
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	520	0
Investment, Identifier [Axis]: Chroma Color
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	381	0
Investment, Identifier [Axis]: ClaimLogiq
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	891	0
Investment, Identifier [Axis]: CrossCountry Consulting
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	560	560
Investment, Identifier [Axis]: Elevation Labs
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	599	599
Investment, Identifier [Axis]: Engage
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,040	0
Investment, Identifier [Axis]: Ergotech (INS)
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,139	0
Investment, Identifier [Axis]: Evergreen Services Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	267
Investment, Identifier [Axis]: Evergreen Services Group II
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	923	0
Investment, Identifier [Axis]: EyeSouth
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	266	735
Investment, Identifier [Axis]: Health Management Associates
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	415	0
Investment, Identifier [Axis]: Heartland Veterinary Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	5,000
Investment, Identifier [Axis]: ITSavvy
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	36	480
Investment, Identifier [Axis]: Impact Environmental Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,832	0
Investment, Identifier [Axis]: Industrial Service Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,019	1,282
Investment, Identifier [Axis]: Infobase
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	122	122
Investment, Identifier [Axis]: Kenco
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	850	850
Investment, Identifier [Axis]: LMI Consulting, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2	0
Investment, Identifier [Axis]: Legacy Service Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	306	0
Investment, Identifier [Axis]: Leo Facilities
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,571	0
Investment, Identifier [Axis]: MEI Buyer LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	501	0
Investment, Identifier [Axis]: Mobile Communications America Inc
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,463	0
Investment, Identifier [Axis]: Motion & Control Enterprises
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,704	0
Investment, Identifier [Axis]: National Power
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	799	0
Investment, Identifier [Axis]: NearU
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,919	2,149
Investment, Identifier [Axis]: OMNIA Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	129	0
Investment, Identifier [Axis]: Online Labels Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	237	0
Investment, Identifier [Axis]: Ovation Holdings
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	127	0
Investment, Identifier [Axis]: Palmetto Exterminators
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	503	0
Investment, Identifier [Axis]: Patriot Growth
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	5,568
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,455	0
Investment, Identifier [Axis]: Precision Aviation Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,480	0
Investment, Identifier [Axis]: Propark Mobility
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	665	0
Investment, Identifier [Axis]: Randy's Worldwide Automotive
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,332	1,332
Investment, Identifier [Axis]: Rhino Tool House
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	306	0
Investment, Identifier [Axis]: Riveron
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	779	0
Investment, Identifier [Axis]: Sugar Foods
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,173	0
Investment, Identifier [Axis]: Sunny Sky Products
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	464	0
Investment, Identifier [Axis]: TIDI Products
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,201	0
Investment, Identifier [Axis]: Tech24
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	919	0
Investment, Identifier [Axis]: Trilon Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	363
Investment, Identifier [Axis]: Vertex Service Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,777	0
Investment, Identifier [Axis]: WSB / EST
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,096	0
Investment, Identifier [Axis]: Wellspring
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	1,895
Investment, Identifier [Axis]: Young Innovations
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	$ 1,431	$ 0

XML

COMMITMENTS AND CONTINGENCIES - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Cash and cash equivalents	$ 8,679	$ 65,785
Unused Portion	84,250	$ 95,000
Unused Portion Under the Bank of America Credit Facility
Debt Instrument [Line Items]
Unused Portion	$ 51,883

XML

NET ASSETS - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands			12 Months Ended
	Mar. 31, 2022	Mar. 30, 2022	Dec. 31, 2023
Class of Stock [Line Items]
Maximum number of shares to be repurchased, percent			5.00%
Common stock market price percent of NAV, threshold			98.00%
Common shares repurchased (in shares)			0
Class I Common Shares
Class of Stock [Line Items]
Issuance of shares (in shares)			3,517,694
TIAA
Class of Stock [Line Items]
Portfolio investments to the fund amount	$ 296,231
Share repurchase program, percentage of outstanding shares offered to repurchase, NAV			1.67%
TIAA | Class I Common Shares
Class of Stock [Line Items]
Purchased and sold shares (in share)		40
Issuance Price per share (in dollars per share)		$ 25.00
Issuance of shares (in shares)	10,540,000
Shares issued price per share (in dollars per share)	$ 25.00

XML

NET ASSETS - Schedule of Shares Issued (Details) - USD ($) $ in Thousands	11 Months Ended		12 Months Ended
	Dec. 31, 2022	[1]	Dec. 31, 2023
Class S Common Shares
Class of Stock [Line Items]
Subscriptions (in shares)			149,441
Subscriptions	$ 0		$ 3,671
Share transfers between classes (in shares)			0
Share transfers between classes			$ 0
Distributions reinvested (in shares)			397
Distributions reinvested	0		$ 10
Shares repurchases (in shares)			0
Shares repurchases			$ 0
Net increase (decrease) (in shares)			149,838
Net increase (decrease) in net assets resulting from capital share transactions	0		$ 3,681
Class D Common Shares
Class of Stock [Line Items]
Subscriptions (in shares)			106,881
Subscriptions	0		$ 2,629
Share transfers between classes (in shares)			0
Share transfers between classes			$ 0
Distributions reinvested (in shares)			385
Distributions reinvested	0		$ 9
Shares repurchases (in shares)			0
Shares repurchases			$ 0
Net increase (decrease) (in shares)			107,266
Net increase (decrease) in net assets resulting from capital share transactions	0		$ 2,638
Class I Common Shares
Class of Stock [Line Items]
Subscriptions (in shares)			3,517,694
Subscriptions	263,501		$ 86,550
Share transfers between classes (in shares)			0
Share transfers between classes			$ 0
Distributions reinvested (in shares)			33,652
Distributions reinvested	0		$ 828
Shares repurchases (in shares)			0
Shares repurchases			$ 0
Net increase (decrease) (in shares)			3,551,346
Net increase (decrease) in net assets resulting from capital share transactions	$ 263,501		$ 87,378

[1] Period from February 8, 2022 (inception) through December 31, 2022

XML

NET ASSETS - Schedule of Net Offering Price Per Share (Details) - $ / shares	Dec. 31, 2023	Nov. 30, 2023	Oct. 31, 2023	Sep. 30, 2023	Aug. 31, 2023	Jul. 31, 2023	Jun. 30, 2023	May 31, 2023	Apr. 30, 2023	Mar. 31, 2023	Feb. 28, 2023	Jan. 31, 2023	Dec. 31, 2022	Feb. 07, 2022
Class S Common Shares
Class of Stock [Line Items]
Net Offering Price Per Share (in dollars per share)	$ 24.69	$ 24.59	$ 24.58	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Class D Common Shares
Class of Stock [Line Items]
Net Offering Price Per Share (in dollars per share)	24.73	24.60	24.59	0	0	0	0	0	0	0	0	0	0
Class I Common Shares
Class of Stock [Line Items]
Net Offering Price Per Share (in dollars per share)	$ 24.73	$ 24.60	$ 24.60	$ 24.61	$ 24.56	$ 24.60	$ 24.63	$ 24.66	$ 24.68	$ 24.65	$ 24.70	$ 24.70	$ 24.70	$ 0

XML

NET ASSETS - Schedule of Fund's Dividends Declared (Details) - USD ($) $ / shares in Units, $ in Thousands																		1 Months Ended
	Dec. 31, 2023	Dec. 28, 2023	Nov. 27, 2023	Oct. 27, 2023	Sep. 29, 2023	Aug. 23, 2023	Jul. 28, 2023	Jun. 28, 2023	May 25, 2023	Apr. 28, 2023	Mar. 31, 2023	Feb. 28, 2023	Jan. 31, 2023	Dec. 31, 2022	Nov. 30, 2022	Oct. 31, 2022	Sep. 30, 2022	Sep. 30, 2022	Aug. 31, 2022	Jul. 31, 2022	Jun. 30, 2022	May 31, 2022	Apr. 30, 2022
Class of Stock [Line Items]
Gross Distribution																		$ 0.15	$ 0.15	$ 0.15	$ 0.14	$ 0.14	$ 0.14
Regular Dividend
Class of Stock [Line Items]
Gross Distribution	$ 0.19					$ 0.25	$ 0.25							$ 0.19
Supplemental Dividend
Class of Stock [Line Items]
Gross Distribution	$ 0.105													0.105
Special Dividend
Class of Stock [Line Items]
Gross Distribution						0.020	0.020
Class S Common Shares
Class of Stock [Line Items]
Gross Distribution		$ 0.233	$ 0.233	$ 0.233
Distribution Amount		$ 35	$ 17	$ 9
Class D Common Shares
Class of Stock [Line Items]
Gross Distribution		$ 0.245	$ 0.245	$ 0.245
Distribution Amount		$ 26	$ 11	$ 2
Class I Common Shares
Class of Stock [Line Items]
Gross Distribution		$ 0.250	$ 0.250	$ 0.250	$ 0.250	$ 0.270	$ 0.270	$ 0.240	$ 0.240	$ 0.240	$ 0.230	$ 0.200	$ 0.200	$ 0.295	$ 0.190	$ 0.180	$ 0.870
Distribution Amount		$ 3,523	$ 3,435	$ 3,244	$ 3,070	$ 3,133	$ 3,081	$ 2,605	$ 2,530	$ 2,530	$ 2,424	$ 2,108	$ 2,108	$ 3,109	$ 2,003	$ 1,897	$ 9,170

XML

NET ASSETS - Schedule of Cash Distributions Declared (Details) - USD ($) $ / shares in Units, $ in Thousands	11 Months Ended		12 Months Ended
	Dec. 31, 2022		Dec. 31, 2023
Class S Common Shares
Class of Stock [Line Items]
Net investment income (loss) (in dollars per share)	$ 0		$ 0.699
Net investment income	$ 0		$ 61
Net realized gains (in dollars per share)	$ 0		$ 0
Net realized gains	$ 0		$ 0
Total	$ 0		$ 0.699
Total	$ 0	[1]	$ 61
Class D Common Shares
Class of Stock [Line Items]
Net investment income (loss) (in dollars per share)	$ 0		$ 0.735
Net investment income	$ 0		$ 39
Net realized gains (in dollars per share)	$ 0		$ 0
Net realized gains	$ 0		$ 0
Total	$ 0		$ 0.735
Total	$ 0	[1]	$ 39
Class I Common Shares
Class of Stock [Line Items]
Net investment income (loss) (in dollars per share)	$ 1.535		$ 2.890
Net investment income	$ 16,179		$ 33,789
Net realized gains (in dollars per share)	$ 0		$ 0
Net realized gains	$ 0		$ 0
Total	$ 1.535		$ 2.890
Total	$ 16,179	[1]	$ 33,789

[1] Period from February 8, 2022 (inception) through December 31, 2022

XML

CONSOLIDATED FINANCIAL HIGHLIGHTS (Details) - USD ($) $ / shares in Units, $ in Thousands	11 Months Ended		12 Months Ended
	Dec. 31, 2022		Dec. 31, 2023	Feb. 07, 2022	[1]
Supplemental Data:
Net assets at end of period	$ 260,301	[1]	$ 354,831	$ 0
Ratio to average net assets:
Ratio of interest and debt financing expenses to average net assets	1.82%
Ratio of total expenses to average net assets	3.02%
Effect of expense support to average net assets ratio	(0.61%)
Class S Common Shares
Per share data:
Net asset value at beginning of period (in dollars per share)			$ 0
Net investment income (loss) (in dollars per share)			0.73
Net realized gains (losses) (in dollars per share)			0
Net change in unrealized appreciation (depreciation) (in dollars per share)			0.17
Net increase (decrease) in net assets resulting from operations (in dollars per share)			0.90
Shareholder distributions from income (in dollars per share)	$ 0		(0.699)
Issuance of common shares (in dollars per share)			24.61
Other (in dollars per share)			(0.12)
Net asset value at end of period (in dollars per share)	$ 0		$ 24.69
Supplemental Data:
Shares outstanding at end of period (in shares)	0		149,838
Total return			3.21%
Ratio to average net assets:
Ratio of net expenses to average net assets before expense support and waived fees			8.30%
Ratio of net expenses to average net assets after expense support and waived fees			5.58%
Ratio of net investment income (loss) to average net assets			13.82%
Portfolio turnover rate			11.44%
Asset coverage ratio			314.08%
Ratio of interest and debt financing expenses to average net assets			3.96%
Class S Common Shares | Common Stock
Supplemental Data:
Net assets at end of period			$ 3,699
Class D Common Shares
Per share data:
Net asset value at beginning of period (in dollars per share)			$ 0
Net investment income (loss) (in dollars per share)			0.76
Net realized gains (losses) (in dollars per share)			0
Net change in unrealized appreciation (depreciation) (in dollars per share)			0.22
Net increase (decrease) in net assets resulting from operations (in dollars per share)			0.98
Shareholder distributions from income (in dollars per share)	$ 0		(0.735)
Issuance of common shares (in dollars per share)			24.61
Other (in dollars per share)			(0.12)
Net asset value at end of period (in dollars per share)	$ 0		$ 24.73
Supplemental Data:
Shares outstanding at end of period (in shares)	0		107,266
Total return			3.53%
Ratio to average net assets:
Ratio of net expenses to average net assets before expense support and waived fees			6.55%
Ratio of net expenses to average net assets after expense support and waived fees			3.96%
Ratio of net investment income (loss) to average net assets			12.18%
Portfolio turnover rate			11.44%
Asset coverage ratio			314.08%
Ratio of interest and debt financing expenses to average net assets			3.21%
Class D Common Shares | Common Stock
Supplemental Data:
Net assets at end of period			$ 2,652
Class I Common Shares
Per share data:
Net asset value at beginning of period (in dollars per share)	$ 0		$ 24.70
Net investment income (loss) (in dollars per share)	1.60		2.97
Net realized gains (losses) (in dollars per share)	(0.02)		0.07
Net change in unrealized appreciation (depreciation) (in dollars per share)	(0.34)		(0.06)
Net increase (decrease) in net assets resulting from operations (in dollars per share)	1.24		2.98
Shareholder distributions from income (in dollars per share)	(1.535)		(2.890)
Issuance of common shares (in dollars per share)	25.00		0
Other (in dollars per share)	0		(0.06)
Net asset value at end of period (in dollars per share)	$ 24.70		$ 24.73
Supplemental Data:
Shares outstanding at end of period (in shares)	10,540,040		14,091,386
Total return	4.91%		12.52%
Ratio to average net assets:
Ratio of net expenses to average net assets before expense support and waived fees	2.41%		6.34%
Ratio of net expenses to average net assets after expense support and waived fees			4.56%
Ratio of net investment income (loss) to average net assets	7.13%		12.02%
Portfolio turnover rate	12.11%		11.44%
Asset coverage ratio	267.94%		314.08%
Ratio of interest and debt financing expenses to average net assets			3.73%
Class I Common Shares | Common Stock
Supplemental Data:
Net assets at end of period	$ 260,301		$ 348,480

[1] Period from February 8, 2022 (inception) through December 31, 2022

XML

INCOME TAX - Schedule of Tax-basis Cost for Federal Income Tax Purposes (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Tax cost of investments	$ 516,168	$ 352,998
Gross unrealized appreciation on investments	3,128	1,389
Gross unrealized depreciation on investments	(7,260)	(4,869)
Net unrealized appreciation (depreciation) on investments	$ (4,132)	$ (3,480)

XML

INCOME TAX - Schedule of Components of Accumulated Earnings (Losses) (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Operating Loss Carryforwards [Line Items]
Undistributed Ordinary Income - Net	$ 884
Undistributed Long-Term Income - Net	634
Total Undistributed Earnings	1,518
Capital loss carryforward	0
Unrealized Earnings (Losses) - Net	(4,194)
Other book-to-tax differences	123
Total Accumulated Earnings (Losses) - Net	$ (2,553)	$ (3,200)
Previously Reported
Operating Loss Carryforwards [Line Items]
Undistributed Ordinary Income - Net		370
Undistributed Long-Term Income - Net		0
Total Undistributed Earnings		370
Capital loss carryforward		(88)
Unrealized Earnings (Losses) - Net		(3,480)
Other book-to-tax differences		0
Total Accumulated Earnings (Losses) - Net		$ (3,198)

XML

INCOME TAX - Narrative (Details) - USD ($)	11 Months Ended		12 Months Ended
	Dec. 31, 2022		Dec. 31, 2023
Income Tax Disclosure [Abstract]
Capital loss carryforward			$ 0
Excise taxes	$ 2,000	[1]	31,000
Deferred tax liabilities, net			61,000
Income tax (provision) benefit	$ 0		$ 61,000

[1] Period from February 8, 2022 (inception) through December 31, 2022

XML

INCOME TAX - Schedule of Tax Character of Distributions (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Ordinary income	$ 33,890	$ 16,179
Net long-term capital gains	0	0
Total taxable distributions	$ 33,890	$ 16,179

XML

SUBSEQUENT EVENTS - Schedule of Aggregate Distributions Declared for Each Class of Common Share (Details) - $ / shares																			1 Months Ended
	Feb. 28, 2024	Jan. 26, 2024	Dec. 28, 2023	Nov. 27, 2023	Oct. 27, 2023	Sep. 29, 2023	Aug. 23, 2023	Jul. 28, 2023	Jun. 28, 2023	May 25, 2023	Apr. 28, 2023	Mar. 31, 2023	Feb. 28, 2023	Jan. 31, 2023	Dec. 31, 2022	Nov. 30, 2022	Oct. 31, 2022	Sep. 30, 2022	Sep. 30, 2022	Aug. 31, 2022	Jul. 31, 2022	Jun. 30, 2022	May 31, 2022	Apr. 30, 2022
Subsequent Event [Line Items]
Net Distribution																			$ 0.15	$ 0.15	$ 0.15	$ 0.14	$ 0.14	$ 0.14
Class I Common Shares
Subsequent Event [Line Items]
Net Distribution			$ 0.250	$ 0.250	$ 0.250	$ 0.250	$ 0.270	$ 0.270	$ 0.240	$ 0.240	$ 0.240	$ 0.230	$ 0.200	$ 0.200	$ 0.295	$ 0.190	$ 0.180	$ 0.870
Class I Common Shares | Subsequent Event
Subsequent Event [Line Items]
Gross Distribution	$ 0.250	$ 0.250
Shareholder Servicing Fee	0	0
Net Distribution	0.250	0.250
Class S Common Shares
Subsequent Event [Line Items]
Net Distribution			0.233	0.233	0.233
Class S Common Shares | Subsequent Event
Subsequent Event [Line Items]
Gross Distribution	0.250	0.250
Shareholder Servicing Fee	0.017	0.017
Net Distribution	0.233	0.233
Class D Common Shares
Subsequent Event [Line Items]
Net Distribution			$ 0.245	$ 0.245	$ 0.245
Class D Common Shares | Subsequent Event
Subsequent Event [Line Items]
Gross Distribution	0.250	0.250
Shareholder Servicing Fee	0.005	0.005
Net Distribution	$ 0.245	$ 0.245

XML

SUBSEQUENT EVENTS - Narrative (Details) $ in Millions	1 Months Ended
	Oct. 31, 2023 USD ($)
Subsequent Events [Abstract]
Net proceeds received	$ 384.2